0001213900-12-004471.txt : 20120814 0001213900-12-004471.hdr.sgml : 20120814 20120814091547 ACCESSION NUMBER: 0001213900-12-004471 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20120630 FILED AS OF DATE: 20120814 DATE AS OF CHANGE: 20120814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neonode, Inc CENTRAL INDEX KEY: 0000087050 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 941517641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35526 FILM NUMBER: 121029773 BUSINESS ADDRESS: STREET 1: 2350 MISSION COLLEGE BLVD STREET 2: SUITE 190 CITY: SANTA CLARA STATE: CA ZIP: 95054 BUSINESS PHONE: 408 496-6722 MAIL ADDRESS: STREET 1: 2350 MISSION COLLEGE BLVD STREET 2: SUITE 190 CITY: SANTA CLARA STATE: CA ZIP: 95054 FORMER COMPANY: FORMER CONFORMED NAME: SBE INC DATE OF NAME CHANGE: 19920703 10-Q 1 f10q0612_neonode.htm QUARTERLY REPORT f10q0612_neonode.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)

x           Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2012

o           Transition report pursuant to section 13 or 15(d) of the Securities and Exchange Act of 1934

For the transition period from _______ to ________

Commission file number 0-8419
 
NEONODE INC.
 

(Exact name of registrant as specified in its charter)
 
Delaware
 
 
94-1517641
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
2350 Mission College Blvd, Suite 190, Santa Clara,
 CA 95054 USA

(Address of principal executive offices and zip code)
 
(408) 496-6722

(Registrant's telephone number, including area code)
  
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 Yes   ý    No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 Yes ý            No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “non-accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer   o
 
Accelerated filer o
Non-accelerated filer o
 
Smaller reporting company x
(do not check if a smaller reporting company)
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.  Yes ¨   No ý

The number of shares of the registrant’s common stock outstanding as of August 7, 2012, was 33,003,782.
 
 
 

 
 
NEONODE INC.

INDEX TO JUNE 30, 2012 FORM 10-Q
 
 
PART I
Financial Information
 
     
Item 1
Financial Statements
 
     
 
Condensed Consolidated Balance Sheets as of  June 30, 2012 (Unaudited) and December 31, 2011
3
     
 
Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2012 and 2011
4
     
 
Unaudited Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2012 and 2011
5
     
 
Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2012 and 2011
6
     
 
Notes to Unaudited Condensed Consolidated Financial Statements
7
     
Item 2
Management's Discussion and Analysis of Financial Condition and Results of Operations
27
     
Item 3
Quantitative and Qualitative Disclosures about Market Risk
31
     
Item 4
Controls and Procedures
31
     
PART II
Other Information
 
     
Item 1
Legal Proceedings 
32
     
Item 1A
Risk Factors
32
     
Item 6
Exhibits
 32
     
SIGNATURES
 
33
     
EXHIBITS
   
 
 
 

 
 
PART I.     Financial Information

Item 1.       Financial Statements
 
NEONODE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
 
   
June
30, 2012
   
December
31, 2011
 
ASSETS
 
(Unaudited)
       
Current assets:
           
Cash
 
$
11,275
   
$
12,940
 
Accounts receivable
   
1,725
     
3,345
 
Prepaid expenses and other current assets
   
327
     
234
 
Total current assets
   
13,327
     
16,519
 
Property and equipment, net
   
332
     
108
 
Total assets
 
$
13,659
   
$
16,627
 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
Current liabilities:
               
Accounts payable
 
$
351
   
$
447
 
Accrued expenses
   
776
     
601
 
Deferred revenue
   
1,543
     
1,906
 
Total current liabilities
   
2,670
     
2,954
 
Total liabilities
   
2,670
     
2,954
 
Commitments and contingencies (Note 8)
               
                 
Stockholders' equity:
               
Series A Preferred stock, 444,541 shares authorized with par value $0.001 per share; 83 shares issued and outstanding at June 30, 2012 and December 31, 2011. (In the event of dissolution, each share of Series A Preferred stock has a liquidation preference equal to par value of $0.001 over the shares of common stock)
     -       -  
Series B Preferred stock, 54,425 shares authorized with par value $0.001 per share; 95 and 114 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively. (In the event of dissolution, each share of Series B Preferred stock has a liquidation preference equal to par value of $0.001 over the shares of common stock)
    -       -  
Common stock, 70,000,000 shares authorized with par value $0.001 per share; 32,972,631 and 32,778,993 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively
   
33
     
33
 
Additional paid-in capital
   
145,314
     
142,955
 
Accumulated other comprehensive (loss) income
   
(15)
     
13
 
Accumulated deficit
   
(134,343
)
   
(129,328
)
Total stockholders' equity
   
10,989
     
13,673
 
Total liabilities and stockholders' equity
 
$
13,659
   
$
16,627
 
                 
See accompanying notes to condensed consolidated financial statements.
 
 
3

 
 
NEONODE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
 
   
Three months ended June 30,
   
Six months ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
Net revenues
 
$
1,974
   
$
283
   
$
3,138
   
$
822
 
Cost of revenues
   
494
     
238
     
743
     
393
 
Gross margin
   
1,480
     
45
     
2,395
     
429
 
                                 
Operating expenses:
                               
Product research and development
   
1,478
     
382
     
2,165
     
658
 
Sales and marketing
   
1,718
     
363
     
2,517
     
715
 
General and administrative
   
1,691
     
921
     
2,686
     
1,785
 
                                 
Total operating expenses
   
4,887
     
1,666
     
7,368
     
3,158
 
Operating loss
   
(3,407
)
   
(1,621
)
   
(4,973
)
   
(2,729
)
Other expense, net:
                               
Interest expense
   
--
     
(81
)
   
--
     
(135
)
Non-cash items related to debt discounts and
                               
deferred financing fees and the valuation of
                               
conversion features and warrants
   
--
     
(1,014
)
   
--
     
(9,568
)
Total other expense, net
   
--
     
(1,095
)
   
--
     
(9,703
)
Loss before provision for income taxes
   
(3,407
)
   
(2,716
)
   
(4,973
)
   
(12,432
)
                                 
Provision for income taxes
   
20
     
6
     
42
     
11
 
Net loss
 
$
(3,427
)
 
$
(2,722
)
 
$
(5,015
)
 
$
(12,443
)
Loss per common share:
                               
Basic and diluted loss per share
 
$
(0.10
)
 
$
(0.10
)
 
$
(0.15
)
 
$
(0.50
)
Basic and diluted – weighted average shares used in per share computations
   
32,969
     
27,642
     
32,889
     
25,039
 
 
See accompanying notes to condensed consolidated financial statements.

 
4

 
 
NEONODE INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
(Unaudited)
 
   
Three months ended June 30,
   
Six months ended June 30,
 
   
2012
   
2011
   
2012
   
2011
 
                         
Net loss
 
$
(3,427
)
 
$
(2,722
)
 
$
(5,015
)
 
$
(12,443
)
Other comprehensive income (loss):
                               
Foreign currency translation adjustments
   
(72
)
   
(21
)
   
(28
)
   
18
 
Total comprehensive loss  
$
(3,499
)
 
$
(2,743
)
 
$
(5,043
)
 
$
(12,425
)
  
See accompanying notes to condensed consolidated financial statements.
 
 
5

 
NEONODE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) (Unaudited)
 
   
Six months ended June 30,
 
   
2012
   
2011
 
Cash flows from operating activities:
           
Net loss
 
$
(5,015
)
 
$
(12,443
)
Adjustments to reconcile net loss to net cash used in operating activities:
               
Stock-based compensation expense
   
2,351
     
472
 
Depreciation and amortization
   
40
     
10
 
Debt discounts and deferred financing fees and the valuation of conversion
               
features and  warrants
   
--
     
9,569
 
Changes in operating assets and liabilities:
               
Accounts receivable
   
1,623
     
(2,961
)
Other assets
   
--
     
--
 
Prepaid expenses
   
(96
)
   
(70
)
Accounts payable and accrued expenses
   
87
     
(160
)
Deferred revenue
   
(363
)
   
2,535
 
Net cash used in operating activities
   
(1,373
)
   
(3,048
)
Cash flows from investing activities:
               
Purchase of property and equipment
   
(268
)
   
(25
)
Net cash used in investing activities
   
(268
)
   
(25
)
Cash flows from financing activities:
               
Proceeds from issuance of convertible debt
   
--
     
4,228
 
Repayment of convertible debt
   
--
     
(25
)
Proceeds from exercise of warrants
   
8
     
515
 
Net cash provided by financing activities
   
8
     
4,718
 
Effect of exchange rate changes on cash
   
(32
)
   
3
 
Net (decrease) increase in cash
   
(1,665
)
   
1,648
 
Cash at beginning of period
   
12,940
     
911
 
Cash at end of period
 
$
11,275
   
$
2,559
 
Supplemental disclosure of cash flow information:
               
Interest paid
 
$
--
   
$
90
 
Income taxes paid
 
$
42
   
$
4
 
Supplemental disclosure of non-cash transactions:
               
Fair value of shares of common stock and warrants issued
               
to brokers in connection with financing, recorded as debt
               
issuance costs
 
$
--
   
$
1
 
Debt discount recorded as part of convertible debt financing
               
transactions including, warrants issued
 
$
--
   
$
4,228
 
Debt issuance costs related to 2011 financing
 
$
--
   
$
35
 
Accrued expenses converted to common stock
 
$
--
   
$
120
 
Conversion of debt and accrued interest to common stock
 
$
--
   
$
2,860
 
Reduction of derivative liabilities upon conversion of debt
 
$
--
   
$
13,379
 
 
See accompanying notes to condensed consolidated financial statements
 
 
6

 
 
NEONODE INC.
Notes to the Condensed Consolidated Financial Statements
(Unaudited)

1. Interim Period Reporting
 
The unaudited interim condensed consolidated financial statements, include all adjustments, consisting of normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the financial position and results of operations and cash flows for the interim periods. The results of operations for the three and six months ended June 30, 2012 are not necessarily indicative of expected results for the full 2012 fiscal year.
 
The accompanying condensed consolidated financial statements as of June 30, 2012 and for the three and six months ended June 30, 2012 and 2011 have been prepared by us, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally contained in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes contained in our consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2011.
 
Operations
 
Neonode Inc., “we”, “us”, “our”, the “Company”, develops and licenses MultiSensing TM touch user interfaces and optical multi-touch solutions. The cornerstone of our interface solutions is zForce®, our patented touch technology. Neonode licenses the Neonode MultiSensing TM touch technology to Original Equipment Manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”) who embed our technology into devices that they produce and sell. Our solution is currently being integrated into products such as mobile phones, e-Readers and tablets, printers and office equipment, toys and gaming consoles, automotive and in-vehicle infotainment systems.
 
Intellectual Property
 
We rely on a combination of intellectual property laws, as well as confidentiality procedures and contractual provisions, to protect our proprietary technology and our brand. We have registered, and applied for the registration of, U.S. and international trademarks, service marks, domain names, and copyrights. Additionally, we have filed U.S. and international patent applications covering certain of our proprietary technology. Over time, we have assembled a portfolio of patents, trademarks, service marks, copyrights, domain names, and trade secrets covering our products and services. Our proprietary technology is not dependent on any single patent or copyright or groups of related patents or copyrights. We believe the duration of our patents is adequate relative to the expected lives of our products. Although we rigorously protect our proprietary technology, any significant impairment of, or third-party claim against, our intellectual property rights could harm our business or our ability to compete.
 
2. Summary of Significant Accounting Policies
 
Fiscal Year
 
Our fiscal year is the calendar year.

Principles of Consolidation

The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include the accounts of Neonode Inc. and its wholly owned Swedish subsidiary, Neonode Technologies AB. All inter-company accounts and transactions have been eliminated in consolidation.
         
 
7

 
 
Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectability of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets, the fair value of embedded derivatives, and the fair value of securities, such as options and warrants issued for stock-based compensation and in certain financing transactions.

Cash and Cash Equivalents

We have not had any liquid investments other than normal cash deposits with banking institutions to date.  If in the future the Company purchases cash equivalents, the Company will consider all highly liquid investments with original maturities of three months of less to be cash equivalents.
 
Concentration of Cash Balance Risks
 
Cash balances are maintained at various banks in the U.S. and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (“FDIC”), which provides basic deposit coverage with limits up to $250,000 per owner. In addition to the basic insurance deposit coverage, the FDIC is providing temporary unlimited coverage for noninterest bearing transaction accounts through December 31, 2012. The Swedish government provides insurance coverage up to 100,000 Euro per customer and covers deposits in all types of accounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to the deposits. As of June 30, 2012, the Company has approximately $10.4 million in excess of insurance limits.

Accounts Receivable and Allowance for Doubtful Accounts  

Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectability of our trade receivable balances based on a combination of factors. When a customer’s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer’s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance for all customers based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.  We determined that an allowance for doubtful accounts was not necessary at June 30, 2012 or December 31, 2011.

Debt Issuance Costs

Debt issuance costs represent costs incurred in connection with the issuance of the convertible notes payable. Debt issuance costs are amortized over the term of the financing instrument on a straight-line basis, which approximates the effective interest method.

 
8

 
 
Property and Equipment

Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets ranging from three to five years as follows:

Computer equipment
3 years
Furniture and fixtures
5 years

Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.
 
Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.
 
Long-lived Assets

We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.  At June 30, 2012, we believe there is no impairment of our long-lived assets. There can be no assurance, however, that market conditions will not change or sufficient commercial demand for our products and services will materialize, which could result in impairment of long-lived assets in the future.

Foreign Currency Translation and Transaction Gains and Losses

The functional currency of our foreign subsidiary is the applicable local currency, the Swedish Krona. The translation from Swedish Krona to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive income (loss). Gains or (losses) resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $73,000 and $8,000 during the three months ended June 30, 2012 and 2011, respectively, and $11,000 and $(57,000) during the six months ended June 30, 2012 and 2011, respectively. Foreign currency translation gain (loss) was $(72,000) and $(21,000) for the three months ended June 30, 2012 and 2011, respectively, and was $(28,000) and $18,000 for the six months ended June 30, 2012 and 2011, respectively.

Liability for Warrants and Embedded Derivatives  

We do not enter into derivative contracts for purposes of risk management or speculation.  However, from time to time, we enter into contracts that are not considered derivative financial instruments in their entirety but that include embedded derivative features, such as conversion features. Such embedded derivatives are assessed at inception of the contract and every reporting period, depending on their characteristics, are accounted for as separate derivative financial instruments pursuant to accounting guidance, if such embedded conversion features, if freestanding, would meet the classification of a liability. Accounting guidance requires that we analyze all material contracts and determine whether or not they contain embedded derivatives. Any such embedded conversion features that meet the above criteria are then bifurcated from their host contract and recorded on the consolidated balance sheet at fair value and the changes in the fair value of these derivatives are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features and warrants.
 
 
9

 
 
Similarly, if warrants meet the criteria in accordance with accounting guidance to be classified as liabilities, then the fair value of the warrants are recorded on the consolidated balance sheet at their fair values, and any changes in such fair values are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features.
 
On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company’s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.
 
Concentration of Credit and Business Risks
 
In the short term, we anticipate that we will depend on a limited number of customers for substantially all of our future revenue. Failure to anticipate or respond adequately to technological developments in our industry, changes in customer or supplier requirements or changes in regulatory requirements or industry standards, or any significant delays in the development or introduction of products or services, could have a material adverse effect on our business, operating results and cash flows.
 
Our accounts receivable as of June 30, 2012 was due from eleven customers, three of which accounted for 84% of our accounts receivable as of June 30, 2012.

Our net revenues for the three months ended June 30, 2012 was earned from twelve customers. Our customers are located in the U.S., Europe and Asia. Customers who accounted for 10% or more of our net revenues during the three months ended June 30, 2012 are as follows:

  
Amazon - 53%
  
Kobo - 11%
●  
Sony Corporation - 11%

Our net revenues for the six months ended June 30, 2012 was earned from sixteen customers. Customers who accounted for 10% or more of our net revenues during the six months ended June 30, 2012 are as follows:

  
Amazon  - 53%
  
Sony Corporation – 13%

Our accounts receivable as of December 31, 2011 was due from five customers, two of which accounted for 87% of our accounts receivable as of December 31, 2011. Our net revenues for the three months ended June 30, 2011 was earned from five customers, four of which accounted for approximately 99% of our total net revenues for the three months ended June 30, 2011. Our net revenues for the six months ended June 30, 2011 was earned from six customers, one of which accounted for approximately 71% of our net revenues for the six months ended June 30, 2011. Our customers are located in the US, Europe and Asia.
 
Risks and Uncertainties

Our long-term success is dependent on our obtaining sufficient capital to fund our operations and to develop our products, and on our bringing such products to the worldwide market and obtaining sufficient sales volume to be profitable. To achieve these objectives, we may be required to raise additional capital through public or private financings or other arrangements. It cannot be assured that such financings will be available on terms attractive to us, if at all. Such financings may be dilutive to our stockholders and may contain restrictive covenants.

We are subject to certain risks common to technology-based companies in similar stages of development. Principal risks include risks relating to the uncertainty of market acceptance for our products, a history of losses since inception, our ability to remain competitive in response to new technologies, the costs to defend, as well as risks of losing patents and intellectual property rights, on our future customers ability to develop and sell products that incorporate our technology, the concentration of our operations in a limited number of facilities, the uncertainty of demand for our products in certain markets, our ability to manage growth effectively, our dependence on key members of our management and development team, our limited experience in conducting operations internationally, and our ability to obtain adequate capital to fund future operations.
 
 
10

 
 
We are exposed to a number of economic and industry factors that could result in portions of our technology becoming obsolete or not gaining market acceptance. These factors include, but are not limited to, technological changes in our markets, our ability to meet changing customer requirements, competitive pressures in products and prices, and the ability of our customers to manufacture and sell their products that incorporate our technology.

A significant portion of our business is conducted in currencies other than the U.S. dollar (the currency in which its financial statements are reported), primarily the Swedish Krona and, to a lesser extent, the Euro. We incur a significant portion of our expenses in Swedish Krona, including a significant portion of our product development expenses and a substantial portion of our general and administrative expenses. As a result, appreciation of the value of the Swedish Krona relative to the other currencies, particularly the U.S. dollar, could adversely affect operating results. We do not currently undertake hedging transactions to cover our currency exposure, but we may choose to hedge a portion of our currency exposure in the future as deemed appropriate.

Our future success depends on market acceptance of our technology as well as our ability to introduce new versions of our technology to meet the evolving needs of our customers.

Revenue Recognition

Engineering Services:

We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.  Generally, we recognize revenue as the engineering services stipulated under the contact are completed and accepted by our customers.  
   
Licensing Revenues:

We also derive revenue from the licensing of internally developed intellectual property (“IP”). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and royalties payable following the sale by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. As of September 30, 2011, Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers.   For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize new technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) customer distributes or license the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.
 
Prior to September 30, 2011, we deferred the technology license fee revenue until such time as the warranty period stipulated in the license agreement expired because we did not have sufficient historical experience in estimating potential warranty costs.  From June 2010 to September 30, 2011, we entered into 12 technology license contracts with customers.  During that time there were no warranty related costs incurred for any customer products after they have been released to market.  During the quarter ended September 30, 2011, the Company performed an analysis and determined that it had sufficient historical evidence regarding estimated warranty costs and therefore began recognizing technology license fee revenues, net of warranty costs, if any, as the products incorporating the Neonode technology are distributed or licensed by our customers, assuming all other revenue recognition criteria has been met.  Our customers report to us the quantities of products distributed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.
 
 
11

 
 
Explicit return rights are not offered to customers. There have been no returns through June 30, 2012.

Hardware Products:

We may from time-to-time develop custom hardware products for our customers that incorporate our touchscreen technology. Our policy is to recognize revenue from hardware product sales when title transfers and risk of loss has passed to the customer, which is generally upon shipment of our hardware products to our customers. We will estimate expected sales returns and record the amount as a reduction of revenue and cost of hardware and other revenue at the time of shipment. To date, we have not sold any hardware products.

Software Products:

We may derive revenues from software licensing sales.  We will account for the licensing of software in accordance with accounting guidance and such guidance requires judgment, including whether a software arrangement includes multiple elements, and if so, whether vendor-specific objective evidence (“VSOE”) of fair value exists for those elements.

For software license arrangements that do not require significant modification or customization of the underlying software, we will recognize new software license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of software; (2) we deliver the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.

We allocate revenues to all deliverables based on their relative selling price using a specific hierarchy. The hierarchy is as follows: vendor-specific objective evidence (“VSOE”), third-party evidence of selling price (“TPE”) or best estimate of selling price (“BESP”).

When a sale involves multiple elements, we will allocate the entire fee from the arrangement to each respective element based on VSOE of fair value and recognize revenue when each element’s revenue recognition criteria are met. VSOE of fair value for each element is established based on the price charged when the same element is sold separately. We have established VSOE for our software licenses based on historical stand-alone sales to third parties or from the stated renewal rates contained in the customer contracts. Maintenance service revenue is recognized on a straight-line basis over the support period.

We have not yet demonstrated VSOE for the professional services that are rendered in conjunction with our software license sales. In accordance with the hierarchy we would attempt to establish the selling price of professional services using TPE. Our product contains significant differentiation such that the comparable pricing of products with similar functionality cannot be obtained. We are typically not able to obtain TPE for professional services.

When we are unable to establish selling prices using VSOE or TPE, we use BESP. The objective of BESP is to determine the price at which we would transact a sale if professional services were sold on a stand-alone basis. BESP is generally used for offerings that are not typically sold on a stand-alone basis or for highly customized offerings.

We will also continue to defer revenues that represent undelivered post-delivery engineering support until the engineering support has been completed and the software product is accepted. To date, we have not sold any software products.
 
 
12

 
 
Deferred Revenue

From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. The Company defers these revenues until the services have been provided or until the license fees are earned.

Advertising

Advertising costs are expensed as incurred. Advertising costs for the three and six months ended June 30, 2012 and 2011 amounted to approximately $85,000 and $29,000 and $282,000 and $74,000, respectively.

Product Research and Development

Research and development (“R&D”) costs are expensed as incurred. R&D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.

Stock-Based Compensation Expense
 
We measure the cost of employee services received in exchange for an award of equity instruments, including share options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.

We account for equity instruments issued to non-employees at their fair value and the unvested portion is re-measured each reporting period as long as the instrument requires variable accounting.

When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.

Accounting for Debt Issued with Detachable Stock Purchase Warrants and Beneficial Conversion Features

We account for debt issued with stock purchase warrants by allocating the proceeds of the debt between the debt and the detachable warrants based on the relative fair values of the debt security without the warrants and the warrants themselves, if the warrants are equity instruments.   The relative fair value of the warrants are recorded as a debt discount and amortized to expense over the life of the related debt using the effective interest method. At each balance sheet date, we make a determination if these warrant instruments should be classified as liabilities or equity, and reclassify them if the circumstances dictate.  

In certain instances, the Company enters into convertible notes that provide for an effective or actual rate of conversion that is below market value, and the embedded conversion feature does not qualify for derivative treatment (a “BCF”).  In these instances, we account for the value of the BCF as a debt discount, which is then amortized to expense over the life of the related debt using the straight-line method which approximates the effective interest method.

Income Taxes

We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the “not more likely than not” criteria of the accounting guidance.
 
 
13

 
 
Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of June 30, 2012 and December 31, 2011. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such a determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes payable for the current period.

We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.  As a result, we did not recognize a liability for unrecognized tax benefits.  As of June 30, 2012 and December 31, 2011, we had no unrecognized tax benefits.
 
Net Loss Per Share

Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for three and six months ended June 30, 2012 and 2011 exclude the potential common stock equivalents, as the effect would be anti-dilutive (See Note 10).

Comprehensive Income (Loss)

Accounting Standards Codification (“ASC”) Topic 220, Comprehensive Income,   establishes standards for reporting and displaying comprehensive income (loss) and its components in the condensed consolidated financial statements. Accumulated other comprehensive income (loss) includes foreign currency translation gains or losses as a result of consolidation.
   
Cash Flow Information

Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations was 6.95 and 6.26 Swedish Krona to one U.S. Dollar for the three months ended June 30, 2012 and 2011, respectively. The weighted-average exchange rate for the condensed consolidated statements of operations was 6.85 and 6.34 Swedish Krona to one U.S. Dollar for the six months ended June 30, 2012 and 2011, respectively. The exchange rate for the condensed consolidated balance sheets was 6.96 and 6.92 Swedish Krona to one U.S. Dollar as of June 30, 2012 and December 31, 2011, respectively.  

Fair Value of Financial Instruments

We disclose the estimated fair values for all financial instruments for which it is practicable to estimate fair value. Financial instruments including cash and cash equivalents, accounts receivable, payables and accrued expenses are deemed to approximate fair value due to their short maturities.

New Accounting Pronouncements
 
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) No. 2011-4, Fair Value Measurement ("ASU 2011-04"). ASU 2011-04 amends existing guidance to achieve convergence in measurement and disclosure between U.S. GAAP and International Financial Reporting Standards ("IFRS"). ASU 2011-04 is effective for fiscal year 2012. The adoption of ASU 2011-04 did not impact the Company’s results of operations or its financial position.
 
 
14

 
 
In June 2011, the FASB issued ASU No. 2011-05,   Presentation of Comprehensive Income (“ASU 2011-05”).  The provisions of ASU 2011-05 allow an entity the option to present the total of comprehensive income (loss), the components of net income (loss), and the components of other comprehensive income (loss) either in a single continuous statement of comprehensive income (loss) or in two separate but consecutive statements.  In both choices, an entity is required to present each component of net income (loss) along with total net income (loss), each component of other comprehensive income (loss) along with a total for other comprehensive income (loss), and a total amount for comprehensive income (loss).  The statement(s) are required to be presented with equal prominence as the other primary financial statements.  ASU No. 2011-05 eliminates the option to present the components of other comprehensive income (loss) as part of the statement of changes in stockholders’ equity but does not change the items that must be reported in other comprehensive income (loss) or when an item of other comprehensive income (loss) must be reclassified to net income (loss).  Certain provisions of ASU No. 2011-05 are effective for the Company’s interim reporting period beginning on or after December 15, 2011, with retrospective application required.  The adoption of ASU No. 2011-05 resulted in presentation changes to the Company’s consolidated statements of operations and the addition of separate consolidated statements of comprehensive income (loss).  The adoption of ASU No. 2011-05 did not impact the Company’s results of operations or its financial position.
   
3. Convertible Debt

Senior Convertible Secured Notes- 2007

At December 31, 2011, all of convertible promissory notes (“Senior Convertible Secured Notes-2007”) have been converted in shares of our common stock. The Senior Convertible Secured Notes – 2007 were originally due August 26, 2010. On September 22, 2010, we entered into a debt modification agreement with the two holders of an aggregate of $126,362 of convertible promissory notes that were due on August 26, 2010. Based on the terms of the modification, this transaction qualified as debt extinguishment accounting under the relevant accounting guidance. As part of the debt extinguishment, the maturity date of the convertible promissory notes was extended until April 26, 2011. We entered into a debt-for-equity repayment plan whereby we were retiring the convertible promissory notes in equal installments by issuing our common stock priced at a 15% discount from the average market closing price for the five days ending on the 25th of each month over the eight month period beginning September 26, 2010 ending on April 26, 2011.  The holders of the notes had the right to convert the outstanding balance priced at $2.25 per share if the market value of our common stock is greater than $2.50 per share for five consecutive days.

During the six months ended June 30, 2011, we issued the note holders 31,570 shares of our common stock pursuant to the debt-for-equity repayment plan and retired the remaining note principal balance on April 26, 2011. We recorded $84,657 of note principal reduction and $1,054 of interest payment.

September 2009 Senior Convertible Secured Notes Financing transaction

During the period from August 25, 2009 through December 15, 2009, we completed a private placement of convertible notes totaling $987,000 that were converted, at the holder’s option, into shares of our common stock at a conversion price of $0.50 per share (the “Convertible Notes - 2009”).  The convertible note holders had the right to have the conversion price adjusted to equal the lower stock price if we issued common stock or convertible notes at a lower conversion price than $0.50 per share during the period that the notes were outstanding. The Convertible Notes - 2009 that were originally due on December 31, 2010 were extended to June 30, 2011 (see below under Warrant Repricing and Debt Extension Financing Transaction – 2010) and bore annual interest rate of 7%, payable on June 30 and December 31 of each year that the convertible notes were outstanding. In addition, we issued 986,983 three-year warrants to the convertible note holders with an exercise price of $1.00 per share. The warrants may be exercised and converted to common stock, at the warrant holder’s option, beginning on the six-month anniversary of the date of issuance until the warrant expiration date.  As a result of the conversions and repayments during the six months ended June 30, 2011, the Company reclassified approximately $4.6 million of the related derivative liabilities to additional paid-in capital. As of June 30, 2011, the fair value of the remaining embedded conversion features was $0 due to the repayment or conversion of all the Convertible Notes - 2009. The Company recorded a loss of $2.3 million due to the change in the fair value of the embedded conversion features of these Convertible Notes – 2009 during the six months ended June 30, 2011. As of June 30, 2011, all of the Convertible Notes – 2009 have been paid in full with cash or have been converted to shares of our common stock.
 
 
15

 
 
The embedded conversion feature of the Convertible Notes – 2009 met the definition of a derivative financial instrument and was classified as a liability in accordance with relevant accounting guidance. The note holders had the right to convert the debt into shares of our common stock, and the notes included price protection whereby these notes were protected for as long as the notes remained outstanding against future private placements made at lower share prices, and therefore, the total number of shares of our common stock that the convertible notes can be convertible into was not fixed. The embedded conversion features were revalued on each balance sheet date and marked-to-market with the change recorded to non-cash items related to debt discounts, deferred financing fees and the valuation of conversion features and warrants on the consolidated statements of operations.

During the three and six months ended June 30, 2011 we recorded a total of $15,000 in interest expense related to the principal balance of the Convertible Notes – 2009.

Senior Convertible Secured Notes- 2010

During the period from January through June 30, 2010, we received $1,597,000 in cash proceeds and converted $163,000 of accounts payable related to a private placement of convertible notes (the “Convertible Notes – 2010”) and stock purchase warrants that were convertible, at the holder’s option, into shares of our common stock at a conversion price of $0.50 per share and we issued 1,760,712 stock purchase warrants that had an exercise price of $1.00 per share. The convertible note holders had the right to have the conversion price adjusted to equal the lower stock price if we issued stock or convertible notes at a lower conversion price than $0.50 during the period that the notes were outstanding. These convertible notes were originally due on December 31, 2010 and were extended to June 30, 2011(see below under Warrant Repricing and Debt Extension Financing Transaction – 2010) and bore annual interest rate of 7%, payable on June 30 and December 31 of each year that the convertible notes were outstanding. The warrants may be exercised and converted to common stock, at the warrant holder’s option, beginning on the six-month anniversary date of issuance until the warrant expiration date. We are not obligated to register the common stock related to the convertible debt or the warrants. During the year ended December 31, 2011, we issued 3,557,171 shares of our common stock to holders of Convertible Notes – 2010 who converted principal of $1,750,143 and $28,442 of related accrued interest. As of December 31, 2011, all of the Convertible Notes – 2010 have been converted to shares of our common stock.

During the three and six months ended June 30, 2011 we recorded a total of $28,000 in interest expense related to the principal balance of the Convertible Notes – 2010.

The embedded conversion feature of the convertible debt issued in the 2010 convertible debt financing transaction met the definition of a derivative financial instrument and was classified as a liability in accordance with accounting guidance. The note holders had the right to convert the debt into shares of our common stock, and the notes included price protection whereby these notes were protected for as long as the notes remain outstanding against future private placements made at lower share prices, and therefore, the total number of shares of our common stock that the convertible notes may be convertible into was not fixed. The embedded conversion features were revalued on each balance sheet date and marked to market with the increase or decrease included in fair value to non-cash items related to debt discounts and deferred financing fees and the valuation of conversion features and warrants on the condensed consolidated statements of operations. As a result of the conversions during the six months ended June 30, 2011, the Company reclassified approximately $8.7 million of the related derivative liabilities to additional paid-in capital. As of June 30, 2011, all of the Convertible Notes – 2010 have been converted to shares of our common stock. As of June 30, 2011, the fair value of the remaining embedded conversion features is $0 as all the Convertible Notes – 2010 were converted. The Company recorded a loss of approximately $4.3 million due to the change in the fair value of the embedded conversion feature of these Convertible Notes – 2010 during the six months ended June 30, 2011.
 
 
16

 

Senior Convertible Secured Notes- 2011

In March 2011, we received $3.7 million in cash proceeds and commitments for an additional $491,000 related to a private placement of convertible notes, bearing interest at a rate of seven percent (7%) per annum, that matured on March 1, 2014, and that could be converted at the holder’s option into 1,691,320 shares of our common stock at a conversion price of $2.50 per share (the “Convertible Secured Notes – 2011”). The Company received the $491,000 in cash proceeds related to the unpaid commitments in April and May 2011. The notes would automatically be converted into shares of the Company’s common stock in the event that on or before the note due date either (a) the Company’s common stock is traded at a price per share of $6.25 or higher for five (5) consecutive trading days, or (b) the Company consummates a financing in the amount of at least $5 million.  In the event that the loan principal and accrued interest was not repaid by the Company by the due date, and the investor has not previously converted the note, the investor’s sole remedy for such non-payment shall be the payment of additional annual interest at a rate of 10% per year.  The accrued interest was payable in stock, using the $2.50 conversion price, or cash, at the holder’s option, on June 30 and December 31 of each year.

In addition,  as of March 31, 2011,the Company issued 373,730 new five-year common stock purchase warrants, with an exercise price of $3.13 per share (the “March 2011 Warrants”), with each investor receiving a number of March 2011 Warrants that was equal  to twenty-five percent (25%) of the investor’s note to the Company.  The Company issued an additional 49,100 warrants in April 2011 related to the collection of the payment totaling $491,000. The March 2011 Warrants may be exercised by cash payment or through cashless exercise by the surrender of warrant shares having a value equal to the exercise price of the portion of the warrants being exercised.
 
In connection with the March 2011 financing transaction the Company valued the warrants issued to the convertible note holders on a relative fair value basis using the Black-Scholes option pricing model, totaling $813,000. This relative fair value of the warrants was recorded as a debt discount. The embedded conversion features to the notes was determined to meet the definition of a derivative liability and as of the date of issuance was valued at $4.1 million. In accordance with relevant accounting guidance, the Company recorded an additional debt discount ($2.9 million) up to the full amount of the notes, recorded the derivative liability for the embedded conversion feature at $4.1 million and recorded the fair value in excess of face amount of debt as interest expense on the issuance date of $1.2 million. The debt discount was amortized in full upon the conversion of the notes to common stock on December 14, 2011. As of December 31, 2011, the fair value of the embedded conversion feature was $0 due to the conversion of all the Senior Convertible Secure Notes – 2011.
 
On June 30, 2011, the Company issued 27,851 shares of unregistered common stock to note holders of the Senior Convertible Secured Notes – 2011 private placement financing transaction in lieu of cash for their $69,628 accrued interest payment that was due June 30, 2011. In addition, the Company paid $10,277 of the accrued interest in cash to note holders who declined to convert their interest payment to stock.

As of June 30, 2011, the fair value of the embedded conversion feature was $6.2 million and as such, the Company recorded a loss on the change in fair value of the embedded conversion feature of $1.4 million, which is included in the accompanying consolidated condensed statement of operations as a component on non-cash items related to debt discounts, deferred financing fees and valuation of conversion features and warrants.

In October and November 2011, note holders of $575,000 of the original $4.2 million Senior Convertible Secure Notes – 2011 exercised their right to convert their notes and accrued interest and were issued 232,125 shares of our common stock.
 
On December 13, 2011, following a public offering pursuant to a Registration Statement on Form S-3, the Company received gross proceeds in excess of $5 million. Pursuant to the terms, as defined, in the Senior Convertible Secure Notes – 2011 agreements, the remaining outstanding principal balance plus accrued interest, was automatically converted into shares of common stock at a conversion price of $2.50 per share. In accordance with the terms of the agreement, the Company automatically converted approximately $3.7 million of remaining principal and approximately $130,000 of accrued interest into 1,513,237 shares of the Company’s common stock. In addition, the Company issued 99,461 shares of common stock related to the bonus interest feature associated with the mandatory conversion of the debt. As of December 31, 2011, the fair value of the embedded conversion features was $0. As of December 31, 2011, all of the Senior Convertible Secure Notes - 2011 plus accrued interest was paid or converted into shares of common stock.  
 
 
17

 
 
4. Stockholders’ Equity

On February 29, 2012, the Company filed a Certificate of Correction with the Secretary of State of Delaware effectively reducing the amount of its authorized shares from 848,000,000 shares of Common Stock and 2,000,000 shares of Preferred Stock to 70,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. This reflects the new capital structure of the Company following its 1-for-25 reverse split that became effective at the close of business on March 25, 2011.

On May 1, 2012, the Company began trading its common stock on the NASDAQ Stock Market Capital Markets under trading symbol NEON.

Common Stock
 
On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.

During the six months ended June 30, 2012, Series B Preferred stockholders exchanged 19 shares of Series B Preferred stock for 2,509 shares of our common stock.

During the six months ended June 30, 2012, a warrant holder exercised a warrant to purchase 21,000 shares of common stock using the net exercise provision allowed in the warrant and received 13,831 shares of our common stock. Another warrant holder exercised a warrant to purchase 2,500 shares of common stock and paid a cash exercise price of $3.13 per share for a total exercise price of $7,813.

Preferred Stock

The terms of the Series A and Series B Preferred stock are as follows:
 
Dividends and Distributions.
 
 
Series A Preferred:
The holders of shares of Series A Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series A Preferred stock held by them.
 
 
Series B Preferred:
The holders of shares of Series B Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series B Preferred stock held by them.
 
Liquidation Preference.
 
 
Series A Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of any other series of Preferred stock to be established by the Board of Directors (the “Senior Preferred Stock”), the holders of Series A Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series A Preferred stock then outstanding.
 
 
18

 
 
 
Series B Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of the Series A Preferred stock and Senior Preferred Stock, the holders of Series B Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series B Preferred stock then outstanding.
 
Voting.
 
The holders of shares of Series A Preferred stock and Series B Preferred stock shall have one vote for each share of Series A Preferred stock and Series B Preferred stock held by them.
 
Conversion.
 
Initially, each share of Series A Preferred stock and each share of Series B Preferred stock was convertible into one share of our common stock.  Any modification to the conversion rate requires shareholder approval (see below). On March 31, 2009, our shareholders approved a resolution to increase the authorized share capital, and to increase the conversion ratio to 480.63 shares of common stock for each share of Series A Preferred stock and to 132.07 shares of our common stock for each shares of Series B Preferred stock, thus completing the restructuring begun in December 2008.  

Conversion of Preferred Stock Issued to Common Stock

On April 24, 2009, we initiated the process of allowing the shareholders of our preferred stock to convert the Series A and B Preferred stock to shares of our common stock. In order to convert the preferred stock to common stock each preferred stock shareholder is required to submit the preferred stock certificate to our transfer agent and request conversion to common stock. The conversion to common stock is not mandatory and shareholders who own preferred stock may choose not to convert their preferred stock to shares of our common stock.  The following table summarizes the Preferred stock not yet converted as of June 30, 2012.
   
Shares of Preferred Stock Not Exchanged as of June 30, 2012
   
Conversion Ratio
   
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at June 30, 2012
 
                   
Series A Preferred stock
   
83
     
480.63
     
39,892
 
Series B Preferred stock
   
95
     
132.07
     
12,547
 
Total  Remaining Not Exchanged
   
178
             
52,439
 
 
 
19

 
 
5. Fair Value Measurement of Assets and Liabilities

Accounting guidance defines fair value, establishes a framework for measuring fair value, and expands disclosure requirements about fair value measurements. The accounting guidance does not mandate any new fair-value measurements and is applicable to assets and liabilities that are required to be recorded at fair value under other accounting pronouncements.
 
The three levels of the fair-value hierarchy are described as follows:
 
Level 1: Quoted prices (unadjusted) in active markets for identical assets and liabilities. As of June 30, 2012 and December 31, 2011, we had no level 1 assets or liabilities.
 
Level 2: Inputs other than Level 1 that are observable, either directly or indirectly. As of June 30, 2012 and December 31, 2011, we had no level 2 assets or liabilities.

Level 3: Inputs other than Level 1 that are observable, either directly or indirectly. As of June 30, 2012 and December 31, 2011, we had no level 3 assets or liabilities.
 
    For the Six  
   
Months Ended
June 30, 2011
 
       
Annual dividend yield
   
--
 
Expected life (years)
   
0.08 – 3.0
 
Risk-free interest rate
   
0.08%- 1.27%
 
Expected volatility
   
110% - 263%
 

The assumptions above were used to value warrants granted to employees and consultants as well as the embedded conversion features associated with convertible debt for the six months ended June 30, 2011.
 
On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company’s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.
 
6. Deferred Revenue

Engineering development fees are recorded as deferred revenue until such time as the engineering services have been provided.

As of June 30, 2012 and December 31, 2011, we have $1.4 million and $1.5 million, respectively, of deferred license fee revenue related to a prepayment for future license fees from one customer and a total of $0.1 million and $0.4 million, respectively, of deferred engineering development fees from four and four customers, respectively. We are deferring the engineering development fee revenue until such time as the engineering work has been completed.

7. Stock-Based Compensation

We have three approved stock option plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. All employee and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants was based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments.
 
 
20

 
 
Stock Options

As of June 30, 2012, we had two equity incentive plans:
 
The 1998 Non-Officer Stock Option Plan (the 1998 Plan), which expired in June 2008 ;
The 2006 Equity Incentive Plan (the 2006 Plan).
 
We also had one non-employee director stock option plan as of June 30, 2012:
 
The 2001 Non-Employee Director Stock Option Plan (the Director Plan), which expired in March 2011.
 
A summary of the combined activity under all of the stock option plans is set forth below:

  
 
Number of Options Outstanding
   
Weighted Average Exercise Price
 
Outstanding at January 1, 2012
   
19,324
   
$
92.19
 
Granted
   
1,460,000
     
4.26
 
Cancelled or expired
   
(8,124
   
69.36
 
Exercised
   
---
     
---
 
Outstanding at June 30, 2012
   
1,471,200
   
$
6.79
 
 
   
For the Six
   
Months Ended
June 30, 2012
       
Annual dividend yield
   
--
 
Expected life (years)
   
3.8
 
Risk-free interest rate
   
0.55% - 0.57%
 
Expected volatility
   
186% - 187%
 

The assumptions above were used to value stock options granted to employees and directors during the six months ended June 30, 2012.

The aggregate intrinsic value of the 1,471,200 stock options that are outstanding, vested and expected to vest at June 30, 2012 is $2.8 million.

The 1998 Plan terminated effective June 15, 2008 and the Director Plan terminated effective March 2011. Although we can no longer issue stock options out of the plans, the outstanding options at the date of termination will remain outstanding and vest in accordance with their terms. Options granted under the Director Plan vested over a one to four-year period, expire five to seven years after the date of grant and have exercise prices reflecting market value of the shares of our common stock on the date of grant. Stock options granted under the 1998 and 2006 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant.
 
During the three and six months ended June 30, 2011, the Company recorded $35,000 and $70,000, respectively, of stock option expense related to the vesting of stock options.
 
We did not grant any options to purchase shares of our common stock to employees or members of our Board of Directors (Board) during the six months ended June 30, 2011.
 
 
21

 
 
During the three months ended June 30, 2012, we granted 1.1 million options to purchase shares of our common stock to employees and 360,000 options to purchase shares of our common stock to members of our Board. The options have a 7-year life and 1/3 of the options vested on the date of grant with the remaining vesting monthly over the following 24-months. During the three and six months ended June 30, 2012, we recorded $2.3 million of stock based compensation expense related to vesting of such options.

Warrants
 
On December 3, 2010, we issued 120,000 warrants at an exercise price of $1.625 per share to an employee. The fair value of the warrants was $198,000 on the date of grant, using the Black-Scholes option pricing model, which is to be amortized over 24 months. During the three and six months ended June 30, 2012 and 2011, we recorded $25,000 and $50,000, respectively, of stock based compensation expense related to vesting of such warrants.
 
We issued 80,000 five-year stock purchase warrants at an exercise price of $2.50 per share to our legal advisor during the six months ended June 30, 2011. We also issued 20,000 three-year stock purchase warrants at an exercise price or $2.00 per share to our US based employee during the six months ended June 30, 2011. The warrants to purchase an aggregate of 100,000 shares of our common stock vested on the date of grant. The vested warrants granted to the employee and legal advisor had an aggregate fair value on the date of grant of $230,000 and is included in general and administrative expense for the three and six months ended June 30, 2011. The fair value of stock-based compensation related to the employee warrants is calculated using the Black-Scholes option pricing model as of the grant date of the underlying warrant.

On September 12, 2011, we issued 20,000 warrants at an exercise price of $3.90 per share to an employee. The fair value of the warrants was $75,000 on the date of grant, using the Black-Scholes option pricing model, which is to be amortized over 24 months. During the three and six months ended June 30, 2012, we recorded $9,000 and $18,000, respectively, of stock based compensation expense related to vesting of such warrants.

The stock-based compensation expense reflects the fair value of the vested portion of options and warrants for the recipients at the date of issuance plus the amortization of the unvested portion of the stock options and warrants. Stock-based compensation expense related to stock options and warrants in the accompanying consolidated statements of operations is as follows (in thousands):

   
Three months
 ended
June 30,
2011
   
Three months
 ended
June 30,
2012
 
Stock-based compensation
  $ 183     $ 2,317  

   
Six months
ended
June 30,
2011
   
Six months
ended
June 30,
2012
   
Remaining unamortized
 expense at
June 30,
2012
 
Stock-based compensation
 
$
472
   
$
2,351
   
$
3,607
 

The remaining unamortized expense related to stock options and warrants will be recognized on a straight line basis monthly as compensation expense over the remaining vesting period which approximates 22 months.

See Note 5 for assumptions used to value warrants during the three and six months ended June 30, 2011.
 
 
22

 
 
A summary of all warrant activity is set forth below:
 
   
June 30, 2012
Outstanding and exercisable
 
Warrants
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life
January 1, 2012
   
5,405,606
   
$
1.57
     
2.45
 
   Issued
   
--
   
$
--
     
--
 
   Expired/forfeited
   
--
     
--
     
--
 
   Exercised
   
(223,500
)
 
$
0.61
     
--
 
Outstanding and exercisable, June 30, 2012
   
5,182,106
   
$
1.61
     
1.87
 

On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.

During the three months ended June 30, 2012, a warrant holder exercised a warrant to purchase 21,000 shares of common stock using the net exercise provision allowed in the warrant and received 13,831 shares of our common stock. Another warrant holder exercised a warrant to purchase 2,500 shares of common stock and paid a cash exercise price of $3.13 per share for a total exercise price of $7,813.

The fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term and forfeiture rate of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior, as well as expected behavior on outstanding options. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of our stock price. These factors could change in the future, which would affect fair values of stock options granted in such future periods, and could cause volatility in the total amount of the stock-based compensation expense reported in future periods.

Below is a summary of Outstanding Warrants to Purchase
Common Stock as of June 30, 2012:
 
                 
Description
Issue  Date
 
Exercise Price
 
Shares
 
Expiration Date
 
                 
September 2007 Investor Warrant
9/26/2007
 
$
31.75
 
233
   
9/26/2012
 
August 2009 Employee Warrants
8/25/2009
 
$
0.50
 
240,000
   
8/25/2016
 
January 2010 Investor Warrant
1/28/2010
 
$
1.00
 
40,000
   
1/28/2013
 
2007 Debt Extension Warrants
9/22/2010
 
$
1.00
 
16,000
   
9/22/2015
 
September 2010 Repricing Warrant
9/28/2010
 
$
1.38
 
4,000
   
9/28/2013
 
October 2010 Repricing Warrants
10/18/2010
 
$
1.38
 
2,434,830
   
10/18/2013
 
October 2010 Employee Warrants
10/15/2010
 
$
1.38
 
1,440,000
   
10/15/2013
 
December 2010 Employee Warrants
12/3/2010
 
$
1.63
 
200,000
   
12/3/2015
 
January 2011 Employee Warrant
1/21/2011
 
$
2.00
 
20,000
   
1/21/2014
 
February 2011 Legal Advisor Warrant
2/22/2011
 
$
2.00
 
80,000
   
2/22/2016
 
March  2011 Investor Warrants
3/9/2011
 
$
3.13
 
617,943
   
3/9/2016
 
March  2011 Investor Warrants
4/7/2011
 
$
3.13
 
49,100
   
4/7/2016
 
May 2011 Consultant Warrant
5/17/2011
 
$
4.05
 
20,000
   
5/17/2014
 
September 2011 Employee Warrant
9/12/2011
 
$
3.90
 
20,000
   
9/12/2014
 
Total Warrants Outstanding
         
5,182,106
       
 
 
23

 
 
8. Commitments and Contingencies

Indemnities and Guarantees

We have agreed to indemnify each of our executive officers and directors for certain events or occurrences arising as a result of the officer or director serving in such capacity. The term of the indemnification period is for the officer's or director's lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited.  However, we have directors’ and officers’ liability insurance policy that should enable us to recover a portion of future amounts paid. As a result of our insurance policy coverage, we believe the estimated fair value of these indemnification agreements is minimal and have no liabilities recorded for these agreements as of June 30, 2012 and December 31, 2011, respectively.

We enter into indemnification provisions under our agreements with other companies in the ordinary course of business, typically with business partners, contractors, customers and landlords. Under these provisions we generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of our activities or, in some cases, as a result of the indemnified party's activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by us with regard to intellectual property rights. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is unlimited. We have not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the estimated fair value of these agreements is minimal. Accordingly, we have no liabilities recorded for these agreements as of June 30, 2012 and December 31, 2011, respectively.
 
Operating Leases

Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,207 square feet of office space located at Linnegatan 89, Stockholm, Sweden for approximately $6,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $72,000 per year including property tax (excluding VAT). This lease has a notice period of 3 months.

Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,723 square feet of office space located at Linnegatan 89D, Stockholm, Sweden for approximately $8,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $93,000 per year including property tax (excluding VAT). This lease is valid through December 31, 2014, with a 9-month notice period. The contract will be extended for an additional 3 years if it is not terminated according to the terms in the contract.

On March 18, 2011, we entered into a twelve month lease with CA-Santa Clara Office Center Limited Partnership for 1,718 square feet of office space located at 2700 Augustine Drive, Suite 100, Santa Clara, California, USA for $2,647 per month. The lease expired on April 30, 2012.

On March 22, 2012, we entered into a three year lease with 2350 Mission Investors LLC for 3,185 square feet of office space located at 2350 Mission College Blvd, Suite 190, Santa Clara, CA 95054 USA commencing May 1, 2012. The initial lease payment is approximately $7,000 per month, increasing to approximately $7,700 per month over the term of the lease. The annual payment for this space equates to approximately $84,000 per year including property taxes.

On April 15, 2012, Neonode Technologies AB entered into a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $13,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $161,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2013.
 
 
24

 
 
9.  Segment Information

The Company has one reportable segment, which is comprised of the touchscreen technology licensing business. All of our sales for the three and six months ended June 30, 2012 and 2011 were to customers located in the U.S., Europe and Asia.

The following table presents net revenues by geographic region for the three and six months ended June 30, 2012 and 2011 (dollars in thousands):

   
Three months ended
June 30, 2012
   
Three months ended
June 30, 2011
 
   
Amount
   
Percentage
   
Amount
   
Percentage
 
Net revenues made in the U.S.
 
$
1,218
     
62
%
 
$
130
     
46
%
                                 
Net revenues made outside of the U.S.
   
756
     
38
%
   
153
     
54
%
                                 
   
$
1,974
     
100
%
 
$
283
     
100
%
 
   
Six months ended
June 30, 2012
   
Six months ended
June 30, 2011
 
   
Amount
   
Percentage
   
Amount
   
Percentage
 
Net revenues made in the U.S.
 
$
2,000
     
64
%
 
$
130
     
16
%
                                 
Net revenues made outside of the U.S.
   
1,138
     
36
%
   
692
     
84
%
                                 
   
$
3,138
     
100
%
 
$
822
     
100
%

10. Net Loss Per Share

Basic net loss per common share for the three and six months ended June 30, 2012 and 2011 was computed by dividing the net loss for the relevant period by the weighted average number of shares of common stock outstanding. Diluted earnings per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock and common stock equivalents outstanding.
 
Potential common stock equivalents of 103,000 and zero stock options outstanding under the treasury stock method, 3.4 million and 5.4 million outstanding stock warrants under the treasury stock method, 52,000 and 55,000 shares issuable upon conversion of preferred stock and zero and 1.7 million shares issuable upon conversion of notes are excluded from the diluted earnings per share calculation for the six months ended June 30, 2012 and 2011, respectively, due to their anti-dilutive effect. 

   
Three Months ended
 
(in thousands, except per share amounts)
 
June 30,
 
   
2012
   
2011
 
BASIC AND DILUTED
           
Weighted average number of
           
common shares outstanding
   
32,969
     
27,642
 
Number of shares for computation of
               
net loss per share
   
32,969
     
27,642
 
Net loss
 
$
(3,427
)
 
$
(2,722
)
                 
Net loss per share - basic and diluted
 
$
(0.10
)
 
$
(0.10
)
 
 
25

 
 
   
Six Months ended
 
(in thousands, except per share amounts)
 
June 30,
 
   
2012
   
2011
 
BASIC AND DILUTED
           
Weighted average number of
           
common shares outstanding
   
32,889
     
25,039
 
Number of shares for computation of
               
net loss per share
   
32,889
     
25,039
 
Net loss
 
$
(5,015
)
 
$
(12,443
)
                 
Net loss per share - basic and diluted
 
$
(0.15
)
 
$
(0.50
)

11. Subsequent Events

We have evaluated subsequent events through the filing date of this Form 10-Q, and have determined that no subsequent events have occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto.
 
 
26

 
 
Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, adopted pursuant to the Private Securities Litigation Reform Act of 1995.  Statements that are not purely historical may be forward-looking.  You can identify some forward-looking statements by the use of words such as "believes," "anticipates," "expects," "intends" and similar expressions.  Forward- looking statements involve inherent risks and uncertainties regarding events, conditions and financial trends that may affect our future plans of operation, business strategy, results of operations and financial position.  A number of important factors could cause actual results to differ materially from those included within or contemplated by such forward-looking statements, including, but not limited to risks relating to the uncertainty of growth in market acceptance for our technology, a history of losses since inception, our ability to remain competitive in response to new technologies, the costs to defend, as well as risks of losing, patents and intellectual property rights, a reliance on our future customers’ ability to develop and sell products that incorporate our technology, the concentration of our operations in a limited number of facilities, the uncertainty of demand for our technology in certain markets, our ability to manage growth effectively, our dependence on key members of our management and development team, our limited experience in conducting operations internationally, and our ability to obtain adequate capital to fund future operations, For a discussion of these and other factors that could cause actual results to differ from those contemplated in the forward-looking statements, please see the discussion under ‘‘Risk Factors’’ contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011 and in our publicly available filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only as of the date hereof.  Actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. We do not undertake any responsibility to update or revise any of these factors or to announce publicly any revisions to forward-looking statements, whether as a result of new information, future events or otherwise.
 
The following Management’s Discussion and Analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q and consolidated financial statements and notes thereto for the year ended December 31, 2011 included in our Annual Report on Form 10-K.
   
Overview
 
Neonode Inc., “we”, “us”, “our”, the “Company”, develops and licenses the next generation of MultiSensing TM touch user interfaces and optical multi-touch solutions for some of the world’s largest companies. The cornerstone of our interface solutions is zForce®, our patented touch technology which provides a more augmented user experience compared to traditional touch. The Neonode MultiSensingTM touch technology is suited for small to midsized consumer and industrial electronic devices and supports extensive gestures, multi-touch and sweep navigation.  The Neonode MultiSensingTM touch technology applies to any surface and integrates with all various devices. The Neonode MultiSensingTM touch technology uses infrared light with zero latency that responds with most objects, such as a pen, finger, brush or gloved finger, at a very high scanning speed.

Neonode licenses the Neonode MultiSensingTM touch technology to Original Equipment Manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”) who embed our technology into devices that they produce and sell. Our technology is currently being integrated into products such as mobile phones, e-readers and tablets, printers and office equipment, toy and gaming consoles, automotive and in-vehicle infotainment systems.

Our technology licensing model allows us to focus on the development of solutions for multi-touch enabled screens, and thus we do not have to manufacture products. We license the right to use zForce and Neonode MultiSensingTM software which, together with standard components from partners, create a complete optical touch solution.
 
Intellectual Property
 
We rely on a combination of intellectual property laws, as well as confidentiality procedures and contractual provisions, to protect our proprietary technology and our brand. We have registered, and applied for the registration of, U.S. and international trademarks, service marks, domain names, and copyrights. Additionally, we have filed U.S. and international patent applications covering certain of our proprietary technology. Over time, we have assembled a portfolio of patents, trademarks, service marks, copyrights, domain names, and trade secrets covering our products and services. Our proprietary technology is not dependent on any single patent or copyright or groups of related patents or copyrights. We believe the duration of our patents is adequate relative to the expected lives of our products. Although we rigorously protect our proprietary technology, any significant impairment of, or third-party claim against, our intellectual property rights could harm our business or our ability to compete.
 
Critical Accounting Policies

The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The condensed consolidated financial statements for the three and six months ended June 30, 2012 and 2011, and as of June 30, 2012 and December 31, 2011 include the accounts of Neonode Inc. and our wholly owned subsidiary, Neonode Technologies AB.  All inter-company accounts and transactions have been eliminated in consolidation. As we have not made any changes to our critical accounting policies for the six months ended June 30, 2012, please note the critical accounting policies disclosed in our annual report on Form 10-K for the year ended December 31, 2011.
 
 
27

 
 
Results of Operations

Net Revenues

Net revenues for the three and six months ended June 30, 2012 was $2.0 million and $3.1 million compared to net revenue for the three and six months ended June 30, 2011 of $283,000 and $822,000, respectively.  Our net revenues for the three and six months ended June 30, 2012 included $1.6 million and $2.5 million from license fees related to the shipment of e-Readers plus $377,000 and $645,000 in fees for engineering design services related to our touch screen solution for customers.  Our net revenue for the three and six months ended June 30, 2011 included $56,000 and $577,000, respectively, from license fees related to the shipment of e-Readers by Sony Corporation (Sony). Net revenues for the three and six months ended June 30, 2011 also included $214,000 and $233,000, respectively, in fees for engineering design services related to our touch screen solution for numerous customers. On June 18, 2010, in conjunction with the signing of the technology license agreement with Sony, they issued an initial purchase order for $475,000 of touchscreen licenses. We recorded the $475,000 pre-payment as deferred revenue until the initial warranty period expired. Sony began shipping its first e-Reader product on September 1, 2010. During the six months ended June 30, 2011, we recognized the $475,000 of deferred revenue related to the Sony initial purchase order.

As of June 30, 2012, we have nineteen signed technology license agreements with global OEMs and customers. We signed one new license agreement with a global OEM subsequent to June 30, 2012. In addition, we are currently developing prototype products and are engaged in product engineering design discussions with numerous global OEMs who are in the process of qualifying our touchscreen technology for incorporation in various products such as printer products, GPS devices, e-Readers, tablets, touch panels for automobiles, household appliances, mobile phones and games and toys. The development and product release cycle for these products typically takes six to eighteen months.

Drivers of the touch screen market include mobile phones, printers, laptops, tablets, e-Readers, navigation screens, etc.   The proliferation and mass market acceptance of touch screens have prompted new applications and uses for existing and new offerings, thus making the production and utilization of these modules one of the fastest growing tech segments. The typical sales cycle is 9-18 months with new customers while existing customer lead times are typically 6-9 months. During the initial cycle, there are three phases: evaluation, design, and commercial.  In the evaluation phase, prospects validate the Neonode technology using a Neonode evaluation kit and may produce short runs. During the design phase, true product development begins, with solution definition occurring as well.  This phase tends to be the longest and it should be noted that this phase is where delays typically occur, drawing out the term of the overall cycle.  In the final phase, commercialization, the customer enters into full production mode, and Neonode earns license revenue.

Gross Margin

Gross margin was $1.5 million and $2.4 million for the three and six months ended June 30, 2012 compared to $45,000 and $429,000 for the same periods in 2011, respectively. Our cost of revenues includes the direct cost of production of the components plus the costs of Company employed engineering personnel plus engineering consultants to complete the engineering design contract. The gross margin related to our license fees is 100% and as license fees as a percentage of our total revenues increase our gross margin will increase.

Product Research and Development

Product research and development (R&D) expenses for the three and six months ending June 30, 2012 were $1.5 million and $2.2 million compared to $382,000 and $658,000 for the same periods in 2011.  R&D costs mainly consist of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.   Factors that contributed to the increase in R&D costs include an increase in the amount of time our engineering department spends engaged in R&D activities. Included in R&D expenses are $178,000 and $187,000 of non-cash stock option and warrant expense for the three and six months ended June 30, 2012 compared to $72,000 and $109,000  for the same periods in 2011.Other costs related to customer specific activities are included in our cost of revenue.
 
 
28

 
 
Sales and Marketing

Sales and marketing (S&M) expenses for the three and six months ending June 30, 2012 were $1.7 million and $2.5 million compared to $363,000 and $715,000 for the same periods in 2011, respectively. This increase in 2012 as compared to 2011 is primarily related to an increase in sales and marketing staff, marketing activities and travel related costs. Marketing related expense increased to $85,000 and $282,000 for the three and six months ended June 30, 2012 compared to $29,000 and $74,000 for the same periods in 2011. Included in S&M expenses are $918,000 and $943,000 of non-cash stock option and warrant expense for the three and six months ended June 30, 2012 compared to $23,000 and $48,000 for the same periods in 2011.

General and Administrative

General and administrative (G&A) expenses for the three and six months ending June 30, 2012 were $1.7 million and $2.7 million compared to $921,000 and $1.8 million for the same periods in 2011, respectively. This increase in 2012 as compared to 2011 is primarily related to salary expense, stock based compensation expense, legal expenses related to patent filings, corporate and SEC compliance and customer contracts. Included in G&A expenses are $1,221,000 of non-cash stock option and warrant expense for the three and six months ended June 30, 2012 compared to $88,000 and $315,000 for the same periods in 2011.

Interest Expense

Interest expense for the three and six months ending June 30, 2011 was $81,000 and $135,000, respectively. We did not have any interest expense for the three and six months ending June 30, 2012. We had $3.9 million of convertible debt outstanding at June 30, 2011. All the convertible debt and accrued interest was converted to shares of our common stock or paid by December 14, 2011.

Non-cash items related to debt discounts, deferred financing fees and the valuation of conversion features and warrants

In connection with the March and April 2011 financing transactions the Company determined that the embedded conversion feature to the notes meet the definition of a derivative liability, and as of the date of issuance was valued at $4.8 million. In accordance with relevant accounting guidance, the Company recorded a full debt discount up to the face amount of the notes ($4.2 million), recorded the derivative liability for the embedded conversion feature of $4.8 million and recorded the excess value of $1.5 million on the issuance as non-cash interest expense.

During the three and six months ended June 30, 2011, the Company recorded an aggregate loss of $7.4 million and $8.1 million, respectively, as a change in fair value of derivative liabilities.

On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company’s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.

Income Taxes

Our tax provision for the three and six months ending June 30, 2012 and 2011 represents income taxes withheld by one of our foreign customers. We recorded valuation allowances for the three and six months ending June 30, 2012 and 2011 for deferred tax assets related to net operating losses due to the uncertainty of realization. In the event of future taxable income, our effective income tax rate in future periods could be lower than the statutory rate as such tax assets are realized.
 
 
29

 
 
Net Loss

As a result of the factors discussed above, we recorded a net loss of $3.4 million and $5.0 million for the three and six months ended June 30, 2012, compared to a net loss of $2.7 million and $12.4 million in the comparable periods in 2011.
 
Off-Balance Sheet Arrangements

We do not have any transactions, arrangements, or other relationships with unconsolidated entities that are reasonably likely to affect our liquidity or capital resources other than the operating leases noted in note 8. We have no special purpose or limited purpose entities that provide off-balance sheet financing, liquidity, or market or credit risk support; or engage in leasing, hedging, research and development services, or other relationships that expose us to liability that is not reflected on the face of the condensed consolidated financial statements.

Liquidity and Capital Resources

Our liquidity is dependent on many factors, including sales volume, operating profit and the efficiency of asset use and turnover. Our future liquidity will be affected by, among other things:

actual versus anticipated licensing of our technology;
our actual versus anticipated operating expenses;
the timing of our OEM customer product shipments;
the timing of payment for our technology licensing agreements;
our actual versus anticipated gross profit margin;
our ability to raise additional capital, if necessary; and
our ability to secure credit facilities, if necessary.

Our cash is subject to interest rate risk. We invest primarily on a short-term basis. Our financial instrument holdings at June 30, 2012, were analyzed to determine their sensitivity to interest rate changes. The fair values of these instruments were determined by net present values. In our sensitivity analysis, the same change in interest rate was used for all maturities and all other factors were held constant. If interest rates increased by 10%, the expected effect on net loss related to our financial instruments would be immaterial. The functional currency of our foreign subsidiary is the applicable local currency, the Swedish Krona, and is subject to foreign currency exchange rate risk. Any increase or decrease in the exchange rate of the U.S. Dollar compared to the Swedish Krona will impact Neonode’ future operating results.

At June 30, 2012, we had cash  of $11.3 million as compared to $12.9 million at December 31, 2011. In the six month period ended June 30, 2012, $1.4 million of cash was used by operating activities. Our net loss for the six months ended June 30, 2012 increased by the following non-cash items (in thousands):

Depreciation and amortization
 
$
40
 
Stock-based compensation expense
   
2,351
 
Total net non-cash items included in cash provided by our operations
 
$
2,391
 

Working capital was $10.7 million (current assets less current liabilities) at June 30, 2012, compared to working capital of $13.6 million at December 31, 2011.

In the six months ended June 30, 2012, we purchased $268,000 of equipment, primarily computers and furniture related to our Stockholm office.

Historically, the majority of our cash has been provided by borrowings from senior secured notes and bridge notes that have been convertible into shares of our common stock or from the sale of our common stock and common stock purchase warrants to private investors. During 2011, we raised approximately $15.5 million through debt and equity offerings.  We believe we have sufficient cash to operate for at least the next twelve months.
 
 
30

 
 
In the future, we may require sources of capital in addition to cash on hand to continue operations and to implement our strategy. If our operations do not become cash flow positive, we may be forced to seek credit line facilities from financial institutions, additional private equity investment or debt arrangements. No assurances can be given that we will be successful in obtaining such additional financing on reasonable terms, or at all. If adequate funds are not available on acceptable terms, or at all, we may be unable to adequately fund our business plans and it could have a negative effect on our business, results of operations and financial condition. In addition, if funds are available, the issuance of equity securities or securities convertible into equity could dilute the value of shares of our common stock and cause the market price to fall, and the issuance of debt securities could impose restrictive covenants that could impair our ability to engage in certain business transactions.

Item 3.   Quantitative and Qualitative Disclosures about Market Risk

Not Applicable

Item 4.   Controls and Procedures

Disclosure Controls and Procedures

Under the supervision of and with the participation of our management, including the Company’s Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective.
 
During the three months ended June 30, 2012, management determined that we had material weaknesses relating to the segregation of duties within our accounting functions and our quarterly and annual financial close processes. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Because these material weaknesses as to internal control over financial reporting also bear upon our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer were unable to conclude that our disclosure controls and procedures were effective.
 
Despite the conclusion that disclosure controls and procedures were not effective as of the end of the period covered by this report, the Chief Executive Officer and Chief Financial Officer believe that the consolidated financial statements and other information contained in this quarterly report present fairly, in all material respects, our business, financial condition and results of operations.

Internal Control over Financial Reporting

There were no changes in our internal controls over financial reporting during the period covered by this report that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

We are currently taking steps to both remedy the material weaknesses described above and facilitate our management’s assessment of internal control over financial reporting in accordance with the Sarbanes-Oxley Act and Commission rules. Our remediation steps include:

 
We added personnel to our accounting department, consultants, or other resources (including those with public company reporting experience) to enhance our policies and procedures, including those related to complex accounting issues;
 
 
We retained a Sarbanes-Oxley consulting firm to assist us to prepare written policies and procedures for accounting and financial reporting to establish a formal process to close our books and account for all transactions.
 
 
 
31

 
 
PART II.   Other Information

ITEM  1.    Legal Proceedings

We are not currently involved in any material legal proceedings. However, from time to time, we may become subject to additional legal proceedings, claims, and litigation arising in the ordinary course of business, including, but not limited to, employee, customer and vendor disputes
 
ITEM  1A.  Risk Factors

Please refer to Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2011.

ITEM 6.     Exhibits

Exhibits
 
Exhibit #
 
  Description
3.1
 
Amended and Restated Certificate of Incorporation of Neonode Inc., dated April 17, 2009 (incorporated by reference to Exhibit 10.22 of our Quarterly Report on Form 10-Q filed on August 4, 2009).
3.1.1
 
Certificate of Amendment, dated December 13, 2010 (incorporated by reference to Exhibit 3.1.1 of our Annual Report on Form 10-K filed on March 31, 2011)
3.1.2
 
Certificate of Amendment, dated March 18, 2011 (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed on March 28, 2011)
3.1.3
 
Certificate of Correction, dated February 29, 2011 (incorporated by reference to Exhibit 3.1.3 of our Annual Report on Form 10-K filed on March 31, 2011)
3.2
Bylaws, as amended through December 5, 2007 (incorporated by reference to Exhibit 3.2 of our Annual Report on Form 10-K filed on April 15, 2008)
31.1
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002
31.2
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002
32.1
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101
The following materials from the Company’s Form 10-Q for the quarter ended June 30, 2012 and 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Operations; (iii) Consolidated statements of Comprehensive Loss; (iv) Consolidated Statements of Cash Flows; and (v) Notes to Consolidated Financial Statements*
 
* Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections
 
 
32

 
 
 SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly this report to be signed on its behalf by the undersigned thereunto duly authorized, on August 14, 2012.

 
Neonode Inc.
Registrant
 
       
Date:  August 14, 2012  
By:
/s/ David W. Brunton
 
   
David W. Brunton
 
   
Chief Financial Officer,
 
   
Vice President, Finance
 
   
and Secretary
 
   
(Principal Financial and
 
   
Accounting Officer)
 

 33

 

 
EX-31.1 2 f10q0612ex31i_neonode.htm CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 f10q0612ex31i_neonode.htm
EXHIBIT 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas Eriksson, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Neonode Inc.;

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13(a)-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)           Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under the supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)          Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report  based on such evaluation; and

d)          Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.           The registrant’s other certifying officers(s) and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Thomas Eriksson
     
Thomas Eriksson 
     
Chief Executive Officer
     
August 14, 2012  
     
 
EX-31.2 3 f10q0612ex31ii_neonode.htm CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 f10q0612ex31ii_neonode.htm
EXHIBIT 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David W. Brunton certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Neonode Inc.;

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13(a)-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d -15(f)) for the registrant and we have:

a)           Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under the supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)           Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report  based on such evaluation; and

d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting: and

5.           The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ David W. Brunton
 
David W. Brunton
 
Chief Financial Officer
 
Vice President, Finance
 
and Secretary
 
August 14, 2012
 

 
EX-32.1 4 f10q0612ex32i_neonode.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 f10q0612ex32i_neonode.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to the requirement set forth in Rule 13a-14(b) under the Securities Act of 1934, as amended (the “Exchange Act”) and Section 1350 of Title 18 of the United States Code, the undersigned officers of Neonode Inc. (the “Company”) each hereby certifies that, to his knowledge:

1.  
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2012 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
2.  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
 
         
s/ Thomas Eriksson
   
/s/ David W. Brunton
 
Thomas Eriksson 
   
David W. Brunton
 
Chief Executive Officer
   
Chief Financial Officer
 
August 14, 2012  
   
Vice President, Finance
 
     
and Secretary
 
     
August 14, 2012
 
EX-101.INS 5 neond-20120630.xml XBRL INSTANCE DOCUMENT 0000087050 neond:SeptemberTwoThousandNineSeniorConvertibleSecuredNotesFinancingTransactionMember 2009-12-15 0000087050 neond:SeptemberTwoThousandNineSeniorConvertibleSecuredNotesFinancingTransactionMember 2009-08-25 2009-12-15 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandTenMember 2010-01-01 2010-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandTenMember 2010-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandSevenMember 2010-09-22 0000087050 us-gaap:WarrantMember 2010-12-03 0000087050 2010-12-31 0000087050 2010-12-01 2010-12-31 0000087050 us-gaap:WarrantMember 2010-12-01 2010-12-31 0000087050 neond:CaSantaClaraOfficeCenterLimitedPartnershipMember 2011-03-18 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-01-01 2011-03-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-03-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-03-01 2011-03-31 0000087050 neond:CaSantaClaraOfficeCenterLimitedPartnershipMember 2011-03-01 2011-03-31 0000087050 neond:CaSantaClaraOfficeCenterLimitedPartnershipMember neond:MonthMember 2011-03-01 2011-03-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-04-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-04-01 2011-04-30 0000087050 2011-04-01 2011-06-30 0000087050 neond:SeptemberTwoThousandNineSeniorConvertibleSecuredNotesFinancingTransactionMember 2011-04-01 2011-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandTenMember 2011-04-01 2011-06-30 0000087050 country:US 2011-04-01 2011-06-30 0000087050 neond:OutsideOfUnitedStatesMember 2011-04-01 2011-06-30 0000087050 us-gaap:StockOptionsMember 2011-04-01 2011-06-30 0000087050 us-gaap:WarrantMember 2011-04-01 2011-06-30 0000087050 neond:FiveYearStockPurchaseWarrantsMember 2011-04-01 2011-06-30 0000087050 neond:StockOptionsAndWarrantsMember 2011-04-01 2011-06-30 0000087050 2011-01-01 2011-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandSevenMember 2011-01-01 2011-06-30 0000087050 neond:SeptemberTwoThousandNineSeniorConvertibleSecuredNotesFinancingTransactionMember 2011-01-01 2011-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandTenMember 2011-01-01 2011-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-01-01 2011-06-30 0000087050 us-gaap:MinimumMember 2011-01-01 2011-06-30 0000087050 us-gaap:MaximumMember 2011-01-01 2011-06-30 0000087050 country:US 2011-01-01 2011-06-30 0000087050 neond:OutsideOfUnitedStatesMember 2011-01-01 2011-06-30 0000087050 us-gaap:StockOptionsMember 2011-01-01 2011-06-30 0000087050 us-gaap:WarrantMember 2011-01-01 2011-06-30 0000087050 neond:FiveYearStockPurchaseWarrantsMember 2011-01-01 2011-06-30 0000087050 neond:ThreeYearStockPurchaseWarrantsMember 2011-01-01 2011-06-30 0000087050 neond:StockOptionsAndWarrantsMember 2011-01-01 2011-06-30 0000087050 us-gaap:CommonStockMember 2011-01-01 2011-06-30 0000087050 us-gaap:WarrantMember 2011-01-01 2011-06-30 0000087050 us-gaap:ConvertiblePreferredStockMember 2011-01-01 2011-06-30 0000087050 us-gaap:ConvertibleDebtSecuritiesMember 2011-01-01 2011-06-30 0000087050 2011-06-30 0000087050 neond:SeptemberTwoThousandNineSeniorConvertibleSecuredNotesFinancingTransactionMember 2011-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandTenMember 2011-06-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-06-30 0000087050 neond:FiveYearStockPurchaseWarrantsMember 2011-06-30 0000087050 neond:ThreeYearStockPurchaseWarrantsMember 2011-06-30 0000087050 2011-09-12 0000087050 us-gaap:WarrantMember 2011-09-12 0000087050 2010-06-01 2011-09-30 0000087050 2011-09-01 2011-09-30 0000087050 us-gaap:WarrantMember 2011-09-01 2011-09-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-10-01 2011-11-30 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-12-13 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandTenMember 2011-01-01 2011-12-31 0000087050 2011-12-31 0000087050 us-gaap:SeriesAPreferredStockMember 2011-12-31 0000087050 us-gaap:SeriesBPreferredStockMember 2011-12-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandSevenMember 2011-12-31 0000087050 neond:SeptemberTwoThousandNineSeniorConvertibleSecuredNotesFinancingTransactionMember 2011-12-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandTenMember 2011-12-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-12-31 0000087050 neond:FutureLicenseFeesFromOneCustomerMember 2011-12-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandSevenMember 2011-12-01 2011-12-31 0000087050 neond:SeniorConvertibleSecuredNotesTwoThousandElevenMember 2011-12-01 2011-12-31 0000087050 2012-02-29 0000087050 2012-02-01 2012-02-29 0000087050 2012-03-16 0000087050 us-gaap:CommonStockMember 2012-03-16 0000087050 neond:MissionInvestorsLlcMember 2012-03-22 0000087050 neond:MissionInvestorsLlcMember 2012-03-01 2012-03-31 0000087050 neond:MissionInvestorsLlcMember neond:MonthMember 2012-03-01 2012-03-31 0000087050 neond:MissionInvestorsLlcMember neond:AnnualMember 2012-03-01 2012-03-31 0000087050 neond:PicnicMember 2012-04-01 2012-04-30 0000087050 neond:PicnicMember neond:MonthMember 2012-04-01 2012-04-30 0000087050 neond:PicnicMember neond:AnnualMember 2012-04-01 2012-04-30 0000087050 2012-04-01 2012-06-30 0000087050 country:US 2012-04-01 2012-06-30 0000087050 neond:OutsideOfUnitedStatesMember 2012-04-01 2012-06-30 0000087050 us-gaap:StockOptionsMember 2012-04-01 2012-06-30 0000087050 us-gaap:WarrantMember 2012-04-01 2012-06-30 0000087050 us-gaap:MinimumMember 2012-04-01 2012-06-30 0000087050 neond:CustomerOneMember 2012-04-01 2012-06-30 0000087050 neond:CustomerTwoMember 2012-04-01 2012-06-30 0000087050 neond:StockOptionsAndWarrantsMember 2012-04-01 2012-06-30 0000087050 neond:WarrantsOneMember 2012-04-01 2012-06-30 0000087050 neond:KoboMember 2012-04-01 2012-06-30 0000087050 2012-01-01 2012-06-30 0000087050 us-gaap:ComputerEquipmentMember 2012-01-01 2012-06-30 0000087050 us-gaap:FurnitureAndFixturesMember 2012-01-01 2012-06-30 0000087050 neond:VasakronanFastigheterAbMember 2012-01-01 2012-06-30 0000087050 us-gaap:SeriesAPreferredStockMember 2012-01-01 2012-06-30 0000087050 us-gaap:SeriesBPreferredStockMember 2012-01-01 2012-06-30 0000087050 us-gaap:CommonStockMember 2012-01-01 2012-06-30 0000087050 us-gaap:MinimumMember 2012-01-01 2012-06-30 0000087050 us-gaap:MaximumMember 2012-01-01 2012-06-30 0000087050 neond:September2007InvestorWarrantMember 2012-01-01 2012-06-30 0000087050 neond:August2009EmployeeWarrantsMember 2012-01-01 2012-06-30 0000087050 neond:January2010InvestorWarrantMember 2012-01-01 2012-06-30 0000087050 neond:DebtExtensionWarrantsMember 2012-01-01 2012-06-30 0000087050 neond:September2010RepricingWarrantMember 2012-01-01 2012-06-30 0000087050 neond:October2010RepricingWarrantsMember 2012-01-01 2012-06-30 0000087050 neond:October2010EmployeeWarrantsMember 2012-01-01 2012-06-30 0000087050 neond:December2010EmployeeWarrantsMember 2012-01-01 2012-06-30 0000087050 neond:January2011EmployeeWarrantMember 2012-01-01 2012-06-30 0000087050 neond:February2011LegalAdvisorWarrantMember 2012-01-01 2012-06-30 0000087050 neond:March2011InvestorWarrantsMember 2012-01-01 2012-06-30 0000087050 neond:March2011InvestorWarrantsOneMember 2012-01-01 2012-06-30 0000087050 neond:May2011ConsultantWarrantMember 2012-01-01 2012-06-30 0000087050 neond:September2011EmployeeWarrantMember 2012-01-01 2012-06-30 0000087050 country:US 2012-01-01 2012-06-30 0000087050 neond:OutsideOfUnitedStatesMember 2012-01-01 2012-06-30 0000087050 us-gaap:StockOptionsMember 2012-01-01 2012-06-30 0000087050 us-gaap:WarrantMember 2012-01-01 2012-06-30 0000087050 neond:NonEmployeeDirectorStockOptionPlanMember us-gaap:MaximumMember 2012-01-01 2012-06-30 0000087050 neond:NonEmployeeDirectorStockOptionPlanMember us-gaap:MinimumMember 2012-01-01 2012-06-30 0000087050 neond:NonOfficerStockOptionPlanAndEquityIncentivePlanMember us-gaap:MaximumMember 2012-01-01 2012-06-30 0000087050 neond:NonOfficerStockOptionPlanAndEquityIncentivePlanMember us-gaap:MinimumMember 2012-01-01 2012-06-30 0000087050 neond:CustomerOneMember 2012-01-01 2012-06-30 0000087050 neond:CustomerTwoMember 2012-01-01 2012-06-30 0000087050 neond:StockOptionsAndWarrantsMember 2012-01-01 2012-06-30 0000087050 neond:WarrantsOneMember 2012-01-01 2012-06-30 0000087050 us-gaap:CommonStockMember 2012-01-01 2012-06-30 0000087050 us-gaap:WarrantMember 2012-01-01 2012-06-30 0000087050 us-gaap:ConvertiblePreferredStockMember 2012-01-01 2012-06-30 0000087050 us-gaap:ConvertibleDebtSecuritiesMember 2012-01-01 2012-06-30 0000087050 neond:VasakronanFastigheterAbOneMember 2012-01-01 2012-06-30 0000087050 neond:VasakronanFastigheterAbMember neond:MonthMember 2012-01-01 2012-06-30 0000087050 neond:VasakronanFastigheterAbMember neond:AnnualMember 2012-01-01 2012-06-30 0000087050 neond:VasakronanFastigheterAbOneMember neond:MonthMember 2012-01-01 2012-06-30 0000087050 neond:VasakronanFastigheterAbOneMember neond:AnnualMember 2012-01-01 2012-06-30 0000087050 2012-06-30 0000087050 us-gaap:SeriesAPreferredStockMember 2012-06-30 0000087050 us-gaap:SeriesBPreferredStockMember 2012-06-30 0000087050 country:SE 2012-06-30 0000087050 country:US 2012-06-30 0000087050 neond:VasakronanFastigheterAbMember 2012-06-30 0000087050 us-gaap:CommonStockMember 2012-06-30 0000087050 neond:FutureLicenseFeesFromOneCustomerMember 2012-06-30 0000087050 neond:September2007InvestorWarrantMember 2012-06-30 0000087050 neond:August2009EmployeeWarrantsMember 2012-06-30 0000087050 neond:January2010InvestorWarrantMember 2012-06-30 0000087050 neond:DebtExtensionWarrantsMember 2012-06-30 0000087050 neond:September2010RepricingWarrantMember 2012-06-30 0000087050 neond:October2010RepricingWarrantsMember 2012-06-30 0000087050 neond:October2010EmployeeWarrantsMember 2012-06-30 0000087050 neond:December2010EmployeeWarrantsMember 2012-06-30 0000087050 neond:January2011EmployeeWarrantMember 2012-06-30 0000087050 neond:February2011LegalAdvisorWarrantMember 2012-06-30 0000087050 neond:March2011InvestorWarrantsMember 2012-06-30 0000087050 neond:March2011InvestorWarrantsOneMember 2012-06-30 0000087050 neond:May2011ConsultantWarrantMember 2012-06-30 0000087050 neond:September2011EmployeeWarrantMember 2012-06-30 0000087050 us-gaap:StockOptionsMember 2012-06-30 0000087050 us-gaap:WarrantMember 2012-06-30 0000087050 neond:PicnicMember 2012-06-30 0000087050 neond:StockOptionsAndWarrantsMember 2012-06-30 0000087050 neond:VasakronanFastigheterAbOneMember 2012-06-30 0000087050 2012-08-07 0000087050 us-gaap:WarrantMember 2011-12-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure iso4217:EUR 27642000 25039000 32969000 32889000 P3Y P5Y Neonode, Inc 0000087050 false --12-31 10-Q 2012-06-30 2012 Q2 Yes Smaller Reporting Company 33003782 12940000 11275000 3345000 1725000 234000 327000 16519000 13327000 108000 332000 16627000 13659000 447000 351000 601000 776000 1906000 1500000 1543000 1400000 2954000 2670000 2954000 2670000 33000 33000 142955000 145314000 13000 -15000 -129328000 -134343000 13673000 10989000 16627000 13659000 2000000 444541 54425 1000000 444541 54425 0.001 0.001 0.001 0.001 83 114 83 95 83 114 83 95 0.001 0.001 0.001 0.001 848000000 70000000 70000000 70000000 0.001 0.001 32778993 32972631 32778993 32972631 283000 822000 1974000 3138000 238000 393000 494000 743000 45000 429000 1480000 2395000 382000 658000 1478000 2165000 363000 715000 1718000 2517000 921000 1785000 1691000 2686000 1666000 3158000 4887000 7368000 -1621000 -2729000 -3407000 -4973000 81000 135000 -1014000 -9568000 -1095000 -9703000 -2716000 -12432000 -3407000 -4973000 6000 11000 20000 42000 -2722000 -12443000 -3427000 -5015000 27642 25039 32969 32889 -21000 18000 -72000 -28000 -2743000 -12425000 -3499000 -5043000 183000 472000 472000 2317000 2351000 2351000 10000 40000 2961000 -1623000 -160000 87000 2535000 -363000 -3048000 -1373000 25000 268000 -25000 -268000 4228000 491000 515000 8000 4718000 8000 3000 -32000 1648000 -1665000 911000 2559000 12940000 11275000 90000 4000 42000 4228000 35000 120000 2860000 13379000 <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">1. Interim Period Reporting</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The unaudited interim condensed consolidated financial statements, include all adjustments, consisting of normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the financial position and results of operations and cash flows for the interim periods. The results of operations for the three and six months ended June 30, 2012 are not necessarily indicative of expected results for the full 2012 fiscal year.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying condensed consolidated financial statements as of June 30, 2012 and for the three and six months ended June 30, 2012 and 2011 have been prepared by us, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally contained in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted.&#160;&#160;These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes contained in our consolidated financial statements and the notes thereto for the fiscal year ended December&#160;31, 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Operations</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Neonode Inc., &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, the &#8220;Company&#8221;, develops and licenses MultiSensing <font style="display: inline; font-size: 70%; vertical-align: text-top;">TM</font> touch user interfaces and optical multi-touch solutions. The cornerstone of our interface solutions is zForce&#174;, our patented touch technology. Neonode licenses the Neonode MultiSensing <font style="display: inline; font-size: 70%; vertical-align: text-top;">TM</font> touch technology to Original Equipment Manufacturers (&#8220;OEMs&#8221;) and Original Design Manufacturers (&#8220;ODMs&#8221;) who embed our technology into devices that they produce and sell. Our solution is currently being integrated into products such as mobile phones, e-Readers and tablets, printers and office equipment, toys and gaming consoles, automotive and in-vehicle infotainment systems.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;<font style="display: inline; font-weight: bold;">Intellectual Property</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We rely on a combination of intellectual property laws, as well as confidentiality procedures and contractual provisions, to protect our proprietary technology and our brand. We have registered, and applied for the registration of, U.S. and international trademarks, service marks, domain names, and copyrights. Additionally, we have filed U.S. and international patent applications covering certain of our proprietary technology. Over time, we have assembled a portfolio of patents, trademarks, service marks, copyrights, domain names, and trade secrets covering our products and services. Our proprietary technology is not dependent on any single patent or copyright or groups of related patents or copyrights. We believe the duration of our patents is adequate relative to the expected lives of our products. Although we rigorously protect our proprietary technology, any significant impairment of, or third-party claim against, our intellectual property rights could harm our business or our ability to compete.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">2.</font> <font style="display: inline; font-weight: bold;">Summary of Significant Accounting Policies</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fiscal Year</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our fiscal year is the calendar year.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Principles of Consolidation</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include the accounts of Neonode Inc. and its wholly owned Swedish subsidiary, Neonode Technologies AB. All inter-company accounts and transactions have been eliminated in consolidation.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;<font style="font-style: italic; display: inline; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Estimates</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectability of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets, the fair value of embedded derivatives,&#160;and the fair value of securities, such as options and warrants issued for stock-based compensation and in certain financing transactions.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash and Cash Equivalents</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We have not had any liquid investments other than normal cash deposits with banking institutions to date.&#160; If in the future the Company purchases cash equivalents, the Company will consider all highly liquid investments with original maturities of three months of less to be cash equivalents.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Cash Balance Risks</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash balances are maintained at various banks in the U.S. and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;), which provides basic deposit coverage with limits up to $250,000 per owner. In addition to the basic insurance deposit coverage, the FDIC is providing temporary unlimited coverage for noninterest bearing transaction accounts through December 31, 2012. The Swedish government provides insurance coverage up to 100,000 Euro per customer and covers deposits in all types of accounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to the deposits. As of June 30, 2012, the Company has approximately $10.4 million in excess of insurance limits.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounts Receivable and Allowance for Doubtful Accounts&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectability of our trade receivable balances based on a combination of factors.&#160;When a customer&#8217;s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer&#8217;s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance for all customers based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.&#160;&#160;We determined that an allowance for doubtful accounts was not necessary at June 30, 2012 or December 31, 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Debt Issuance Costs</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Debt issuance costs represent costs incurred in connection with the issuance of the convertible notes payable. Debt issuance costs are amortized over the term of the financing instrument on a straight-line basis, which approximates the effective interest method.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" > <div > <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Property and Equipment</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets ranging from three to five years as follows:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: center;"> <table style="text-align: center; width: 50%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: center;" bgcolor="#cceeff"> <td style="text-align: justify;" valign="top" width="28%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Computer equipment</font></div> </td> <td style="text-align: justify;" valign="top" width="15%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3 years</font></div> </td> </tr> <tr bgcolor="white"> <td style="text-align: justify;" valign="top" width="28%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Furniture and fixtures</font></div> </td> <td style="text-align: justify;" valign="top" width="15%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5 years</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Long-lived Assets</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.&#160;&#160;At June 30, 2012, we believe there is no impairment of our long-lived assets. There can be no assurance, however, that market conditions will not change or sufficient commercial demand for our products and services will materialize, which could result in impairment of long-lived assets in the future.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Foreign Currency Translation and Transaction Gains and Losses</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The functional currency of our foreign subsidiary is the applicable local currency, the Swedish Krona. The translation from Swedish Krona to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive income (loss). Gains or (losses) resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $73,000 and $8,000 during the three months ended June 30, 2012 and 2011, respectively, and $11,000 and $(57,000) during the six months ended June 30, 2012 and 2011, respectively. Foreign currency translation gain (loss) was $(72,000) and $(21,000) for the three months ended June 30, 2012 and 2011, respectively, and was $(28,000) and $18,000 for the six months ended June 30, 2012 and 2011, respectively.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline; font-weight: bold;">Liability for Warrants and Embedded Derivatives</font> <font style="display: inline; font-weight: bold;">&#160;</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We do not enter into derivative contracts for purposes of risk management or speculation. &#160;However, from time to time, we enter into contracts that are not considered derivative financial instruments in their entirety but that include embedded derivative features, such as conversion features. Such embedded derivatives are assessed at inception of the contract and every reporting period, depending on their characteristics, are accounted for as separate derivative financial instruments pursuant to accounting guidance, if such embedded conversion features, if freestanding, would meet the classification of a liability. Accounting guidance requires that we analyze all material contracts and determine whether or not they contain embedded derivatives. Any such embedded conversion features that meet the above criteria are then bifurcated from their host contract and recorded on the consolidated balance sheet at fair value and the&#160;changes in the fair value of these derivatives are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features and warrants.</font></div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" > <div > <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Similarly, if warrants meet the criteria in accordance with accounting guidance to be classified as liabilities, then the fair value of the warrants are recorded on the consolidated balance sheet at their fair values, and any changes in such fair values are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company&#8217;s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Credit and Business Risks</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the short term, we anticipate that we will depend on a limited number of customers for substantially all of our future revenue. Failure to anticipate or respond adequately to technological developments in our industry, changes in customer or supplier requirements or changes in regulatory requirements or industry standards, or any significant delays in the development or introduction of products or services, could have a material adverse effect on our business, operating results and cash flows.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of June 30, 2012 was due from eleven customers, three of which accounted for 84% of our accounts receivable as of June 30, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our net revenues for the three months ended June 30, 2012 was earned from twelve customers. Our customers are located in the U.S., Europe and Asia. Customers who accounted for 10% or more of our net revenues during the three months ended June 30, 2012 are as follows:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amazon - 53%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Kobo - 11%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679; &#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation - 11%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our net revenues for the six months ended June 30, 2012 was earned from sixteen customers. Customers who accounted for 10% or more of our net revenues during the six months ended June 30, 2012 are as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amazon&#160;&#160;- 53%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation &#8211; 13%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of December 31, 2011 was due from five customers, two of which accounted for 87% of our accounts receivable as of December 31, 2011. <font style="display: inline;">Our net revenues for the three months ended June 30, 2011 was earned from five customers, four of which accounted for approximately 99% of our total net revenues for the three months ended June 30, 2011. Our net revenues for the six months ended June 30, 2011 was earned from six customers, one of which accounted for approximately 71% of our net revenues for the six months ended June 30, 2011. Our customers are located in the US, Europe and Asia.</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="margin-left: 36pt;" ></font>Risks and Uncertainties</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our long-term success is dependent on our obtaining sufficient capital to fund our operations and to develop our products, and on our bringing such products to the worldwide market and obtaining sufficient sales volume to be profitable. To achieve these objectives, we may be required to raise additional capital through public or private financings or other arrangements. It cannot be assured that such financings will be available on terms attractive to us, if at all. Such financings may be dilutive to our stockholders and may contain restrictive covenants.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We are subject to certain risks common to technology-based companies in similar stages of development. Principal risks include risks relating to the uncertainty of market acceptance for our products, a history of losses since inception, our ability to remain competitive in response to new technologies, the costs to defend, as well as risks of losing patents and intellectual property rights, on our future customers ability to develop and sell products that incorporate our technology, the concentration of our operations in a limited number of facilities, the uncertainty of demand for our products in certain markets, our ability to manage growth effectively, our dependence on key members of our management and development team, our limited experience in conducting operations internationally, and our ability to obtain adequate capital to fund future operations.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We are exposed to a number of economic and industry factors that could result in portions of our technology becoming obsolete or not gaining market acceptance. These factors include, but are not limited to, technological changes in our markets, our ability to meet changing customer requirements, competitive pressures in products and prices, and the ability of our customers to manufacture and sell their products that incorporate our technology.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A significant portion of our business is conducted in currencies other than the U.S. dollar (the currency in which its financial statements are reported), primarily the Swedish Krona and, to a lesser extent, the Euro. We incur a significant portion of our expenses in Swedish Krona, including a significant portion of our product development expenses and a substantial portion of our general and administrative expenses. As a result, appreciation of the value of the Swedish Krona relative to the other currencies, particularly the U.S. dollar, could adversely affect operating results. We do not currently undertake hedging transactions to cover our currency exposure, but we may choose to hedge a portion of our currency exposure in the future as deemed appropriate.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our future success depends on market acceptance of our technology as well as our ability to introduce new versions of our technology to meet the evolving needs of our customers.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Revenue Recognition</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Engineering Services:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.&#160;&#160;Generally, we recognize revenue as the engineering services stipulated under the contact are completed and accepted by our customers.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; <font style="font-style: italic; display: inline;">&#160;</font></font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Licensing Revenues:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We also derive revenue from the licensing of internally developed intellectual property (&#8220;IP&#8221;). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and&#160;royalties payable following the sale by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. As of September 30, 2011, Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company&#8217;s customers.&#160;&#160;&#160;For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize new technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) customer distributes or license the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Prior to September 30, 2011, we deferred the technology license fee revenue until such time as the warranty period stipulated in the license agreement expired because we did not have sufficient historical experience in estimating potential warranty costs.&#160; From June 2010 to September 30, 2011, we entered into 12 technology license contracts with customers.&#160; During that time there were no warranty related costs incurred for any customer products after they have been released to market.&#160; During the quarter ended September 30, 2011, the Company performed an analysis and determined that it had sufficient historical evidence regarding estimated warranty costs and therefore began recognizing technology license fee revenues, net of warranty costs, if any, as the products incorporating the Neonode technology are distributed or licensed by our customers, assuming all other revenue recognition criteria has been met.&#160; Our customers report to us the quantities of products distributed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Explicit return rights are not offered to customers. There have been no returns through June 30, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Hardware Products:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may from time-to-time develop custom hardware products for our customers that incorporate our touchscreen technology. Our policy is to recognize revenue from hardware product sales when title transfers and risk of loss has passed to the customer, which is generally upon shipment of our hardware products to our customers. We will estimate expected sales returns and record the amount as a reduction of revenue and cost of hardware and other revenue at the time of shipment. To date, we have not sold any hardware products.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Software Products:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may derive revenues from software licensing sales.&#160;&#160;We will account for the licensing of software in accordance with accounting guidance and such guidance requires judgment, including whether a software arrangement includes multiple elements, and if so, whether vendor-specific objective evidence (&#8220;VSOE&#8221;) of fair value exists for those elements.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For software license arrangements that do not require significant modification or customization of the underlying software, we will recognize new software license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of software; (2) we deliver the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We allocate revenues to all deliverables based on their relative selling price using a specific hierarchy. The hierarchy is as follows: vendor-specific objective evidence (&#8220;VSOE&#8221;), third-party evidence of selling price (&#8220;TPE&#8221;) or best estimate of selling price (&#8220;BESP&#8221;).</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When a sale involves multiple elements, we will allocate the entire fee from the arrangement to each respective element based on VSOE of fair value and recognize revenue when each element&#8217;s revenue recognition criteria are met. VSOE of fair value for each element is established based on the price charged when the same element is sold separately. We have established VSOE for our software licenses based on historical stand-alone sales to third parties or from the stated renewal rates contained in the customer contracts. Maintenance service revenue is recognized on a straight-line basis over the support period.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We have not yet demonstrated VSOE for the professional services that are rendered in conjunction with our software license sales. In accordance with the hierarchy we would attempt to establish the selling price of professional services using TPE. Our product contains significant differentiation such that the comparable pricing of products with similar functionality cannot be obtained. We are typically not able to obtain TPE for professional services.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When we are unable to establish selling prices using VSOE or TPE, we use BESP. The objective of BESP is to determine the price at which we would transact a sale if professional services were sold on a stand-alone basis. BESP is generally used for offerings that are not typically sold on a stand-alone basis or for highly customized offerings.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We will also continue to defer revenues that represent undelivered post-delivery engineering support until the engineering support has been completed and the software product is accepted. To date, we have not sold any software products.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Deferred Revenue</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. The Company defers these revenues until the services have been provided or until the license fees are earned.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Advertising</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Advertising costs are expensed as incurred. Advertising costs for the three and six months ended June 30, 2012 and 2011 amounted to approximately $85,000 and $29,000 and $282,000 and $74,000, respectively.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Product Research and Development</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Research and development (&#8220;R&amp;D&#8221;) costs are expensed as incurred. R&amp;D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock-Based Compensation Expense</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We measure the cost of employee services received in exchange for an award of equity instruments, including share options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We account for equity instruments issued to non-employees at their fair value and the unvested portion is re-measured each reporting period as long as the instrument requires variable accounting.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounting for Debt Issued with Detachable Stock Purchase Warrants and Beneficial Conversion Features</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We account for debt issued with stock purchase warrants by allocating the proceeds of the debt between the debt and the detachable warrants based on the relative fair values of the debt security without the warrants and the warrants themselves, if the warrants are equity instruments.&#160;&#160;&#160;The relative fair value of the warrants are recorded as a debt discount and amortized to expense over the life of the related debt using the effective interest method. At each balance sheet date, we make a determination if these warrant instruments should be classified as liabilities or equity, and reclassify them if the circumstances dictate.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In certain instances, the Company enters into convertible notes that provide for an effective or actual rate of conversion that is below market value, and the embedded conversion feature does not qualify for derivative treatment (a &#8220;BCF&#8221;).&#160;&#160;In these instances, we account for the value of the BCF as a debt discount, which is then amortized to expense over the life of the related debt using the straight-line method which approximates the effective interest method.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Income Taxes</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the &#8220;not more likely than not&#8221; criteria of the accounting guidance.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" > <div > <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of June 30, 2012 and December 31, 2011. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such a determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes payable for the current period.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.&#160;&#160;As a result, we did not recognize a liability for unrecognized tax benefits.&#160;&#160;As of June 30, 2012 and December 31, 2011, we had no unrecognized tax benefits.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Net Loss Per Share</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for three and six months ended June 30, 2012 and 2011 exclude the potential common stock equivalents, as the effect would be anti-dilutive&#160;(See Note 10).</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Comprehensive Income (Loss)</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Accounting Standards Codification (&#8220;ASC&#8221;) Topic 220<font style="font-style: italic; display: inline;">, Comprehensive Income,</font> &#160;&#160;establishes standards for reporting and displaying comprehensive income (loss) and its components in the condensed consolidated financial statements. Accumulated other comprehensive income (loss) includes foreign currency translation gains or losses as a result of consolidation.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; <font style="font-style: italic; display: inline; font-weight: bold;">&#160;</font></font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash Flow Information</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations was 6.95 and 6.26 Swedish Krona to one U.S. Dollar for the three months ended June 30, 2012 and 2011, respectively. The weighted-average exchange rate for the condensed consolidated statements of operations was 6.85 and 6.34 Swedish Krona to one U.S. Dollar for the six months ended June 30, 2012 and 2011, respectively. The exchange rate for the condensed consolidated balance sheets was 6.96 and 6.92 Swedish Krona to one U.S. Dollar as of June 30, 2012 and December 31, 2011, respectively.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We disclose the estimated fair values for all financial instruments for which it is practicable to estimate fair value. Financial instruments including cash and cash equivalents, accounts receivable, payables and accrued expenses are deemed to approximate fair value due to their short maturities.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">New Accounting Pronouncements</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In May 2011, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Updates (&#8220;ASU&#8221;) No.&#160;2011-4, <font style="font-style: italic; display: inline;">Fair Value Measurement</font> ("ASU 2011-04"). ASU 2011-04 amends existing guidance to achieve convergence in measurement and disclosure between U.S. GAAP and International Financial Reporting Standards ("IFRS"). ASU 2011-04 is effective for fiscal year 2012. The adoption of ASU 2011-04 did not impact the Company&#8217;s results of operations or its financial position.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In June 2011, the FASB issued ASU No. 2011-05, &#160; <font style="font-style: italic; display: inline;">Presentation of Comprehensive Income</font> (&#8220;ASU 2011-05&#8221;).&#160; The provisions of ASU 2011-05 allow an entity the option to present the total of comprehensive income (loss), the components of net income (loss), and the components of other comprehensive income (loss) either in a single continuous statement of comprehensive income (loss) or in two separate but consecutive statements.&#160; In both choices, an entity is required to present each component of net income (loss) along with total net income (loss), each component of other comprehensive income (loss) along with a total for other comprehensive income (loss), and a total amount for comprehensive income (loss).&#160; The statement(s) are required to be presented with equal prominence as the other primary financial statements.&#160; ASU No. 2011-05 eliminates the option to present the components of other comprehensive income (loss) as part of the statement of changes in stockholders&#8217; equity but does not change the items that must be reported in other comprehensive income (loss) or when an item of other comprehensive income (loss) must be reclassified to net income (loss).&#160; Certain provisions of ASU No. 2011-05 are effective for the Company&#8217;s interim reporting period beginning on or after December 15, 2011, with retrospective application required.&#160; The adoption of ASU No. 2011-05&#160;resulted in presentation changes to the Company&#8217;s consolidated statements of operations and the addition of separate consolidated statements of comprehensive income (loss).&#160; The adoption of ASU No. 2011-05 did not impact the Company&#8217;s results of operations or its financial position.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">3.&#160;Convertible Debt</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Senior Convertible Secured Notes- 2007</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">At December 31, 2011, all of convertible promissory notes (&#8220;Senior Convertible Secured Notes-2007&#8221;) have been converted in shares of our common stock. The Senior Convertible Secured Notes &#8211; 2007 were originally due August 26, 2010. On September 22, 2010, we entered into a debt modification agreement with the two holders of an aggregate of $126,362 of convertible promissory notes that were due on August 26, 2010. Based on the terms of the modification, this transaction qualified as debt extinguishment accounting under the relevant accounting guidance. As part of the debt extinguishment, the maturity date of the convertible promissory notes was extended until April 26, 2011. We entered into a debt-for-equity repayment plan whereby we were retiring the convertible promissory notes in equal installments by issuing our common stock priced at a 15% discount from the average market closing price for the five days ending on the 25th of each month over the eight month period beginning September 26, 2010 ending on April 26, 2011.&#160;&#160;The holders of the notes had the right to convert the outstanding balance priced at $2.25 per share if the market value of our common stock is greater than $2.50 per share for five consecutive days.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the six months ended June 30, 2011, we issued the note holders 31,570 shares of our common stock pursuant to the debt-for-equity repayment plan and retired the remaining note principal balance on April 26, 2011. We recorded $84,657 of note principal reduction and $1,054 of interest payment.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">September 2009 Senior Convertible Secured Notes Financing transaction</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the period from August 25, 2009 through December 15, 2009, we completed a private placement of convertible notes totaling $987,000 that were converted, at the holder&#8217;s option, into shares of our common stock at a conversion price of $0.50 per share (the &#8220;Convertible Notes - 2009&#8221;).&#160;&#160;The convertible note holders had the right to have the conversion price adjusted to equal the lower stock price if we issued common stock or convertible notes at a lower conversion price than $0.50 per share during the period that the notes were outstanding. The Convertible Notes - 2009 that were originally due on December 31, 2010 were extended to June 30, 2011 (see below under Warrant Repricing and Debt Extension Financing Transaction &#8211; 2010) and bore annual interest rate of 7%, payable on June 30 and December 31 of each year that the convertible notes were outstanding. In addition, we issued 986,983 three-year warrants to the convertible note holders with an exercise price of $1.00 per share. The warrants may be exercised and converted to common stock, at the warrant holder&#8217;s option, beginning on the six-month anniversary of the date of issuance until the warrant expiration date.&#160; <font style="display: inline;">As a result of the conversions and repayments during the six months ended June 30, 2011, the Company reclassified approximately $4.6 million of the related derivative liabilities to additional paid-in capital. As of June 30, 2011, the fair value of the remaining embedded conversion features was $0 due to the repayment or conversion of all the Convertible Notes - 2009. The Company recorded a loss of $2.3 million due to the change in the fair value of the embedded conversion features of these Convertible Notes &#8211; 2009 during the six months ended June 30, 2011.</font> As of June 30, 2011, all of the Convertible Notes &#8211; 2009 have been paid in full with cash or have been converted to shares of our common stock<font style="display: inline; font-family: times new roman;">.</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The embedded conversion feature of the Convertible Notes &#8211; 2009 met the definition of a derivative financial instrument and was classified as a liability in accordance with relevant accounting guidance. The note holders had the right to convert the debt into shares of our common stock, and the notes included price protection whereby these notes were protected for as long as the notes remained outstanding against future private placements made at lower share prices, and therefore, the total number of shares of our common stock that the convertible notes can be convertible into was not fixed. The embedded conversion features were revalued on each balance sheet date and marked-to-market with the change recorded to non-cash items related to debt discounts, deferred financing fees and the valuation of conversion features and warrants on the consolidated statements of operations.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three and six months ended June 30, 2011 we recorded a total of $15,000 in interest expense related to the principal balance of the Convertible Notes &#8211; 2009.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Senior Convertible Secured Notes- 2010</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the period from January through June 30, 2010, we received $1,597,000 in cash proceeds and converted $163,000 of accounts payable related to a private placement of convertible notes (the &#8220;Convertible Notes &#8211; 2010&#8221;) and stock purchase warrants that were convertible, at the holder&#8217;s option, into shares of our common stock at a conversion price of $0.50 per share and we issued 1,760,712 stock purchase warrants that had an exercise price of $1.00 per share. The convertible note holders had the right to have the conversion price adjusted to equal the lower stock price if we issued stock or convertible notes at a lower conversion price than $0.50 during the period that the notes were outstanding. These convertible notes were originally due on December 31, 2010 and were extended to June 30, 2011(see below under Warrant Repricing and Debt Extension Financing Transaction &#8211; 2010) and bore annual interest rate of 7%, payable on June 30 and December 31 of each year that the convertible notes were outstanding. The warrants may be exercised and converted to common stock, at the warrant holder&#8217;s option, beginning on the six-month anniversary date of issuance until the warrant expiration date. We are not obligated to register the common stock related to the convertible debt or the warrants. During the year ended December 31, 2011, we issued 3,557,171 shares of our common stock to holders of Convertible Notes &#8211; 2010 who converted principal of $1,750,143 and $28,442 of related accrued interest. As of December 31, 2011, all of the Convertible Notes &#8211; 2010 have been converted to shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three and six months ended June 30, 2011 we recorded a total of $28,000&#160;in interest expense related to the principal balance of the Convertible Notes &#8211; 2010.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The embedded conversion feature of the convertible debt issued in the 2010 convertible debt financing transaction met the definition of a derivative financial instrument and was classified as a liability in accordance with accounting guidance. The note holders had the right to convert the debt into shares of our common stock, and the notes included price protection whereby these notes were protected for as long as the notes remain outstanding against future private placements made at lower share prices, and therefore, the total number of shares of our common stock that the convertible notes may be convertible into was not fixed. The embedded conversion features were revalued on each balance sheet date and marked to market with the increase or decrease included in fair value to non-cash items related to debt discounts and deferred financing fees and the valuation of conversion features and warrants on the condensed consolidated statements of operations. <font style="display: inline;">As a result of the conversions during the six months ended June 30, 2011, the Company reclassified approximately $8.7 million of the related derivative liabilities to additional paid-in capital. As of June 30, 2011, all of the Convertible Notes &#8211; 2010 have been converted to shares of our common stock. As of June 30, 2011, the fair value of the remaining embedded conversion features is $0 as all the Convertible Notes &#8211; 2010 were converted. The Company recorded a loss of approximately $4.3 million due to the change in the fair value of the embedded conversion feature of these Convertible Notes &#8211; 2010 during the six months ended June 30, 2011.</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Senior Convertible Secured Notes- 2011</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In March 2011, we received $3.7 million in cash proceeds and commitments for an additional $491,000 related to a private placement of convertible notes, bearing interest at a rate of seven percent (7%) per annum, that matured on March 1, 2014, and that could be converted at the holder&#8217;s option into 1,691,320 shares of our common stock at a conversion price of $2.50 per share (the &#8220;Convertible Secured Notes &#8211; 2011&#8221;). The Company received the $491,000 in cash proceeds related to the unpaid commitments in April and May 2011. The notes would automatically be converted into shares of the Company&#8217;s common stock in the event that on or before the note due date either (a) the Company&#8217;s common stock is traded at a price per share of $6.25 or higher for five (5) consecutive trading days, or (b) the Company consummates a financing in the amount of at least $5 million.&#160;&#160;In the event that the loan principal and accrued interest was not repaid by the Company by the due date, and the investor has not previously converted the note, the investor&#8217;s sole remedy for such non-payment shall be the payment of additional annual interest at a rate of 10% per year.&#160;&#160;The accrued interest was payable in stock, using the $2.50 conversion price, or cash, at the holder&#8217;s option, on June 30 and December 31 of each year.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In addition,&#160;&#160;as of March 31, 2011,the Company issued 373,730 new five-year common stock purchase warrants, with an exercise price of $3.13 per share (the &#8220;March 2011 Warrants&#8221;), with each investor receiving a number of March 2011 Warrants that was equal&#160;&#160;to twenty-five percent (25%) of the investor&#8217;s note to the Company.&#160;&#160;The Company issued an additional 49,100 warrants in April 2011 related to the collection of the payment totaling $491,000. The March 2011 Warrants may be exercised by cash payment or through cashless exercise by the surrender of warrant shares having a value equal to the exercise price of the portion of the warrants being exercised.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In connection with the March 2011 financing transaction the Company valued the warrants issued to the convertible note holders on a relative fair value basis using the Black-Scholes option pricing model, totaling $813,000. This relative fair value of the warrants was recorded as a debt discount. The embedded conversion features to the notes was determined to meet the definition of a derivative liability and as of the date of issuance was valued at $4.1 million. In accordance with relevant accounting guidance, the Company recorded an additional debt discount ($2.9 million) up to the full amount of the notes, recorded the derivative liability for the embedded conversion feature at $4.1 million and recorded the fair value in excess of face amount of debt as interest expense on the issuance date of $1.2 million. The debt discount was amortized in full upon the conversion of the notes to common stock on December 14, 2011. As of December 31, 2011, the fair value of the embedded conversion feature was $0 due to the conversion of all the Senior Convertible Secure Notes &#8211; 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;" ></font>On June 30, 2011, the Company issued 27,851 shares of unregistered common stock to note holders of the Senior Convertible Secured Notes &#8211; 2011 private placement financing transaction in lieu of cash for their $69,628 accrued interest payment that was due June 30, 2011. In addition, the Company paid $10,277 of the accrued interest in cash to note holders who declined to convert their interest payment to stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of June 30, 2011, the fair value of the embedded conversion feature was $6.2 million and as such, the Company recorded a loss on the change in fair value of the embedded conversion feature of $1.4 million, which is included in the accompanying consolidated condensed statement of operations as a component on non-cash items related to debt discounts, deferred financing fees and valuation of conversion features and warrants.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In October and November 2011, note holders of $575,000 of the original $4.2 million Senior Convertible Secure Notes &#8211; 2011 exercised their right to convert their notes and accrued interest and were issued 232,125 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On December 13, 2011, following a public offering pursuant to a Registration Statement on Form S-3, the Company received gross proceeds in excess of $5 million. Pursuant to the terms, as defined, in the Senior Convertible Secure Notes &#8211; 2011 agreements, the remaining outstanding principal balance&#160;plus accrued interest, was automatically converted into shares of common stock at a conversion price of $2.50 per share. In accordance with the terms of the agreement, the Company automatically converted approximately $3.7 million of remaining principal and approximately $130,000 of accrued interest into 1,513,237 shares of the Company&#8217;s common stock. In addition, the Company issued 99,461 shares of common stock related to the bonus interest feature associated with the mandatory conversion of the debt. As of December 31, 2011, the fair value of the embedded conversion features was $0. As of December 31, 2011, all of the Senior Convertible Secure Notes - 2011 plus accrued interest was paid or converted into shares of common stock.&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">4.</font> <font style="display: inline; font-weight: bold;">Stockholders&#8217; Equity</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On February 29, 2012, the Company filed a Certificate of Correction with the Secretary of State of Delaware effectively reducing the amount of its authorized shares from 848,000,000 shares of Common Stock and 2,000,000 shares of Preferred Stock to 70,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. This reflects the new capital structure of the Company following its 1-for-25 reverse split that became effective at the close of business on March 25, 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On May 1, 2012, the Company began trading its common stock on the NASDAQ Stock Market Capital Markets under trading symbol NEON.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Common Stock</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the six months ended June 30, 2012, Series B Preferred stockholders exchanged 19 shares of Series B Preferred stock for 2,509 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the six months ended June 30, 2012, a warrant holder exercised a warrant to purchase 21,000 shares of common stock using the net exercise provision allowed in the warrant and received 13,831 shares of our common stock. Another warrant holder exercised a warrant to purchase 2,500 shares of common stock and paid a cash exercise price of $3.13 per share for a total exercise price of $7,813.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Preferred Stock</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The terms of the Series A and Series B Preferred stock are as follows:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify;"> <table style="text-align: justify; width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify;"> <td style="text-align: justify; text-indent: 36pt;" valign="top" width="7%"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: symbol,serif; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></div> </td> <td style="text-align: justify;" valign="top" width="93%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Dividends and Distributions.</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify;"> <table style="text-align: justify; width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify;"> <td style="text-align: justify;" valign="top" width="7%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="text-align: justify;" valign="top" width="13%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series A Preferred:</font></div> </td> <td style="text-align: justify;" valign="top" width="80%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The holders of shares of Series A Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series A Preferred stock held by them.</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify;"> <table style="text-align: justify; width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify;"> <td style="text-align: justify;" valign="top" width="7%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="text-align: justify;" valign="top" width="13%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B Preferred:</font></div> </td> <td style="text-align: justify;" valign="top" width="80%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The holders of shares of Series B Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series B Preferred stock held by them.</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify;"> <table style="text-align: justify; width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify;"> <td style="text-align: justify; text-indent: 36pt;" valign="top" width="7%"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: symbol,serif; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></div> </td> <td style="text-align: justify;" valign="top" width="93%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Liquidation Preference.</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify;"> <table style="text-align: justify; width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify;"> <td style="text-align: justify;" valign="top" width="7%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="text-align: justify;" valign="top" width="13%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series A Preferred:</font></div> </td> <td style="text-align: justify;" valign="top" width="80%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of any other series of Preferred stock to be established by the Board of Directors (the &#8220;Senior Preferred Stock&#8221;), the holders of Series A Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series A Preferred stock then outstanding.</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" > <div > <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify;"> <table style="text-align: justify; width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify;"> <td style="text-align: justify;" valign="top" width="7%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="text-align: justify;" valign="top" width="14%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B Preferred:</font></div> </td> <td style="text-align: justify;" valign="top" width="79%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of the Series A Preferred stock and Senior Preferred Stock, the holders of Series B Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series B Preferred stock then outstanding.</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify;"> <table style="text-align: justify; width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: justify;"> <td style="text-align: justify; text-indent: 36pt;" valign="top" width="7%"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: symbol,serif; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></div> </td> <td style="text-align: justify;" valign="top" width="93%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Voting.</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The holders of shares of Series A Preferred stock and Series B Preferred stock shall have one vote for each share of Series A Preferred stock and Series B Preferred stock held by them.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td style="text-align: left; text-indent: 36pt;" valign="top" width="7%"> <div style="text-align: left; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: symbol,serif; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></div> </td> <td align="left" valign="top" width="93%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Conversion.</font></div> </td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Initially, each share of Series A Preferred stock and each share of Series B Preferred stock was convertible into one share of our common stock.&#160;&#160;Any modification to the conversion rate requires shareholder approval (see below). On March 31, 2009, our shareholders approved a resolution to increase the authorized share capital, and to increase the conversion ratio to 480.63 shares of common stock for each share of Series A Preferred stock and to 132.07 shares of our common stock for each shares of Series B Preferred stock, thus completing the restructuring begun in December 2008.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Conversion of Preferred Stock Issued to Common Stock</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 24, 2009, we initiated the process of allowing the shareholders of our preferred stock to convert the Series A and B Preferred stock to shares of our common stock. In order to convert the preferred stock to common stock each preferred stock shareholder is required to submit the preferred stock certificate to our transfer agent and request conversion to common stock. The conversion to common stock is not mandatory and shareholders who own preferred stock may choose not to convert their preferred stock to shares of our common stock.&#160;&#160;The following table summarizes the Preferred stock not yet converted as of June 30, 2012.</font></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Preferred Stock Not Exchanged as of June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Conversion Ratio</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series A Preferred stock</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">83</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">480.63</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">39,892</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B Preferred stock</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">95</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">132.07</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12,547</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total&#160;&#160;Remaining Not Exchanged</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">178</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">52,439</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">5.</font> <font style="display: inline; font-weight: bold;">Fair Value Measurement of Assets and Liabilities</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Accounting guidance defines fair value, establishes a framework for measuring fair value, and expands disclosure requirements about fair value measurements. The accounting guidance does not mandate any new fair-value measurements and is applicable to assets and liabilities that are required to be recorded at fair value under other accounting pronouncements.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The three levels of the fair-value hierarchy are described as follows:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Level&#160;1: Quoted prices (unadjusted) in active markets for identical assets and liabilities. As of June 30, 2012 and December 31, 2011, we had no level 1 assets or liabilities.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Level&#160;2: Inputs other than Level&#160;1 that are observable, either directly or indirectly. As of June 30, 2012 and December 31, 2011, we had no level 2 assets or liabilities.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Level&#160;3: Inputs other than Level&#160;1 that are observable, either directly or indirectly. As of June 30, 2012 and December 31, 2011, we had no level 3 assets or liabilities.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: center;" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the Six</font></font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Months Ended</font></font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2011</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Annual dividend yield</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected life (years)</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.08 &#8211; 3.0</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Risk-free interest rate</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.08%- 1.27%</font></div> </div> </td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> </div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected volatility</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">110% - 263%</font></div> </div> </td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> </div> </td> </tr> </table> </div> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The assumptions above were used to value warrants granted to employees and consultants as well as the embedded conversion features associated with convertible debt for the six months ended June 30, 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company&#8217;s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">6.&#160;Deferred Revenue</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Engineering development fees are recorded as deferred revenue until such time as the engineering services have been provided.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of June 30, 2012 and December 31, 2011, we have $1.4 million and $1.5 million, respectively, of deferred license fee revenue related to a prepayment for future license fees from one customer and a total of $0.1 million and $0.4 million, respectively, of deferred engineering development fees from four and four customers, respectively. We are deferring the engineering development fee revenue until such time as the engineering work has been completed.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">7.</font> <font style="display: inline; font-weight: bold;">Stock-Based Compensation</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We have three approved stock option plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. All employee and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants was based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock Options</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of June 30, 2012, we had two equity incentive plans:</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="text-indent: 36pt;" valign="top" width="7%"> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></font></div> </td> <td align="left" valign="top" width="93%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The 1998 Non-Officer Stock Option Plan (the 1998 Plan), which expired in June 2008 ;</font></div> </td> </tr> <tr> <td align="left" style="text-indent: 36pt;" valign="top" width="7%"> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></div> </td> <td align="left" valign="top" width="93%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The 2006 Equity Incentive Plan (the 2006 Plan). </font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We also had one non-employee director stock option plan as of June 30, 2012:</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="text-indent: 36pt;" valign="top" width="7%"> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></div> </td> <td align="left" valign="top" width="93%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The 2001 Non-Employee Director Stock Option Plan (the Director Plan), which expired in March 2011.</font></div> </td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A summary of the combined activity under all of the stock option plans is set forth below:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of Options Outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted Average Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at January 1, 2012</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">19,324</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">92.19</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Granted</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,460,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.26</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cancelled or expired</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(8,124</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">69.36</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercised</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">---</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">---</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at June 30, 2012</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,471,200</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.79</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td valign="bottom" colspan="3"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the Six</font></div> </td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="3"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Months Ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2012</font></div> </td> </tr> <tr> <td align="left" valign="bottom">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" valign="bottom" colspan="2">&#160;</td> <td align="left" valign="bottom">&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Annual dividend yield</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected life (years)</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.8</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Risk-free interest rate</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.55% - 0.57%</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected volatility</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">186% - 187%</font></div> </div> </td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> </div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The assumptions above were used to value stock options granted to employees and directors during the six months ended June 30, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The aggregate intrinsic value of the 1,471,200 stock options that are outstanding, vested and expected to vest at June 30, 2012 is $2.8 million.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The 1998 Plan terminated effective June 15, 2008 and the Director Plan terminated effective March 2011. Although we can no longer issue stock options out of the plans, the outstanding options at the date of termination will remain outstanding and vest in accordance with their terms. Options granted under the Director Plan vested over a one to four-year period, expire five to seven years after the date of grant and have exercise prices reflecting market value of the shares of our common stock on the date of grant. Stock options granted under the 1998 and 2006 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three and six months ended June 30, 2011, the Company recorded $35,000 and $70,000, respectively, of stock option expense related to the vesting of stock options.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We did not grant any options to purchase shares of our common stock to employees or members of our Board of Directors (Board) during the six months ended June 30, 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three months ended June 30, 2012, we granted 1.1 million options to purchase shares of our common stock to employees and 360,000 options to purchase shares of our common stock to members of our Board. The options have a 7-year life and 1/3 of the options vested on the date of grant with the remaining vesting monthly over the following 24-months. During the three and six months ended June 30, 2012, we recorded $2.3 million of stock based compensation expense related to vesting of such options.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Warrants</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On December 3, 2010, we issued 120,000 warrants at an exercise price of $1.625 per share to an employee. The fair value of the warrants was $198,000 on the date of grant, using the Black-Scholes option pricing model, which is to be amortized over 24 months. During the three and six months ended June 30, 2012 and 2011, we recorded $25,000 and $50,000, respectively, of stock based compensation expense related to vesting of such warrants.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We issued 80,000 five-year stock purchase warrants at an exercise price of $2.50 per share to our legal advisor during the six months ended June 30, 2011. We also issued 20,000 three-year stock purchase warrants at an exercise price or $2.00 per share to our US based employee during the six months ended June 30, 2011. The warrants to purchase an aggregate of 100,000 shares of our common stock vested on the date of grant. The vested warrants granted to the employee and legal advisor had an aggregate fair value on the date of grant of $230,000 and is included in general and administrative expense for the three and six months ended June 30, 2011. The fair value of stock-based compensation related to the employee warrants is calculated using the Black-Scholes option pricing model as of the grant date of the underlying warrant.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On September 12, 2011, we issued 20,000 warrants at an exercise price of $3.90 per share to an employee. The fair value of the warrants was $75,000 on the date of grant, using the Black-Scholes option pricing model, which is to be amortized over 24 months. During the three and six months ended June 30, 2012, we recorded $9,000 and $18,000, respectively, of stock based compensation expense related to vesting of such warrants.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The stock-based compensation expense reflects the fair value of the vested portion of options and warrants for the recipients at the date of issuance plus the amortization of the unvested portion of the stock options and warrants. Stock-based compensation expense related to stock options and warrants in the accompanying consolidated statements of operations is as follows (in thousands):</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three months</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2011</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three months</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="76%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock-based compensation</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">183</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,317</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><a name="fis_unidentified_table_7"></a><!--EFPlaceholder--></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Six months </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Six months </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30,</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining unamortized</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;expense at</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock-based compensation</font></div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">472</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,351</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,607</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The remaining unamortized expense related to stock options and warrants will be recognized on a straight line basis monthly as compensation expense over the remaining vesting period which approximates 22 months.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">See Note 5 for assumptions used to value warrants during the three and six months ended June 30, 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A summary of all warrant activity is set forth below:</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" > <div > <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="11"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 9.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Warrants</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercise </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="3"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Contractual </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Life</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 1, 2012</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,405,606</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.57</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.45</font></div> </td> <td align="left" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Issued</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Expired/forfeited</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Exercised</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(223,500</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.61</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable, June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,182,106</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.61</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.87</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three months ended June 30, 2012, a warrant holder exercised a warrant to purchase 21,000 shares of common stock using the net exercise provision allowed in the warrant and received 13,831 shares of our common stock. Another warrant holder exercised a warrant to purchase 2,500 shares of common stock and paid a cash exercise price of $3.13 per share for a total exercise price of $7,813.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term and forfeiture rate of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior, as well as expected behavior on outstanding options. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of our stock price. These factors could change in the future, which would affect fair values of stock options granted in such future periods, and could cause volatility in the total amount of the stock-based compensation expense reported in future periods.</font></div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><a name="fis_unidentified_table_9"></a><!--EFPlaceholder--></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="99%" colspan="10"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 23.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Below is a summary of Outstanding Warrants to Purchase</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 23.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Common Stock as of June 30, 2012:</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Description</font></div> </td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Issue&#160;&#160;Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Expiration Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2007 Investor Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/26/2007</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">31.75</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">233</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/26/2012</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">August 2009 Employee Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2009</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.50</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">240,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 2010 Investor Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/28/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">40,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/28/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2007 Debt Extension Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2015</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2010 Repricing Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Repricing Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,434,830</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Employee Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,440,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 2010 Employee Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.63</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">200,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2015</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 2011 Employee Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2014</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">February 2011 Legal Advisor Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">80,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">617,943</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">49,100</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">May 2011 Consultant Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.05</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2014</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2011 Employee Warrant</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.90</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2014</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Total Warrants Outstanding</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">5,182,106</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">8.&#160;Commitments and Contingencies</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Indemnities and Guarantees</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We have agreed to indemnify each of our executive officers and directors for certain events or occurrences arising as a result of the officer or director serving in such capacity. The term of the indemnification period is for the officer's or director's lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited.&#160;&#160;However, we have directors&#8217; and officers&#8217; liability insurance policy that should enable us to recover a portion of future amounts paid. As a result of our insurance policy coverage, we believe the estimated fair value of these indemnification agreements is minimal and have no liabilities recorded for these agreements as of June 30, 2012 and December 31, 2011, respectively.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We enter into indemnification provisions under our agreements with other companies in the ordinary course of business, typically with business partners, contractors, customers and<font style="display: inline; text-decoration: line-through;">&#160;</font>landlords. Under these provisions we generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of our activities or, in some cases, as a result of the indemnified party's activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by us with regard to intellectual property rights. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is unlimited. We have not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the estimated fair value of these agreements is minimal. Accordingly, we have no liabilities recorded for these agreements as of June 30, 2012 and December 31, 2011, respectively.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline;">Operating Leases</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,207 square feet of office space located at Linnegatan 89, Stockholm, Sweden for approximately $6,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $72,000 per year including property tax (excluding VAT). This lease has a notice period of 3 months.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,723 square feet of office space located at Linnegatan 89D, Stockholm, Sweden for approximately $8,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $93,000 per year including property tax (excluding VAT). This lease is valid through December 31, 2014, with a 9-month notice period. The contract will be extended for an additional 3 years if it is not terminated according to the terms in the contract.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 18, 2011, we entered into a twelve month lease with CA-Santa Clara Office Center Limited Partnership for 1,718 square feet of office space located at 2700 Augustine Drive, Suite 100, Santa Clara, California, USA for $2,647 per month. The lease expired on April 30, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 22, 2012, we entered into a three year lease with 2350 Mission Investors LLC for&#160;3,185 square feet of office space located at 2350 Mission College Blvd, Suite 190, Santa Clara, CA 95054&#160;USA commencing May 1, 2012. The initial lease payment is approximately $7,000 per month, increasing to approximately $7,700 per month over the term of the lease. The annual payment for this space equates to approximately $84,000 per year including property taxes.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 15, 2012, Neonode Technologies AB entered into a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $13,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $161,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2013.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">9.&#160;</font> <font style="display: inline; font-weight: bold;">Segment Information</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The Company has one reportable segment, which is comprised of the touchscreen technology licensing business. All of our sales for the three and six months ended June 30, 2012 and 2011 were to customers located in the U.S., Europe and Asia.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The following table presents net revenues by geographic region for the three and six months ended June 30, 2012 and 2011 (dollars in thousands):</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><a name="fis_unidentified_table_10"></a><!--EFPlaceholder--></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Three months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Three months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,218</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">62</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">130</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">46</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made outside of the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">756</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">38</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">153</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">54</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,974</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">283</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="middle" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="22%" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Six months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="22%" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Six months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, </font><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">64</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">130</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made outside of the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,138</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">36</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">692</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">84</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,138</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">822</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" valign="middle" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">10.</font> <font style="display: inline; font-weight: bold;">Net Loss Per Share</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Basic net loss per common share for the three and six months ended June 30, 2012 and 2011 was computed by dividing the net loss for the relevant period by the weighted average number of shares of common stock outstanding. Diluted earnings per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock and common stock equivalents outstanding.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Potential common stock equivalents of 103,000 and zero stock options outstanding under the treasury stock method, 3.4 million and 5.4 million outstanding stock warrants under the treasury stock method, 52,000 and 55,000 shares issuable upon conversion of preferred stock and zero and 1.7 million shares issuable upon conversion of notes are excluded from the diluted earnings per share calculation for the six months ended June 30, 2012 and 2011, respectively, due to their anti-dilutive effect.&#160;</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three Months ended</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: 2px solid black;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(in thousands, except per share amounts)</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30,</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">BASIC AND DILUTED</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average number of</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">common shares outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,969</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">27,642</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of shares for computation of</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">net loss per share</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,969</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">27,642</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,427</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,722</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share - basic and diluted</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.10</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.10</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Six Months ended</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: 2px solid black;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(in thousands, except per share amounts)</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30,</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">BASIC AND DILUTED</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average number of</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">common shares outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,889</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">25,039</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of shares for computation of</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">net loss per share</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,889</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">25,039</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(5,015</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(12,443</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share - basic and diluted</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.15</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.50</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> </table> </div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;"></font></font>&#160;</div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">11.</font> <font style="display: inline; font-weight: bold;">Subsequent Events</font></font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We have evaluated subsequent events through the filing date of this Form 10-Q, and have determined that no&#160;subsequent events have occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fiscal Year</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our fiscal year is the calendar year.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Principles of Consolidation</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include the accounts of Neonode Inc. and its wholly owned Swedish subsidiary Neonode Technologies AB. All inter-company accounts and transactions have been eliminated in consolidation.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Estimates</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectability of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets, the fair value of embedded derivatives,&#160;and the fair value of securities, such as options and warrants issued for stock-based compensation and in certain financing transactions.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash and Cash Equivalents</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We have not had any liquid investments other than normal cash deposits with banking institutions to date.&#160; If in the future the Company purchases cash equivalents, the Company will consider all highly liquid investments with original maturities of three months of less to be cash equivalents.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Credit and Business Risks</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the short term, we anticipate that we will depend on a limited number of customers for substantially all of our future revenue. Failure to anticipate or respond adequately to technological developments in our industry, changes in customer or supplier requirements or changes in regulatory requirements or industry standards, or any significant delays in the development or introduction of products or services, could have a material adverse effect on our business, operating results and cash flows.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of June 30, 2012 was due from eleven customers, three of which accounted for 84% of our accounts receivable as of June 30, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our net revenues for the three months ended June 30, 2012 was earned from twelve customers. Our customers are located in the U.S., Europe and Asia. Customers who accounted for 10% or more of our net revenues during the three months ended June 30, 2012 are as follows:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt;; font-family:symbol, serif"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amazon - 53%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt;; font-family:symbol, serif"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Kobo - 11%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt;; font-family:symbol, serif"><font style="display: inline; font-family: times new roman;">&#9679; &#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation - 11%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our net revenues for the six months ended June 30, 2012 was earned from sixteen customers. Customers who accounted for 10% or more of our net revenues during the six months ended June 30, 2012 are as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt;; font-family:symbol, serif"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amazon&#160;&#160;- 53%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 54pt;"> <div><font style="display: inline; font-size: 10pt;; font-family:symbol, serif"><font style="display: inline; font-family: times new roman;">&#9679;</font>&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation &#8211; 13%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of December 31, 2011 was due from five customers, two of which accounted for 87% of our accounts receivable as of December 31, 2011. <font style="display: inline;">Our net revenues for the three months ended June 30, 2011 was earned from five customers, four of which accounted for approximately 99% of our total net revenues for the three months ended June 30, 2011. Our net revenues for the six months ended June 30, 2011 was earned from six customers, one of which accounted for approximately 71% of our net revenues for the six months ended June 30, 2011. Our customers are located in the US, Europe and Asia.</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Debt Issuance Costs</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Debt issuance costs represent costs incurred in connection with the issuance of the convertible notes payable. Debt issuance costs are amortized over the term of the financing instrument on a straight-line basis, which approximates the effective interest method.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Property and Equipment</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets ranging from three to five years as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 55%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr bgcolor="#cceeff"> <td align="left" valign="top" width="28%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Computer equipment</font></div> </td> <td align="left" valign="top" width="15%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3 years</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="top" width="28%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Furniture and fixtures</font></div> </td> <td align="left" valign="top" width="15%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5 years</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Foreign Currency Translation and Transaction Gains and Losses</font></div> <font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The functional currency of our foreign subsidiary is the applicable local currency, the Swedish Krona. The translation from Swedish Krona to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive income (loss). Gains or (losses) resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $73,000 and $8,000 during the three months ended June 30, 2012 and 2011, respectively, and $11,000 and $(57,000) during the six months ended June 30, 2012 and 2011, respectively. Foreign currency translation gain (loss) was $(72,000) and $(21,000) for the three months ended June 30, 2012 and 2011, respectively, and was $(28,000) and $18,000 for the six months ended June 30, 2012 and 2011, respectively.</font></div> <font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Long-lived Assets</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.&#160;&#160;At June 30, 2012, we believe there is no impairment of our long-lived assets. There can be no assurance, however, that market conditions will not change or sufficient commercial demand for our products and services will materialize, which could result in impairment of long-lived assets in the future.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline; font-weight: bold;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="font-style: italic; display: inline; font-weight: bold;">Liability for Warrants and Embedded Derivatives</font> <font style="display: inline; font-weight: bold;">&#160;</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We do not enter into derivative contracts for purposes of risk management or speculation. &#160;However, from time to time, we enter into contracts that are not considered derivative financial instruments in their entirety but that include embedded derivative features, such as conversion features. Such embedded derivatives are assessed at inception of the contract and every reporting period, depending on their characteristics, are accounted for as separate derivative financial instruments pursuant to accounting guidance, if such embedded conversion features, if freestanding, would meet the classification of a liability. Accounting guidance requires that we analyze all material contracts and determine whether or not they contain embedded derivatives. Any such embedded conversion features that meet the above criteria are then bifurcated from their host contract and recorded on the consolidated balance sheet at fair value and the&#160;changes in the fair value of these derivatives are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features and warrants.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Similarly, if warrants meet the criteria in accordance with accounting guidance to be classified as liabilities, then the fair value of the warrants are recorded on the consolidated balance sheet at their fair values, and any changes in such fair values are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company&#8217;s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Cash Balance Risks</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash balances are maintained at various banks in the U.S. and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;), which provides basic deposit coverage with limits up to $250,000 per owner. In addition to the basic insurance deposit coverage, the FDIC is providing temporary unlimited coverage for noninterest bearing transaction accounts through December 31, 2012. The Swedish government provides insurance coverage up to 100,000 Euro per customer and covers deposits in all types of accounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to the deposits. As of June 30, 2012, the Company has approximately&#160;$10.4 million in excess of insurance limits.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Revenue Recognition</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Engineering Services:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.&#160;&#160;Generally, we recognize revenue as the engineering services stipulated under the contact are completed and accepted by our customers.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; <font style="font-style: italic; display: inline;">&#160;</font></font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Licensing Revenues:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We also derive revenue from the licensing of internally developed intellectual property (&#8220;IP&#8221;). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and&#160;royalties payable following the sale by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. As of September 30, 2011, Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company&#8217;s customers.&#160;&#160;&#160;For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize new technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) customer distributes or license the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Prior to September 30, 2011, we deferred the technology license fee revenue until such time as the warranty period stipulated in the license agreement expired because we did not have sufficient historical experience in estimating potential warranty costs.&#160; From June 2010 to September 30, 2011, we entered into 12 technology license contracts with customers.&#160; During that time there were no warranty related costs incurred for any customer products after they have been released to market.&#160; During the quarter ended September 30, 2011, the Company performed an analysis and determined that it had sufficient historical evidence regarding estimated warranty costs and therefore began recognizing technology license fee revenues, net of warranty costs, if any, as the products incorporating the Neonode technology are distributed or licensed by our customers, assuming all other revenue recognition criteria has been met.&#160; Our customers report to us the quantities of products distributed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Explicit return rights are not offered to customers. There have been no returns through June 30, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Hardware Products:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may from time-to-time develop custom hardware products for our customers that incorporate our touchscreen technology. Our policy is to recognize revenue from hardware product sales when title transfers and risk of loss has passed to the customer, which is generally upon shipment of our hardware products to our customers. We will estimate expected sales returns and record the amount as a reduction of revenue and cost of hardware and other revenue at the time of shipment. To date, we have not sold any hardware products.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Software Products:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may derive revenues from software licensing sales.&#160;&#160;We will account for the licensing of software in accordance with accounting guidance and such guidance requires judgment, including whether a software arrangement includes multiple elements, and if so, whether vendor-specific objective evidence (&#8220;VSOE&#8221;) of fair value exists for those elements.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For software license arrangements that do not require significant modification or customization of the underlying software, we will recognize new software license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of software; (2) we deliver the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We allocate revenues to all deliverables based on their relative selling price using a specific hierarchy. The hierarchy is as follows: vendor-specific objective evidence (&#8220;VSOE&#8221;), third-party evidence of selling price (&#8220;TPE&#8221;) or best estimate of selling price (&#8220;BESP&#8221;).</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When a sale involves multiple elements, we will allocate the entire fee from the arrangement to each respective element based on VSOE of fair value and recognize revenue when each element&#8217;s revenue recognition criteria are met. VSOE of fair value for each element is established based on the price charged when the same element is sold separately. We have established VSOE for our software licenses based on historical stand-alone sales to third parties or from the stated renewal rates contained in the customer contracts. Maintenance service revenue is recognized on a straight-line basis over the support period.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We have not yet demonstrated VSOE for the professional services that are rendered in conjunction with our software license sales. In accordance with the hierarchy we would attempt to establish the selling price of professional services using TPE. Our product contains significant differentiation such that the comparable pricing of products with similar functionality cannot be obtained. We are typically not able to obtain TPE for professional services.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When we are unable to establish selling prices using VSOE or TPE, we use BESP. The objective of BESP is to determine the price at which we would transact a sale if professional services were sold on a stand-alone basis. BESP is generally used for offerings that are not typically sold on a stand-alone basis or for highly customized offerings.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We will also continue to defer revenues that represent undelivered post-delivery engineering support until the engineering support has been completed and the software product is accepted. To date, we have not sold any software products.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" > <div > <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Deferred Revenue</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. The Company defers these revenues until the services have been provided or until the license fees are earned.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Advertising</font></div> <font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Advertising costs are expensed as incurred. Advertising costs for the three and six months ended June 30, 2012 and 2011 amounted to approximately $85,000 and $29,000 and $282,000 and $74,000, respectively.</font></div> <font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font></font> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Product Research and Development</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Research and development (&#8220;R&amp;D&#8221;) costs are expensed as incurred. R&amp;D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.</font></div> 2010-12-31 2010-12-31 2014-03-01 2010-08-26 126362 2011-06-30 2011-06-30 2011-04-26 <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock-Based Compensation Expense</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We measure the cost of employee services received in exchange for an award of equity instruments, including share options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We account for equity instruments issued to non-employees at their fair value and the unvested portion is re-measured each reporting period as long as the instrument requires variable accounting.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounting for Debt Issued with Detachable Stock Purchase Warrants and Beneficial Conversion Features</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We account for debt issued with stock purchase warrants by allocating the proceeds of the debt between the debt and the detachable warrants based on the relative fair values of the debt security without the warrants and the warrants themselves, if the warrants are equity instruments.&#160;&#160;&#160;The relative fair value of the warrants are recorded as a debt discount and amortized to expense over the life of the related debt using the effective interest method. At each balance sheet date, we make a determination if these warrant instruments should be classified as liabilities or equity, and reclassify them if the circumstances dictate.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In certain instances, the Company enters into convertible notes that provide for an effective or actual rate of conversion that is below market value, and the embedded conversion feature does not qualify for derivative treatment (a &#8220;BCF&#8221;).&#160;&#160;In these instances, we account for the value of the BCF as a debt discount, which is then amortized to expense over the life of the related debt using the straight-line method which approximates the effective interest method.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Income Taxes</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the &#8220;not more likely than not&#8221; criteria of the accounting guidance.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of&#160;June 30, 2012 and December 31, 2011. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such a determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes payable for the current period.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We follow&#160;the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.&#160;&#160;As a result, we did not recognize a liability for unrecognized tax benefits.&#160;&#160;As of June 30, 2012 and December 31, 2011, we had no unrecognized tax benefits.</font></div> 15% discount from the average market closing price for the five days ending on the 25th of each month over the eight month period beginning September 26, 2010 ending on April 26, 2011. <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Net Loss Per Share</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for three and six months ended June 30, 2012 and 2011 exclude the potential common stock equivalents, as the effect would be anti-dilutive&#160;(See Note 10).</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Comprehensive Income (Loss)</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Accounting Standards Codification (&#8220;ASC&#8221;) Topic 220<font style="font-style: italic; display: inline;">, Comprehensive Income,</font> &#160;&#160;establishes standards for reporting and displaying comprehensive income (loss) and its components in the condensed consolidated financial statements. Accumulated other comprehensive income (loss) includes foreign currency translation gains or losses as a result of consolidation.</font></div> 0.15 <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Fair Value of Financial Instruments</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We disclose the estimated fair values for all financial instruments for which it is practicable to estimate fair value. Financial instruments including cash and cash equivalents, accounts receivable, payables and accrued expenses are deemed to approximate fair value due to their short maturities.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">New Accounting Pronouncements</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In May 2011, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Updates (&#8220;ASU&#8221;) No.&#160;2011-4, <font style="font-style: italic; display: inline;">Fair Value Measurement</font> ("ASU 2011-04"). ASU 2011-04 amends existing guidance to achieve convergence in measurement and disclosure between U.S. GAAP and International Financial Reporting Standards ("IFRS"). ASU 2011-04 is effective for fiscal year 2012. The adoption of ASU 2011-04 did not impact the Company&#8217;s results of operations or its financial position.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In June 2011, the FASB issued ASU No. 2011-05, &#160; <font style="font-style: italic; display: inline;">Presentation of Comprehensive Income</font> (&#8220;ASU 2011-05&#8221;).&#160; The provisions of ASU 2011-05 allow an entity the option to present the total of comprehensive income (loss), the components of net income (loss), and the components of other comprehensive income (loss) either in a single continuous statement of comprehensive income (loss) or in two separate but consecutive statements.&#160; In both choices, an entity is required to present each component of net income (loss) along with total net income (loss), each component of other comprehensive income (loss) along with a total for other comprehensive income (loss), and a total amount for comprehensive income (loss).&#160; The statement(s) are required to be presented with equal prominence as the other primary financial statements.&#160; ASU No. 2011-05 eliminates the option to present the components of other comprehensive income (loss) as part of the statement of changes in stockholders&#8217; equity but does not change the items that must be reported in other comprehensive income (loss) or when an item of other comprehensive income (loss) must be reclassified to net income (loss).&#160; Certain provisions of ASU No. 2011-05 are effective for the Company&#8217;s interim reporting period beginning on or after December 15, 2011, with retrospective application required.&#160; The adoption of ASU No. 2011-05&#160;resulted in presentation changes to the Company&#8217;s consolidated statements of operations and the addition of separate consolidated statements of comprehensive income (loss).&#160; The adoption of ASU No. 2011-05 did not impact the Company&#8217;s results of operations or its financial position.</font></div> Convert the outstanding balance priced at $2.25 per share if the market value of our common stock is greater than $2.50 per share for five consecutive days 2.25 2.50 31570 3557171 P3Y P5Y <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 55%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr bgcolor="#cceeff"> <td align="left" valign="top" width="28%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Computer equipment</font></div> </td> <td align="left" valign="top" width="15%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3 years</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="top" width="28%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Furniture and fixtures</font></div> </td> <td align="left" valign="top" width="15%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5 years</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> 0.50 0.50 2.50 2.50 10400000 0.07 0.07 0.07 0.07 0.07 1760712 373730 49100 986983 200000 200000 100000 21000 1.00 3.13 1.00 3.13 31.75 0.50 1.00 1.00 1.38 1.38 1.38 1.63 2.00 2.00 3.13 3.13 4.05 3.90 0 4100000 4600000 8700000 0.87 4300000 1400000 0 0 6200000 0 0 12 P30D P45D 0 1-for-25 19 2509 One vote for each share One vote for each share 178 83 95 52439 39892 12547 P29D P3Y 0.0008 0.0127 1.10 2.63 29000 74000 85000 282000 0 0 6.26 6.34 6.95 6.85 163000 19324 1471200 5182106 5405606 1460000 -8124 -223500 (a) the Company's common stock is traded at a price per share of $6.25 or higher for five (5) consecutive trading days, or (b) the Company consummates a financing in the amount of at least $5 million 0.10 4.26 92.19 6.79 1.61 1.57 Each investor receiving a number of March 2011 Warrants that was equal to twenty-five percent (25%) of the investor's note to the Company 0.61 <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-indent: 0pt; display: block;"><br />&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of Options Outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted Average Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at January 1, 2012</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">19,324</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">92.19</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Granted</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,460,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.26</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cancelled or expired</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(8,124</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">69.36</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercised</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">---</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">---</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at June 30, 2012</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,471,200</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">6.79</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three months ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2011</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three months ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2012</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="70%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock-based compensation</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="12%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">183</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="12%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$2,317</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><a name="fis_unidentified_table_7"></a></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Six months ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Six months ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining unamortized expense at</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="55%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock-based compensation</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">472</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,351</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,607</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> 2900000 3607000 1200000 813000 575000 4200000 232125 1513237 5000000 99461 P1Y10M13D P2Y5M12D <div style="text-indent: 0pt; display: block;">&#160; <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="11"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 9.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Warrants</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercise </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="3"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Contractual </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Life</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 1, 2012</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,405,606</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.57</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.45</font></div> </td> <td align="left" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Issued</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Expired/forfeited</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Exercised</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(223,500</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.61</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable, June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5,182,106</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.61</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.87</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="top" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> P12M P3Y P3M P9M 2647 7700 84000 13000 161000 6000 72000 8000 93000 1718 3185 2207 2853 2723 P3Y 2012-04-30 2013-04-15 2014-12-31 174798 13831 480.63 132.07 <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" > <div > <div align="right" style="width: 100%;" ><font style="display: inline; font-family: times new roman; font-size: 8pt;">&#160; </font></div> </div> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Preferred Stock Not Exchanged as of</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Conversion Ratio</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="55%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series A Preferred stock</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">83</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">480.63</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">39,892</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="55%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B Preferred stock</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">95</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">132.07</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12,547</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="55%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total&#160;&#160;Remaining Not Exchanged</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">178</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="12%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="12%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">52,439</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> 5182106 233 240000 40000 16000 4000 2434830 1440000 200000 20000 80000 617943 49100 20000 20000 2007-09-26 2009-08-25 2010-01-28 2010-09-22 2010-09-28 2010-10-18 2010-10-15 2010-12-03 2011-01-21 2011-02-22 2011-03-09 2011-04-07 2011-05-17 2011-09-12 2012-09-26 2016-08-25 2013-01-28 2015-09-22 2013-09-28 2013-10-18 2013-10-15 2015-12-03 2014-01-21 2016-02-22 2016-03-09 2016-04-07 2014-05-17 2014-09-12 2 1 1471200 P4Y P1Y P4Y P1Y 1.00 0.46 0.54 1.00 0.16 0.84 1.00 0.62 0.38 0.53 0.11 0.11 1.00 0.64 0.36 0.53 0.13 <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-indent: 0pt; display: block;"><br />&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three Months ended</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: 2px solid black;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(in thousands, except per share amounts)</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30,</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">BASIC AND DILUTED</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average number of</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">common shares outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,969</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">27,642</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of shares for computation of</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">net loss per share</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,969</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">27,642</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,427</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(2,722</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share - basic and diluted</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.10</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.10</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Six Months ended</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: 2px solid black;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">(in thousands, except per share amounts)</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30,</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">BASIC AND DILUTED</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average number of</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">common shares outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,889</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">25,039</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of shares for computation of</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">net loss per share</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,889</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">25,039</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(5,015</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(12,443</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share - basic and diluted</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.15</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.50</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </td> </tr> </table> </div> 27642000 25039000 32969000 32889000 -0.10 -0.50 -0.10 -0.15 2800000 35000 25000 70000 50000 2300000 25000 9000 2300000 50000 18000 P7Y P5Y P10Y 120000 80000 80000 20000 20000 198000 75000 230000 P24M P24M P22M <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounts Receivable and Allowance for Doubtful Accounts&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectability of our trade receivable balances based on a combination of factors.&#160;When a customer&#8217;s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer&#8217;s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance for all customers based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.&#160;&#160;We determined that an allowance for doubtful accounts was not necessary at June 30, 2012 or December 31, 2011.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash Flow Information</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations was 6.95 and 6.26 Swedish Krona to one U.S. Dollar for the three months ended June 30, 2012 and 2011, respectively. The weighted-average exchange rate for the condensed consolidated statements of operations&#160;was 6.85 and 6.34 Swedish Krona to one U.S. Dollar for the six months ended June 30, 2012 and 2011, respectively. The exchange rate for the condensed consolidated balance sheets was 6.96 and 6.92 Swedish Krona to one U.S. Dollar as of June 30, 2012 and December 31, 2011, respectively.</font></div> 100000 250000 8000 -57000 73000 11000 6.92 6.96 987000 1597000 3700000 P2Y6M P5Y P3Y <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"></font>&#160;</div> <div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: center;" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the Six</font></font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Months Ended</font></font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2011</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Annual dividend yield</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected life (years)</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.08 &#8211; 3.0</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Risk-free interest rate</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.08%- 1.27%</font></div> </div> </td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> </div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected volatility</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">110% - 263%</font></div> </div> </td> </tr> </table> </div> </div> 7000 1.625 2.50 2.00 3.90 3.13 70000 96000 25000 1000 27851 2500 13831 7813 0.99 0.71 0.10 0.10 69.36 <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><a name="fis_unidentified_table_9"></a><!--EFPlaceholder--></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="99%" colspan="10"></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Description</font></div> </td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Issue&#160;&#160;Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 2.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Expiration Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2007 Investor Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/26/2007</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">31.75</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">233</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/26/2012</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">August 2009 Employee Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2009</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.50</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">240,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 2010 Investor Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/28/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">40,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/28/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2007 Debt Extension Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2015</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2010 Repricing Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Repricing Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,434,830</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Employee Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,440,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 2010 Employee Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2010</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.63</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">200,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2015</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 2011 Employee Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2014</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">February 2011 Legal Advisor Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">80,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">617,943</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">49,100</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2016</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">May 2011 Consultant Warrant</font></div> </td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2011</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.05</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2014</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2011 Employee Warrant</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.90</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2014</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Total Warrants Outstanding</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="10%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="10%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">5,182,106</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> 1100000 360000 P24M P7Y 0.3333 21000 2500 7813 5 11 5 6 12 16 4 1 3700000 84657000 1750143 130000 15000 28000 1054000 15000 28000 28442 Beginning on the six-month anniversary of the date of issuance until the warrant expiration date. Beginning on the six-month anniversary of the date of issuance until the warrant expiration date. 491000 6.25 5000000 1691320 69628 400000 400000 100000 100000 3 283000 130000 153000 822000 130000 692000 1974000 1218000 756000 3138000 2000000 1138000 <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><br />&#160;</div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><a name="fis_unidentified_table_10"></a><!--EFPlaceholder--></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Three months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Three months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,218</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">62</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">130</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">46</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made outside of the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">756</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">38</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">153</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">54</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,974</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">283</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="middle" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="22%" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Six months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, 2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="22%" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Six months ended </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 5.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">June 30, </font><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2011</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">64</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">130</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues made outside of the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,138</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">36</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">692</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">84</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="52%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,138</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">822</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" valign="middle" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> 1 0 5400000 55000 1700000 103000 3400000 52000 0 0.84 <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"></font>&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Risks and Uncertainties</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our long-term success is dependent on our obtaining sufficient capital to fund our operations and to develop our products, and on our bringing such products to the worldwide market and obtaining sufficient sales volume to be profitable. To achieve these objectives, we may be required to raise additional capital through public or private financings or other arrangements. It cannot be assured that such financings will be available on terms attractive to us, if at all. Such financings may be dilutive to our stockholders and may contain restrictive covenants.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We are subject to certain risks common to technology-based companies in similar stages of development. Principal risks include risks relating to the uncertainty of market acceptance for our products, a history of losses since inception, our ability to remain competitive in response to new technologies, the costs to defend, as well as risks of losing patents and intellectual property rights, on our future customers ability to develop and sell products that incorporate our technology, the concentration of our operations in a limited number of facilities, the uncertainty of demand for our products in certain markets, our ability to manage growth effectively, our dependence on key members of our management and development team, our limited experience in conducting operations internationally, and our ability to obtain adequate capital to fund future operations.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We are exposed to a number of economic and industry factors that could result in portions of our technology becoming obsolete or not gaining market acceptance. These factors include, but are not limited to, technological changes in our markets, our ability to meet changing customer requirements, competitive pressures in products and prices, and the ability of our customers to manufacture and sell their products that incorporate our technology.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A significant portion of our business is conducted in currencies other than the U.S. dollar (the currency in which its financial statements are reported), primarily the Swedish Krona and, to a lesser extent, the Euro. We incur a significant portion of our expenses in Swedish Krona, including a significant portion of our product development expenses and a substantial portion of our general and administrative expenses. As a result, appreciation of the value of the Swedish Krona relative to the other currencies, particularly the U.S. dollar, could adversely affect operating results. We do not currently undertake hedging transactions to cover our currency exposure, but we may choose to hedge a portion of our currency exposure in the future as deemed appropriate.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our future success depends on market acceptance of our technology as well as our ability to introduce new versions of our technology to meet the evolving needs of our customers.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> P3Y9M18D 0.0055 0.0057 1.86 1.87 <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-indent: 0pt; display: block;"><br />&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td valign="bottom" colspan="3"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the Six</font></div> </td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td align="left" style="padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="3"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Months Ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">June 30, 2012</font></div> </td> </tr> <tr> <td align="left" valign="bottom">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" valign="bottom" colspan="2">&#160;</td> <td align="left" valign="bottom">&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Annual dividend yield</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected life (years)</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.8</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Risk-free interest rate</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.55% - 0.57%</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Expected volatility</font></div> </div> </td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">186% - 187%</font></div> </div> </td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> </div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> EX-101.SCH 6 neond-20120630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 001 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Interim Period Reporting link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Convertible Debt link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Fair Value Measurement of Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Deferred Revenue link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Fair Value Measurement of Assets and Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Convertible Debt (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Stockholders' Equity (Details Textual) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Fair Value Measurement of Assets and Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Deferred Revenue (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Stock-Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Stock-Based Compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Stock-Based Compensation (Details 3) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Stock-Based Compensation (Details 4) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Stock-Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Segment Information (Details Textual) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Net Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Net Loss Per Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 neond-20120630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 neond-20120630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 neond-20120630_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT EX-101.PRE 10 neond-20120630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Revenues by geographic region        
Net revenues $ 1,974 $ 283 $ 3,138 $ 822
Percentage 100.00% 100.00% 100.00% 100.00%
U.S. [Member]
       
Revenues by geographic region        
Net revenues 1,218 130 2,000 130
Percentage 62.00% 46.00% 64.00% 16.00%
Outside of U.S. [Member]
       
Revenues by geographic region        
Net revenues $ 756 $ 153 $ 1,138 $ 692
Percentage 38.00% 54.00% 36.00% 84.00%
XML 12 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 1)
6 Months Ended
Jun. 30, 2012
Summary of assumptions used to value stock options granted to employees and directors  
Annual dividend yield   
Expected life (years) 3 years 9 months 18 days
Risk-free interest rate, Minimum 0.55%
Risk-free interest rate, Maximum 0.57%
Expected volatility, Minimum 186.00%
Expected volatility, Maximum 187.00%
XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Details)
6 Months Ended
Jun. 30, 2012
Computer Equipment [Member]
 
Estimated useful life of assets  
Useful lives 3 years
Furniture and Fixtures [Member]
 
Estimated useful life of assets  
Useful lives 5 years
XML 15 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share (Details Textual)
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Potential Common Stock [Member]
   
Net Loss Per Share (Textual)    
Antidilutive securities excluded from computation of earnings per share 103,000 0
Warrant [Member]
   
Net Loss Per Share (Textual)    
Antidilutive securities excluded from computation of earnings per share 3,400,000 5,400,000
Convertible Preferred Stock [Member]
   
Net Loss Per Share (Textual)    
Antidilutive securities excluded from computation of earnings per share 52,000 55,000
Conversion of notes [Member]
   
Net Loss Per Share (Textual)    
Antidilutive securities excluded from computation of earnings per share 0 1,700,000
XML 16 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details Textual) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Sep. 30, 2011
Dec. 31, 2010
Jun. 30, 2012
Jun. 30, 2012
Mar. 16, 2012
Sep. 12, 2011
Jun. 30, 2012
Stock Options [Member]
Jun. 30, 2011
Stock Options [Member]
Jun. 30, 2012
Stock Options [Member]
Jun. 30, 2011
Stock Options [Member]
Sep. 30, 2011
Warrant [Member]
Dec. 31, 2010
Warrant [Member]
Jun. 30, 2012
Warrant [Member]
Jun. 30, 2011
Warrant [Member]
Jun. 30, 2012
Warrant [Member]
Jun. 30, 2011
Warrant [Member]
Sep. 12, 2011
Warrant [Member]
Dec. 03, 2010
Warrant [Member]
Jun. 30, 2012
September 2011 Warrant [Member]
Jun. 30, 2012
September 2011 Warrant [Member]
Jun. 30, 2011
Five Year Stock Purchase Warrants [Member]
Jun. 30, 2011
Five Year Stock Purchase Warrants [Member]
Jun. 30, 2011
Three Year Stock Purchase Warrants [Member]
Jun. 30, 2012
2001 Non-Employee Director Stock Option Plan [Member]
Minimum [Member]
Jun. 30, 2012
2001 Non-Employee Director Stock Option Plan [Member]
Maximum [Member]
Jun. 30, 2012
1998 Non Officer Stock Option Plan and Equity Incentive Plan [Member]
Minimum [Member]
Jun. 30, 2012
1998 Non Officer Stock Option Plan and Equity Incentive Plan [Member]
Maximum [Member]
Stock Based Compensation (Textual)                                                      
Options outstanding, vested and expected to vest, aggregate intrinsic value             $ 2,800,000   $ 2,800,000                                    
Options outstanding, vested and expected to vest, outstanding, number             1,471,200   1,471,200                                    
Stock option vesting period                                               1 year 4 years 1 year 4 years
Stock option expiration period                                               5 years 7 years   10 years
Share-based compensation expense             2,300,000 35,000 2,300,000 70,000     25,000 25,000 50,000 50,000     9,000 18,000              
Warrant issued in period                     20,000 120,000                 80,000 80,000 20,000        
Fair value of warrants           75,000             230,000   230,000     198,000                  
Common stock issuable upon exercise of warrants     100,000 100,000 200,000                                            
Excercise price of warrants per share     $ 3.13 $ 3.13                         $ 3.90 $ 1.625     $ 2.50 $ 2.50 $ 2.00        
Number of approved stock option plans       3                                              
Number of equity incentive plans       2                                              
Number of non-employee director stock option plan       1                                              
Options granted to purchase of common stock to employee     1,100,000                                                
Options granted to purchase of common stock to members of Board     360,000                                                
Options life       7 years                                              
Number of options vesting on grant date       0.3333                                              
Vesting period of options following grant date       24 months                                              
Amortized period of warrants 24 months 24 months                                                  
Remaining vesting period of warrants       22 months                                              
Warrant exercised to purchase common stock one     21,000 21,000                                              
Warrant exercised to purchase common stock two     2,500 2,500                                              
Conversion of warrant into common stock, shares converted     13,831 13,831 174,798                                            
Warrant total excercise price     $ 7,813                                                
XML 17 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Convertible Debt
6 Months Ended
Jun. 30, 2012
Debt Disclosure [Abstract]  
Convertible Debt
 
3. Convertible Debt
 
Senior Convertible Secured Notes- 2007
 
At December 31, 2011, all of convertible promissory notes (“Senior Convertible Secured Notes-2007”) have been converted in shares of our common stock. The Senior Convertible Secured Notes – 2007 were originally due August 26, 2010. On September 22, 2010, we entered into a debt modification agreement with the two holders of an aggregate of $126,362 of convertible promissory notes that were due on August 26, 2010. Based on the terms of the modification, this transaction qualified as debt extinguishment accounting under the relevant accounting guidance. As part of the debt extinguishment, the maturity date of the convertible promissory notes was extended until April 26, 2011. We entered into a debt-for-equity repayment plan whereby we were retiring the convertible promissory notes in equal installments by issuing our common stock priced at a 15% discount from the average market closing price for the five days ending on the 25th of each month over the eight month period beginning September 26, 2010 ending on April 26, 2011.  The holders of the notes had the right to convert the outstanding balance priced at $2.25 per share if the market value of our common stock is greater than $2.50 per share for five consecutive days.
 
During the six months ended June 30, 2011, we issued the note holders 31,570 shares of our common stock pursuant to the debt-for-equity repayment plan and retired the remaining note principal balance on April 26, 2011. We recorded $84,657 of note principal reduction and $1,054 of interest payment.
 
September 2009 Senior Convertible Secured Notes Financing transaction
 
During the period from August 25, 2009 through December 15, 2009, we completed a private placement of convertible notes totaling $987,000 that were converted, at the holder’s option, into shares of our common stock at a conversion price of $0.50 per share (the “Convertible Notes - 2009”).  The convertible note holders had the right to have the conversion price adjusted to equal the lower stock price if we issued common stock or convertible notes at a lower conversion price than $0.50 per share during the period that the notes were outstanding. The Convertible Notes - 2009 that were originally due on December 31, 2010 were extended to June 30, 2011 (see below under Warrant Repricing and Debt Extension Financing Transaction – 2010) and bore annual interest rate of 7%, payable on June 30 and December 31 of each year that the convertible notes were outstanding. In addition, we issued 986,983 three-year warrants to the convertible note holders with an exercise price of $1.00 per share. The warrants may be exercised and converted to common stock, at the warrant holder’s option, beginning on the six-month anniversary of the date of issuance until the warrant expiration date.  As a result of the conversions and repayments during the six months ended June 30, 2011, the Company reclassified approximately $4.6 million of the related derivative liabilities to additional paid-in capital. As of June 30, 2011, the fair value of the remaining embedded conversion features was $0 due to the repayment or conversion of all the Convertible Notes - 2009. The Company recorded a loss of $2.3 million due to the change in the fair value of the embedded conversion features of these Convertible Notes – 2009 during the six months ended June 30, 2011. As of June 30, 2011, all of the Convertible Notes – 2009 have been paid in full with cash or have been converted to shares of our common stock.
  
The embedded conversion feature of the Convertible Notes – 2009 met the definition of a derivative financial instrument and was classified as a liability in accordance with relevant accounting guidance. The note holders had the right to convert the debt into shares of our common stock, and the notes included price protection whereby these notes were protected for as long as the notes remained outstanding against future private placements made at lower share prices, and therefore, the total number of shares of our common stock that the convertible notes can be convertible into was not fixed. The embedded conversion features were revalued on each balance sheet date and marked-to-market with the change recorded to non-cash items related to debt discounts, deferred financing fees and the valuation of conversion features and warrants on the consolidated statements of operations.
 
During the three and six months ended June 30, 2011 we recorded a total of $15,000 in interest expense related to the principal balance of the Convertible Notes – 2009.
 
Senior Convertible Secured Notes- 2010
 
During the period from January through June 30, 2010, we received $1,597,000 in cash proceeds and converted $163,000 of accounts payable related to a private placement of convertible notes (the “Convertible Notes – 2010”) and stock purchase warrants that were convertible, at the holder’s option, into shares of our common stock at a conversion price of $0.50 per share and we issued 1,760,712 stock purchase warrants that had an exercise price of $1.00 per share. The convertible note holders had the right to have the conversion price adjusted to equal the lower stock price if we issued stock or convertible notes at a lower conversion price than $0.50 during the period that the notes were outstanding. These convertible notes were originally due on December 31, 2010 and were extended to June 30, 2011(see below under Warrant Repricing and Debt Extension Financing Transaction – 2010) and bore annual interest rate of 7%, payable on June 30 and December 31 of each year that the convertible notes were outstanding. The warrants may be exercised and converted to common stock, at the warrant holder’s option, beginning on the six-month anniversary date of issuance until the warrant expiration date. We are not obligated to register the common stock related to the convertible debt or the warrants. During the year ended December 31, 2011, we issued 3,557,171 shares of our common stock to holders of Convertible Notes – 2010 who converted principal of $1,750,143 and $28,442 of related accrued interest. As of December 31, 2011, all of the Convertible Notes – 2010 have been converted to shares of our common stock.
 
During the three and six months ended June 30, 2011 we recorded a total of $28,000 in interest expense related to the principal balance of the Convertible Notes – 2010.
 
The embedded conversion feature of the convertible debt issued in the 2010 convertible debt financing transaction met the definition of a derivative financial instrument and was classified as a liability in accordance with accounting guidance. The note holders had the right to convert the debt into shares of our common stock, and the notes included price protection whereby these notes were protected for as long as the notes remain outstanding against future private placements made at lower share prices, and therefore, the total number of shares of our common stock that the convertible notes may be convertible into was not fixed. The embedded conversion features were revalued on each balance sheet date and marked to market with the increase or decrease included in fair value to non-cash items related to debt discounts and deferred financing fees and the valuation of conversion features and warrants on the condensed consolidated statements of operations. As a result of the conversions during the six months ended June 30, 2011, the Company reclassified approximately $8.7 million of the related derivative liabilities to additional paid-in capital. As of June 30, 2011, all of the Convertible Notes – 2010 have been converted to shares of our common stock. As of June 30, 2011, the fair value of the remaining embedded conversion features is $0 as all the Convertible Notes – 2010 were converted. The Company recorded a loss of approximately $4.3 million due to the change in the fair value of the embedded conversion feature of these Convertible Notes – 2010 during the six months ended June 30, 2011.
 
Senior Convertible Secured Notes- 2011
 
In March 2011, we received $3.7 million in cash proceeds and commitments for an additional $491,000 related to a private placement of convertible notes, bearing interest at a rate of seven percent (7%) per annum, that matured on March 1, 2014, and that could be converted at the holder’s option into 1,691,320 shares of our common stock at a conversion price of $2.50 per share (the “Convertible Secured Notes – 2011”). The Company received the $491,000 in cash proceeds related to the unpaid commitments in April and May 2011. The notes would automatically be converted into shares of the Company’s common stock in the event that on or before the note due date either (a) the Company’s common stock is traded at a price per share of $6.25 or higher for five (5) consecutive trading days, or (b) the Company consummates a financing in the amount of at least $5 million.  In the event that the loan principal and accrued interest was not repaid by the Company by the due date, and the investor has not previously converted the note, the investor’s sole remedy for such non-payment shall be the payment of additional annual interest at a rate of 10% per year.  The accrued interest was payable in stock, using the $2.50 conversion price, or cash, at the holder’s option, on June 30 and December 31 of each year.
 
In addition,  as of March 31, 2011,the Company issued 373,730 new five-year common stock purchase warrants, with an exercise price of $3.13 per share (the “March 2011 Warrants”), with each investor receiving a number of March 2011 Warrants that was equal  to twenty-five percent (25%) of the investor’s note to the Company.  The Company issued an additional 49,100 warrants in April 2011 related to the collection of the payment totaling $491,000. The March 2011 Warrants may be exercised by cash payment or through cashless exercise by the surrender of warrant shares having a value equal to the exercise price of the portion of the warrants being exercised.
 
In connection with the March 2011 financing transaction the Company valued the warrants issued to the convertible note holders on a relative fair value basis using the Black-Scholes option pricing model, totaling $813,000. This relative fair value of the warrants was recorded as a debt discount. The embedded conversion features to the notes was determined to meet the definition of a derivative liability and as of the date of issuance was valued at $4.1 million. In accordance with relevant accounting guidance, the Company recorded an additional debt discount ($2.9 million) up to the full amount of the notes, recorded the derivative liability for the embedded conversion feature at $4.1 million and recorded the fair value in excess of face amount of debt as interest expense on the issuance date of $1.2 million. The debt discount was amortized in full upon the conversion of the notes to common stock on December 14, 2011. As of December 31, 2011, the fair value of the embedded conversion feature was $0 due to the conversion of all the Senior Convertible Secure Notes – 2011.
 
On June 30, 2011, the Company issued 27,851 shares of unregistered common stock to note holders of the Senior Convertible Secured Notes – 2011 private placement financing transaction in lieu of cash for their $69,628 accrued interest payment that was due June 30, 2011. In addition, the Company paid $10,277 of the accrued interest in cash to note holders who declined to convert their interest payment to stock.
 
As of June 30, 2011, the fair value of the embedded conversion feature was $6.2 million and as such, the Company recorded a loss on the change in fair value of the embedded conversion feature of $1.4 million, which is included in the accompanying consolidated condensed statement of operations as a component on non-cash items related to debt discounts, deferred financing fees and valuation of conversion features and warrants.
 
In October and November 2011, note holders of $575,000 of the original $4.2 million Senior Convertible Secure Notes – 2011 exercised their right to convert their notes and accrued interest and were issued 232,125 shares of our common stock.
 
On December 13, 2011, following a public offering pursuant to a Registration Statement on Form S-3, the Company received gross proceeds in excess of $5 million. Pursuant to the terms, as defined, in the Senior Convertible Secure Notes – 2011 agreements, the remaining outstanding principal balance plus accrued interest, was automatically converted into shares of common stock at a conversion price of $2.50 per share. In accordance with the terms of the agreement, the Company automatically converted approximately $3.7 million of remaining principal and approximately $130,000 of accrued interest into 1,513,237 shares of the Company’s common stock. In addition, the Company issued 99,461 shares of common stock related to the bonus interest feature associated with the mandatory conversion of the debt. As of December 31, 2011, the fair value of the embedded conversion features was $0. As of December 31, 2011, all of the Senior Convertible Secure Notes - 2011 plus accrued interest was paid or converted into shares of common stock. 
EXCEL 18 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F M,S(S.38V-&0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I7 M;W)K#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-E9VUE;G1?26YF;W)M871I;VX\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O5]486)L M97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I7 M;W)K#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT,SPO>#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I7;W)K M#I7;W)K#I7;W)K M#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M<&5N#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-T;V-K0F%S961?0V]M<&5N#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DYE=%],;W-S7U!E#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O M=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D M/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D M('=I=&@@36EC'1087)T7S(Q-6,R-3`R7V4T M9C)?-#`T-5\Y.#=A7V,P,68S,C,Y-C8T9`T*0V]N=&5N="U,;V-A=&EO;CH@ M9FEL93HO+R]#.B\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F,S(S.38V M-&0O5V]R:W-H965T'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^3F5O;F]D92P@26YC/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!+ M97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^+2TQ,BTS,3QS<&%N/CPO'0^,3`M43QS<&%N/CPO M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^665S/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!#;VUM;VX@4W1O M8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3H\+W-TF5D('=I=&@@<&%R('9A;'5E("0P+C`P,7!E3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'!E;G-E'0^ M)FYB'0^)FYB'0^)FYB'0^)FYB&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#QS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-C@I/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)FYB2!F:6YA;F-I;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S('!A:60\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB'0^)FYB'0^)FYB'0^)FYB3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F,S(S M.38V-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C$U8S(U,#)? M931F,E\T,#0U7SDX-V%?8S`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,B!A65A6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@86-C;VUP86YY:6YG M(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@ M87,@;V8@2G5N92`S,"P@,C`Q,B!A;F0@9F]R('1H92!T:')E92!A;F0@2!U65A3L@=&5X="UI;F1E;G0Z M(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[ M(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3W!E3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$ M)V1I6QE/3-$)V1I2!P7,@86YD(&=A;6EN M9R!C;VYS;VQE6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M=V5I9VAT.B!B;VQD.R<^26YT96QL96-T M=6%L(%!R;W!E3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`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`P<'0[(&1I65A65A6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I M2!O=VYE9"!3=V5D:7-H('-U8G-I9&EA2!A8V-O=6YT6QE M/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT M+7=E:6=H=#H@8F]L9#LG/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.SPO9F]N=#X\+V9O;G0^)B,Q-C`[/"]D:78^ M#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE M.B!I=&%L:6,[(&1I3H@ M8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I2!O9B!A8V-O=6YT2!O9B!L;VYG+6QI=F5D(&%S6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F M;VYT+7-T>6QE.B!I=&%L:6,[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!W:6QL(&-O;G-I9&5R(&%L;"!H:6=H;'D@;&EQ=6ED(&EN M=F5S=&UE;G1S('=I=&@@;W)I9VEN86P@;6%T=7)I=&EE3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I M3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[#0H@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEF%B;&4@=F%L=64N($]U M2!A;F0@2!F:6QI;F'!E8W0@=&\@3H@8FQO8VL[(&UA3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY$96)T(&ES6QE M/3-$)W=I9'1H.B`Q,#`E.R<@/CQF;VYT('-T>6QE/3-$)V1I3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEF%T:6]N(&%R92!C;VUP=71E9"!U65A6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)V1I M3LG('9A;&EG;CTS1'1O<"!W:61T:#TS1#$U)3X-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA65A3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX- M"CQD:78@3L@=&5X="UI;F1E M;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE2X@1F]R96EG;B!C=7)R96YC>2!T"!M M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,B!A;F0@,C`Q,2P@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$ M)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY792!D;R!N;W0@96YT97(@:6YT;R!D97)I=F%T:79E(&-O;G1R86-T M2X@06-C;W5N=&EN9R!G=6ED86YC92!R97%U:7)EF4@86QL(&UA=&5R:6%L(&-O;G1R86-T6QE/3-$)W=I9'1H.B`Q,#`E.R<@/CQF;VYT('-T>6QE/3-$ M)V1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\ M+V1I=CX-"CQD:78@3L@=&5X M="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY/;B!$96-E;6)E28C.#(Q-SMS(&-O;6UO;B!S=&]C:RX@07,@;V8@1&5C96UB97(@ M,S$L(#(P,3$L('1H92!F86ER('9A;'5E(&]F('1H92!E;6)E9&1E9"!C;VYV M97)S:6]N(&9E871U6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I3H@8FQO8VL[ M(&UA6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!T;R!T96-H;F]L;V=I8V%L(&1E=F5L M;W!M96YT2!R97%U:7)E;65N=',@;W(@:6YD=7-T3L@=&5X="UI M;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/=7(@;F5T(')E M=F5N=65S(&9O6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R`@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT3H@6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY!;6%Z;VX@+2`U,R4\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T6QE M/3-$)W=I9'1H.B`U-'!T.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W=I9'1H.B`U-'!T.R<^#0H\9&EV M/CQF;VYT('-T>6QE/3-$)V1I6UB;VPL('-E3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R<^)B,Y-C6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY3 M;VYY($-O6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE'1E96X@8W5S=&]M M97)S+B!#=7-T;VUE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)R`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,#X-"CQT3H@ M6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY!;6%Z;VXF(S$V,#LF(S$V M,#LM(#4S)3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*/"]T86)L93X- M"CPO9&EV/@T*/&1I=CX-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@ M9F]N="UF86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T M.R<@(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(@=F%L M:6=N/3-$=&]P/@T*/'1D(&%L:6=N/3-$3H@:6YL:6YE M.R!F;VYT+7-I>F4Z(#$P<'0[(#L@9F]N="UF86UI;'DZ('-Y;6)O;"P@2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F M=#H@,'!T.R!M87)G:6XM6QE/3-$)V1I M3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/=7(@86-C;W5N=',@3H@:6YL:6YE.R<^3W5R M(&YE="!R979E;G5E&EM871E;'D@.3DE(&]F M(&]U2`W,24@;V8@;W5R(&YE="!R979E;G5E"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,2X@3W5R(&-U3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[ M(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!S96QL(&5N9VEN965R:6YG(&-O;G-U;'1I;F<@2!C;VYS:7-T:6YG M(&]F(&$@<'5R8VAA2P@=V4@6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R<^)B,Q-C`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`N M($9E97,@=6YD97(@=&AE6%L=&EE M2!O=7(@;&EC96YS965S M(&]F('!R;V1U8W1S(&EN8V]R<&]R871I;F<@=&AE(&QI8V5N2!T:&4@0V]M<&%N>28C.#(Q-SMS(&-U2!L:6-E;G-E(&%R3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE'!E2!L:6-E;G-E(&9E M92!R979E;G5E3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^)B,Q M-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@ M3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY(87)D=V%R92!06QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!F6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE.B!I=&%L:6,[(&1I3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY792!M87D@9&5R:79E(')E=F5N M=65S(&9R;VT@&ES=',@9F]R('1H;W-E(&5L96UE;G1S+CPO9F]N=#X\ M+V1I=CX-"CQD:78@3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX- M"CQD:78@3L@=&5X="UI;F1E M;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2X@5&AE M(&AI97)A2!I2!E=FED96YC92!O9B!S96QL:6YG('!R:6-E("@F(S@R,C`[5%!%)B,X M,C(Q.RD@;W(@8F5S="!E3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1IF4@F5D(&]N(&$@6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE2!W92!W;W5L9"!A='1E;7!T('1O M(&5S=&%B;&ES:"!T:&4@6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!U2!S;VQD(&]N(&$@2!C=7-T;VUI>F5D(&]F9F5R:6YG M6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE'!E;G-E9"!A M&EM871E;'D@)#@U+#`P,"!A;F0@)#(Y+#`P,"!A M;F0@)#(X,BPP,#`@86YD("0W-"PP,#`L(')E2X\+V9O;G0^ M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE M.B!I=&%L:6,[(&1I3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY297-E87)C:"!A;F0@9&5V96QO<&UE;G0@*"8C.#(R,#M2)F%M M<#M$)B,X,C(Q.RD@8V]S=',@87)E(&5X<&5N3H@8FQO8VL[ M(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I M6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!O M9B!F=71U"!I;F-O;64L('=E(&9U;&QY(')E"!A&5S(')E M<')E&5S('!A>6%B;&4@9F]R('1H92!C=7)R96YT M('!E6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEFEN9RP@9&4MF4@82!L:6%B M:6QI='D@9F]R('5N3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I M3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I M6QE.B!I=&%L:6,[(&1I3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE&EM871E('=E:6=H=&5D M+6%V97)A9V4@97AC:&%N9V4@2X@5&AE('=E:6=H=&5D M+6%V97)A9V4@97AC:&%N9V4@&-H86YG92!R871E(&9O3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1F%I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F5W($%C8V]U;G1I;F<@4')O M;F]U;F-E;65N=',\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY);B!-87D@,C`Q,2P@=&AE($9I;F%N8VEA;"!! M8V-O=6YT:6YG(%-T86YD87)D&ES=&EN9R!G=6ED86YC92!T;R!A8VAI979E(&-O M;G9E3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF M(S$V,#LF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I28C.#(Q-SMS(&EN=&5R:6T@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^/"]F;VYT/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L M:6,[(&1I3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY!="!$96-E;6)E2!D871E(&]F('1H92!C;VYV97)T:6)L92!P'1E;F1E9"!U;G1I;"!!<')I;"`R-BP@,C`Q,2X@5V4@96YT97)E9"!I M;G1O(&$@9&5B="UF;W(M97%U:71Y(')E<&%Y;65N="!P;&%N('=H97)E8GD@ M=V4@=V5R92!R971I2!N M;W1E6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!R97!A>6UE;G0@<&QA;B!A M;F0@6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I M6%B;&4@;VX@2G5N92`S,"!A;F0@1&5C M96UB97(@,S$@;V8@96%C:"!Y96%R('1H870@=&AE(&-O;G9E&5R8VES92!P3H@:6YL:6YE.R<^07,@82!R97-U;'0@;V8@=&AE(&-O M;G9E6UE;G1S(&1U2!R96-L87-S:69I M960@87!P2`D-"XV(&UI;&QI;VX@;V8@=&AE(')E;&%T960@ M9&5R:79A=&EV92!L:6%B:6QI=&EE2!R96-O"!M;VYT:',@96YD960@2G5N92`S M,"P@,C`Q,2X\+V9O;G0^($%S(&]F($IU;F4@,S`L(#(P,3$L(&%L;"!O9B!T M:&4@0V]N=F5R=&EB;&4@3F]T97,@)B,X,C$Q.R`R,#`Y(&AA=F4@8F5E;B!P M86ED(&EN(&9U;&P@=VET:"!C87-H(&]R(&AA=F4@8F5E;B!C;VYV97)T960@ M=&\@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!I;B!A8V-O&5D+B!4 M:&4@96UB961D960@8V]N=F5R6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`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`S,"P@,C`Q,2P@=&AE($-O;7!A M;GD@&EM871E;'D@)#@N-R!M:6QL:6]N(&]F M('1H92!R96QA=&5D(&1E&EM871E;'D@)#0N,R!M:6QL:6]N(&1U92!T;R!T:&4@8VAA;F=E(&EN M('1H92!F86ER('9A;'5E(&]F('1H92!E;6)E9&1E9"!C;VYV97)S:6]N(&9E M871U6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE.B!I=&%L:6,[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY);B!-87)C:"`R,#$Q+"!W92!R96-E:79E9"`D M,RXW(&UI;&QI;VX@:6X@8V%S:"!P2!R96-E:79E9"!T:&4@)#0Y,2PP,#`@ M:6X@8V%S:"!P2!T:&4@0V]M<&%N>2!B>2!T:&4@9'5E(&1A M=&4L(&%N9"!T:&4@:6YV97-T;W(@:&%S(&YO="!P6UE;G0@6UE;G0@ M;V8@861D:71I;VYA;"!A;FYU86P@:6YT97)E65A3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I M6UE;G0@ M=&]T86QI;F<@)#0Y,2PP,#`N(%1H92!-87)C:"`R,#$Q(%=A2!B92!E>&5R8VES960@8GD@8V%S:"!P87EM96YT(&]R('1H6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY);B!C;VYN96-T:6]N('=I=&@@=&AE($UA&-E'!E;G-E(&]N('1H92!I3L@=&5X="UI;F1E;G0Z(#!P=#L@ M9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6UE M;G0@=&AA="!W87,@9'5E($IU;F4@,S`L(#(P,3$N($EN(&%D9&ET:6]N+"!T M:&4@0V]M<&%N>2!P86ED("0Q,"PR-S<@;V8@=&AE(&%C8W)U960@:6YT97)E M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6EN9R!C;VYS;VQI9&%T960@ M8V]N9&5N3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY);B!/8W1O8F5R(&%N9"!.;W9E;6)E&5R8VES960@=&AE:7(@6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/;B!$96-E;6)E2!A=71O;6%T:6-A;&QY(&-O;G9E M7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA3QB2!;06)S=')A8W1= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`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`P<'0[ M(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE2!F:6QE9"!A($-E3L@=&5X="UI;F1E;G0Z(#!P M=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I M6QE/3-$)V1I6UB;VP@3D5/3BX\+V9O;G0^/"]D M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I M=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#,V<'0[ M(&1I6QE/3-$)V1I&5R8VES92!P6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE&5R8VES92!P6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY4:&4@:&]L9&5R2!D:79I9&5N9',@9&5C;&%R960@;VX@=&AE(&-O;6UO;B!S M=&]C:R!I;B!P2!T M:&5M+CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO M9&EV/@T*/&1I=@T*('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3L@=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU M6QE M/3-$)V1I3LG('9A;&EG;CTS1'1O<"!W:61T:#TS1#@P)3X-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@ M9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3L@=VED=&@Z(#$P,"4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`S-G!T.R<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-R4^#0H\9&EV M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`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`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY);B!T:&4@979E;G0@;V8@86YY(&QI<75I9&%T:6]N+"!D M:7-S;VQU=&EO;BP@;W(@=VEN9&EN9R!U<"!O9B!O=7(@;W!E2!O2P@2!O=&AE6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`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`P M+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I M6QE/3-$)V1I2!T:&5M M+CPO9F]N=#X\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\ M9&EV/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R<@=F%L:6=N M/3-$=&]P('=I9'1H/3-$-R4^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY);FET:6%L;'DL(&5A8V@@ M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^0V]N M=F5R3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$ M)V1I65T(&-O;G9E6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)R!C96QL6QE/3-$)V1I M6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA6QE M/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V)O"!S;VQI M9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@ M86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA&-H86YG960@870@2G5N92`S,"P@,C`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY397)I97,@02!0 M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T* M/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#8T)3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`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`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`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXU,BPT,SD\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X- M"CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[ M)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@=&AR964@;&5V96QS M(&]F('1H92!F86ER+79A;'5E(&AI97)A2!A3L@=&5X M="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$ M)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY,979E;"8C M,38P.S,Z($EN<'5T2X@ M07,@;V8@2G5N92`S,"P@,C`Q,B!A;F0@1&5C96UB97(@,S$L(#(P,3$L('=E M(&AA9"!N;R!L979E;"`S(&%S6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,#`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`P<'0[(&1I'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[ M(&UA3H@8FQO8VL[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXP+C`X("8C M.#(Q,3L@,RXP/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H\+W1R/@T* M/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#@X)3X-"CQD:78@3H@8FQO8VL[(&UA3H@ M8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXP+C`X)2T@,2XR-R4\+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9&EV('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]D:78^#0H\+V1I=CX-"CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(] M,T1W:&ET93X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4^#0H\ M9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY%>'!E M8W1E9"!V;VQA=&EL:71Y/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)B,Q-C`[/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@3H@8FQO8VL[(&UA6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1E3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,3`E("T@,C8S M)3PO9F]N=#X\+V1I=CX-"CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"CQD:78@3H@8FQO8VL[(&UA6QE/3-$ M)V1I65E M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY/;B!$96-E;6)E28C.#(Q-SMS(&-O;6UO;B!S=&]C:RX@07,@;V8@1&5C96UB97(@,S$L(#(P M,3$L('1H92!F86ER('9A;'5E(&]F('1H92!E;6)E9&1E9"!C;VYV97)S:6]N M(&9E871U3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5? M.3@W85]C,#%F,S(S.38V-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,C$U8S(U,#)?931F,E\T,#0U7SDX-V%?8S`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`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`P<'0[(&1I3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F M,S(S.38V-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C$U8S(U M,#)?931F,E\T,#0U7SDX-V%?8S`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@8F]L9#LG/CPO9F]N=#X\+V9O M;G0^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3L@=&5X="UI M;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD M:78@3L@=&5X="UI;F1E;G0Z M(#,V<'0[(&1I6QE/3-$)V1I6EN9R!C;VUM;VX@ M3H@ M8FQO8VL[)SXF(S$V,#LF(S$V,#L\+V1I=CX-"CQD:78@6QE/3-$)V9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4W1O8VL@3W!T:6]N3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\ M+V1I=CX-"CQD:78@3L@=&5X M="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG M/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R<^)B,Y-C3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY4:&4@,C`P-B!%<75I='D@26YC96YT:79E(%!L86X@*'1H92`R,#`V(%!L M86XI+B`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R<@=F%L:6=N/3-$ M=&]P('=I9'1H/3-$-R4^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T M97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)V1I3H@8FQO8VL[(&UA M'!I6QE/3-$)W1E>'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!O9B!T:&4@8V]M8FEN960@86-T:79I M='D@=6YD97(@86QL(&]F('1H92!S=&]C:R!O<'1I;VX@<&QA;G,@:7,@6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)R!C96QL3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I M;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V)O"!S;VQI M9`T*(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/@T*/&1I M=B!A;&EG;CTS1&-E;G1E6QE/3-$)V1I&5R8VES92!06QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T* M/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W-B4^#0H\9&EV(&%L:6=N/3-$;&5F="!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`Q+C9P=#LG/CQF;VYT('-T M>6QE/3-$)V1I2`Q+"`R,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS M1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXQ.2PS,C0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T* M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXY,BXQ.3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY'6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+#0V,"PP,#`\ M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`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`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`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`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`T<'@@9&]U8FQE(&)L86-K.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[ M(&UA6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I M;F3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXV+C#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)R!C96QL6QE/3-$)W!A9&1I;F#LG('9A;&EG M;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$,SX-"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY-;VYT:',@16YD960\+V9O;G0^/"]D:78^#0H\9&EV(&%L M:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY2:7-K+69R964@:6YT97)E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY4:&4@86=G6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M65A&EM M=6T@=&5R;2!O9B!T96X@>65A65A6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY$=7)I;F<@=&AE M('1H2P@;V8@3L@=&5X="UI;F1E;G0Z M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,2X@5V4@86QS;R!I"!M;VYT:',@96YD M960@2G5N92`S,"P@,C`Q,2X@5&AE('=A6EN9R!W87)R86YT+CPO9F]N=#X\ M+V1I=CX-"CQD:78@3L@=&5X M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX- M"CQD:78@3L@=&5X="UI;F1E M;G0Z(#,V<'0[(&1I6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY/;B!397!T96UB97(@,3(L(#(P,3$L('=E(&ES65E+B!4:&4@9F%I"!M;VYT:',@96YD960@2G5N92`S,"P@ M,C`Q,BP@=V4@'!E;G-E(')E M;&%T960@=&\@=F5S=&EN9R!O9B!S=6-H('=A3L@=&5X="UI M;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD M:78@3L@=&5X="UI;F1E;G0Z M(#,V<'0[(&1I6QE/3-$)V1I'!E;G-E(')E M9FQE8W1S('1H92!F86ER('9A;'5E(&]F('1H92!V97-T960@<&]R=&EO;B!O M9B!O<'1I;VYS(&%N9"!W87)R86YTF%T:6]N(&]F M('1H92!U;G9E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I#LG('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY*=6YE(#,P+"`\+V9O;G0^ M/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXR,#$Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X.R<@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`R<'@@ M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY4:')E92!M;VYT:',\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N M=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#ME;F1E9#PO M9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1C96YT97(@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0[('!A9&1I;F6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY3=&]C:RUB87-E9"!C M;VUP96YS871I;VX\+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO=&0^#0H\=&0@ M#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V)O M"!D;W5B;&4@8FQA8VL[('1E>'0M86QI9VXZ(')I M9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ.#,\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@-'!X M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[ M('1E>'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR+#,Q-SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A M9&1I;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T* M/"]D:78^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>2!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\82!N86UE/3-$9FES7W5N:61E;G1I9FEE M9%]T86)L95\W/CPO83X\(2TM1490;&%C96AO;&1E6QE/3-$)W!A9&1I;F3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T M('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY3=&]C:RUB M87-E9"!C;VUP96YS871I;VX\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXT-S(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#AP M=#LG/B8C,38P.R`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`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY7 M87)R86YT6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I M;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY%>&5R M8VES92`\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY06QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY# M;VYT6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY,:69E/"]F;VYT/CPO9&EV M/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXQ+C4W/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXR+C0U/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1&QE9G0-"B!V86QI9VX],T1T;W`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#LF M(S$V,#LF(S$V,#M%>'!I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`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`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`\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXM+3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\ M=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)V1I#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`T<'@@9&]U8FQE(&)L M86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L:6=N M/3-$3H@ M8FQO8VL[(&UA6QE M/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A M9&1I;F6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C@W/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)V1I3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@ M3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V1I&5R8VES92!P6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M&5R8VES92!P3L@=&5X="UI;F1E;G0Z(#!P M=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I M6QE/3-$)V1I65E M'!E8W1E9"!T97)M(&%N9"!F;W)F96ET=7)E(')A=&4@;V8@;W!T:6]N'!E8W1E9"!B96AA M=FEO'!E8W1E9"!V;VQA=&EL:71Y(&ES(&)A'!E;G-E(')E<&]R=&5D(&EN(&9U='5R92!P97)I M;V1S+CPO9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^0V]M;6]N M(%-T;V-K(&%S(&]F($IU;F4@,S`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B M;VQD.R<^17AE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY397!T96UB97(@,C`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY!=6=U M3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I M9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`P+CAP=#LG M/CQF;VYT('-T>6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G M8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0U-B4^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+S(X+S(P,3`\+V9O M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXT,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-38E/@T*/&1I M=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXY+S(R+S(P,3`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ-BPP,#`\+V9O;G0^/"]D M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX] M,T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.@T*(#`N.'!T M.R<^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXY+S(R+S(P M,34\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY397!T96UB97(@,C`Q,"!297!R:6-I M;F<@5V%R3H@ M8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`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`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY/8W1O8F5R(#(P,3`@4F5P6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A M;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C,X M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4^#0H\9&EV(&%L:6=N M/3-$3H@ M8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P+CAP=#LG/CQF M;VYT('-T>6QE/3-$)V1I65E(%=A6QE/3-$)V1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C,X/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,"4^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,"\Q-2\R,#$S/"]F M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H-"B!T:6UE6QE/3-$)V1I M3H@8FQO8VL[ M(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U-B4^#0H\ M9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I2`R,#$Q($5M<&QO>65E(%=A6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXQ+S(Q+S(P,3$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR,"PP,#`\+V9O;G0^ M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI M9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`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`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`T<'@@9&]U8FQE(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3`E/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^-2PQ.#(L,3`V/"]F M;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/"]F;VYT M/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T M:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY792!H879E(&%G2!T:&%T('-H;W5L9"!E;F%B;&4@=7,@=&\@2X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@ M:6YL:6YE.R!T97AT+61E8V]R871I;VXZ(&QI;F4M=&AR;W5G:#LG/B8C,38P M.SPO9F]N=#YL86YD;&]R9',N(%5N9&5R('1H97-E('!R;W9I2!A;F0@:&]L9"!H87)M;&5S2=S(&%C=&EV:71I97,@=6YD97(@=&AE M(&%G2!S=7)V:79E('1E3H@ M8FQO8VL[(&UA6QE/3-$)V1I3L@=&5X="UI;F1E;G0Z(#!P=#L@ M9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I2`D-BPP,#`@<&5R(&UO;G1H(&EN M8VQU9&EN9R!P2!T87@@*&5X8VQU9&EN9R!6050I+B!4:&4@86YN M=6%L('!A>6UE;G0@9F]R('1H:7,@"`H97AC;'5D:6YG(%9!5"DN(%1H:7,@;&5A6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE"`H97AC;'5D:6YG(%9!5"DN(%1H92!A;FYU86P@ M<&%Y;65N="!F;W(@=&AI&EM871E M;'D@)#DS+#`P,"!P97(@>65A&-L=61I;F<@5D%4*2X@5&AI3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@ M3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/;B!-87)C:"`R,BP@,C`Q M,BP@=V4@96YT97)E9"!I;G1O(&$@=&AR964@>65A6UE;G0@:7,@87!P2`D-RPP,#`@<&5R M(&UO;G1H+"!I;F-R96%S:6YG('1O(&%P<')O>&EM871E;'D@)#2`D.#0L,#`P('!E2!T87AE M6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE&EM871E;'D@)#$S+#`P,"!P97(-"B!M;VYT:"!I;F-L=61I M;F<@<')O<&5R='D@=&%X("AE>&-L=61I;F<@5D%4*2X@5&AE(&%N;G5A;"!P M87EM96YT(&9O2`D,38Q+#`P,"!P97(@>65A&-L=61I;F<@5D%4*2X@5&AI'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T M:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY4:&4@0V]M<&%N>2!H87,@;VYE(')E<&]R=&%B;&4@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^5&AR964@;6]N=&AS(&5N9&5D(#PO M9F]N=#X\+V1I=CX-"CQD:78@86QI9VX],T1C96YT97(@#LG('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE#LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY097)C96YT M86=E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE#LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY!;6]U;G0\+V9O;G0^/"]D M:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG M+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!C M;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT.B`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`P M+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXE/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A M;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,S`\ M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`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`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`P+CAP=#LG/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXE/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@ M86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+#DW-#PO9F]N=#X\+V1I=CX- M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXQ,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N M/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@86QI9VX],T1L969T('-T>6QE/3-$)V)O"!D M;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQD M:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE M/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L-"B!M87)G:6XM3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR.#,\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O M;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M-'!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@86QI9VX],T1L969T('-T>6QE/3-$)V)O"!D M;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS M1&UI9&1L92!W:61T:#TS1#$E/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^4VEX(&UO;G1H6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^2G5N92`S,"P@,C`Q,CPO9F]N=#X\ M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I M;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B M;&%C:SLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(R)2!C;VQS<&%N/3-$ M-CX-"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^,C`Q,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@ M86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY! M;6]U;G0\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE M/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY.970@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR+#`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`P+CAP=#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`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`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`P M+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`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`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`P+CAP=#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`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`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T M>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI M9VX],T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`T<'@@9&]U8FQE M(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L M:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS M1')I9VAT('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA M8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX] M,T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`T M<'@@9&]U8FQE(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@8FQO8VL[ M(&UA'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@8F]L9#LG/CPO9F]N=#X\+V9O M;G0^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE2!D:79I9&EN9R!T:&4@;F5T(&QO2!D:79I9&EN9R!N970@;&]S2!T:&4@=V5I9VAT960@879E3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!S=&]C:R!M971H M;V0L(#,N-"!M:6QL:6]N(&%N9"`U+C0@;6EL;&EO;B!O=71S=&%N9&EN9R!S M=&]C:R!W87)R86YTF5R;R!A;F0@,2XW(&UI M;&QI;VX@2P@9'5E('1O('1H M96ER(&%N=&DM9&EL=71I=F4@969F96-T+B8C,38P.SPO9F]N=#X\+V1I=CX- M"CQD:78@3H@8FQO M8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE M('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY4:')E92!-;VYT:',@96YD960\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`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`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`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`T M<'@@9&]U8FQE(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R M:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`T<'@@9&]U8FQE(&)L86-K M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L:6=N/3-$ M3H@8FQO M8VL[(&UA6QE/3-$)W!A M9&1I;F3H@8FQO8VL[ M(&UA#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T M('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQD:78@86QI9VX],T1L969T M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V/@T*/&1I=B!A;&EG;CTS M1&-E;G1E6QE/3-$)V1I6QE/3-$)V)O"!S;VQI M9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;3X-"CQD:78@86QI9VX],T1L969T M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[)SXH:6X@=&AO=7-A;F1S+"!E>&-E<'0@<&5R('-H M87)E(&%M;W5N=',I/"]F;VYT/CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@ M86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I#LG M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG#0H@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX- M"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA6QE/3-$)V1I6QE M/3-$)V1I6QE M/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!A;&EG;CTS M1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1I3H@ M8FQO8VL[(&UA6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$ M,CX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D M(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/@T*/&1I=B!A;&EG;CTS1&QE M9G0@3H@8FQO8VL[ M(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T M('-T>6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@ M8FQO8VL[(&UA6QE/3-$ M)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`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`T<'@@9&]U8FQE(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F#LG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M86QI9VX],T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`T<'@@9&]U M8FQE(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV M(&%L:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F3H@8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)V1I3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)W!A9&1I;F3H@8FQO8VL[(&UA6QE/3-$)V1I3H@8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&1I=B!A M;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,3$N/"]F;VYT/B`\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M4W5B3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY792!H879E(&5V86QU871E9"!S=6)S97%U M96YT(&5V96YT'1087)T7S(Q-6,R-3`R7V4T9C)?-#`T-5\Y.#=A7V,P,68S,C,Y-C8T M9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R,35C,C4P,E]E-&8R M7S0P-#5?.3@W85]C,#%F,S(S.38V-&0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F M;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[ M(&UA6QE/3-$)V1I'0^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT M+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3H@ M8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I2!O=VYE9"!3=V5D:7-H('-U8G-I9&EA6QE/3-$)V9O;G0M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/"]F;VYT/B8C,38P.SPO M9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT M+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE2!A8V-E<'1E9"!I M;B!T:&4@56YI=&5D(%-T871E"!A'0^/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F M;VYT+7-T>6QE.B!I=&%L:6,[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!W:6QL(&-O;G-I9&5R(&%L;"!H:6=H;'D@;&EQ=6ED(&EN M=F5S=&UE;G1S('=I=&@@;W)I9VEN86P@;6%T=7)I=&EE6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X M="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O;G0M M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^0V]N8V5N=')A=&EO;B!O9B!#87-H($)A;&%N8V4@4FES:W,\ M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY#87-H(&)A;&%N8V5S(&%R92!M86EN=&%I;F5D(&%T('9A2!T:&4@1F5D97)A;"!$97!O7!E'!E M'!O2!S:6=N:69I8V%N="!C&EM871E;'DF(S$V,#LD M,3`N-"!M:6QL:6]N(&EN(&5X8V5S3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O M;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I M9VAT.B!B;VQD.R<^/"]F;VYT/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES M<&QA>3H@8FQO8VL[(&UA3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/=7(@86-C;W5N=',@2!O9B!O M=7(@8W5S=&]M97)S('1O(&UA:V4@2!A="!*=6YE(#,P M+"`R,#$R(&]R($1E8V5M8F5R(#,Q+"`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEF%T:6]N(&%R M92!C;VUP=71E9"!U65A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W=I9'1H.B`U-24[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY#;VUP=71E6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY%<75I<&UE;G0@<'5R8VAA6QE/3-$)W1E>'0M:6YD M96YT.B`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`@ M86YD("0H-3"!M;VYT:',@96YD960@2G5N M92`S,"P@,C`Q,B!A;F0@,C`Q,2P@6QE.B!I=&%L:6,[(&1I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M2!F;W(@5V%R6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE M/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT M+7=E:6=H=#H@8F]L9#LG/CPO9F]N=#X\+V9O;G0^)B,Q-C`[/"]D:78^#0H\ M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+7=E:6=H=#H@8F]L9#LG/DQI86)I;&ET>2!F M;W(@5V%R3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@6QE/3-$)V1I2!R97!O7IE(&%L;"!M871E3H@ M8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M3L@=&5X="UI;F1E;G0Z M(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78^#0H\ M=&%B;&4@6QE/3-$)W=I9'1H.B`U-'!T.R<^#0H\9&EV/CQF M;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R<^)B,Y-C3H@:6YL M:6YE.R!F;VYT+7-I>F4Z(#$P<'0[.R!F;VYT+69A;6EL>3IS>6UB;VPL('-E M2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F M=#H@,'!T.R!M87)G:6XM6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[.R!F;VYT M+69A;6EL>3IS>6UB;VPL('-E3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@6QE/3-$)V1I"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q M,B!W87,@96%R;F5D(&9R;VT@3H@8FQO8VL[)SXF(S$V,#L\ M+V1I=CX-"CQD:78^#0H\=&%B;&4@6QE/3-$)W=I9'1H.B`U M-'!T.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R<^)B,Y-C6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R`@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,#X-"CQT6QE/3-$ M)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY3 M;VYY($-O6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2`Y.24@;V8@;W5R('1O=&%L(&YE="!R979E M;G5E3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY/=7(@;&]N9RUT97)M('-U8V-E2!B92!R97%U:7)E9"!T;R!R86ES92!A9&1I M=&EO;F%L(&-A<&ET86P@=&AR;W5G:"!P=6)L:6,@;W(@<')I=F%T92!F:6YA M;F-I;F=S(&]R(&]T:&5R(&%R2!C;VYT86EN(')E6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!T;R!M86YA9V4@9W)O=W1H(&5F9F5C=&EV96QY+"!O M=7(@9&5P96YD96YC92!O;B!K97D@;65M8F5R6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE'!O2!F86-T;W)S('1H870@8V]U;&0@6QE/3-$)V1I'1E;G0L('1H M92!%=7)O+B!792!I;F-U3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/=7(@9G5T=7)E M('-U8V-E2!A6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M2!S96QL(&5N M9VEN965R:6YG(&-O;G-U;'1I;F<@2!C;VYS:7-T:6YG(&]F(&$@<'5R8VAA2P@=V4@6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R<^ M)B,Q-C`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`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY02!P97)I;V0@2!C;W-T2!L:6-E;G-E(&-O;G1R86-T2!C=7-T;VUE7-I2!C;W-T6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I2!U<&]N('-H:7!M96YT M(&]F(&]U3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@ M3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M2!B:6YD:6YG(&%R6UE;G0@:7,@9&5E;65D M(&9I>&5D(&]R(&1E=&5R;6EN86)L92!A;F0@9G)E92!O9B!C;VYT:6YG96YC M:65S(&]R('-I9VYI9FEC86YT('5N8V5R=&%I;G1I97,[(&%N9"`H-"D@8V]L M;&5C=&EO;B!I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY792!A;&QO8V%T92!R979E;G5E6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,#`E.R<@/CQF;VYT('-T M>6QE/3-$)V1I3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY$969E3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY&2!R96-E:79E6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O M;G0@3H@8FQO8VL[(&UA6QE/3-$)V9O;G0M M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^/&9O;G0@6QE.B!I=&%L:6,[(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE'!E;G-E9"!A&EM M871E;'D@)#@U+#`P,"!A;F0@)#(Y+#`P,"!A;F0@)#(X,BPP,#`@86YD("0W M-"PP,#`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`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4W1O M8VLM0F%S960@0V]M<&5N6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY792!M96%S=7)E M('1H92!C;W-T(&]F(&5M<&QO>65E('-EF4@=&AE('9A;'5E(&%S(&-O;7!E;G-A=&EO;B!E>'!E;G-E(&]V97(@=&AE M('!E&-H86YG92!F;W(@=&AE(&%W87)D+"!U6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I M=CX-"CQD:78@3L@=&5X="UI M;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z M(#,V<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M06-C;W5N=&EN9R!F;W(@1&5B="!)6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE'!E;G-E(&]V97(@=&AE(&QI9F4@;V8@=&AE(')E M;&%T960@9&5B="!U2!T:&5M(&EF('1H92!C:7)C=6US=&%N8V5S(&1I8W1A=&4N M)B,Q-C`[)B,Q-C`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z M(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[ M(&1I6QE/3-$)V1I"!L:6%B:6QI=&EE"!C;VYS97%U96YC97,@ M;V8@:71E;7,@=&AA="!H879E(&)E96X@:6YC;'5D960@:6X@=&AE(&-O;G-O M;&ED871E9"!F:6YA;F-I86P@&5S(&)A"!R871EF%T:6]N(&]F(&1E9F5R"!A'!E8W1A=&EO;G,@ M86)O=70@9G5T=7)E('1A>&%B;&4@:6YC;VUE+B!686QU871I;VX@86QL;W=A M;F-E6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!O9B!F=71U"!I;F-O;64L('=E(&9U;&QY(')EF4@;W5R(&1E9F5R"!A3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I"!P;W-I M=&EO;G,N)B,Q-C`[)B,Q-C`[07,@82!R97-U;'0L('=E(&1I9"!N;W0@F5D('1A>"!B96YE M9FET3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^/"]F;VYT/B8C,38P.SPO9&EV M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN M9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q,B!A;F0@ M,C`Q,2!E>&-L=61E('1H92!P;W1E;G1I86P@8V]M;6]N('-T;V-K(&5Q=6EV M86QE;G1S+"!A'0^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN M9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[ M(&1I3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE M/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^0V%S:"!&;&]W($EN9F]R;6%T:6]N/"]F;VYT M/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/B8C,38P.SPO9&EV M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN M9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY#87-H(&9L;W=S(&EN(&9O&-H86YG92!R871E(&9O&-H86YG M92!R871E(&9O6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^1F%I M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F M;VYT+7-T>6QE.B!I=&%L:6,[(&1I3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I M6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F5W($%C8V]U M;G1I;F<@4')O;F]U;F-E;65N=',\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY);B!-87D@,C`Q,2P@=&AE($9I M;F%N8VEA;"!!8V-O=6YT:6YG(%-T86YD87)D&ES=&EN9R!G=6ED86YC92!T;R!A M8VAI979E(&-O;G9E28C.#(Q-SMS(')E3H@ M8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I28C.#(Q-SMS(&EN=&5R:6T@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O9B!3:6=N:69I M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A486)L97,I/&)R/CPO6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)W=I9'1H.B`U-24[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY#;VUP=71E6QE M/3-$)V1I3H@ M8FQO8VL[(&UA6QE/3-$)V1I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2`H5&%B;&5S*3QB2!;06)S=')A8W1= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\65T(&-O;G9E'0^/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA M>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#AP=#LG/B8C,38P M.R`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^0V]N=F5R6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I M;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@6QE/3-$)V1I65T($5X8VAA;F=E9"!A="`\+V9O;G0^/"]D:78^#0H\9&EV(&%L M:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M=V5I9VAT.B!B;VQD.R<^2G5N92`S,"P@,C`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXX,SPO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,B4^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA M6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY397)I M97,@0B!03H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI M9VX],T1L969T('-T>6QE/3-$)V)O"!S M;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`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`@("`\=&%B;&4@8VQA6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\ M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,#`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`P<'0[(&1I'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY2 M:7-K+69R964@:6YT97)E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3PO9F]N=#X\+V1I=CX-"CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XF(S$V,#L\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B8C,38P.SPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F,S(S.38V-&0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C$U8S(U,#)?931F,E\T,#0U7SDX M-V%?8S`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!U;F1E'0^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SLG/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQB6QE/3-$)W!A9&1I M;F6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M:6YD96YT.B`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`Q+C9P=#LG M/CQF;VYT('-T>6QE/3-$)V1I2`Q+"`R,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ.2PS,C0\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXY,BXQ.3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY'6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ M+#0V,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`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`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`R<'@@6QE/3-$)V1I#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I M9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`T<'@@9&]U8FQE M(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L M:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXV M+C#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO M8VL[)SXF(S$V,#L\+V1I=CX\3H@8FQO M8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3H@8FQO8VL[)SX\8G(@+SXF(S$V,#L\+V1I=CX-"CQD M:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)R!C96QL6QE/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O;3XF M(S$V,#L\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S M;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,SX-"CQD M:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY- M;VYT:',@16YD960\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY2:7-K+69R964@:6YT97)E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ M.#8E("T@,3@W)3PO9F]N=#X\+V1I=CX-"CPO9&EV/@T*/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQD:78@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF M(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL6QE M/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY4:')E92!M;VYT:',@96YD960\+V9O;G0^/"]D:78^#0H\9&EV(&%L M:6=N/3-$8V5N=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY*=6YE M(#,P+"`R,#$Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@ M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:')E M92!M;VYT:',@96YD960\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N M=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY*=6YE(#,P+"`R,#$R M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`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`T<'@[ M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U-24^#0H\9&EV(&%L:6=N/3-$ M;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF M;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`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`@("`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`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY7 M87)R86YT6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I M;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY%>&5R M8VES92`\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY06QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY# M;VYT6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY,:69E/"]F;VYT/CPO9&EV M/@T*/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXQ+C4W/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#LF M(S$V,#LF(S$V,#M%>'!I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#LF(S$V,#LF(S$V,#M%>&5R8VES960\+V9O M;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&1I=B!A M;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I M;F3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`R<'@@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXM+3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\ M=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)V1I#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U M8FQE.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L:6=N M/3-$3H@ M8FQO8VL[(&UA6QE M/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A M9&1I;F6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C@W/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)V1I'0^/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@ M8FQO8VL[(&UA2!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\82!N86UE/3-$9FES7W5N:61E M;G1I9FEE9%]T86)L95\Y/CPO83X\(2TM1490;&%C96AO;&1E6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$;&5F M="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`R<'@@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^ M27-S=64F(S$V,#LF(S$V,#M$871E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!A;&EG;CTS1&QE9G0@#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M&5R8VES92!06QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`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`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`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`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXX M+S(U+S(P,38\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY*86YU87)Y(#(P,3`@26YV M97-T;W(@5V%R3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT M/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C`P/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,"4^#0H\9&EV(&%L:6=N/3-$6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+S(X+S(P,3,\+V9O;G0^/"]D:78^ M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A M;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C`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`P+CAP=#LG/CQF;VYT('-T M>6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W M:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-38E/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA6QE M/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/8W1O M8F5R(#(P,3`@16UP;&]Y964@5V%R6QE/3-$)W1E>'0M:6YD96YT M.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY$96-E;6)E65E(%=A6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&1I=B!A;&EG M;CTS1&QE9G0@3H@ M8FQO8VL[(&UA3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,B\S+S(P,34\+V9O;G0^/"]D:78^ M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY*86YU87)Y(#(P,3$@16UP;&]Y964@5V%R3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I M=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR M+C`P/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4^#0H\9&EV(&%L M:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXQ+S(Q+S(P,30\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXR+S(R+S(P,3$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXX,"PP,#`\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H M="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY-87)C:"8C,38P.R8C,38P.S(P,3$@26YV97-T M;W(@5V%R6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXS+SDO,C`Q M,3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`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`P+CAP=#LG/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$ M)V1I6QE/3-$)V1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY-87D@,C`Q,2!# M;VYS=6QT86YT(%=A6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXU M+S$W+S(P,3$\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXR,"PP,#`\+V9O;G0^/"]D:78^#0H\+W1D M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T M>6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T1W M:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA65E(%=A#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X-"CQD:78@ M86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`R M<'@@3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXY+S$R+S(P,30\+V9O;G0^/"]D:78^#0H\+W1D/@T* M/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R M/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!S M='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-38E/@T*/&1I=B!A;&EG;CTS1&QE9G0@6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE M/3-$)W!A9&1I;F6QE/3-$ M)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,"4^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE M/3-$)W!A9&1I;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I=B!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/B8C,38P M.SPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!G96]G'0^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T M:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\8G(@+SXF(S$V,#L\+V1I=CX-"CQD:78@ M86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I M;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^2G5N92`S,"P@,C`Q,CPO9F]N=#X\+V1I=CX- M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI M9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^2G5N M92`S,"P@,C`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`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY0 M97)C96YT86=E/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE M9G0@#LG('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY.970@6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`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`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`P+CAP M=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY.970@6QE/3-$)V1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI M9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ-3,\+V9O;G0^/"]D:78^#0H\+W1D M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`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`P+CAP M=#LG/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,#`\+V9O;G0^ M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$,24^ M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[#0H@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE M/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI M9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^4VEX(&UO;G1H6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M=V5I9VAT.B!B;VQD.R<^2G5N92`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`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`P+CAP M=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`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`P+CAP=#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXQ+#$S.#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXV.3(\ M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,#`\+V9O;G0^/"]D:78^#0H\+W1D M/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXE/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$ M)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H M="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V1I7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@3H@8FQO8VL[)SX\8G(@+SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX] M,T1L969T/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:')E92!-;VYT:',@96YD960\ M+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D(&%L:6=N/3-$ M;&5F="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`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`T<'@@9&]U8FQE(&)L86-K.R<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`T M<'@@9&]U8FQE(&)L86-K.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M#0H\9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F3H@8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`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`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT M('-T>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H M="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V M/@T*/&1I=B!A;&EG;CTS1&-E;G1E6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;3X-"CQD M:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT M9"!A;&EG;CTS1&QE9G0@#LG M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXR,#$Q/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@ M#LG('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)W1E M>'0M:6YD96YT.B`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`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`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXS,BPX.#D\+V9O;G0^/"]D:78^ M#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXR-2PP,SD\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L M:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R M(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY.970@;&]S6QE/3-$)W!A9&1I;F6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD M/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE M/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)V1I6QE/3-$)W!A M9&1I;F3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH,"XU,#PO M9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$ M)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXI/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE M/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F,S(S.38V-&0-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C$U8S(U,#)?931F,E\T,#0U M7SDX-V%?8S`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!O M9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*3QB M'0^ M,R!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W M85]C,#%F,S(S.38V-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,C$U8S(U,#)?931F,E\T,#0U7SDX-V%?8S`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@8VAA MF]N(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%SF]N(%M-96UB97)=/&)R/CPO=&@^ M#0H@("`@("`@(#QT:"!C;&%S#(P86,[*3QB'1U86PI/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^-2!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7,\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!L:6-E M;G-E(&-O;G1R86-T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$F5D M('1A>"!B96YE9FET'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^075G(#(V+`T*"0DR M,#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^1&5C(#,Q+`T*"0DR,#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^1&5C(#,Q+`T*"0DR,#$P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^36%R(#$L#0H)"3(P M,30\6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S2!R97!A>6UE;G0@<&QA;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,34E(&1I7,@96YD:6YG(&]N('1H M92`R-71H(&]F(&5A8V@@;6]N=&@@;W9E'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,R!Y96%R65A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^0F5G:6YN:6YG(&]N('1H92!S:7@M;6]N=&@@86YN M:79E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^*&$I('1H92!#;VUP86YY)W,@8V]M;6]N('-T;V-K(&ES('1R861E M9"!A="!A('!R:6-E('!E2=S(&-O M;6UO;B!S=&]C:R!I7,L(&]R("AB*2!T:&4@0V]M<&%N>2!C;VYS=6UM871E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^16%C:"!I;G9E2UF:79E('!E3QS<&%N/CPO&5R M8VES92!O9B!W87)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,35C,C4P,E]E M-&8R7S0P-#5?.3@W85]C,#%F,S(S.38V-&0-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,C$U8S(U,#)?931F,E\T,#0U7SDX-V%?8S`Q9C,R,SDV M-C1D+U=O'0O:'1M;#L@8VAA65T($5X8VAA;F=E9"!A="!*=6YE(#,P+"`R,#$R/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,BPT,SD\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$65T($5X8VAA;F=E9"!A="!*=6YE(#,P+"`R,#$R/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.2PX.3(\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$65T($5X8VAA;F=E9"!A="!*=6YE(#,P+"`R,#$R/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ,BPU-#<\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2`H1&5T86EL'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5R8VES92!P&5R8VES960@8GD@ M86YO=&AE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`H5&5X='5A;"D\+W-T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^ M,CD@9&%Y'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E8W1E9"!V;VQA=&EL:71Y M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3`N,#`E/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M65A M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'1U86PI/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES92!P'0^)FYB&5R8VES92!P M3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W M85]C,#%F,S(S.38V-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,C$U8S(U,#)?931F,E\T,#0U7SDX-V%?8S`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@8VAA M2!O9B!A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA65A7,\&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'!E8W1E9"!V;VQA=&EL:71Y+"!-:6YI;75M/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#8N,#`E/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E8W1E M9"!V;VQA=&EL:71Y+"!-87AI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ.#3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F,S(S.38V M-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C$U8S(U,#)?931F M,E\T,#0U7SDX-V%?8S`Q9C,R,SDV-C1D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L-C`W/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA2!O9B!A;&P@=V%R3PO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2`Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ.2PS,C0\'0^)FYB&5R8VES92!P2`Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD M(#DR+C$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&5R8VES92!0'0^)FYB&5R8VES M92!P2!O9B!A;&P@=V%R3PO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`Q+"`R,#$R M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#0P-2PV,#8\&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES92!P2`Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XD(#$N-3<\'0^ M)FYB'!I'0^)FYB&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA65A7,\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O9B!O=71S=&%N9&EN9R!W M87)R86YT'0^4V5P(#(V+`T*"0DR,#$R M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^075G(#(U+`T*"0DR,#`Y/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^075G(#(U+`T*"0DR,#$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^2F%N(#(X+`T*"0DR,#$S/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O9B!O=71S=&%N9&EN M9R!W87)R86YT'0^4V5P(#(R+`T*"0DR,#$P/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O9B!O=71S=&%N9&EN9R!W87)R86YT'0^4V5P(#(X+`T*"0DR M,#$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^3V-T(#$X+`T*"0DR,#$S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&5R8VES92!0'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^1&5C(#,L#0H)"3(P,34\2!O9B!O M=71S=&%N9&EN9R!W87)R86YT'0^2F%N(#(Q+`T*"0DR,#$Q/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^1F5B M(#(R+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0'!I'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&5R8VES92!0'0^07!R(#2`R,#$Q($-O;G-U;'1A;G0@5V%R'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2`Q-RP-"@D),C`Q,3QS<&%N/CPO'0^36%Y(#$W+`T*"0DR,#$T/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O9B!O=71S=&%N M9&EN9R!W87)R86YT'!I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA65E($1I'1U86PI/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'!E M8W1E9"!T;R!V97-T+"!O=71S=&%N9&EN9RP@;G5M8F5R/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^-"!Y96%R65A65A'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^-2!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S2!I;F-E;G1I=F4@<&QA;G,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S&-L=61I;F<@5D%4*3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^,3(@;6]N=&AS/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,R!Y96%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!I M7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!G M96]G'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!G96]G M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI/&)R/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N M;&5S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,35C,C4P M,E]E-&8R7S0P-#5?.3@W85]C,#%F,S(S.38V-&0-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,C$U8S(U,#)?931F,E\T,#0U7SDX-V%?8S`Q9C,R M,SDV-C1D+U=O'0O:'1M;#L@8VAA'1U86PI/&)R/CPO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-L=61E9"!F'1U86PI/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'1U86PI/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\R,35C,C4P,E]E-&8R7S0P-#5?.3@W85]C,#%F,S(S.38V-&0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C$U8S(U,#)?931F,E\T,#0U7SDX M-V%?8S`Q9C,R,SDV-C1D+U=O&UL#0I#;VYT M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U'1087)T7S(Q-6,R-3`R7V4T9C)?-#`T-5\Y.#=A 17V,P,68S,C,Y-C8T9"TM#0H` ` end XML 19 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details Textual) (USD $)
1 Months Ended 6 Months Ended
Feb. 29, 2012
Jun. 30, 2012
Mar. 16, 2012
Dec. 31, 2011
Dec. 31, 2010
Stockholders Equity (Textual)          
Common stock issuable upon exercise of warrants   100,000 200,000    
Common stock, shares authorized 70,000,000 70,000,000   70,000,000 848,000,000
Preferred stock, shares authorized 1,000,000       2,000,000
Stockholders' equity, reverse stock split 1-for-25        
Shares received by using the net exercise provision   13,831      
Common stock shares exercised by another warrant holder   2,500      
Cash exercise price per share   $ 3.13      
Total exercise price   $ 7,813      
Conversion of warrant into common stock, shares converted   13,831 174,798    
Common Stock [Member]
         
Stockholders Equity (Textual)          
Common stock issuable upon exercise of warrants   21,000 200,000    
Conversion of Stock, Shares Issued   2,509      
Series A Preferred Stock [Member]
         
Stockholders Equity (Textual)          
Preferred stock, liquidation preference   $ 0.001   0.001  
Preferred stock, voting rights   One vote for each share      
Preferred stock conversion ratio per share of common stock   480.63      
Preferred stock, shares authorized   444,541   444,541  
Series B Preferred Stock [Member]
         
Stockholders Equity (Textual)          
Conversion of Stock, Shares Issued   19      
Preferred stock, liquidation preference   $ 0.001   0.001  
Preferred stock, voting rights   One vote for each share      
Preferred stock conversion ratio per share of common stock   132.07      
Preferred stock, shares authorized   54,425   54,425  
XML 20 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details)
6 Months Ended
Jun. 30, 2012
Summary of preferred stock not yet converted  
Shares of Preferred Stock Not Exchanged as of March 31, 2011 178
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at June 30, 2012 52,439
Series A Preferred Stock [Member]
 
Summary of preferred stock not yet converted  
Shares of Preferred Stock Not Exchanged as of March 31, 2011 83
Preferred Stock Conversion Ratio 480.63
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at June 30, 2012 39,892
Series B Preferred Stock [Member]
 
Summary of preferred stock not yet converted  
Shares of Preferred Stock Not Exchanged as of March 31, 2011 95
Preferred Stock Conversion Ratio 132.07
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at June 30, 2012 12,547
XML 21 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurement of Assets and Liabilities (Details) (USD $)
6 Months Ended
Jun. 30, 2011
Dec. 31, 2011
Fair value assumptions and methodology for assets and liabilities    
Annual dividend yield     
Fair value measurement of assets and liabilities (Textual)    
Fair value of embedded conversion features   $ 0
Minimum [Member]
   
Fair value assumptions and methodology for assets and liabilities    
Expected life (years) 29 days  
Risk-free interest rate 0.08%  
Expected volatility 110.00%  
Maximum [Member]
   
Fair value assumptions and methodology for assets and liabilities    
Expected life (years) 3 years  
Risk-free interest rate 1.27%  
Expected volatility 263.00%  
XML 22 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Deferred Revenue (Details) (USD $)
Jun. 30, 2012
Dec. 31, 2011
Deferred Revenue (Textual)    
Engineering development fees recorded as deferred revenue $ 1,543,000 $ 1,906,000
Deferred engineering development fees from second set of customers 100,000 100,000
Deferred engineering development fees from first set of customers 400,000 400,000
Future License Fees From One Customer [Member]
   
Deferred Revenue (Textual)    
Engineering development fees recorded as deferred revenue $ 1,400,000 $ 1,500,000
XML 23 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2012
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
 
2. Summary of Significant Accounting Policies
 
Fiscal Year
 
Our fiscal year is the calendar year.
 
Principles of Consolidation
 
The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include the accounts of Neonode Inc. and its wholly owned Swedish subsidiary, Neonode Technologies AB. All inter-company accounts and transactions have been eliminated in consolidation.
          
Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectability of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets, the fair value of embedded derivatives, and the fair value of securities, such as options and warrants issued for stock-based compensation and in certain financing transactions.
 
Cash and Cash Equivalents
 
We have not had any liquid investments other than normal cash deposits with banking institutions to date.  If in the future the Company purchases cash equivalents, the Company will consider all highly liquid investments with original maturities of three months of less to be cash equivalents.
 
Concentration of Cash Balance Risks
 
Cash balances are maintained at various banks in the U.S. and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (“FDIC”), which provides basic deposit coverage with limits up to $250,000 per owner. In addition to the basic insurance deposit coverage, the FDIC is providing temporary unlimited coverage for noninterest bearing transaction accounts through December 31, 2012. The Swedish government provides insurance coverage up to 100,000 Euro per customer and covers deposits in all types of accounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to the deposits. As of June 30, 2012, the Company has approximately $10.4 million in excess of insurance limits.
 
Accounts Receivable and Allowance for Doubtful Accounts  
 
Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectability of our trade receivable balances based on a combination of factors. When a customer’s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer’s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance for all customers based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.  We determined that an allowance for doubtful accounts was not necessary at June 30, 2012 or December 31, 2011.
 
Debt Issuance Costs
 
Debt issuance costs represent costs incurred in connection with the issuance of the convertible notes payable. Debt issuance costs are amortized over the term of the financing instrument on a straight-line basis, which approximates the effective interest method.
 
 
 
Property and Equipment
 
Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets ranging from three to five years as follows:
 
Computer equipment
3 years
Furniture and fixtures
5 years
 
Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.
 
Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.
 
Long-lived Assets
 
We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.  At June 30, 2012, we believe there is no impairment of our long-lived assets. There can be no assurance, however, that market conditions will not change or sufficient commercial demand for our products and services will materialize, which could result in impairment of long-lived assets in the future.
 
Foreign Currency Translation and Transaction Gains and Losses
 
The functional currency of our foreign subsidiary is the applicable local currency, the Swedish Krona. The translation from Swedish Krona to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive income (loss). Gains or (losses) resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $73,000 and $8,000 during the three months ended June 30, 2012 and 2011, respectively, and $11,000 and $(57,000) during the six months ended June 30, 2012 and 2011, respectively. Foreign currency translation gain (loss) was $(72,000) and $(21,000) for the three months ended June 30, 2012 and 2011, respectively, and was $(28,000) and $18,000 for the six months ended June 30, 2012 and 2011, respectively.
 
Liability for Warrants and Embedded Derivatives  
 
We do not enter into derivative contracts for purposes of risk management or speculation.  However, from time to time, we enter into contracts that are not considered derivative financial instruments in their entirety but that include embedded derivative features, such as conversion features. Such embedded derivatives are assessed at inception of the contract and every reporting period, depending on their characteristics, are accounted for as separate derivative financial instruments pursuant to accounting guidance, if such embedded conversion features, if freestanding, would meet the classification of a liability. Accounting guidance requires that we analyze all material contracts and determine whether or not they contain embedded derivatives. Any such embedded conversion features that meet the above criteria are then bifurcated from their host contract and recorded on the consolidated balance sheet at fair value and the changes in the fair value of these derivatives are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features and warrants.
 
 
Similarly, if warrants meet the criteria in accordance with accounting guidance to be classified as liabilities, then the fair value of the warrants are recorded on the consolidated balance sheet at their fair values, and any changes in such fair values are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features.
 
On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company’s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.
 
Concentration of Credit and Business Risks
 
In the short term, we anticipate that we will depend on a limited number of customers for substantially all of our future revenue. Failure to anticipate or respond adequately to technological developments in our industry, changes in customer or supplier requirements or changes in regulatory requirements or industry standards, or any significant delays in the development or introduction of products or services, could have a material adverse effect on our business, operating results and cash flows.
 
Our accounts receivable as of June 30, 2012 was due from eleven customers, three of which accounted for 84% of our accounts receivable as of June 30, 2012.
 
Our net revenues for the three months ended June 30, 2012 was earned from twelve customers. Our customers are located in the U.S., Europe and Asia. Customers who accounted for 10% or more of our net revenues during the three months ended June 30, 2012 are as follows:
 
  
Amazon - 53%
  
Kobo - 11%
●  
Sony Corporation - 11%
 
Our net revenues for the six months ended June 30, 2012 was earned from sixteen customers. Customers who accounted for 10% or more of our net revenues during the six months ended June 30, 2012 are as follows:
 
  
Amazon  - 53%
  
Sony Corporation – 13%
 
Our accounts receivable as of December 31, 2011 was due from five customers, two of which accounted for 87% of our accounts receivable as of December 31, 2011. Our net revenues for the three months ended June 30, 2011 was earned from five customers, four of which accounted for approximately 99% of our total net revenues for the three months ended June 30, 2011. Our net revenues for the six months ended June 30, 2011 was earned from six customers, one of which accounted for approximately 71% of our net revenues for the six months ended June 30, 2011. Our customers are located in the US, Europe and Asia.
 
Risks and Uncertainties
 
Our long-term success is dependent on our obtaining sufficient capital to fund our operations and to develop our products, and on our bringing such products to the worldwide market and obtaining sufficient sales volume to be profitable. To achieve these objectives, we may be required to raise additional capital through public or private financings or other arrangements. It cannot be assured that such financings will be available on terms attractive to us, if at all. Such financings may be dilutive to our stockholders and may contain restrictive covenants.
 
We are subject to certain risks common to technology-based companies in similar stages of development. Principal risks include risks relating to the uncertainty of market acceptance for our products, a history of losses since inception, our ability to remain competitive in response to new technologies, the costs to defend, as well as risks of losing patents and intellectual property rights, on our future customers ability to develop and sell products that incorporate our technology, the concentration of our operations in a limited number of facilities, the uncertainty of demand for our products in certain markets, our ability to manage growth effectively, our dependence on key members of our management and development team, our limited experience in conducting operations internationally, and our ability to obtain adequate capital to fund future operations.
  
We are exposed to a number of economic and industry factors that could result in portions of our technology becoming obsolete or not gaining market acceptance. These factors include, but are not limited to, technological changes in our markets, our ability to meet changing customer requirements, competitive pressures in products and prices, and the ability of our customers to manufacture and sell their products that incorporate our technology.
 
A significant portion of our business is conducted in currencies other than the U.S. dollar (the currency in which its financial statements are reported), primarily the Swedish Krona and, to a lesser extent, the Euro. We incur a significant portion of our expenses in Swedish Krona, including a significant portion of our product development expenses and a substantial portion of our general and administrative expenses. As a result, appreciation of the value of the Swedish Krona relative to the other currencies, particularly the U.S. dollar, could adversely affect operating results. We do not currently undertake hedging transactions to cover our currency exposure, but we may choose to hedge a portion of our currency exposure in the future as deemed appropriate.
 
Our future success depends on market acceptance of our technology as well as our ability to introduce new versions of our technology to meet the evolving needs of our customers.
 
Revenue Recognition
 
Engineering Services:
 
We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.  Generally, we recognize revenue as the engineering services stipulated under the contact are completed and accepted by our customers.  
   
Licensing Revenues:
 
We also derive revenue from the licensing of internally developed intellectual property (“IP”). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and royalties payable following the sale by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. As of September 30, 2011, Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers.   For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize new technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) customer distributes or license the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.
 
Prior to September 30, 2011, we deferred the technology license fee revenue until such time as the warranty period stipulated in the license agreement expired because we did not have sufficient historical experience in estimating potential warranty costs.  From June 2010 to September 30, 2011, we entered into 12 technology license contracts with customers.  During that time there were no warranty related costs incurred for any customer products after they have been released to market.  During the quarter ended September 30, 2011, the Company performed an analysis and determined that it had sufficient historical evidence regarding estimated warranty costs and therefore began recognizing technology license fee revenues, net of warranty costs, if any, as the products incorporating the Neonode technology are distributed or licensed by our customers, assuming all other revenue recognition criteria has been met.  Our customers report to us the quantities of products distributed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.
  
Explicit return rights are not offered to customers. There have been no returns through June 30, 2012.
 
Hardware Products:
 
We may from time-to-time develop custom hardware products for our customers that incorporate our touchscreen technology. Our policy is to recognize revenue from hardware product sales when title transfers and risk of loss has passed to the customer, which is generally upon shipment of our hardware products to our customers. We will estimate expected sales returns and record the amount as a reduction of revenue and cost of hardware and other revenue at the time of shipment. To date, we have not sold any hardware products.
 
Software Products:
 
We may derive revenues from software licensing sales.  We will account for the licensing of software in accordance with accounting guidance and such guidance requires judgment, including whether a software arrangement includes multiple elements, and if so, whether vendor-specific objective evidence (“VSOE”) of fair value exists for those elements.
 
For software license arrangements that do not require significant modification or customization of the underlying software, we will recognize new software license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of software; (2) we deliver the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.
 
We allocate revenues to all deliverables based on their relative selling price using a specific hierarchy. The hierarchy is as follows: vendor-specific objective evidence (“VSOE”), third-party evidence of selling price (“TPE”) or best estimate of selling price (“BESP”).
 
When a sale involves multiple elements, we will allocate the entire fee from the arrangement to each respective element based on VSOE of fair value and recognize revenue when each element’s revenue recognition criteria are met. VSOE of fair value for each element is established based on the price charged when the same element is sold separately. We have established VSOE for our software licenses based on historical stand-alone sales to third parties or from the stated renewal rates contained in the customer contracts. Maintenance service revenue is recognized on a straight-line basis over the support period.
 
We have not yet demonstrated VSOE for the professional services that are rendered in conjunction with our software license sales. In accordance with the hierarchy we would attempt to establish the selling price of professional services using TPE. Our product contains significant differentiation such that the comparable pricing of products with similar functionality cannot be obtained. We are typically not able to obtain TPE for professional services.
 
When we are unable to establish selling prices using VSOE or TPE, we use BESP. The objective of BESP is to determine the price at which we would transact a sale if professional services were sold on a stand-alone basis. BESP is generally used for offerings that are not typically sold on a stand-alone basis or for highly customized offerings.
 
We will also continue to defer revenues that represent undelivered post-delivery engineering support until the engineering support has been completed and the software product is accepted. To date, we have not sold any software products.
  
Deferred Revenue
 
From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. The Company defers these revenues until the services have been provided or until the license fees are earned.
 
Advertising
 
Advertising costs are expensed as incurred. Advertising costs for the three and six months ended June 30, 2012 and 2011 amounted to approximately $85,000 and $29,000 and $282,000 and $74,000, respectively.
 
Product Research and Development
 
Research and development (“R&D”) costs are expensed as incurred. R&D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.
 
Stock-Based Compensation Expense
 
We measure the cost of employee services received in exchange for an award of equity instruments, including share options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.
 
We account for equity instruments issued to non-employees at their fair value and the unvested portion is re-measured each reporting period as long as the instrument requires variable accounting.
 
When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.
 
Accounting for Debt Issued with Detachable Stock Purchase Warrants and Beneficial Conversion Features
 
We account for debt issued with stock purchase warrants by allocating the proceeds of the debt between the debt and the detachable warrants based on the relative fair values of the debt security without the warrants and the warrants themselves, if the warrants are equity instruments.   The relative fair value of the warrants are recorded as a debt discount and amortized to expense over the life of the related debt using the effective interest method. At each balance sheet date, we make a determination if these warrant instruments should be classified as liabilities or equity, and reclassify them if the circumstances dictate.  
 
In certain instances, the Company enters into convertible notes that provide for an effective or actual rate of conversion that is below market value, and the embedded conversion feature does not qualify for derivative treatment (a “BCF”).  In these instances, we account for the value of the BCF as a debt discount, which is then amortized to expense over the life of the related debt using the straight-line method which approximates the effective interest method.
 
Income Taxes
 
We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the “not more likely than not” criteria of the accounting guidance.
 
 
Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of June 30, 2012 and December 31, 2011. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such a determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes payable for the current period.
 
We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.  As a result, we did not recognize a liability for unrecognized tax benefits.  As of June 30, 2012 and December 31, 2011, we had no unrecognized tax benefits.
 
Net Loss Per Share
 
Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for three and six months ended June 30, 2012 and 2011 exclude the potential common stock equivalents, as the effect would be anti-dilutive (See Note 10).
 
Comprehensive Income (Loss)
 
Accounting Standards Codification (“ASC”) Topic 220, Comprehensive Income,   establishes standards for reporting and displaying comprehensive income (loss) and its components in the condensed consolidated financial statements. Accumulated other comprehensive income (loss) includes foreign currency translation gains or losses as a result of consolidation.
   
Cash Flow Information
 
Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations was 6.95 and 6.26 Swedish Krona to one U.S. Dollar for the three months ended June 30, 2012 and 2011, respectively. The weighted-average exchange rate for the condensed consolidated statements of operations was 6.85 and 6.34 Swedish Krona to one U.S. Dollar for the six months ended June 30, 2012 and 2011, respectively. The exchange rate for the condensed consolidated balance sheets was 6.96 and 6.92 Swedish Krona to one U.S. Dollar as of June 30, 2012 and December 31, 2011, respectively.  
 
Fair Value of Financial Instruments
 
We disclose the estimated fair values for all financial instruments for which it is practicable to estimate fair value. Financial instruments including cash and cash equivalents, accounts receivable, payables and accrued expenses are deemed to approximate fair value due to their short maturities.
 
New Accounting Pronouncements
 
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) No. 2011-4, Fair Value Measurement ("ASU 2011-04"). ASU 2011-04 amends existing guidance to achieve convergence in measurement and disclosure between U.S. GAAP and International Financial Reporting Standards ("IFRS"). ASU 2011-04 is effective for fiscal year 2012. The adoption of ASU 2011-04 did not impact the Company’s results of operations or its financial position.
  
In June 2011, the FASB issued ASU No. 2011-05,   Presentation of Comprehensive Income (“ASU 2011-05”).  The provisions of ASU 2011-05 allow an entity the option to present the total of comprehensive income (loss), the components of net income (loss), and the components of other comprehensive income (loss) either in a single continuous statement of comprehensive income (loss) or in two separate but consecutive statements.  In both choices, an entity is required to present each component of net income (loss) along with total net income (loss), each component of other comprehensive income (loss) along with a total for other comprehensive income (loss), and a total amount for comprehensive income (loss).  The statement(s) are required to be presented with equal prominence as the other primary financial statements.  ASU No. 2011-05 eliminates the option to present the components of other comprehensive income (loss) as part of the statement of changes in stockholders’ equity but does not change the items that must be reported in other comprehensive income (loss) or when an item of other comprehensive income (loss) must be reclassified to net income (loss).  Certain provisions of ASU No. 2011-05 are effective for the Company’s interim reporting period beginning on or after December 15, 2011, with retrospective application required.  The adoption of ASU No. 2011-05 resulted in presentation changes to the Company’s consolidated statements of operations and the addition of separate consolidated statements of comprehensive income (loss).  The adoption of ASU No. 2011-05 did not impact the Company’s results of operations or its financial position.
XML 24 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details) (USD $)
6 Months Ended
Jun. 30, 2012
Summary of the combined activity under all of the stock option plans  
Number of options outstanding, Outstanding at January 1, 2012 19,324
Number of options outstanding granted 1,460,000
Number of options outstanding cancelled or expired (8,124)
Number of options outstanding exercised   
Number of options outstanding, Outstanding at June 30, 2012 1,471,200
Share based compensation weighted average exercise price, Outstanding at January 1, 2012 $ 92.19
Share based Compensation weighted average exercise price granted $ 4.26
Share based compensation weighted average exercise price, expired/forfeited $ 69.36
Share based compensation weighted average exercise price exercised   
Share based compensation weighted average exercise price, Outstanding at June 30, 2012 $ 6.79
XML 25 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Details Textual)
6 Months Ended
Jun. 30, 2012
Segment Information (Textual)  
Number of reportable segments 1
XML 26 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Current assets:    
Cash $ 11,275 $ 12,940
Accounts receivable 1,725 3,345
Prepaid expenses and other current assets 327 234
Total current assets 13,327 16,519
Property and equipment, net 332 108
Total assets 13,659 16,627
Current liabilities:    
Accounts payable 351 447
Accrued expenses 776 601
Deferred revenue 1,543 1,906
Total current liabilities 2,670 2,954
Total liabilities 2,670 2,954
Stockholders' equity:    
Common stock, 70,000,000 shares authorized with par value $0.001per share; 32,972,631 and 32,778,993 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively 33 33
Additional paid-in capital 145,314 142,955
Accumulated other comprehensive (loss) income (15) 13
Accumulated deficit (134,343) (129,328)
Total stockholders' equity 10,989 13,673
Total liabilities and stockholders' equity 13,659 16,627
Series A Preferred Stock [Member]
   
Stockholders' equity:    
Preferred stock, value      
Series B Preferred Stock [Member]
   
Stockholders' equity:    
Preferred stock, value      
XML 27 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities:    
Net loss $ (5,015) $ (12,443)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,351 472
Depreciation and amortization 40 10
Debt discounts and deferred financing fees and the valuation of conversion features and warrants    9,568
Changes in operating assets and liabilities:    
Accounts receivable 1,623 (2,961)
Other assets      
Prepaid expenses (96) (70)
Accounts payable and accrued expenses 87 (160)
Deferred revenue (363) 2,535
Net cash used in operating activities (1,373) (3,048)
Cash flows from investing activities:    
Purchase of property and equipment (268) (25)
Net cash used in investing activities (268) (25)
Cash flows from financing activities:    
Proceeds from issuance of convertible debt    4,228
Repayment of convertible debt    (25)
Proceeds from exercise of warrants 8 515
Net cash provided by financing activities 8 4,718
Effect of exchange rate changes on cash (32) 3
Net (decrease) increase in cash (1,665) 1,648
Cash at beginning of period 12,940 911
Cash at end of period 11,275 2,559
Supplemental disclosure of cash flow information:    
Interest paid    90
Income taxes paid 42 4
Supplemental disclosure of non-cash transactions:    
Fair value of shares of common stock and warrants issued to brokers in connection with financing, recorded as debt issuance costs    1
Debt discount recorded as part of convertible debt financing transactions including, warrants issued    4,228
Debt issuance costs related to 2011 financing    35
Accrued expenses converted to common stock    120
Conversion of debt and accrued interest to common stock    2,860
Reduction of derivative liabilities upon conversion of debt    $ 13,379
XML 28 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 3) (USD $)
6 Months Ended
Jun. 30, 2012
Summary of all warrant activity  
Number of options outstanding, Outstanding at January 1, 2012 19,324
Warrants, issued 1,460,000
Warrants, exercised   
Number of options outstanding, Outstanding at June 30, 2012 1,471,200
Share based compensation weighted average exercise price, Outstanding at January 1, 2012 $ 92.19
Weighted Average Exercise Price, issued $ 4.26
Weighted Average Exercise Price, expired/forfeited $ 69.36
Weighted Average Exercise Price, exercised   
Share based compensation weighted average exercise price, Outstanding at June 30, 2012 $ 6.79
Warrant [Member]
 
Summary of all warrant activity  
Number of options outstanding, Outstanding at January 1, 2012 5,405,606
Warrants, issued   
Warrants, expired/forfeited   
Warrants, exercised (223,500)
Number of options outstanding, Outstanding at June 30, 2012 5,182,106
Share based compensation weighted average exercise price, Outstanding at January 1, 2012 $ 1.57
Weighted Average Exercise Price, issued   
Weighted Average Exercise Price, expired/forfeited   
Weighted Average Exercise Price, exercised $ 0.61
Share based compensation weighted average exercise price, Outstanding at June 30, 2012 $ 1.61
Share Based Compensation Weighted Average Remaining Contractual Life 2 years 5 months 12 days
Weighted averageremaining contractual life, Outstanding and exercisable, March 31, 2012 1 year 10 months 13 days
XML 29 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Summary of the combined activity under all of the stock option plans
 

 
  
 
Number of Options Outstanding
   
Weighted Average Exercise Price
 
Outstanding at January 1, 2012
   
19,324
   
$
92.19
 
Granted
   
1,460,000
     
4.26
 
Cancelled or expired
   
(8,124
   
69.36
 
Exercised
   
---
     
---
 
Outstanding at June 30, 2012
   
1,471,200
   
$
6.79
 
 
Summary of assumptions used to value stock options granted to employees and directors
 

 
   
For the Six
   
Months Ended
June 30, 2012
       
Annual dividend yield
   
--
 
Expected life (years)
   
3.8
 
Risk-free interest rate
   
0.55% - 0.57%
 
Expected volatility
   
186% - 187%
 
 
Stock based compensation expense related to stock options and warrants
 
   
Three months ended
June 30, 2011
   
Three months ended
June 30, 2012
 
Stock-based compensation
  $ 183     $ $2,317  
 
 
   
Six months ended
June 30, 2011
   
Six months ended
June 30, 2012
   
Remaining unamortized expense at
June 30, 2012
 
Stock-based compensation
 
$
472
   
$
2,351
   
$
3,607
 
Summary of all warrant activity
 
 
   
June 30, 2012
Outstanding and exercisable
 
Warrants
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life
January 1, 2012
   
5,405,606
   
$
1.57
     
2.45
 
   Issued
   
--
   
$
--
     
--
 
   Expired/forfeited
   
--
     
--
     
--
 
   Exercised
   
(223,500
)
 
$
0.61
     
--
 
Outstanding and exercisable, June 30, 2012
   
5,182,106
   
$
1.61
     
1.87
 
Summary of outstanding warrants to purchase common stock
 
 
                 
Description
Issue  Date
 
Exercise Price
 
Shares
 
Expiration Date
 
                 
September 2007 Investor Warrant
9/26/2007
 
$
31.75
 
233
   
9/26/2012
 
August 2009 Employee Warrants
8/25/2009
 
$
0.50
 
240,000
   
8/25/2016
 
January 2010 Investor Warrant
1/28/2010
 
$
1.00
 
40,000
   
1/28/2013
 
2007 Debt Extension Warrants
9/22/2010
 
$
1.00
 
16,000
   
9/22/2015
 
September 2010 Repricing Warrant
9/28/2010
 
$
1.38
 
4,000
   
9/28/2013
 
October 2010 Repricing Warrants
10/18/2010
 
$
1.38
 
2,434,830
   
10/18/2013
 
October 2010 Employee Warrants
10/15/2010
 
$
1.38
 
1,440,000
   
10/15/2013
 
December 2010 Employee Warrants
12/3/2010
 
$
1.63
 
200,000
   
12/3/2015
 
January 2011 Employee Warrant
1/21/2011
 
$
2.00
 
20,000
   
1/21/2014
 
February 2011 Legal Advisor Warrant
2/22/2011
 
$
2.00
 
80,000
   
2/22/2016
 
March  2011 Investor Warrants
3/9/2011
 
$
3.13
 
617,943
   
3/9/2016
 
March  2011 Investor Warrants
4/7/2011
 
$
3.13
 
49,100
   
4/7/2016
 
May 2011 Consultant Warrant
5/17/2011
 
$
4.05
 
20,000
   
5/17/2014
 
September 2011 Employee Warrant
9/12/2011
 
$
3.90
 
20,000
   
9/12/2014
 
Total Warrants Outstanding
         
5,182,106
       
 
XML 30 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 4) (USD $)
6 Months Ended
Jun. 30, 2012
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 3.13
Shares 5,182,106
September 2007 Investor Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 31.75
Issue Date Sep. 26, 2007
Shares 233
Expiration Date Sep. 26, 2012
August 2009 Employee Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 0.50
Issue Date Aug. 25, 2009
Shares 240,000
Expiration Date Aug. 25, 2016
January 2010 Investor Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 1.00
Issue Date Jan. 28, 2010
Shares 40,000
Expiration Date Jan. 28, 2013
2007 Debt Extension Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 1.00
Issue Date Sep. 22, 2010
Shares 16,000
Expiration Date Sep. 22, 2015
September 2010 Repricing Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 1.38
Issue Date Sep. 28, 2010
Shares 4,000
Expiration Date Sep. 28, 2013
October 2010 Repricing Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 1.38
Issue Date Oct. 18, 2010
Shares 2,434,830
Expiration Date Oct. 18, 2013
October 2010 Employee Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 1.38
Issue Date Oct. 15, 2010
Shares 1,440,000
Expiration Date Oct. 15, 2013
December 2010 Employee Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 1.63
Issue Date Dec. 03, 2010
Shares 200,000
Expiration Date Dec. 03, 2015
January 2011 Employee Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 2.00
Issue Date Jan. 21, 2011
Shares 20,000
Expiration Date Jan. 21, 2014
February 2011 Legal Advisor Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 2.00
Issue Date Feb. 22, 2011
Shares 80,000
Expiration Date Feb. 22, 2016
March 2011 Investor Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 3.13
Issue Date Mar. 09, 2011
Shares 617,943
Expiration Date Mar. 09, 2016
March 2011 Investor Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 3.13
Issue Date Apr. 07, 2011
Shares 49,100
Expiration Date Apr. 07, 2016
May 2011 Consultant Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 4.05
Issue Date May 17, 2011
Shares 20,000
Expiration Date May 17, 2014
September 2011 Employee Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Investment Warrants, Exercise Price $ 3.90
Issue Date Sep. 12, 2011
Shares 20,000
Expiration Date Sep. 12, 2014
XML 31 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2012
Earnings Per Share [Abstract]  
Basic and diluted for Net Loss Per Share
 
 

 
   
Three Months ended
 
(in thousands, except per share amounts)
 
June 30,
 
   
2012
   
2011
 
BASIC AND DILUTED
           
Weighted average number of
           
common shares outstanding
   
32,969
     
27,642
 
Number of shares for computation of
               
net loss per share
   
32,969
     
27,642
 
Net loss
 
$
(3,427
)
 
$
(2,722
)
                 
Net loss per share - basic and diluted
 
$
(0.10
)
 
$
(0.10
)
  
   
Six Months ended
 
(in thousands, except per share amounts)
 
June 30,
 
   
2012
   
2011
 
BASIC AND DILUTED
           
Weighted average number of
           
common shares outstanding
   
32,889
     
25,039
 
Number of shares for computation of
               
net loss per share
   
32,889
     
25,039
 
Net loss
 
$
(5,015
)
 
$
(12,443
)
                 
Net loss per share - basic and diluted
 
$
(0.15
)
 
$
(0.50
)
XML 32 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 33 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Interim Period Reporting
6 Months Ended
Jun. 30, 2012
Interim Period Reporting [Abstract]  
Interim Period Reporting
 
1. Interim Period Reporting
 
The unaudited interim condensed consolidated financial statements, include all adjustments, consisting of normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the financial position and results of operations and cash flows for the interim periods. The results of operations for the three and six months ended June 30, 2012 are not necessarily indicative of expected results for the full 2012 fiscal year.
 
The accompanying condensed consolidated financial statements as of June 30, 2012 and for the three and six months ended June 30, 2012 and 2011 have been prepared by us, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally contained in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes contained in our consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2011.
 
Operations
 
Neonode Inc., “we”, “us”, “our”, the “Company”, develops and licenses MultiSensing TM touch user interfaces and optical multi-touch solutions. The cornerstone of our interface solutions is zForce®, our patented touch technology. Neonode licenses the Neonode MultiSensing TM touch technology to Original Equipment Manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”) who embed our technology into devices that they produce and sell. Our solution is currently being integrated into products such as mobile phones, e-Readers and tablets, printers and office equipment, toys and gaming consoles, automotive and in-vehicle infotainment systems.
 
 Intellectual Property
 
We rely on a combination of intellectual property laws, as well as confidentiality procedures and contractual provisions, to protect our proprietary technology and our brand. We have registered, and applied for the registration of, U.S. and international trademarks, service marks, domain names, and copyrights. Additionally, we have filed U.S. and international patent applications covering certain of our proprietary technology. Over time, we have assembled a portfolio of patents, trademarks, service marks, copyrights, domain names, and trade secrets covering our products and services. Our proprietary technology is not dependent on any single patent or copyright or groups of related patents or copyrights. We believe the duration of our patents is adequate relative to the expected lives of our products. Although we rigorously protect our proprietary technology, any significant impairment of, or third-party claim against, our intellectual property rights could harm our business or our ability to compete.
XML 34 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Jun. 30, 2012
Dec. 31, 2011
Common stock, shares authorized 70,000,000 70,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares issued 32,972,631 32,778,993
Common stock, shares outstanding 32,972,631 32,778,993
Series A Preferred Stock [Member]
   
Preferred stock, shares authorized 444,541 444,541
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares issued 83 83
Preferred stock, shares outstanding 83 83
Preferred stock, liquidation preference $ 0.001 $ 0.001
Series B Preferred Stock [Member]
   
Preferred stock, shares authorized 54,425 54,425
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares issued 95 114
Preferred stock, shares outstanding 95 114
Preferred stock, liquidation preference $ 0.001 $ 0.001
XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events
6 Months Ended
Jun. 30, 2012
Subsequent Events [Abstract]  
Subsequent Events
 
11. Subsequent Events
 
We have evaluated subsequent events through the filing date of this Form 10-Q, and have determined that no subsequent events have occurred that would require recognition in the consolidated financial statements or disclosure in the notes thereto.
XML 36 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document And Entity Information
6 Months Ended
Jun. 30, 2012
Aug. 07, 2012
Entity Registrant Name Neonode, Inc  
Entity Central Index Key 0000087050  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Jun. 30, 2012  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q2  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   33,003,782
XML 37 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2012
Accounting Policies [Abstract]  
Fiscal Year
 
Fiscal Year
 
Our fiscal year is the calendar year.
Principles of Consolidation
 
Principles of Consolidation
 
The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include the accounts of Neonode Inc. and its wholly owned Swedish subsidiary Neonode Technologies AB. All inter-company accounts and transactions have been eliminated in consolidation.
Estimates
 
Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectability of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets, the fair value of embedded derivatives, and the fair value of securities, such as options and warrants issued for stock-based compensation and in certain financing transactions.
Cash and Cash Equivalents
 
Cash and Cash Equivalents
 
We have not had any liquid investments other than normal cash deposits with banking institutions to date.  If in the future the Company purchases cash equivalents, the Company will consider all highly liquid investments with original maturities of three months of less to be cash equivalents.
Concentration of Cash Balance Risks
 
Concentration of Cash Balance Risks
 
Cash balances are maintained at various banks in the U.S. and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (“FDIC”), which provides basic deposit coverage with limits up to $250,000 per owner. In addition to the basic insurance deposit coverage, the FDIC is providing temporary unlimited coverage for noninterest bearing transaction accounts through December 31, 2012. The Swedish government provides insurance coverage up to 100,000 Euro per customer and covers deposits in all types of accounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk related to the deposits. As of June 30, 2012, the Company has approximately $10.4 million in excess of insurance limits.
Accounts Receivable and Allowance for Doubtful Accounts
 
Accounts Receivable and Allowance for Doubtful Accounts  
 
Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectability of our trade receivable balances based on a combination of factors. When a customer’s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer’s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance for all customers based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.  We determined that an allowance for doubtful accounts was not necessary at June 30, 2012 or December 31, 2011.
Debt Issuance Costs
 
Debt Issuance Costs
 
Debt issuance costs represent costs incurred in connection with the issuance of the convertible notes payable. Debt issuance costs are amortized over the term of the financing instrument on a straight-line basis, which approximates the effective interest method.
Property and Equipment
 
Property and Equipment
 
Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets ranging from three to five years as follows:
 
Computer equipment
3 years
Furniture and fixtures
5 years
 
Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.
 
Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.
Long-lived Assets
 
Long-lived Assets
 
We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.  At June 30, 2012, we believe there is no impairment of our long-lived assets. There can be no assurance, however, that market conditions will not change or sufficient commercial demand for our products and services will materialize, which could result in impairment of long-lived assets in the future.
Foreign Currency Translation and Transaction Gains and Losses
 
Foreign Currency Translation and Transaction Gains and Losses
 
The functional currency of our foreign subsidiary is the applicable local currency, the Swedish Krona. The translation from Swedish Krona to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive income (loss). Gains or (losses) resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $73,000 and $8,000 during the three months ended June 30, 2012 and 2011, respectively, and $11,000 and $(57,000) during the six months ended June 30, 2012 and 2011, respectively. Foreign currency translation gain (loss) was $(72,000) and $(21,000) for the three months ended June 30, 2012 and 2011, respectively, and was $(28,000) and $18,000 for the six months ended June 30, 2012 and 2011, respectively.
 
Liability for Warrants and Embedded Derivatives
 
Liability for Warrants and Embedded Derivatives  
 
We do not enter into derivative contracts for purposes of risk management or speculation.  However, from time to time, we enter into contracts that are not considered derivative financial instruments in their entirety but that include embedded derivative features, such as conversion features. Such embedded derivatives are assessed at inception of the contract and every reporting period, depending on their characteristics, are accounted for as separate derivative financial instruments pursuant to accounting guidance, if such embedded conversion features, if freestanding, would meet the classification of a liability. Accounting guidance requires that we analyze all material contracts and determine whether or not they contain embedded derivatives. Any such embedded conversion features that meet the above criteria are then bifurcated from their host contract and recorded on the consolidated balance sheet at fair value and the changes in the fair value of these derivatives are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features and warrants.
 
Similarly, if warrants meet the criteria in accordance with accounting guidance to be classified as liabilities, then the fair value of the warrants are recorded on the consolidated balance sheet at their fair values, and any changes in such fair values are recorded each period in the consolidated statements of operations as an increase or decrease to non-cash charges for conversion features.
 
On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company’s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.
Concentration of Credit and Business Risks
 
Concentration of Credit and Business Risks
 
In the short term, we anticipate that we will depend on a limited number of customers for substantially all of our future revenue. Failure to anticipate or respond adequately to technological developments in our industry, changes in customer or supplier requirements or changes in regulatory requirements or industry standards, or any significant delays in the development or introduction of products or services, could have a material adverse effect on our business, operating results and cash flows.
 
Our accounts receivable as of June 30, 2012 was due from eleven customers, three of which accounted for 84% of our accounts receivable as of June 30, 2012.
 
Our net revenues for the three months ended June 30, 2012 was earned from twelve customers. Our customers are located in the U.S., Europe and Asia. Customers who accounted for 10% or more of our net revenues during the three months ended June 30, 2012 are as follows:
 
  
Amazon - 53%
  
Kobo - 11%
●  
Sony Corporation - 11%
 
Our net revenues for the six months ended June 30, 2012 was earned from sixteen customers. Customers who accounted for 10% or more of our net revenues during the six months ended June 30, 2012 are as follows:
 
  
Amazon  - 53%
  
Sony Corporation – 13%
 
Our accounts receivable as of December 31, 2011 was due from five customers, two of which accounted for 87% of our accounts receivable as of December 31, 2011. Our net revenues for the three months ended June 30, 2011 was earned from five customers, four of which accounted for approximately 99% of our total net revenues for the three months ended June 30, 2011. Our net revenues for the six months ended June 30, 2011 was earned from six customers, one of which accounted for approximately 71% of our net revenues for the six months ended June 30, 2011. Our customers are located in the US, Europe and Asia.
 
Risks and Uncertainties
 
Risks and Uncertainties
 
Our long-term success is dependent on our obtaining sufficient capital to fund our operations and to develop our products, and on our bringing such products to the worldwide market and obtaining sufficient sales volume to be profitable. To achieve these objectives, we may be required to raise additional capital through public or private financings or other arrangements. It cannot be assured that such financings will be available on terms attractive to us, if at all. Such financings may be dilutive to our stockholders and may contain restrictive covenants.
 
We are subject to certain risks common to technology-based companies in similar stages of development. Principal risks include risks relating to the uncertainty of market acceptance for our products, a history of losses since inception, our ability to remain competitive in response to new technologies, the costs to defend, as well as risks of losing patents and intellectual property rights, on our future customers ability to develop and sell products that incorporate our technology, the concentration of our operations in a limited number of facilities, the uncertainty of demand for our products in certain markets, our ability to manage growth effectively, our dependence on key members of our management and development team, our limited experience in conducting operations internationally, and our ability to obtain adequate capital to fund future operations.
  
We are exposed to a number of economic and industry factors that could result in portions of our technology becoming obsolete or not gaining market acceptance. These factors include, but are not limited to, technological changes in our markets, our ability to meet changing customer requirements, competitive pressures in products and prices, and the ability of our customers to manufacture and sell their products that incorporate our technology.
 
A significant portion of our business is conducted in currencies other than the U.S. dollar (the currency in which its financial statements are reported), primarily the Swedish Krona and, to a lesser extent, the Euro. We incur a significant portion of our expenses in Swedish Krona, including a significant portion of our product development expenses and a substantial portion of our general and administrative expenses. As a result, appreciation of the value of the Swedish Krona relative to the other currencies, particularly the U.S. dollar, could adversely affect operating results. We do not currently undertake hedging transactions to cover our currency exposure, but we may choose to hedge a portion of our currency exposure in the future as deemed appropriate.
 
Our future success depends on market acceptance of our technology as well as our ability to introduce new versions of our technology to meet the evolving needs of our customers.
 
Revenue Recognition
 
Revenue Recognition
 
Engineering Services:
 
We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.  Generally, we recognize revenue as the engineering services stipulated under the contact are completed and accepted by our customers.  
   
Licensing Revenues:
 
We also derive revenue from the licensing of internally developed intellectual property (“IP”). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and royalties payable following the sale by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. As of September 30, 2011, Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers.   For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize new technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) customer distributes or license the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.
 
Prior to September 30, 2011, we deferred the technology license fee revenue until such time as the warranty period stipulated in the license agreement expired because we did not have sufficient historical experience in estimating potential warranty costs.  From June 2010 to September 30, 2011, we entered into 12 technology license contracts with customers.  During that time there were no warranty related costs incurred for any customer products after they have been released to market.  During the quarter ended September 30, 2011, the Company performed an analysis and determined that it had sufficient historical evidence regarding estimated warranty costs and therefore began recognizing technology license fee revenues, net of warranty costs, if any, as the products incorporating the Neonode technology are distributed or licensed by our customers, assuming all other revenue recognition criteria has been met.  Our customers report to us the quantities of products distributed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.
 
Explicit return rights are not offered to customers. There have been no returns through June 30, 2012.
 
Hardware Products:
 
We may from time-to-time develop custom hardware products for our customers that incorporate our touchscreen technology. Our policy is to recognize revenue from hardware product sales when title transfers and risk of loss has passed to the customer, which is generally upon shipment of our hardware products to our customers. We will estimate expected sales returns and record the amount as a reduction of revenue and cost of hardware and other revenue at the time of shipment. To date, we have not sold any hardware products.
 
Software Products:
 
We may derive revenues from software licensing sales.  We will account for the licensing of software in accordance with accounting guidance and such guidance requires judgment, including whether a software arrangement includes multiple elements, and if so, whether vendor-specific objective evidence (“VSOE”) of fair value exists for those elements.
 
For software license arrangements that do not require significant modification or customization of the underlying software, we will recognize new software license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of software; (2) we deliver the products; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured.
 
We allocate revenues to all deliverables based on their relative selling price using a specific hierarchy. The hierarchy is as follows: vendor-specific objective evidence (“VSOE”), third-party evidence of selling price (“TPE”) or best estimate of selling price (“BESP”).
 
When a sale involves multiple elements, we will allocate the entire fee from the arrangement to each respective element based on VSOE of fair value and recognize revenue when each element’s revenue recognition criteria are met. VSOE of fair value for each element is established based on the price charged when the same element is sold separately. We have established VSOE for our software licenses based on historical stand-alone sales to third parties or from the stated renewal rates contained in the customer contracts. Maintenance service revenue is recognized on a straight-line basis over the support period.
 
We have not yet demonstrated VSOE for the professional services that are rendered in conjunction with our software license sales. In accordance with the hierarchy we would attempt to establish the selling price of professional services using TPE. Our product contains significant differentiation such that the comparable pricing of products with similar functionality cannot be obtained. We are typically not able to obtain TPE for professional services.
 
When we are unable to establish selling prices using VSOE or TPE, we use BESP. The objective of BESP is to determine the price at which we would transact a sale if professional services were sold on a stand-alone basis. BESP is generally used for offerings that are not typically sold on a stand-alone basis or for highly customized offerings.
 
We will also continue to defer revenues that represent undelivered post-delivery engineering support until the engineering support has been completed and the software product is accepted. To date, we have not sold any software products.
 
 
Deferred Revenue
 
From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. The Company defers these revenues until the services have been provided or until the license fees are earned.
Advertising
 
Advertising
 
Advertising costs are expensed as incurred. Advertising costs for the three and six months ended June 30, 2012 and 2011 amounted to approximately $85,000 and $29,000 and $282,000 and $74,000, respectively.
 
Product Research and Development
 
Product Research and Development
 
Research and development (“R&D”) costs are expensed as incurred. R&D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.
Stock-Based Compensation Expense
 
Stock-Based Compensation Expense
 
We measure the cost of employee services received in exchange for an award of equity instruments, including share options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.
 
We account for equity instruments issued to non-employees at their fair value and the unvested portion is re-measured each reporting period as long as the instrument requires variable accounting.
 
When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.
Accounting for Debt Issued with Detachable Stock Purchase Warrants and Beneficial Conversion Features
 
Accounting for Debt Issued with Detachable Stock Purchase Warrants and Beneficial Conversion Features
 
We account for debt issued with stock purchase warrants by allocating the proceeds of the debt between the debt and the detachable warrants based on the relative fair values of the debt security without the warrants and the warrants themselves, if the warrants are equity instruments.   The relative fair value of the warrants are recorded as a debt discount and amortized to expense over the life of the related debt using the effective interest method. At each balance sheet date, we make a determination if these warrant instruments should be classified as liabilities or equity, and reclassify them if the circumstances dictate.  
 
In certain instances, the Company enters into convertible notes that provide for an effective or actual rate of conversion that is below market value, and the embedded conversion feature does not qualify for derivative treatment (a “BCF”).  In these instances, we account for the value of the BCF as a debt discount, which is then amortized to expense over the life of the related debt using the straight-line method which approximates the effective interest method.
Income Taxes
 
Income Taxes
 
We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the “not more likely than not” criteria of the accounting guidance.
 
Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of June 30, 2012 and December 31, 2011. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such a determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes payable for the current period.
 
We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.  As a result, we did not recognize a liability for unrecognized tax benefits.  As of June 30, 2012 and December 31, 2011, we had no unrecognized tax benefits.
Net Loss Per Share
 
Net Loss Per Share
 
Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for three and six months ended June 30, 2012 and 2011 exclude the potential common stock equivalents, as the effect would be anti-dilutive (See Note 10).
Comprehensive Income (Loss)
 
Comprehensive Income (Loss)
 
Accounting Standards Codification (“ASC”) Topic 220, Comprehensive Income,   establishes standards for reporting and displaying comprehensive income (loss) and its components in the condensed consolidated financial statements. Accumulated other comprehensive income (loss) includes foreign currency translation gains or losses as a result of consolidation.
Cash Flow Information
 
Cash Flow Information
 
Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations was 6.95 and 6.26 Swedish Krona to one U.S. Dollar for the three months ended June 30, 2012 and 2011, respectively. The weighted-average exchange rate for the condensed consolidated statements of operations was 6.85 and 6.34 Swedish Krona to one U.S. Dollar for the six months ended June 30, 2012 and 2011, respectively. The exchange rate for the condensed consolidated balance sheets was 6.96 and 6.92 Swedish Krona to one U.S. Dollar as of June 30, 2012 and December 31, 2011, respectively.
Fair Value of Financial Instruments
 
Fair Value of Financial Instruments
 
We disclose the estimated fair values for all financial instruments for which it is practicable to estimate fair value. Financial instruments including cash and cash equivalents, accounts receivable, payables and accrued expenses are deemed to approximate fair value due to their short maturities.
 
New Accounting Pronouncements
 
New Accounting Pronouncements
 
In May 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updates (“ASU”) No. 2011-4, Fair Value Measurement ("ASU 2011-04"). ASU 2011-04 amends existing guidance to achieve convergence in measurement and disclosure between U.S. GAAP and International Financial Reporting Standards ("IFRS"). ASU 2011-04 is effective for fiscal year 2012. The adoption of ASU 2011-04 did not impact the Company’s results of operations or its financial position.
 
In June 2011, the FASB issued ASU No. 2011-05,   Presentation of Comprehensive Income (“ASU 2011-05”).  The provisions of ASU 2011-05 allow an entity the option to present the total of comprehensive income (loss), the components of net income (loss), and the components of other comprehensive income (loss) either in a single continuous statement of comprehensive income (loss) or in two separate but consecutive statements.  In both choices, an entity is required to present each component of net income (loss) along with total net income (loss), each component of other comprehensive income (loss) along with a total for other comprehensive income (loss), and a total amount for comprehensive income (loss).  The statement(s) are required to be presented with equal prominence as the other primary financial statements.  ASU No. 2011-05 eliminates the option to present the components of other comprehensive income (loss) as part of the statement of changes in stockholders’ equity but does not change the items that must be reported in other comprehensive income (loss) or when an item of other comprehensive income (loss) must be reclassified to net income (loss).  Certain provisions of ASU No. 2011-05 are effective for the Company’s interim reporting period beginning on or after December 15, 2011, with retrospective application required.  The adoption of ASU No. 2011-05 resulted in presentation changes to the Company’s consolidated statements of operations and the addition of separate consolidated statements of comprehensive income (loss).  The adoption of ASU No. 2011-05 did not impact the Company’s results of operations or its financial position.
ZIP 38 0001213900-12-004471-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-12-004471-xbrl.zip M4$L#!!0````(`/U)#D%>F+T&CNT``$@$#0`2`!P`;F5O;F0M,C`Q,C`V,S`N M>&UL550)``.-3RI0C4\J4'5X"P`!!"4.```$.0$``.Q=Z7/C-I;_GJK\#QIO MUYWGH%R(*F\>5(_"0%8$D2I)0HGW[WXG`X M/'9+0Y];,.ECW+AX_*_;FP=U!N9*&QJ6K1@JYBO$%MP@RKK*N@ZTS(XD]C?5 M\KX(5M+``@&5&#:UWO!802HR=7`\552[#=X7NF(HMHD^QOCOP<94TS%L]!'6 MI@743R_FZ[%?Z)JM+8AM60Q5=1#"2$RKZY>F5-8`3*Z'"U*J@'=UEER'E*14 M@L8KL.SD:EY92D5#@:J57,\M(M7$>#4+JLF5<$%:%7N!4NK@DI1*CM5^493% MJMY4L9Y=Z_L%*5*]ZQNP]J^;95\@'9]TC!/+A?L]F+;(',! MD`V!%>C`7@/VQP+7MN!\H:]^FR$P_7+D>H[VTD-\>K>TH];QT@-=F(8-WNW6 M`U!MXKQ\Y^2Y']4OA+A#^!\^C:RGR?1)[+8O@=HF/>+I$CS;U[@/(MD(RSC:H,:#R1]``)%&*6CQ61(&,GX*8&RND0J\M"^RQXHUF'"V50DMP1(J; MGM6(Y)E>DMK8U^YL^@?P>CC&#PA;AOF';4DJROR"[,'>.3#/`1_3&:H"/ZXWW4R3107`-CA^CN2C^D\"XH;0G.1*2=#+J(*9*AO5Z^ M0:B#MG]X!_7!-M7ODP49%VMB\91MU+@@W,I\G_P`;#N&K^!WH""W`]PY2)TI M%O"55<\N[?GO'')Q%"3Z\9&A-<#^&R4Z*,OW:K6T0GT>H!2E\?/!U3@?7&^\ M\*6X^B[%U0EG?"ENOTMQS<,*WX4[2,3P3@.^&;;(5H>"Z)!W;&QIW17FR"YPW+UKNJ.!K0Q,N<7YGSAX,`7ZVXR MO5*0`8T7ZPZ@AYF"P/E'<@/>O1]S/C<-5_&R2?:AU*<=F$C:3='10V(PF MH:S6\:SHA=$BLS'RTS.-.3U3*=CPPS![R]]:#]/SLRU-``!?<"\P?*J&4?GZ M>8W-*JZ2;5<[Q"5/$Y2@`[[YNSM#) M/4E.3'RA*Y8UF;H3:[_C(+(A5<>-XU2A`B>LTZ4KQQU6P[SGC39OHG1-,B]/ MME")9`N5,C_?_:WI[F\=O`:/D@_6]'Q^W`P`>`'1/1'/`8%G(=9;PHZ--7(# M5:Q5,`;8*R)S/C'`\F)J72"0)>AJJSB7O/4%0>QU1QXW5B1NC"^LTKT86=A: M"5O(\)'C($#COQ4^;(_!,\&,5-T%-JPQJ2T-"_.U555"!#NN&FBP$],;XYV< MWO(]KVJI+8H=N2WVB@K6`CK8L'I7NQN-.=;L2KF/6*8I)6EMRCS/T]U"BRCM M&H\PV(L@ZT97ZV%>@8H\1%@T^LH?`BL"O_`C1-5:#6.@M#)> M;I)XLN?FVY,G>SX@^_-DSX=G97ZKKTFVY<^D-,^F":/R\F\3`]3#P.EC<4P4 M;NMD6S^^F4VQ]4J4@[8U3\7-+1^(P*S:./-$:\>D.&@+)_CQ7\SGVCOPM0P' M9=U>K18+Z:Z#EZ6TISMDXH;LCSL=NPD\'ES]X<`%0BE]`5J5U:/# MY!`M=`HO2<9R.E2-L3%VD`')11)X&^*I7Q' MIJ$88\6RXJX)2/)O"FZ4\Z!1PI-M[.-]A?KB@6?GX'C@]ST.P_9\ M:Z31-N4OR#?$IKX_\]<3)^@>![B1U#N2(/271\1KM7^=*ELLJ4ZJB!P;B=@8 M.2^.96.M#:_F"]W\`#7+QI^)C"P!.2X2[!`D.2H:Y:CR"$C1T&"4? M.*XA-EQ'BRM:CD[RL35K,-DL'L=$YGI70R/0;!$/&AL\=4/C[F3>@)#=]?@*O2"36Z7QM%9'(S_>F('$RG4(51(WA7ZFS/ZX-E8C^"AKK M(.D5P+UEK3#:`-=9'8QR/\I32'%;\Q12C;4U3R'%+<]32#74PE@0#>H."97< MES`AR0]Q]:[JC@8T\H2NETE&(;UC,KU2D`&-%^L.1UXS!8'SC^0&ZGG;N4!E M\/O2Y>.O7BO796"/KX.7X_=6CPO7,?-'25YPHXXX-HO')KG`MR[EV$S"9I*. M#AJ;.V1(J\VT8?=@G6>>P9?[SXHA]+!<:*$0/5@O.K*>)M/*IM"'AD4N#J7H8%W*6`<\ M6W$YJTM5-2]//EQK\WKW4`FS/P'S!2F+&53OP0O6EF?CJZJ:$KJ,GVSF?WVQ MZN'J@*Q6W3MPE%8KYCK=]R%,W-U#%N@-C`"RR981G8\L#?_4P=+:@JR0XN>1M$@AX8N^-(AZ& MJ7F>[H,P,T^[?1!FYEFT&VQQ'<98G*%:33,KS$C7$D/Q2\=XO%9=I>J'?'CDOU;^A M,6@+_<+@+[8O@4IT(/(H8D>XBFUL+5G\_ M_G#]?^)_CW^[^P=X!Y?=7G_P^SWX`YY=S[Z#UZOO$+V_?5$[G8[:[7;5Q_^= MG75.!R?C_OA4/#G]W!$'O=,OXI?AX(O8[?Q\TA_W3SJ=?YSZ[7N,.(0RP8>; MH`+KT/]]#A3+0>#,UY!;N&1^6;;\.VDCH<5O#Y>QYJ!E=B2Q?X++Z%M;IM%8 MM:K!5XRDL\"G7YTY0(IMHBT)Q^J3'R^!8; M3"])RA.@>1@CKYO@_J%!XZ7E]X-[,%U[*#ETUU,\:A'J[A<^1EL:4.%DRWRPP=?0;.`5YF'Y*;>?\8S5:>^F&`%J5+Y,*099,X@*3O MS@63LZ\X`#8U\)^M:T,]/4YK*TSG`I"`6K\V-/#^"_C(1R@8$J4VM:0SPF)J M1-2QKN3#^]D40QMX38=J+YN\Q&/UWY:4TM2 MEZ;J+.\&Y&M>%-J_>FT'ZT;;\VZ>4_&]GEN$FP\U%:6S%FR,?['R4PK3B#23 M3,5CA(+.KXE4`LU$L.K9ZAXL3#P=-%[(E9V\I'XG$4Y64V%R8Z@#=(%U^F*B MG!WC`3ME7*FU:K=%7)QB?`1IA]J-2+B^891OJ(C/"3<-%@(>*V1!D/L#*:2, M#52#GO5"L68;N`C,R@)P90"/+`K;%4'&2W`FQEX,L0R[S:E&6^KMPR5QK8J\KAD/!W6GG1I0IN!E6&JND),7:2B>W,45X% M]?L]>HXB=WE9.M*A$.8GF10K9AA>OTX7JXO%Z@I"X6+E]@[=CEPB,Z7IN$.M MXV(ZN33LAF.HS9VIF'XM]?K"=DP4K8(MR+(0.A*E!A(P_:;H3O):0-Q?;)>8 M+,+TNP5/#*A_.;*QJSTZ+H>SY)Q:A7&VTSM=&6Q M0\V0JCIS1\<@]":L9-4*@1G9L'X%UX:*A[X;T[+&)@+PQ?#0$`@O+MD5I*$OA27HV979\YE>^W)$C42H=GZY+FIFZ!I"U>EU5=\C: MZAU9(\;VL&T$GQV;S`,?S:^F0?A&IJ[C3ZXQUPA8;*8T MFYPYYJ[5E9/MZD$CY*R,/;V>?&U9SGX'XH&\V==X')8JQU9N4Q0[Y0A2])A6 MED&*'L>&&8-8/CGR'2':>R])/8Y:AD3%]!?V(NV[Y^Q5HD+Z4"Z);B">MFKN MXIE7``RUXF%@(LO[D;"@@*%H"?(V_!47[\R=*P+_7D9'WEYH@ZP&6@J+0S_UORQE1E*;SYYZF23^RD MW\-,.J\SB&[Q>2WGII9^:3*!VD"2=J.6?L,Q\21CO\-2N*QS&:(E2F;0S[!0C;]89W4Y.>7]"IF7=(7.: ML@M/9=W(!9I`VS0DJ0S;D88L:-+U4R\292QHUD%%>9A+N_?``B0_Y,C0+K&Y M==.]I>!?<]G=Q/(@ZA$WD-N-+RH<]+I17U887Y18Z9?&&!V>Q%YW.\8>@'O, M`G]WJZ#O@%R>9`>O7N3<2RJM'3BB`E8_HNMLQ-%B3OSAJ.#*8D8J\79B=&@YX!NN!6C`Q^#!B@BW('@WZQ&L@*=^7> M-AI8G\'='05ML1=Q-@EDMN&""@IMJ1\)B!EQ086'MMP14@#!4A=97'2&D5.T M&5PL#X[ZF"%OENV.BT$8%`DTMF&!;J21NT7PD`&)#9=.9B:"/P301M,IE/RF[?90$AMV(.ZZAQ-NCNTQ+T/#UU33,L`-D%F=CC$=6)U*);<\1)0;[ M@EPT1]MC9!?)Z3SMZI81,N>D/6@XF*8_$IJ&Y8'1^^Y1>0?6+31,Y%ZY\)PT MCJK#K7@W`VZ!/3,U[P42`FT6(934%WN1D:HT]JND-3JDBU(GDJSD0-6V8XQZ MH%K;,:;>J]9P<[[?/`<&8+*'D>2`8F2VY80N;(_.')BR0M59)*$\K62M-22Y MNHVL>'LDC&;Y>'X=2PSEMTY!D]K!1[;SMB)*ZQYC"=-V%C2+9E>(++8GTTS) MF>N>0`@<0#A7+*B2W0POERZE\9.O)Y(4T)G)>S,8*4@4FFS0@I\,NJ*BT.2% M%ORTT!45A29#M.`GB&8I"FWB`<5-MH[;HL^60.E((XNEA?"Y)TW0#?.#YBJ" M;LCI2\W5!-U`*)6-B83&EY\Q2PM!&VC%CC`Q9;%LZ:E#ODC2WYJ+3QM\#H=- MDIXV#"X/^FXH@>,'H!$BF(+K+/+T7ZIWZ3)&P,BAGT2>MN2:[C1A9`@JDA-V M^BN4ZTC'9<>U)$?/#!6G[,RSE9&7CU\-)=\F]HAEFV81;O5B"YS;4!DV&<1V-XH1*9(S MF0'FN['S*ADT63.8&9[VLL"^@4'R5H=BS>Z029[ET\X_OF%_C:VQW`X>X/"L:)^GY(@?F-_&]DWQ4 M]NW&-]3*X"HK--F*IY3N,X:&8JB,O4TG>LW+A7;#`Q2$-X""#_(BX2!-.0+9#M[6MF+/PK(CN\1[B,(?>#ND/^M!6$SR\/(J9U2"+I_5W9ZAW)-:MWK(DHK7Y3H]>01B][X_C"YMK!O?@2C](63WZ!\;D3K1 MV7>P^=TH;WGZ;$W:`*:AG9"(\Q):[MK*/5!-A,?@$?X&X:%B-08']FH91O+; M,5`HZS1@B5Z"L+".'?=VA(,P8;*CA3O2!!&&H*+[?V>JRLCRT\X'G5[ MMO;F/Q9N=C+UU_V6%R8?3>:33=$_1DI/NS".MU,5:9Q06R4_8K""-.BE*2=& MC1U3^<6_!YKCXH\00G@0(_>K`VO$WQ:F$>6&+!OY$[G)=+FQQ>(ZH]P?!G3% MC+7]2)O?!NX0#>=>M+MZN/P1-WFNY[7WV5]U^[,&7UN*#E^,+TBO+_9G0F:*>5@VO6H(&CHTP.<6*6Q/E3G4\8\VG.,IL`'>6LB<*X9?:L$_ MP4E+=,FX/[P!C\JSJ6MK,L>DS/V+,E]\_@^Q)W@_8RG)KS_^T"R1Q4\M'PC_ MW]Z;-K>-)(NBWQWA_X#KYXYK1Y`T08I:NFW=/2(?I]Q$`46+'M8#:Q(S893K6-^HVLU]!W ML0LK_##DIICE`@2B(VS8@)BS(8_-#P_`'EJ!!CS M1+-#?=:(1E9D6`'#U>`'9O@3QT/+`UX$X"T^B+4!Z`Q8&%K!%+`)#,L86DY@ M3,"'@+_R.WIX`=]/09WX(0VX,RS/AJ^'L0O?@Z?\I%B(_H(FCS%T_:>0EL8U M)#4FQ/)ART!BY:\@7XE&`6.T7N@\&Z`5HU%H,""F;8`X9$:WW3!0)B*N0)$H M00BV#+YG.P,2^[@Z`Q-C@%277Y3?&,9`:%ID""8S8#AE5M#:)9_J\_BBY]$: M@(XA=<2[$::2+#AYSQB=DX-)`R]$)T9XQWMW?7+UO M&5=@2UL@`QQOB/(B.;A#WX_@O##`M/[8B>"E MEL*DR;]@/WE4LO`FAB,_=H',*&HL@A?>^3/VN"=&`"-)I<@NP!5`/B1=F"63 M'P<%7\;/\04P>X/!AB>B*!5`@H^N09[AO55*@:Y)3&7N74+E"8K2R`9^V/'? M(!XB^/)`67RWQEI:!7O4%-^%-/X*/I`/ILUG;]!J&!Q3[,_[RQ-+?C!_R?PE M#A?]!0YY/:!ECC-`T^7,@ M3&+B/&XK@9@%R1I&OD<6#4J<9)'T6<,)C?]^\H.!H*EY=@*HX\,3$$,>BB:^ M>L0&(\]W_8=IRY`[DQ`%J2E_>7@"I:"A/KP%W@1AZAII]LP7RXL![0CT5A`: M[Y1]O[WYHK+,>R)NLL(U"P&(9:]?S[S^-/(-%,$VD5`!#$CO(TW!W<'`H6>A'HQSY#BN(>/@26'_SV0 MJ#2,WUOW+2%`X#6.(P`$C]@,R/T7``1J#\6E(7ZT@6I@.7O6F,0083*9TIZ` MQKNT;8>OX4X;0`H.UA`DH;WH6US!<5`'PF4:^*"`2.`)5TAHSGQJ@+2&QVEG MTV]:80@:`+]K&1BF&X*-[^,Z_'M(Z<5(IBCE(4POPBL#\`,46`6`7`UP34*+ MAER;+-A))Z08B,TFC(X#L9PW-5!OH_[@U/&#%";\X2'PXPFYEL"FI(4$6IDG M0^*,/@,>>&3$`,!_"1^GU@69'X#3?V+XD:^(BD5XM4D0QH5?ALI6$*:PYVX$ M[MK#"$D/G_4!M-"=%N#BAD#TP7-`\:$?[8#YYP2DN9`[B6N=P&Z"VXJ3N%W+ M&1O6`_9YBQJ)*35_%CGR0`=T(D=6,.9G)0::LI!(A#_S6P4R5C#6P"*V6$W* M.X\55P&92J44K\O$D[X#+APX+-SP\J#*T:L-->(2Y;C_&LPEE7V-A(^=B0C%Q6VZ0R\=?=XGG`$,LG'O?Z-[."\M*CROO.S>(# M(HI6BAK-='A$88")3?E^1\UKA_8D"CD1'&_="Q'5#CC>2M[]+VQENHRX]HN[O<'6N* MZ[;T8\+3D?EO*A7`H1BC0\SDU4S*FV6*-!TTPE-<-.38N#F79EO]:_\V\QX=(KZ&RH8;!`_\&ROSY;!DUL8='S=#/QTC2.)'#&%Z*Y)U4DI_84*[F M\2ET[@$JBF\M>$%>+N=])!"5\_@,DT-;;$I85MXA(LKTG$L>"I'Y,CP$8CN` M-MAVL)GX7LA2,K4R#EY*/:%_&D8_CI)$'13[_"H*0V04=Y%!%"2)U!Q!TFFB M@?_&^)CRF.M[#TT,)=F")IS(CY8;BU0'U_6?2*W*V%;D4\#&%L7]1F0]9]ZE M#*A'JB3!I"&\^,%[>#M)(0T;Z3F4!,^^%";9&8WD"L>?I*E13S*QU.&S<#&B M&F*V;[-O<2-"Z4;#%7@2O!S*[/V,/M66]($$/A8`T9;0/Y12H*/>@!W=DI!1 MB+)A9-D4SG5I8#VLFG8_]S%E!N6O)Q,@*='09I26&'*-T+>\O_C%*B`?B5MQ MO*RU,"Z;$-'X/)0Z81CC53#]4^0-8$+68&11K31^@:5[W<@\]^2`W4NIF2`C M*&ES!.1RE7>AZ*TS#^RVB'^ND8K%$0/3C:1/:IIFI.,JVWAL3<%LQ!X//(Q` MAB6_P08#E1AQ(OH48$8K/O,)H`DHY8:`,#XG3U[Y`1B;G)W5W)M/UY^OU-R; MAO$T1W)UTM1F%V92WH$"P.8'`RRO=@8$0BF1NQ)0S:!!LTYS_<V>$97S(`\X"+\S2L9".:3OB.2]`X`%++@28DU8RN0^`P^*I0T30C"Q?AEJX: M\1&7Q?#72%Y-P^M^R*WPV?O:`5CC\&``XDPUULFU$K`":\]G9&>U,<)I38!& MS^1\@!I^:[9;)P:<0I?2KSQBXS#,\BYGGCJ8T:]?54*GR9YUAM+"$'GF,G'8 M\!A=^W$_&L:NO"T,BT6H*K=I+ZMU\*XFQ^$F_4/Q"](]'HLP@]YU_DM_)&]7 M9*/@_2UEG\!YE0HK=;UYI8T,!]A29/"P`@I&&4L`'!3?GO+IA>`2*__%9(P& M+(@>\%/"4J M5.,1S`+A)J%I&7]@WCZ7,Y/``:PH5\CO$^)2D%%?.Q%7X0(Q-Z(E0D:)C'X: M,0\D'B@/'(.,N4`!>`4V(A*`M&,\]L%=F?FX"J6P4LJ1 MLL^)P<'##WEY:I@KZP>AXCS]@6!:"=A2;9MGOX22F>3"H`BPQ0(H4`O4H1US M:@%R$9(.SH+E^@\Q2VLQ$EI0@BVGA,#(BD/@.G3<2* M#]%$%F+`Q$C"="=\8)0'PC,-U@AC:(`-<%`CDKT5Q),(N'SH8!ON!O^R(ZT8 M^48>-9(A@6FM6Y!73X>I1.3=XC$)\$\8LD,-#:IM$,G=EZE'1,2`FCL`A.&$ M#5"3*A$OP#=@E(K,XWM9'86?Y',A)9QSZMGT$)@PR%Q\M!R M7.69!:L3>+0#3S@DL^D/A^H%%+&MY89^@H(:K*-B1'2KD_.?L&:2Q4>D$GPI M0HSR0(.3_(".]I`$H`!0`L9%A&1%.I?\V%/VO3@RN!^IJ<,Y,P$FMS#I#S;' MC',HV5*=)=+V29A5:1TFO)>M'4,U.&,#+EEY'T.)8#% MFX*C5)%2#(_OS!6.B"+RKI-<-6+2,Y*IB10@%S*4CJKB>?!\%T9W1)@`F[B# M8QJ)6+X3G%FL$(,8V<6R/XDF!?1\TJ7@R;&C$?)"^R?Q^NX8['P^6F2L(/*R MGW3QPV$SE$2Z-94SRZ*ETIV1JHG:#%F36K`9QPY%8H/<.Q[]B<!(NH46:S`!KN&X(;@20#5L=T\\3#(?RGQ4H@F70&OT'L)#]X.]O_K_!@(%V4]^T MEU'R#48,2"5$_N0-Q^7O;SKG/[TYJ,QMG>_SO%UQA@_2L[9*`T7V=@0T>[4B M8)`[==/-PU#/^>RUJ:Q[]I;78WH,6<;R M,/QY/Y&^)?P_ADLYU'(F@&=TFD8]&`X[11H!BYR`C44!;6BYQ!J37`.[038U MMXF+VM-D,,,'?$QF3&Y$,O>I>+])!:L(@;A%X6\-75Y5*\/0:A5"\3\"B5-_B%VZ`FZ2)M1?9XM^H:C&)K]=ZFS']TI^EWZ;8(A<-CFEP!`!/+Q'A)>P"(`R1AK&R']"?=_@=SW8[(%1MVJ>813RNR^\VQ&] M^5!KQ-B5Q^%A[O$8&PV#M8*-(T13P85M'_AJ\F(0>$E&G'E2/K]8Q.W/8C6' M43;?M7Q!Z)J&-\6`=T-.>#>4H>ZTSVIS^'^0BL??_D8Z_J@W:5>U14/1\!&O M>.4FB&,_%)N3%CG*:F711P;#?\;P+H\72Y2]I7$=.89E)N4 MK7GMNR[&*3&ID`58S23*0&3&1#C"3(7$^N/Q4]$W#!/8N$@)1'F-N&:2E4C9 M1:@N20H8AX9=*#;AS" M#802"3TR7O+%8\6^)^26:C7SB_Z!.CY=HO$.O_A>@>`=!^']+`QRBY.MSQ2C M9J`":HK2,6YSVYB%P_LT[_ M5,B\&NPM_#I9^EWO#']XKZY>L'%M=NV6\2F7H&*7 MT4<1>T,)#F_?G77XASD8'9/_E&VCNR&&_`.=<^4#)J>A7'XS%+74W7'?F>+J M-L?_<&0.&VYJ,IB!+@MEA5XZY"&K,3=N7%.H!EHSQB:NC^WS;'"\5))]-.7N M)=WLN/D_B0-,&>=IFY@;GK:O)Y,:3JSHCMTR4JK]CS3.N0JB+#`_[>JF?#C] MFNR9SXUV4="5*?V<*9[@22'2IG:P93/&B(!+L="5EI.M%W+J2(TALRC\GN8= M#I)Q),D?6\8]_C&O#I5GL9`3R2]RX6-LHC;ME[CQZ!0L/9TK\VV(;G&4:"KQ M0/<+7H,'@*4&6%@<)*$H8:@`M(GJ7DD@M;=YCAO:,)PAIT&"9@XEZ*DA:`I0 MJ`0O["0Y/Y342>BZ0`TJ)Y!$L)+ZZ&E+[3@EOYR6?--N/:&A9+G3__+A"TD> M9LHC2,@T(_5IQ,@XH8(/T?Y5]`3/W3&``8L>5F$J/$J)EM7W\51@%B5`0WL1 M8?)MWQG&P8!W&A$1`=B[$48>,QL?B`%@8G^SULF,P1FII.8Z%9`&7*.F2HL4$1BP544#R3'FH5.=>7U74XT3=>FD6O'G2$!X; M:FG!YGX<2<,@DPUL8_JON(G#28-I(BYZCA.<*)IP3M*!/02F2K/.9B8)4%'' M@&;T\;8=LBQQ+DT_KZ,(A=N7*7]R:-N:;U^>;P\8()XO\>^.IW806,A/D4_>1] MO%WJ;)UTVZ9**3%+)7&!>0MM&R#!+H&*?9#4XQ%HU$4^D([7..DSGCXOYEWY MY*UFGY+K&R3JK<`.J;'W;"FYS6!S$C=%`92O$?$;-G'2DOLV!$]0S&S*@+_630\%_$I5VJ!D!JOE"VHT8^U:A;6*%=2$XTR:\K(H2^]$LE,& MD6+\JIIS,\B%TS'8=#0"Q!GNX@PH6W!Q>G:QL`%K4:-I)I<[-RXE&&3):.$7 M%0"78^N_H'B;1J_[T_YRL#5?:[X^+%__K]_W@:M-4W-U7;C:6,:_M6;F>Q]< M,K7-VYX9>S$9M'U<+`UFUCJ&QR.F^D([,W,+3'+?W,C5]FRE)*36^\*>S<-= MF[B:U6O%ZG-607*E9OYBF/OD=6T?%(N-SEUA9N.CU&)#C8X^^0MCHV<%8J/S MC)R9/^5:;,7`*!(TO9\/F:[C#E7Q2K,$(_\.B.?"#.J9S\R/)$PSW1+" MT"TW<0+\U;N_/;5]&,],D/7!M, M/28K*NG-/'"P!#\T'GTW'LL$.5ALZ$2\[=]W]%!'LNH3$\CZ?_+BCC`I-NTK M_82QH:GE8&UI,G8\Q5CT$)[$?=<9H)\[H2Q7I4M@F+9OI7P[GJ$.3O-G))R' MZ<%]QLM'97M0GC>7+B#;U5J/EN.2DL0D/=@JH&U$Z;QBD';,30<7[6L#DG(BBTS-K9@J0Z`LSQ$IECR?%-,>'GA>FI+4T#+$?$^F"*S!*1PPG4BY0ID@V1'1IR<8`CNCR[@:;B$WB1^%^.$(>! M:AC$R'D^)&OQ^/:&%#ZRHCVU5U*`I>3B==>NJ\@F4 MXIB9)+1"%FC10UTF'LTI';&!2A^30PNI^HLK=4B'PJD,=M4?8XMQ.FTB$TMV MX*8S,MN-@&J-<.NEHY2<&=X3GABD'_HNXWEGJ"8?A*J?DTM481VRF9[?2\8* M9O/5E`PSSMT+3@WFOM.SO.1:Y*ZIF6B-C%##QL4A9>XBPFKS!C`2!NI8QN7# M#;P8$9.]V4@`\?S[HF)(J^NM0[&9+$+!O'*[9)8?&LQ"OHG^U+P&FL:XI=/I MDLE,-M7Z&^_X?`!1+@VO<<\\.XQ`*8;@111\CN?[!O(2$,)QI_.=!Y!?&ORP MXLPX[#[Y'%$7*GP4/6]JML\[JUC+4$SF@@)XF4\TE`;[2U<0O)I1%LFJE(6O M9J?.OKVZ\)Z/`+*$B&E0*"-IJ26RZS.I]EE*<5/H,1E]('H+)!L(=+8`HH$8 MIC&SAS(K5&2!8FZMR`.=3?LD@HLB5]&UP9WR)G413C$9,?MA=H8G68?4C(X+ M!\$I)(Q!*G`Q)QR7P8Y[QP]8W_%-3%_^!E;/@T?Q!4WZW9*>]P9%LXTQRC6X%\G\IQYK2\#%_CYI MBR_0STC6P5Y716$`\.SC1[@)=/WJN# MG93A[_`=;G9B61&"AATK(I?Q-CI#YYG9O-"6=SC`(.0O!/2[WGNECYZ-T[>H M?#+P^WR4E*Q5(@,)@YABP)28IZ3"8RM;J\Q4^\YIP&U7OB#=8:5)19P5E'V6 M0RG[F*B$\])#+(ZF\"[-=Y<\)2TC6?B4Y\W_@]N>&)9XRF-&2PQT4=@_V67@ MCHGH5L4;$24J&`!\4.J,.GZ!\89EN1V;N_DMHB,.U:BG(NKO M-V!'CR*CPN#0RF\G03&<4T>=3>:5D^$F-*>)LA3B1+TA7&"V*#*M#C[^?)?\ M8/[RGM2ATJ+H\YWR$>LA8")$0#+R0I29[W/=RWC$R*42%>\ITO7%HUC:=5D&<:R5Q\"9\`EY=;`GUHN MQM[EN##%GJ#V0*H$YNZN:U**NE;`9..64*#A5`I\!7CWB;6*?1O_X04H1 M@4EN/X7E.C#YUR<_X^M*FJIWKIP_1?1%()2)6=$TU:1+E-2_L@^[,*<4]E-O M>C*V0>8"*P5&T@QM56Z#9EN.89SN@8Y"W^$-*^:,T72P:G(>Y.H(7_)-;G(F MSZ:$#Q7"\VZ=8H.X;9F\(<;H\BP`"@CE6H&\@:@HA47+!J"6,<\@0]Q83=H0 MQB/8H\I<30?/I17ZN/!47HF7J3*Z,DE`)=26=S@3%\5MGOB1=CE/@6!Y9P?$ M=G)^4":Y/$V".O@)$UPT-)K*KD**]2V"G(E4D"H"PZ"4Y=%G-$&8('%LDA!4 MXZ_DE2C#8+.7FDI;]HF/3@I&L!-@Z-I:$5[&)S00*%<.D&\O(0E)!MEYQNSD M425M0+=P$JUQ+2LLL'&3&'L;"#?/\U-`90_WF4&;0]%'(94,B40?\M;M;,II M1=X6MI6WA.O*XYJYL##C/[%%K=]Y[F`>"125D'&5>2\^'-&2Z;HGLF<W3-[.!0R;!`-R#Y:7B/BL],]CTC"9G)==EF?H>-.& MY-HE%H/4RFH8>+D6S7B-#9*A=)=*40*ZT\C3VTG7,30[:!?'V6W+IG+RVR>> M<"2W$L,%SHP)I,+)-?PXY1F#NI9PE3K;>S+GY$I&;RCV8I<.STG/L+&I1^[* ME)^*1!+<=J3:I,9>V,TSMF)'@Y-%<>")O)[DVM\?#IG(XE,*UOCTAE1H>;YX M/4Q2^G1WCKT')?X')/`3;M2=D!@Z)K&C@'S2W+@9^4W2^3*'C1\"8'U!^D18 M2^=323[)S2KQP>H*!P&>&M6/10TQ\8$U^(P$?U'4?O;#(EN7HO<4<>97WT.9 MBYH)BH^L18%Q.?7$4>,)-#HZP.#JV4 M%6D3736,;?$\!*635!(J]KAUA;]+X*!$(T-C MC!>D$Q!XX#")[$'*GT0`&\DJ0`K;#YK8S1X#*6FQ0NK*J/'B?]W?WJ@18YY( MG+09I9M.6<&%B4+RVQ43%27D88P_SO#JGJ./\FN-I!=D-@`Y!\W>PX_RBSSX M2$$=G#$6Z#CC,9P`N@_C)9ZI#$>VHBZEQ`BXDZ'!ZUB2H1))[B6FD5`0`-.C MD[E3B>@;.;!`,!B)6Y/D1QKGF_8%V59D8MS)">PF)GQ.TU>0O3/PJ6M\OYN1 MN@'XE6#G)0;DTK<_WMQGK_DT*V[+BI0,Q&_I'`]3'?,5KA2<"=_R\!$.:Z%8 M7CI04Q&$./H6>]>G4Z'DBBEG(U/-Z%[I+&2=(G)\:#FQ1N;R*R=8]_I5=N(' M1NKR/H?B65T73PE.2.F[3CBBGO[I(10\*6?[/LF9`:$U9NK[Y&K(Z2XX[>L/ MX8>H"Q,LTINBLG33V>17G=S#(O<.3B%/N^9"/MD,2H9'8@(;8&D; M#;L3!8M*Q%!JF"1&GIUL+))T$AJ35A#;4V0JN+A5E=/N])G=7GTD/NT4QQ.R ML>]1FK_*5,*2&+(PY*6X:7ZAG-(4X(U"($HP?.]/,>"1&S!Y3"D<"N/SO#\0 M911-DL=F11$;3[@HD*S/F2(CY'DP/`=6KMM`:XC`B8B%"!X.LSVK'0IAXJT2 MH<&OO48B2$#5H*17Z9O"Q&E!K>9*)5P2VEU``" MUL!?BQ!=.J\JU0&8K9DD@A*ORU*41)\N8FJZ4"05(81G*M1%,J_\MA*B"\4- M(\7IJ4H],VTMY<0E"Y-RP/1AV!YWFOA-E-$K5M5\N0/Q+$RET!<.&,\;E@FU MTN#'[0L8%C\R\L:$Z0^[,?'#J"E^G&839H4NY1?[<^FTXJ_)[60V:Y;DKA3I M4I2B3R"R:5?%36??+54S?GU)N*\X[K5,.!$9L5I";!L!F[MT4A,X>(LO3*@, M6%,$?42(%TM=U>P"?O%/A?V\8DYJ&#\IHLM+N.#*3GZ/Q%(H4D(3Z90*F&31 M]!98Y,E2["E],),W2E7PU%OKN#7*`2OD+FT:V85VSE&3?"=U["DM99)3D)10 MT_!`F?;5,N:?S;:NHVN18A.TQ>%76+5";@4M.1"6A*W_.8.Y<#FC0]PY,;^F->AA=X?/8QUGA:V$R`/RZG M54>,JB(;U(@(=H#B^-A7C%EXU:(O'`]Y>N^QNUOS(T5=T38"%N%QI!O.+L?I MZY2*&W:50L&/5](KC5HS@:/L3YEB[@H[G**C[)GW/A(YWH8%;C"ESN+M=(2E M4\FH=C7#@8:@&CYU=X,_9&X2YF>:BD7YGQ\""FF2,YZ]$$D;M-"\>X51A5Q+ M(^\B29@/3!7X4?0^[=@H2]X2M&>Q32!K&'$84X2)(."B2WPB2>%.<\3AW2%S M#C-!N-0B;%1XDU!>M_?%,?# MEI=W,RGG.#C;1T7%4]I3(-)LGT[Z8`D M;>3@\?3\2%X22AM=.!\IT^'/O"=&('+G!JFLYE4I>!'H^D^R/5IVR.7@Y? M\P.,M7VWGK51L@NC)`TSI&T&K.>,CB'%&89,N>=(JK[$I2.^@E%/T$6, M=`SV]8G`$.!"*;U(%#4>:O%RZ+N.S7V0O*:^^$587126\3X_,G?8XG2DW*1_H6(68N!/L&9"U(&RQ7R2U<-[TK*6D5R`IQ^0%$!B9(@3,+7. MG@-!Y74R.PW)H9IG.5B*]N#)MW`5HN&"CW+AQ3R+]H#(,X.SW*@ILX(41[+I M%+!D;'P@+J#P,C@(15\BD/:N4F*180\!EY.?M(I/3/S027U(_A$Y]:2/5F3* M.62<M1)N0\4)BCVY`MR_T)N,XX:4'% MQ@G34HBL,:QH-52$U$7/=?YB%`.SL!HZ4E1=FFXL`WKS-5+E4PSKS[8SLHME M?UHV>)`&(J;SBG8COL[G(]C&"B(O^ZGJ,ORCRK\SDS#$&<.\$CP@_(R1X36, M,:Z+F6@!1KSE)+.\\\3'SLU?7^<,HN-6GH$I)5'2+W,FG7)!TTM^/ID8LY$C M:M1>W`T*R=NX1[+N@+NKL^^)[P#B6-:4*`RQF&RI09=S,YX9MNH<6[:0A620 MR$-%5/S9,=^,PNTC:2DTTPN0-T'4&_>X,'5X$ M)1T!]HC>=EY-JY)DE2J)C$:3'DC"%.GT(`O'.X(ES";<=T"S0ZGXIZM?FS75 M7CGI]2_^M."3N3Y5IJN_TITI->FLQ&K@SESL*74<9&A0T&]!".:RZ,$7V:/X M]66?T->I+WV4#NBG?04Y^!MVIK@#1KG':U$MQ+9D,20I[X`-).4WS4*E*`X6 MW@OQME*J7<#WA]E-"TM-03>E(XIHH9"'DFBR&H]$@XE.U00HE)1!]$(A&?.P M*"VU^!@]WTO`HUS6S/(8M'RT7'%_'NX,;)HAE'2:6_3)5=A]W^>WJ;##D3LE M/^W-;RXW!M9-**3NL+8H7%D)3=)K3?B-J5T&[S7E/,3T5+V[!W"^PK+`ET=> MC;NV,,5QIYN*4PP>!VR$K3K@I(L@V#L4L.^/>A-VDOJ;6H'WU%@XL$/C2FTY MH68;7MY?9;(,O_L39V#`7S;A#_I^P\C;W49F7XT\`RVM+98MD1%RWH)8YG!0 MXB3_*D]75K\D?)!W*'C>\R!4%,ZWN*9&UCR!.Q:%$HAD4M^6C2 M]`5;20+?I&.8J+K.Y1M`(1_JZ,@':5JIZ2LN0014\/#1&)H;=?]?)&#T0(!E MTM<*1\8G=!\_>]AKU3KZ842[X&2BZA`[DZ"2=G3 M5N=T9LP>5I%[8G3>-1]_F"TJ*6#[S52!K(E$GH1?@:HMV)' MT53,QG#]<'$6*;=#L<%5:B6JR4WX5SG.%0,`$^Q#`_9VVM6!2_-TQ9:RFYE$ MZ"3[?H`*A8\"@7]DO5QNX\LD?_Q,0T;=0SEA*HC%5&X^>I5N=JGO6K8V3TU" MLV,Y&-5!MQUK\<>834/WM-H_/EBP\?\RX[B+_-O?UWR7M!PP&P5X]P9@(!HTVR=OWH.SG?YH6&.:FDN=3#-76BB^ M!B.<0B@,Z08@98^U!&=!'FLV!R#,\F2/9RI1HB[.^N#E".]_LA5\X'-,3%P:*06"/I7B:"K,/K@ZX,8<><:A?%!Q8 ME\F>17X<*BEIRX&DH^3A;7?2]9"&K5,2X"#F34O3H*!"2F"/OH\#>4:^0VG` M*=WF*A4YX2AY+T$SEQR&115JO#$=T3B'8O/KK*:6LJXE5J:>7*M>Y/LC7Q'M M[X?^TG=F&2ZAWSL$)&`9XO29I(^L(&'_$;,2,=&&NG/SFQT.ZR0`VS68YL=L ME0_/G$^#N0[EQ(@$Z'RV7I<':5A!$,FTN2S3D8=/(2&ZK1J!E<>"4)'NLH0$ M^2W)61>!`2I03!-/QR`TD50\PL/OW5:#1ZX)II9[M%8QG-)/*=4:6)TYRX@J MM:]$LL>\;%'W@-(T,SISD=JCK'1G/%_#V6<@_JF(D'?0YB.!DD"&V4LR.9"5 M`A8%?A(>`]?'E375672O@IT]RI+X2-: M!K^^?O4W^0;6"5XGYE[R""D#^.$;&_[]S17_]X_3+S<_NNTFJ/4F6FAO?JVV MX[3P#B1#Y\,-[R@!ZEV%S:^4HB3D$AW%.%`_$N;A($B5_/=8>PG2"C,NPB;( MF?;94>_&3J[[H[P`/HT!E.5TG/AD2H6A'TQ%;9[J-*S<+-HK-5J0=YN%1DZ2 M3$2CEI0\'>X(K_I04K-@FK\0@_"L:Q](Z8BIVC$S+N,'M$\ZIX1ONV7<>LI@ MR4Z'_WI^MJ8HOLL,X$A'A":-H-$/$(8:E:W@0P\X2)(7*;XUXBDA\+8*^TG1!1GON'@))KPK*6&F M`\^S6]4$\[`I#&2P`L4($3@T6`,$#_>G26(^6'E.DOJV%!JL*R+O@JHW79?; M3?TI.?5D5,ZP+F^9;-/M+!B7/Z55V.G<`'$?*>I4T0Y)VX-+&W>(YAC-L&0\ M64]L?*<743T7N71BDJ4L^22Y*GXY9_TJ/"]82EEYAL*+BM$51J?,/2(1IC\3 MP\C9\8*@W&M2T@WEM61*H;>=5J>GY/V)HFVU@#=//%"[:"S));QA?V&=7GLF M?Y`(J#KE2,SCOI?828?<-&=TZ74V3XV7K7H$LR0,!-JG=]9>H@&P'T2($V33 M"I>E)YRW`(@<.2PZ8-C)#B&E[P++@6Z8T_E%*[M^&85< ML@ND0_RH"Z79:/=.J.A3ED4+N(Z;U0YJ/":"K=V^6&TUB-`],G&J)(]ZLW8L M%X3J(7TGK1B*LL#NR$FZ,_&7]@6)"Z6'.YZX1[09`+*!$I>=ZQJ!84;\\MN+ M\S-J#IM:4HFUV9#C,[G\R80D>$RCP2V))0*)%+K2.R*9YO&VG54^[V;*:55. MY!Q([LS%RLX1WV>,DXP$G=.Z9&2G]HP"(R\7%&TBR)BA_A#^$X*,?D!C%D_ MI\T?3`Q+($5&6QGO0L9$_Q!N`XL647B_)]I[\00H,'1O)"J1)=\5@SOK MEYAMGF#<]VFPJ\>M2:$L9#.3LY^2I`P$7\`VFW.5&'YT9:C,>YG=FWE*?D[; MMJJ:^>+\M'%QWN69=DU:-NUGY.>NGK`@OQO`'FPL&#@A4XZ$V6HK.R_R\>2Z M.-:SSY+7;#$"5\ES5)DO.;NR4="2,YR)]0H3ISM;/'4\X*3AK?V\5M*[6M3B;N/M-) M^Z1U:H`8=Y5ID6DSF*2_C=IA`?TIP2@8B;4MI5\(L6V\S.R!?UKUQ6XYPN%;+__M',"KS!"UNRTN@E%E&^F ME+U:,VQD3=$IR3.5R9"T=1=;"]Q7-L8KSUYA%LAN!XR6W4)8J:?)2 M(D6OS7"FV9M:PITSE7EY?.K[K,>Y-$K!>Q(N-P#3O`,9&1+]?+C6`ZD;B5&R M,MK$18*BD,4S8KK53'-9_AR7F=27(@VY<8&0/0_?WL'XB&N)5X%T@S>T7Z^E(%P$-R)&XI MP+F@F2!O&("Q(1NGR8@H41*)E0GR4N:+_L`DV/C%N-+@(--8+6RD[2J&B47' M9[N(/7],FO-D.\\E2&3ZQ?HY+9X6W=R6/DZ`Q9LE%V&*\UFP;-A$&U@Q#Y+T MI+G;K5P+K!%=$B,<]Q-@6J=W16LG MEU9[N*4Z;YT=X)9JWP;&'N[&'+H:0_FU\-YKWE[+I#ZLO!";NS#<]?58\=LQ ML[WI[5@I[XS*5#Q1MI";J2VR770%P`'!B1>8QM*ZBCQ=$$T;CYTH[4=B>:HX M?7MR85*$;8-H&KK=%IWAQ)ZG6(P,+H38(AV#+0,:IW/VTWL*)V$L8MS@M@+E MC',]SC'D+N*)-$0L++:5\Z$2V;PJIL8M"[-Q"KAU.TMS3Q<'USK%4[V6E2H` M^ZO)7[,BFN\BKIWLQ-PNSCA'L4=7^NJ^.C+#%:DF&TBD5FTH.IY:<>1C6[HN,&6 M*?;"$N&0:G4X6%.RU/<6[4G3W*(I$F,N3&P MT=PU2``5/TJBIGZ&0W-/*:^#OS\!,]GQX]"=JG:-V)5&YIW,'H!U258+LWE# M=1H=@!:P3-4!\H.-TA?M=V7^SE"5*[,!QXQ@,-L_T39BL&MA.F0N662LTDF\ MK'3$%3^QZ5E^_8IS#&TWGJ@BP?B"05`=9=B!3DN2%/-8@+>EXTHA"1RJYT`& M0L^ZC3/8+?P>GGR>V#A;7Y"]^6@LRV?LMLSN$KF?*N)DLJ@JX,72Q"C)@>1R MGIQSQ8_.64E<(F%9%%Z,Y-$%E<`3;.JT27(NT:Z='JA7(;ES3S6)XFSM^<*S M-T/CK,EP"WZXHXAP!.RHLTFULH/JZO\J@R=V\`,I"K MR#1W4-X[XN]=%H;IU@J!&5++39O37D;[A<8#!Y#O#G=TQ*T4QV">10@+,5O: MGYG/V6?DZ$E(CZ9-;_W[.=F5QX\)RPT?A9%TY+QLP7B=P+5M`!4F2N'<3JV M.A:M,S$8J,D^372#.<"7(($&G*R@9CT>OS@/'XT-`: MJ)8N'[$1\H0BN!_I)%.9DTQS!& MLHBYT`.=L\9Y3[W2QT%3/,U@MDZ++B6BN3KM-1LI@.*:C_7DJS(XKJ[#8HH$ M44]S+HG@7+T]O6B<=L[G/;;$U)-6+9ZH;&@W6ZRDDH1\W[=FN]$Y.Y/8S7U! MQDIFJ8&)##8;N%*M*+=W3I`#H*\3!W;4=Z3XOP>T@\OL4U$8!^RB+TY'K9\7SV]Y93R:S(@/)!$(TUE)&7]>F M4+QB+MSR,A;@UR)7,B_>F&0I2BW4[33,3N\E$ZSJ:,B4D(%O54NZ*\4U'R+* M`R*3N.\Z`^`!$#K4N4;IU6$9W\@X$>F2]ZFP\XQ/?C`V[IO=.6'-+SP>`IH" M)V\X,EZ($E`H;,]?T:C;-7"9:RALT MX';V,#6XDY.Y:%EXR[+1352NZYK0)K&4)';9#5@$V$QF0#>;I)&29N;F(ON6 M"1H_3=:?-=3H1JX'7-;IGJUYT[3$2I2U[1>-DU-S$6EG8I)]WXL5KS9QF\/0 M'SA6TFH6'QUCF^\(>T3-.Z>HF'?I=LKRZ&)YLZOXO2FL^SPF%5*UUO;ZC-#X)]I*TZUUAS53_/S`_ES$]Y26*=S%3: M;[J.RKYJTV;.R@?-5ZJ]E0U&RB?6#ZBZK'/!)U1EE<#0<ANT"Z=?9B!FRM(X([?3:PQFK_;ID'3..3 M8-D^WE$P[I^+6Y/>PNP^?4#6/2"8\V/F'8T^>["\)/M%##[-A-+QZ:^7]]>7 M_T]PU1>>*GTEN(/_&,IVH6*E<#H&:6A\O;G]>MP;N(=L2SD+.3GHVMM^\6W> MV3FE),=3>53_Z8\\\**MP$;'QC+&3&:'8,BE3].=\";.047F!^"J*L63218# M#JJ0.2Z=.6V0.?#I53&.;%!R&\1H!C[F)8URRD^(.T3NO9MG)XVSBW-=@5>" MYJO`1/5X>*)`-%8>,NE#U;]!K=['0:O?:%WN!R;+`U4P*]6@B8 M^YHK\/K0Z<>%VN-E2/DA"M0? M\(PJ/VN1=DPB;:G\VN^6&/-[LNV!-^MUX!,C);%+5ID@6U/PO%TK"GX?9?*( MYCSXRUR3C\;-NOS6&^IF-2JH57;PR;'6IIIJ69-HSK:1CK*,LVQ5QIOR8L80`KU4TE:`/A#7TW%GV"`B`# M+Q&))]+J32O\&K+7U2.\X?%\4ZP[37YL&&'<_U,8Q%1^@DB&\L/\XCSDFYK) MZ$RJ?[$A2H@BQ@E'+.D2]5&F#%W+E*&Y#C:BOL?`2(G8.H[_TK77N1\\(O9;H"$/I0Q7254DX&Z5W:(5M:;+U72"RDB% MHIHM\\K"P%')]-E5DG.P3YVV)]*419A46I=]QN;%V&6IL8Z^*>CXT="[V4EJ MJ..25^?K-7-:O5^"BSKV;=XR0W%1E8P9&MD0L/_$#JIB6EZ4\5'S)SC"1CK" M]GW+2&J<>=.B]D6#0%%>#,6;5/\'BXI@`WX[&FS(=A5BX,7,TUF0 M'1\?.#EOMTZ[BY*$UK0$L'U5M]-JGRTI>9Q9OV0[9JJ/,^ MR"8)8IK$B10@./68I*F<7T-]`\5(.]FA)LGKF\E$G,S?G*JC/#,EE#D1MN53 M`#_CO"-JBY)=-?>CBIP@&3'[D"I;SK)(U*U/2!?O5W-R<6Z6Y]G)M@-:9HA&B M(U4'F9C@,ANO;(!7'+[9LWOH:&B-2+E_^%Z_TIM]-)NMM_J%=(_1?P#B^<'? MW_Q_@P%CP^&;XE07]WNG5(/:X>J*($8`&LB<7ZQ53"EQ'NYT'Q]&CD1 M6V*\KA,@JJ=E.W<5?JAX6YGX9P$>:T>!2XE25E!MBE--Q.!%3_.WQJ,\>&2/ MSUJ(U.1$\F1+?2IKAX?6GO4[JYU&[^0HS^H6`?(%*)\<@8_Q'8?QY.5Q?DL& M36?2P?;`64O)7`;.*B8]`0W#]F/,-:V/^"R.5%WDY]FY9O&]X/'ZE8YO[I[H M%S7!HR[[46(\M+ZJH;[J=1HGW8MC5%F%"K3_]B$.FP^6-?GY7AG#>O.?V(FF M8->R:R?$N>AQP+[#3G_$+?WU]:N_R9<^64[P+\N-E>?"Y$&L5T+^^,:&?W]S MQ?_]X_3+S8]NN_G/V&MB:NR;7R5[5;GK1*$UY].1Y_C[6"OSE6WW&=R&'ADDW:_=;D9>35JF3V M_(!7K8]IVW`) M]0UJ2?`\L6A.1R*-9&DJ[C&LU/?C2'E++,7_RJM*K3P`?:86E#+JEX>8XDK- M^95XDSUJ'N`Z`ZJNQ"9[*7NY*7L9T"%3VS:>Z,HINK5BAM^0!5)LS9^-_Q?[6`Q.`\)#XUWL639BP^SWV(C#&D3.(T,( M_T*Y@Y(3QQA%()'89LRR:*C>_'[+@$55ATHC7IJ[_KNC#*W_: MB@4[+\2"M3?;9C:V6\;-[VKY4[CC866:@1R\RFBKX'D)P,MA95ZXO;KB^^6\ M_?76_(2=S+$?DO.\PCFOT-85+IU>NR`\"\!.:\W77KK\30E*$/M:;\TO\,M1 M:-P`TCG)!\OUGB:B6%,U.,QUJ'BH\U3>S@J5EKJZ_GI/^FM%=MF":[/S\V5M MK'C[;7\+GGQ9:;3*0VI@YS5Z:<+158*RXPEVKX/;R[=(+1KAE@L:U< M=J^OV7R935^G2DV?\MU^?Q&VCZD4'I&A;:;^VTJ/O6A'>^$RUM#PZ:6F:[9^,IM$Y[6IA60=A MN7R:U!HCVH_MFIX2&,,P'D]HYC'F.SXRXPE,22,.>68ASQI[LH+`PDS%!_P/ M_PL;3UQ_RAC/"AK`^[$;T4-6"&NXF#3$!S*/^\S&S$1E`L>061$F?^/G_0$? M?_+D1*/,Z">;]2/*0Z(!*,ZS,>9W%PSO+C*7_J:^M:\'1]XJ`Z',$YFZ@0$:W!(,#A18E+A`/%)I9C8YY'.A&%QHJEHUAPZ2M_/+&\:>)` MG_T2SHR1X=DF.;DE,LE2'!>QX%+&1[#>MA?S;5IIL;1H0JVNN!9=C;[A"/0X MKQ;C&$HLBE5/U+)@8A'JI\ID(9/J$)D M2*HQ4#/S0ZQ=X-0/./4-S,=WC3`>C.ASB$?R!CH&8,/FRYR!5U*OU;T9;)W^^':+I`7M,DTJ_<8ZX\L,HI"DB'RVP MQ>\X7^AJ25TMN0]BG>VH6I*J@IO$L8;*U$LV0RNMM7?Y#Z&)>*U7,G.83W_T MR9DWX",>K^)Y&CDXME?Y8R@&9X91X%`X5,P"!C??YC:+]6@YKJQ$)*<_X_(W MLOX^+,93\OT`:X+`6Y-/9OXV`X.,)8@2Q3C(0X#PM#R#/;-@X(2,5R\9[#^8 MUR)F.O.2I:SO18NZ4^XF*J,^@;SL<#20Q%G@*M!JHMN0J]#=T7A6O5:#WP`,JZ`;VZ;CX M'I8W>"37'0]=6&'XX8)(`4%2E?;HTTKJ.[>XD^*@Z(G M/V5YO,W`BD@21$6J8D4L7E"B=N'XS`\EJ_O)(S7Q7IKX&OF3Y(KF;.U>@QLR M\GZ;U6RWYLZ6(`:Z.#V[6&9SK[CJ*9*ZK.[@1;<>[2+!%C$O+LZ-K[[7O!T. M0=T'ABKOC3N0/L:[2#Z'/[YO")N./4^H`X3C<7G6:;?/C;5(O6X9D3Y@^SL= M^D"(`P%L?&KPGE+&YT0-IP>!_DX'H973TVHGE\8[OR;>%__OVF!4-WOWSP-:8\`)`?(@)KW*;!]6-BB$H#OX*;7[\Z&G[^@^X70$E> M/K+`>F#&C;Q:N\.KM:/AZ-T/@#\[/8R=OF?%IX@W;";[3\N+T<;B>5`;SE-= M/G"V#.W/*SGGXBCF^)H7C6[G9!=.=87WLERP%B%KQ:,5;_A:PQ&R>G[4:[O;*327?>,/?IG5?51 M)M'J'ITEL,HU7^=>HF9&@KS"878T5*"5*2P?W M%L:I)G*ON;K%\:YN+JO`#15&I#PG]?4K?5;U62U#(&,!RDMGBM?$@)G-1E"K M"O9ATY1^3GLQ20EH&+8?8P)I?8R:XDC51%*:C9,SL]'9[O*C^HRN3VP-(V/; M)5AH`<'#/:VSK1(QJGJDRE+*J5"V7,4:VXU?7/OMA4G3W0,E3>^UT&CI!-'= M%=>7?T;GUC4AM6"'Y2,T%\F+:N&XL9^UU>3)/4JHI9<XO7JPH3[CO[1;O1Z.Z8+_ M[G6HH=;FY=#F>B3?6KOR^E5M3KIY?HH'W3S7PTM+W2>JI*T5U<6(_!5J1EUX M`E]^Z_RY,7Q)&W[#CI/9*TM'YW7T#*&=;.+#0\`>P$A%DQ4H'SJ#[$""Y"I_ M9BNCD151XWVE97^#!@A@'S/84B859,2G$\QEP6`#L[>=UKD<\J,W=!<;FG1; M!FB#L>/1E";P\/B<([X#9@]WH'U.^S37K##_1:5=H7'I1B,_?AAA^_D!O.#Y MANM[#RR`+0WG#CTPB&0F:ES7F!N(F,QXB.A/.-Z"WA!P8,N[)^`1(V!CR_$R MKR(&Q%WP>VN``\MHS@7-Y(2UG(!6"5M)$ZSL](YYY`4'@S@+#(O:QP+_XN"H M)@9L<)B&X]L-4;=F#)$T.)$11R<9%-(QK&$D5I:(\*D=""J-!:7Q5SE20S'=:HB-E_KB2I"$W0I,T).8C-`1<="$L\!];S\XX M'A,1^99(+&FRUMS'&\EF/%I`J#BD$1R6Z](,CA54+42A18-34BJMIM"^!4U% M[**JB[OKU%00$X6`?Y;/VVVH$U/3"8=ONSTLU>=SY\ZH;#]GY%RF!R>J-YQN MIPS"PZ7E!)V9Q_<_?D;SW*%ZB]N.#1HO2J3Z-+6)?&,2@YJTPJ52.V/]@MX9 MT\3&Y-F/OA78-+`W,8K?T>_>%S:.]S]7>G;7:VQ5S8F9Q3X)#>21"M=4!EIN MPR$HE+J\E\@&Z^0Q%\T.2];BH\J,,ZZ*Z7(*/VE^Z";#J\63TC;*T:F)Q26, M-*28E(5$+QP2]B@,D*'ONOX3_JESTN34;!GK2W-.[E2(=UK=E.!2_O(A90-E MIE^>Z%;%-L[Q/)34KK-+PG\Q/Q;L#RN@&7):(U9]AWFABZ<,':9SV:9S2:X@ MB)$.EUQ/8M?1R9N?BX@#@,W6::>'K@"7:#1:.!T?R&76_+#Z9%T:3&]>G',Y MF2.B&D8<2@GS$1/^FO>#D>^BZ!1MU0$4+J]LYLJ._0X)VSZ(H[$?1("[\`T[ M)\86DDNX7V(\LR+"%#NTM]P.W4RP27)I>[0>I^^/Y*"=\W.&$0FNR3F;)&;" MZ@/8:?7:V?.'%H/+'BS7L.Q')\2IG84M4$..X1'P"3E`)V03``,$L)T#X._W MXBRD,WZ*`_E=%2&J587S@)+8*%#';'/XEUA;2\PC_B'Q0/(])1Q.`\/5X;-9 MLN,HHPQ$JB#,,\=H/[OM1)HX&(D9N+'-AX\\,(\%N#X.8;?'8*^%46!1H$\* MD:%('B_J6N<):*)+,T=2S7C-">8):0#>@>4.8O[8.H);C''*3LO-&:\K/J5- M/%SH]:LM38![-HFX#8!F>:+9LF=_M0CJMB[:6YH`9[U*6``SBO\BU?OF>97U M?B78?=M+EH5R+=T)"EB'W-V=XUBA"";(3]Q95<=<)_PL13"PB3-QF#@Y*EOC M^:(+CXD;\X\))K7DPESJS7]P=JA0]M/B$F$YB@FS+5X'=0U!-1CPF"L?;.Y1 MV8W%!WG#?\3M`)*!!19?!HZ=%8I006B\HX7\.(35P_=ZT)%('=FN9FJOAG?A MV28E@;QY>&@0M<`XKBF7*&.R%Z^7VC&ABE=07131'5^6(Y1]V MU4)!Z'\QBK7O\?RGP)K\_0W_;XFDEQ:VU6)=+6QKA>AQ"-MU&US52]BN5VNU MFQ9I.C4\LU6+G-=5?%F$2\O7G#4+DP1>(HB^+S5M&9XUAF6' M3O@C]K!)"7S-8?8/@N_'6?+@!TO^Z_\TFS>?[H"QV,AWD>^:*PU>'635TZ^K M%@78\^SK^_0J\04=QSTC^<*N_^M7^T:P#,[_GE'<(-)::0%5:>"U=-72M2[H M2=E:7PPW'QQ03>E4:>"U:.5K?DN*@6(O29^K[QE5[K%$EI05U1?;X[!GCT?H M'GC0S^E)+>9!;'K75)4PN1X2LIMH?!&AH8>$9(;#G^U#]E;U1-4%#RT9M&38 MP>5@;Q]QQJJ>J;K@H66#E@W;$K';.&WG)`[47S;H7J:;%_0%>7&J-4O=J$5A MGQ=U/GB\3M0S+`,KJQ$-`R'$\DTG3%KB6&%^<5W2*F>^FX[HE<=K4ZW))/"? MG3&`%QJ=CBQ(+1"0*;QC1\D3]XP97_V(&3TJPE1;W6;[VR:[;Z_?C*Z>V_3Z MU2$WZM*`G8'O3;%ZU((#*#;$L+!RVHFF6$<:L@BW,1K!\73]IW6K1_?*O&OL M3F:K"WW!R"Y60+VK"5;\]=WMVGDAE;8L(UL7^58KHEQUX+>^QC/-`]WC7>S- MJ.:_F&_CMO])B^MR2\6]O]N9MM9*.^8]N#/U/7,UJ?PLV":Q5GM?:>`UXPK& M)54!SDX!,[NB*%Z">VX]L!IC>"-[<]47Q3OL.J:E:T6`WUJZ'FJ$>Z?^TG7/ M*`KI6E\$TZS(^N)X!;\,K$&$$\WKB^5OSG`M%;)%BEV]L^C^:7DQ1G'-]>,) M!0E5ABNZ2H(J`L3UOC7N-4[:O<9I^U1S7K5`K;C6;YXD3,!OH&@P9>!7: M=3K?1:[=?B,LK+D+>:^&P*^%0<4[81P>2 M8Y-%[=;IP7J@'_1`O7ZUQQJ#^HN&DJ"DS^K.W*A"_%T9'TMW>=VL.+MA;%P* M7Y?64WMJYU82G'1_M6RFO'G>:9C;9GJD>J M+GAH75[+LWJ^_U:II7:`=)_4XBZ09WRQ@L'(,$^YIP..CS_RC&_,"FS?:QB6 M,6;C/@NP%:,?@V?IPQ_P!]L)V"#R@[`A_28&C)2T:HQ\8Q+#PE;(8-UVH]UN M&^'("@`F>'G@C\>^9_#&JW$HFVQZ+$H6,R:!_^B$V$#5#M8''BZI%L",,$\O!=P=6.%*A=P8,'W_;;9E=[`+, MES"H/RU\(++_%24-IX%-(P"(_M@0?:=M9SA$#H1-=(;.`%@<5AL"`>F8 M9)IDMXSO51N`DL@-6!3B23B0$BX'P)F(:@6@#^(B%#*MA"Y!,#I4BP8 MT^(B41A!")#**!,$R1[PD*-`P1T)2'X0,6"S8/>!/JYA6Y&%_<`E@R2@<4Z9 M^&'4E!3GSXP9"@[XNN/QYN!]-K(>'3]H8-OP)^:Z^-\$3OE7_(BO1"LSVQ`X MX5]-9`:.`L#+&=CGDO#WUCT\!S0*XV!*CX0H)!FGEM+B>N`'L&<3GW]"M"0' M@A`A9@BH[-'L]Q3Z*$\)8:OL,ZT8(E/STS3P8]E9").3.[]W(()C>%-P&<<)^`]W1WS/BL,,RXDO<]EKC?T8-@S6Q]^%"Z:" M*3WE)WX@OIO]9!%A+4QK(3YWZ7"H0M0R/&L,RPZ=\$?L.;@LG'9F_R"C^<=% M\N`'2_[K_S2;-Y_NX+`SK@V;S95(E*[?\B*?#YP^I;-O.]\#W'T'H_V-..2_ MF&_M^Q&[I.-AM=3NZNH5B&Q.BC+V3A@VQ=EV*QJ]?E42*EUQN^V>VVTD63)V M[:HV\U7-M"W/N M76ULF9DDUPM1>0=`_M.@]-5.J:DU M[Q[N1JJ0_+@#=CE\5_O#.P!)C_2#=A*O'Z_45;3<4XA?\X66(&3P M6!6.CB>4%-8*@:K=,LVX526K9MR2M+TZ5.1@STE]]VP2\3RL3KM]9GSV\%K9 M#^2=S68FQO*F&@NM^(KE0UY\Z)Q^0*IM8X>5^,SH/J&Z3RBMV35;9]OT#J\& MDQ^'T.ITN[7?R6U`??VJ5&Q7$PDB5&5M1S7M>@1!38S+R_@A#B.T+"^,&YG* MN-VHXN.0TNEZT::E-2UJSW>IMU8:K$CQ^'#*KA0B1.A*LZ[#&'7H<@$%Y118V/NV#ERN4\C]H7..)T;+ZAJ<`FU=+NM8<`3V MR''(+&UA5^S?F3T95D7F66>:LNR7*"60H)@YX##*,NZIM;HP.4""JHYEV;;^,9D"R<= MNRQR:'3L4EN8+Z\?]F]A=L]KS^/'(;-.M(%9+E"/0H!-\ZZ6624"]3B$B%271V=A'GL` M,V-CZL*>-<],3YN8VL2LOW;0)F9MA%;C1*=?E@W4XQ`B4EV6Q<1\_4J',0^R M\]=LH%R1:QMSG4/3^=#5)J8V,>NO'5JG9=$+VL3<.N%>&YCE`O4X1(C0E3H' M\\CL2Z5XW)PS+[5UN;0BSL038];TQ&CK4EN7W"31)3YUD5D=;5R6#-2CD"!2 M59[4E/-TZ#*7?I]8/TAMR]_8@^4:E_:C$^KN1(6$M2B+TP9F#W-VFN+;JLT:53:WMR.,*?F6>/BI/Z[62%0CT.$<%5Y=/;F<0@%UKMNB;K'YO,TFF990/U*"2(5)4Z+=/. M58\3R[8=[Z')4?O9Z$R>?ZF[U9EIR;[;@J#7KS8B;%V$_,4'<_MTSHT(6(*C MN$,\*G[`MC-I-Z%;3;15MW6QE8E4_:.3W;"^']@L4/$P0M]U;-@N"[:K]O)T M>Z.Y^AQ1%SRT=)/6P5:V>%4988L8\`*43^IMJO-?/#'^G;[OVOPSW_W(V"KI3266J8D`F8+1#0>I<+CHB9XE&L_EIJ6@(=A^W'?94=@ M6RX2K;V&>=YIF.VM[F&KSR@:#RV`]F3X?8@L$#'*S^)<_>U#'#8?+&OR\[43 M#EP_C`-V.[SRQQ/FA5;D^-XWYEH1LZ_\,`KO1U;`/EHAL^^LZ1@D3/@=I,U' M%"N_OG[U-[D4O#YV(OK[I0=O>A$0CGD#AX7I5Y(WC0$\`#]\8\._O[GB__YQ M^N7F1[?=_&?L-<%P[[SY5$/ M#3\.#/;,!G'DP)/^<.@,6,!WPG8"-HA\^&GH!P;\.K(Z:!?\T`H:93+AZ-$K6Q#?DBD;(@D=\'-8+8P!D8$VL@1--6\9W M>"-BP5B^+2%V!J0#C`D+'-\V'`Z4LO[_#=4OP$^N,V1()[[FV'IVQO'8F/@1 MP.^`_VR-_=@C*(=Q!&K`F`A-8CPQT`2Q:QM]!KC\)X8UB7ICZR]FQ``0?3B< M!XX(S=<``&/8.1`FS%;D2_JO__&?@)1!`[]&NY20FS]SWC'/?J%]D)NB_MYU MK+[C`L4`!M!A%FP"H`:'<@J@6:ALC3A$\&%Y'[X(&S3Q`X(WQ9T3 M(P0:.';+N,SN(O+(W&=H+>N!$0)]YCJ`#>T'@],Q1D5M#"TG0+LD9F(W5Y)L M['CPKDMH$U$\/T$5!02B`$Z++3<_9.H"P'SP'=#4S.BV&WBUV:&5DN;:79-^ M"_\+R$V`VL#S[K2E!0@%Y9W M`?"P9?RN"`N%#'!BP*2`XX.PIS*9N![,$F#]8.PB)AD)"&R/F$V)^<%T#8%, M83P<,A1//A*?Y#&(K>F"%ZWY"'RP=AA`(9:`0"&59OY(GSN55!U"J+ M).(QW6$2P#E'7R&(/P2IC`BXL3WW(!Y[L/Q17Y`4FP!`L*SXV]B"-P#C6#!2 MP!ZL0"B[B+DNG/(8)`I\#%0'T(#.0U@`IG2'0/(]HG9$O03<*$4G(DGHNE-2 M?1E\#Z-P%'`S"L>0JM_SHY0O4"H'",D`72C\@,V&#)C.M9["V.%:/611!"IC MX%K.6%">`[-*?F?4QII:(5<+P(*#`0F`!W>:ZLE:J(0UY/7A?#&N60ZH-S;Q M,>C%6SC+7"+\QE!2S6^75N>;;\M7YGL^2-7O;##R?-=_P'-V^1&.'QYP%RG. M9>V_K-#Z*_`]RS,^68#!Y(Y@J?.+AG$?`1E`%X[AGT\,*$4K6A,0>,\D1T`LOSW% MU`#T"(PQH#$2^@.Y(I'VD?5LO&//\O?_NOS^GHMGR_-(+7`1+(0'R!X.&,A@ M^`:)R)EOGG62CTZ9%:SQ35BO95PT.689;N<(2-L<'G5=M'R` MJ\`8$9HF(NV&E\XY73=G79O+?`;C>N7"NPC%M^ MDJZXY_@;MUR-.^&[C9P)\8'9.#//BQ["SAEP]F7\@.0$B^\Z`&,.SA^8M@R0 M`/M/^7[#N`+JPR<\!_[]^_TE?>YMIW%Z2RTG@N(E% MJ?EJ9WS5Z7"2YO+5",QZ+K04KNIT>VWCBQ.B%Y0TYPB-WWZ[P@U-B=9MF.>] MPHRD+GKE@Q?YP(R/[J.=<-/%'#==&A>]=N\D_2+RU,`?C_'R`"035GJ:@F&( MJQR,>H-PX\A(00[";=;DR&H)=-('`;PCQ-W3@663@S)T8Y)E]]X\X9>,Y`F#;GO<*F#9@R`;=L.MVK M@I:-F5@9V"GR8,:->6KNWKK)$+^[F)_3&^SUKIW5"^M[]H"O?6,4HO<>CO26 M>HTU5UUEU_]>>RMB7;061+&-35<4+`RZ&([MF**$.CRSRZU&`7E%%R53I;2,2_#-Q%5!:+DLO7;EUAC&4D/G680N#.Z_S8=;J&G_=ZZ;S6,FQ@E-;UV&3J6MA]VP2]#L&'])[(8B4G$'0J^'`'S/#(OAI7Z M4^.!^0^!-0'6P9L4-'\WW_!W-GR5W';<7S\.X2_A^Y\+;.B>,O55*EN&9XTQ MYNR$/V+/P67I4NL'$>B'V4YUB27_]7^:S9M/=R[8('A-QX)FLQ@*2DH?/Z(< M(TK1PYUJ_[3VQAH#YKIH#L&>_OU-F_\L,@/Q9^63:M7%%J4D+YY&6'7@-ZWH M&_BXT?"+T_RLZP%9_3L\)[W#5[20;,G(E.)2H@;X9P3H"LQK=28J#;P^T/I` M%SC0!VL%\>)G8J;"LR9851WXK<54YT!BRMQO\?4EY5\=S6&L.O":;?F:=RQ` MD*T'IEFW(L!KUM42MX+`:[8]6HF[A_[Y\5&NG5&>A0L>V0J`6 MDC`E@;5"9-6@:F:M#%DUJ)I9*T-6#:IFUI*355^4%;XH\^,H=&S9Y:GN%V;E MANZ88@YGO;I.T:[8D:@;66MR/KI[O,^MN!*KQ(75ZU=:157\")J]KE91)8*U M-F2MR?GH[7%8]3&IJ,/.QB[CG=(FB)3KP&?PV'@<;/U0*F/@JF;<5A<\]*G1 MIT;CH4^-/C4:C[*R6`U1TJ>F%/>."U!>/CR]7+Y<-GQ1N0&HQ<[5&@.8:Q') MV*ZN8%L:UB129C8NSK8*EE7_3&GA4&*<]&G-G-;V5N5"6[!XQ77%=A>S6C34 MB1=J:C?@H(1#DK%SOM4==/7/E!8.)<:I[*>U?G;#V+%ME]5,5VQ^6_Z!6K4K M/[]$D_K]'<05=*EE!_N2!K>J'9C#U@2]^X.>P/L#'#]EVOTR'FKFUU*XE'IJQM=36S4[T5("BHJY^20:9RGK=]GA) M[D"CO=V-9"78O&Y'LB2@'L4).=45[)5NLJ(5I)X*H*<"'-%Q+`FHQW$^]%0` M/16@5L>V0J#J=L`:U,J`JIE5@UH94#6S:E`K`ZIF5GU1IJ<"[)N!RPW=4<4< M&N8^&Y]78BO+!6MMR%J3$]+54;F7O+)Z_4HKJ6,_@J<7>QPF7XF-+!>LM2%K M3<['N^$I&7UJ6#%;=:[?N9V[+7KNU%NI'4[JG M=;C6X3OK)'#>T;>Z98)5Z_!:GKG=ZW#=$K]02_R_?8C#YH-E37Z^9P]C0/P; MF_A!Y'@/UTXX.Q[1HC$AI<"*AJ(1@%CAN791CC;8CO3 M9IX>P5;0QI,5XE*3.()G^E-`^]'!0"\MEWQ0KA\PESU:@!M`X/CT`OZ:,P0L M8#VRP'J`%^-Q'V#TAQR^$/\E`8Y0C&&Q0P1`P)=:QK7CTN>9D'KS^#D+@$P` MM*(HQ(YOI?A"R,&7,4!#9@%6G\J'AZS:.3; M#:/;.C$`0A?>I/5ZRL_J0ORM)RL(+(1BY;J]3@)BKT?_%"SNA&%,9R6>P"?` MJ("S$-+7AL8D8$,6!,Q6V)\0Q'^8K;,$L@)K>4!*.)UPA-GSP(U1$`V!]`2S MG7?L^7D?6.X@=BVD9")["DJT!@BI<,(&D?/(W&G#L&,2"+""$\!#D=.D[\)? M#38M^9W,C"_*8=QA M&.?%-W#=41'KWO;7P%5>M28]](Y:O_IQ"*(Y;*`"8)-($?(6]<8.WZ_C*NPL M5>'%N6R+OM)U$R=2D1_-WN]E&,V+8U5UX+<^CC5I[7[(.71EV/=*`Z^9-F': M@\TU>_%]+ZP_:F5Y+@H^?[R\_WQE7'Z]-JX___;[]YOK.CDCJ^Z\9\[QH>-^ M-2)EV>'36[V#Y.\U^[]66V#2FG\LO.[08G+'Z4QU.3T5AT\+RH-4R6Q2&'1V M6HM,(?5N.G/3=R@/I)RI=C4LZUN:/;AN75_5DP>[G<;%Z87F\=KAH<]J[G*P,&Z9&&+7LS]J8K-\G4;V_>>%6YO"YXZ--:P].Z M-W^\]%R^ZY;*QV#-?!76S#'RB^XXDD<^W7%D!T1\UVV<=,ZV.%3I*))-CE7% M63"G4$-+(RV-M#3:5!IU&F?;-4#2LFB[H1X;MX*59F:I1%.%I&@E0-51;0UJ M94#5S*I#%J4(62@%WDVC3WV+L#6':/:A70CM0F@78G_W7$30KNW>>=:NR#8LB M:B!<5ZW)E9=N5:9;E>E693N0,-7`:AW@7[\J(_A;'\CZ]'W2SO?>X;_0S/]PEIYQ[S*\.FMU@)2-R?39T6+1;W5I:F#UJW)#N!O M5.^Z6[<[JO[M<[?3.#_7KH]T]RK.J6Y/ETD^W)JL4J+K4 M0(-:&5`ULY;:)3^&RABU-1DV$-#-R72[H[K;^'OSQZO*Y77!0Y_6&I[6O7GD MI>=R7>F[@;NNFY/M6BI6G"-T`=TN"NA`")N]%SI4%6=`7O]+"J(K"J*>[DQTXG+&H.]G?/L1A\\&R)C_?6($'Y`SO6'"/9MEW(,9' MQ/K7UZ_^)A^ZC_LA^T\,!+IYA/\)DX>,`0`%/WQCP[^_N>+__G'ZY>9'M]W\ M9^PUL3?$FU]GB/]G'$;.<+I+^N^3^L76G*\SG]^TY(=BK=V.A$ZFVUJZK?R#&2/KD1D,Q&IL M875PF-*6$6V-:!3X\<,(_LN,H0.?>C!L>!1SR*.1$QJ?_&`,2S;_7X,\/%K/ M9A$+Q@"5#<]8D>'Y*17GOT"O^(-!'`3RA2<_=FTC@.<<\"`#-O`?/(<2U*E] M&$-Y1(4'S%$B04L\EL+6245 MFPLEHBHV/\%W+!S@WX;^"?"+X\4!;?;1N.M23B$="#,XOQ M;V8%:XJJI00IH9Y84AV]3SPY:QP0T=LX`!%$NSJ%736#3_C+XO( M&E6,J.+E*I%U(`#OX%^#Z8:&V1$<+RUNLO2X"QQ0C1,72]2'1H:5]GTL:V\^ M?>>&",`7,KN`24*&3I\QSY@$;&*AM0-VB348^($-3S/P9J,1_1Q[$1I:DW3S M'IC'`LMUI_AW-HGXNRAG?@?+"'ZZQ^_0)E^.080,+#+'X'TWMAD]*!:F9[XR MW_/A]Y^]08L_"+]_&OGX`?\)#;?[)P8T&I%%Z-B.%4R3E[ZSP M?FP9EZX+7P*;KXFUA)8W3;^%:T>!Y876`'E.)0)S';`1+8'*0&7-(N)RF5A4 MQ>?O(;L=W@!+C8E`6F!J@;F,'@FG:/&X`_'(!9VL++(1+9LZNBP7]`;]!5#T`VJM M-4[D*ZS,A/1S':L/?G,$PK*ANJ3P%,HB@`I]X44OD/Q<\)$`'>B8T3/L>8)J M*#3L.$!$TW>(B&14AB"I!U$,*`!%8C="88A^MNT`VF##PF;B>R%+R=0R[H'I MG"'0$AWVA'I"KS2,?@RP!^19&RC/$<3(;V#[)1=(R3&9$DFD2@!WGCF/&+!L MD&N/#VBZSB.S!4TXD7F$`MD(&,!_(G49,-?BWS-\L,%M!EA0",%Z MSKP[M)R`%B"BLW&?V38\9@-1'F'-1Z!S>@XEP;,OA6P`=.5;$L8#X%#8`<$Y M^,:3%8"20V8&ED+][P?`)W`&FWV+&P=CW!^!@<46Q.;)` MU('-[#I`8)0,()`B$<3$4"6J)@^>#,8@N0>X$S8(]I`L=E26?9X@'P4 M"W7FD_9J*9?"GX=270[C"#40_O-*&.R3.!B,+%0@]`66[G4C\]R3`[8^VNH. MB$^4Q<8(R.7F0D_0^4!.$'`N4#<2(I2KU(`Q8^S3M!`4^RPDH/ML#H!"SD`1 M>3<35,%>UMPT^>:$?UV!YG`B_)<6BUHL+A>+*N]06(5XAR3EQSB$+P$O(R?M M74[6,<);0FG]F8O-<`3FM(%76PWC".\EC*Y$N!!W:^!M>`2-62&BA8G?,CY9CDLRVU>_"RN`*3_Q MT9>Q063"[V`9>"9*0C08EK9A%=>?).X6?@#(#9`$4S#50;T\,.Z'">`,`FTR M<1T62!\JN593G@_80PPVN!],YYZ2ZQO4%M,*<-H/_!IU2*BX%#;8\--0*B8% M4+Y&%/AV/)#G;,)_HO5#%CPZ`[3'N1-#ZM1"+0-F/>!LV>!7H"M#+AWN!F+= M%\<38`&?R"+G2#I#>'Q)]PS!P5BB=0Y_=DLJ9+C&9)_-33D$"`#=2XX M6>C>,NZH,A>/1GJ<&L*D@+>>1LX@B2$(9^S\Y"=YM`I^;N\,<;XHU%Q.3O-K`#CT#PJ\<1<.-[)9K<,7#L5I1B!`(0M-234NF\UC)LX M@(-.1_LR=*R6<96\\S3R9WC$;/^$DF7L\^B,/PN^$EI9B0'-,D.,,5H1_EP& M7E)2[G8V/7*=\9%)\E[D3W*K)[*9C@*NWHEDIPPBQ?A5@36+6S@=@SW70"WB M#'=P`!3Z7YR>72PTF8M:3#,9DAOFC;WHZ;\<6_\%K=LT>MV?=I[8J)E:,_5+ M,/7_^GT?6-HT-4O7@J6-9#QBJ@NT,^MV!2#;V;;:C*V.>-0:7YBQ>;AKRU;S>7WX?,X>X,B?=TSS%\/< M)Z-KRZ!8,/0:?D&W"%V3%+&9#8@.'35"UC"B)W]A,/2L0#!T[G.ME15;6T7] MS#D#9Q:C(0*\`"5K,@G\9TJ$<:?&Q46"8.1'EKL90#S*N+ZI-H\)/JX@XGL+ MX]19/,[,GW)MM6)@$/RO7ZV(D][/1TG7<87J?X>923E>E#2@YA9,3Z'84R9C5=^J).LMC[;1%-'TG2`-,6+_,?W8\47?*LY`] MQB^;*74)Q6/RND@#AF<>61`YJ"=Y->G$FJ+6;!EYGR-7>8Q9N/^%;V"J*]<\ M+!C/)!:+!*X@YI??F#P`/UE(IB92@+HH@>X02B-5$[S:C%]SH\*D0@P61L:8 M12/?+I(]E2.P5'EVA]HAB*9WKN5%EYZ-&59T1Z^%G!9RZQ6C<48B2R/A(BWG MMI1S&;(R25:2/52K8&,]`\JC!EF1/!<_'L<\>]Y&B3APTM1T(:]X(19(M25_ MIF_P^7&P$N;6B`!B1G)Q063P3/AX`J_)0@)\APUCU\"$_U!*1%$+$5C>`RXH MZA+05H]\[A1@26WX@C%(Z=.C-<@"-3J2$ZKI]3:(U*P3J-F@DRW&=&3SG,YY M+;KG7'$V#-(3L%[09C6AS%XM"-7EQV?C@,XFXS1KR&^?XL!S*$D3I>+0><9_ M;S6JH\8\U]N2YW00L3"I$[LJJ>D`+>MAM<;`FJ"!9[B,"CV<4'5-%C@NZ%O":^%X5*P).51LR4],?;.[#HK?@>(_HZ67,`BD?5-2=F6 MRT2B=HY%VB`CE!N110U0LC#A`_YCD@NJMC*@Q[VI\6"!\XP08/-A%HJWAEB" MFH8Z,QT:DBI>"K#R9'`LNS2^6.A!>^3$X_)8P>R(V"DARZ+5#KAWR=>E1BJU0?SBJ'1!G MVY"'VU".,XD?Y;0;_R`IA[_]C<3<"@6CF6HKIMK(>M0T+]-!WE4;DV'LT0G$ M`FQY4&6AGCC`2I\DT0#.POJY`06$\,XU?9575,L&2_\;P+HM`S\3*6>?;)W, M,VAU8%6+<>V[+L:_'!JS@(U3Q.5QWW+);`E'#*SQQ$CB<3G^]0@,%U[`9P2B MDXS"[:6%7#_A(YFMJCB%O2=(2 M,BVUW'@U7AKW4\4A-?*DQB/8'`0=%MY=AL<@?4]8$Y(-\;89U78C,(> M1>I153UM3WXC,;6CJ6JG\JXC#+[]]JS;:+?;](NWY_3/M0J5X#5,%FA0)2F_ M0W*GO/',6_AULO2[WAG^\'Z=1-'51O'UWUN$?YF!T M3/Y3X6*R91CR#W3.E0^8G(8%DW(7H*@U<^DT_#, MQ%(];`DG$P!GOZQT...-V<35J,T&`0_B"BVEAF33""OO'"0[\+C3]+O4P&)L M37GL2L2U>%ZA0AL>PTT^JS032O]U&64U(JW<9Z[#'AGOM(X`>?[,NF@ZS[5Z M(RN8".!A(R!X"3OT!4BZAC'RGS"`W.#--H!U_F(164T.-XBH]P;V4Q(&)[6P M&`Z=@<.S?<9C%E#_/IN-I4&+4"1-)?"7LJL$7TTVDP!>DHDW`]&9'@U$W/XL M5G,893LN%0D0;J)/4!]Y#$CQ\V^B=^`4=-L?HB<=1AE%S[OKM.5=)5723N+S M&XOU7<[^T!04FDXR+)U'R;(\04@V:E2X-D/CC2>(;%;TJ95L`25K^R2#*2\& M4Q%]ITG.RL MG=-.U!@RBY(!TEZA/&TTI,".^&/+N,<_YK4C%166:*[PY"WX&)O(+DCB*HMP MXQ=LL/1TKMMK0S2BPM_X$@]4]/`:/``L-<#^L@&;K4`(T[#*2@+!'F*^:T1] MJ>8-GH;A##D-$C1S*$%/#<&+IU91\'Y##(`98P2*T'6!&M0R2A+!2MKD3K&K M[=R7T\Z_LC<7,)<[_2^C)EM)EZB41V@\J9Q;`\J>4>`(Z($\`_^>TK,8F\C; M,8`!&UNMPE38+A(MJ^_CJ0@<@H;V`GX-MH\SC`->I2%M3]B[$5Z>9C8>N^<& M-K^]G[O@G`D&1FI'6]'D-CU52D^O^>:WW`:G.,`\<)OI<$T1U$R9^@\;"SY$-DL04_1?E%Y@ M6!G<.-M(=I:GH<#NTU#L)-59M-5-:FW/?@G)504VH/;AH%?RBS'S.IM39&&9 M]J%H=WN9%[JE%YDZHIE2N=LA-N;]R,\H-4:MI/>I`Z(E:KF+`E1PE.ZU6Q*& MV$D:/VZL4.=<'X\Q(<^B:9*@V!\MT,=Q2%W/$WN5KL51$N.%.0-_\3+BGVND MO=)'##P*,E.RKDS2,GW5+!$,E[+G`6-\0`0?Q($/P"H\2(FQQ$<'I6]_2L]\ M`FCP+OB:`V%\3IY4.RV\D^*_T_[ET_7GJ^1'\Y?W,NXH5@XI*W<@L3+X](P' M87]1M^'0B"=H9KSM]-ITDSE!/^;)8T$+OF]@#0E]E<>4Q7HI"K,K4X@69(?I.7Z,,^LX*9`1=I[H"<,#JKXSH\*4+F0#S@ MXAY/;);$2,%./LV1-]L<=ZQL)P(DG8VIRR\^'*:LX=!4$2.:3OB.2]`X`++U M_<@*>6SC&6U"!E\5??MYXH(T)S.YJ2(0#G^->!B<7O=#'M.?;88\X'W$*1B2 M#?TGL$J#8";F'LW`F6DCD,J.MV:[=6+`<73%+%7DYS#,,C'GHM56PGHJ7KTS M_<;[&'Q+Y[IJ>T#;`^O00W"0H;#047O^>R`]+R;!$DS&2'C?B[NQ4C0SKK2- M\P>_>PT9*!VF4!BC"R+Q++F(%,.MTAXN5*DS!.7`4^I\#`S&@3OE/U+13LOX M(YF:_=]DB(`ZX"N]Y\3HB^+K\H):F9#FI"EN8P94>6>^-QBJ7M03[-D)*<5N MB-$.CA->J0@*&I+NGL-T>D.PU1IRL_#0MWW&`/&?#N7T?U]BK+'4`>B)8/1 MWW`VQ`XOG[R?L?@D1>$[W#S#V0\(&MX31"[CB65#YYG9//K#X\J8"_H+`?VN M]UZY)\?QFSQF$/A]2AA-!DI0'+R/H6*7/B?FJJGPV,K6)BB#Z<)I`$9T1)] M*Q3V3W89N&,B\C=YY9K<#PI\!YE]Y.$7/@T0K.[,6.8'[(6E.7@E(3IZ[)&;#B#`K24$< M99F4&JI>].<[U8D=2!59,L=.7F.$DOXDJ1-`SW01.Q2]]]1`74GR9?X[[G(E!3*.4]M(4. M-[AS;DPY[F*9)(V9Y*A+F>:?[UK&)T0GD:V8X96N+=+":-5D&4:I^:[(DO,E MQH!)RJN!/[5<&O`F>B(IU@2E4F-UJ)#1*5'5N3XI3>4[XCD[G6@TY911$13` MH/KBTX9#<6\@A"6IO*)PLI,Y&&-*R),[NJ1RVJXH#-0,^?*#A5ONI@<(E164Z>#<@+:L2THF0(\,#A MWU&)&WMB2BP>*V$Z@C4JK$`*XN"YM$(?%Y[R?,EEE<@U,W)*;)/LIK.3@_SJ MYXH?:94'(B"=YZ>` MRC#M3#?!H1AUETJ&1*(/>6(VFW):D:^%2>.6<%QY9G,N+,SX3VQ18C<:"830#610''GK.FQAGL/%/P/R,4GW*@[<8YUG&!' M0?(DS;L9^4W2Q"(0(`X!L+X@?2)"I4N8"E^9L9UQV",?;*%P$."I4;U+E-L3 MNH^D2GY_421]]L/DWXJ(.D6!^77WD!JOSP:J1]:B8+6\\7=4+Y^Z9H8CT=A+ MU$_-8SY[64"1#RIED@K[]2NRPZ@M$H=72HLTH5@-+E.9/4B==`AO$L#UN-6# MOTL@P5]F5:;H*D`[!T]*'"@^C6F49+21^$(9%_HNOU2?PZUB&TY`9$'C@R%C7BZ-59_^(UD M%2"%[0=-K.S!`(?A]_\43,BODK&*]T_RED8?IA^NV*B MHH0\C''!&5[=PX+RBSPH2,$6K.P-=/SO&$X`W5+Q M43FI#$>VAJGA38\3L2C($QUR7G/`"62OHC):)OY,`"P6`D;C.2 M'ZDK:]K7?%N1B?$@)[";$PNOR))7D+TS\*EK?+^;D;H!>)9@YTD3&W9X[WZ+N/^0I7"LZ$;WE8!PM7*<:6MK%0!"%V,L4RI[1[ MD5PQY6QDJAG=*YV%K%M$K@\M)];(7$HM#:*)%*-6WL=0.*NKXAG!6M&^ZX0C M9F>.H.!(V:CU21:7A=:8J>^3HR'K7+$GU1_""U$7)EBD-SFK@92CK\1*Z?ZQ MR2\@N7]%[AV<00//H!#QR5:(^0P!.'I/\#9OR28*394XGM0O2>0ZVZ96),XD M%":=(#:G2&MG<=[+I$[N]\D@\VBDVT6-CWZ,N<"I3"3MBR,*0MQ9,<_YD MO7J`:9ZZB3O$)^0673\,82:=R+(PTP?@YTHKB>^ M#[$G:9]R68;#)"=Q^1_@WI!*P_M%M"FXG92:/\`:^&L1HDLK]U,=@!F427(F M\;HL/TFTZ2*FIFL^4A%">*9"7238RF\K(;I0W/M1G!Y0F>D[D7+BDH5).6!* M+VR/.TV\)LJR%:MJOMR!>!:&4N@+]XOG\LHD5VGNX_:E`^/06R7#'W9CXH=1 M4_PXS2:Q"EW*K]OG4ES%7Y,[PVPF*\E=*=*E*$6/0&2XKHJ:SKZ[?V:I:"+( M^G.7C>QBV9^63<2F2=W\]=V1X'R>`L8*$BS[J8Y7\P4;NH_/BO\G)#LM68)*M#D;V: MB.Q4ZB:+IE?C276N'R@/9E)<47;RPO6MK&-4BQXO;6H<@48.C7?5)8^Z MY/$8FS=7=P>4$[Q"F6@6T9,W*D;S$AH>O8U3TA#B_>&,R=_3YMTVJ1;-0^=(CR2ETA\*-RD7=8M-4B&L'9*V,R- M]3?Z-_Z_Z\R]]RJ5H[PGGA6M#:B6T*4)41/P47W/8^Y%-:;`-A>0-952';"$>,&BQ(OM)=5Q7"B]5UEVS M?O0YZ?K[!;L).M'TF@]>FA=Q5^3K_S![S6LV`"G7OOB17>'RV0E_),4KWY_\ M[R,_#@&1K[#1]\QS_.`J[;-XSP:8T_+5!^P_\=9=WH,RK.4+K?+F5RP,:IJ= M9M=,$5T,^1;X945X.Q^Y)4@H"']GAP=?;$_7;'ZQ`L3`W`:#&Q>#(`H2)\UV MM]D^'!*S<]H][:1H+0`X;>-Y@]U#P%16,;X= M9B$MF0PPF^W39KF^%)ZW&.WY28QE:%RE2&,(GV/ M^N+1@DF=PE-&E<-% MDZP^41;,NX(+_"@SD++U*;HE6]PD:,]BFT#6,.(PINP5@H#[(9Y$S8_C/F^XP@"R1-AWKB$)!LE]G"O*>,E2.L-FN(0 MV3)Y>*84'6<\^.B;\E+W%(BTV@C[./-:B*1*J6*93>43XY1P)U/A2`215N.2 M)U=8\'QR2K6<*'.%1<]_T6-$3:U3CGA&A.6]+C+Z\+6/K@6`W`]&/J9$\X>3 M+,^Q;S.W2-AB`\,OM873(4&?_(",2SH.?SC1Z)I%P,;(C60&W(F.E,KH@X_, M8]@9PW*ODKD*G\18!7V1KTW-M:Z1T[),%-3(B@;G19[CG'*C0>QH2'[,CL=+ M6=)(>=*03%DM45I^=4JS7AQEETBTILUK$YG7G\H"G&32?>#CT("DL2PMU6?1 M$Q.U*`P+?%/%S>VG6,AL5_N=4R9^'2N-ND'0Z/ MK],:J>)APZ%(&$^&$8P9D,6F&1%DO61G1R79M6/K+T8PB;I-;OW(KKD"BXQ] M%8YDM]Z%XZZ,Q#)+#'O^J.CT(S9@X`2#>(S9X6B4V\X`RX1>I)MM[<_Y9\\0 M);:TET3Q;!4;(UPQ?%? M8FX>UEY4(YM@P?IC]MUZUC:EMBG7H0=G'`,X1YM^NS#]TH!;VF+3>LYHR/M_AS!`A,Z2V(Z\M=J1VHG^A^2.$[9]@,X9H:'X M!`UQ2@(E_"-R:&@?;?64<\@%X-BWC'^!GN7?1.?B*1V.EAK0#UAN&U$H-@\H MK(3'Z#25#?L3QX/%&AELG#!M-Y)U.13;`Y,>>Z"P2:<$WEGOMQ#)<0$H=:@:Q@; M-TMVL>#N[^Q[XCO)*%XA3<1BLG$J95?->'HXCF5LV>+4DX'/C6\_R`K8I$"4 M6YQ(3G&!XG@S$%%>,1C2$S<.LXND#?/%L!/,,?-T1X8=JG3>4B=%4G@8[!'= M^+Q6:4JA6BH7,T(\,YPQ%(I3CF.(GGPP_MB$.R6H:956DI3$9[.FVAHY3>3# MGQ9\,M=9N^1-&C%IL*$VXTZM&"M1E-Q+C#VE00CI5G)8%L1VA$9;&2XB3;-TG,F MGT#\4@BV/H/SY?'9;;)3>.>TP5NHIRM?PL==^0>S)1W@]2FLNK(W5H!?#N]8 M0- M?%XU,/G^,+LIQ9<7DS2ACKYRH+TZN![LN(BZFZ",L=,!!L*@,>9A41KOVXX; M*_)-_*1I:?JW3V`@VH3^'));\#4$EBA M1[+IUV,PQ4?8'/>1<0N"/ZUUC]8]Z]`CPTB&B*V^0VWT7BNA;8MZ4T_KGF:U M!79H7*G=@M7:K,O[JTQ-UG=_X@P,^,LFW$'?;QAYN]O([*N1YP2EC2'EE#F$ MG$]UD^EO5&;&O\H+D=4O"8?_'4KI]SRV&87S,P-I,B`O-UL9!FX90,YX+*:^ M\,;[RSZ:].O&Z3S`-R+.,)CRUF@NWP"*)-*0'#[9WDK=2W&#*:""AXN(\*)R M.77N0-AC*A=HS=OAM7"A;CW%W_@=^R(N=E"65-SLP=-+*V[NX%&UY`;42+ME M]J1'M2U:JK+[9#D!1H5AJ4^2,U)<=-F#UG1%Z(%<1)<+=.F>,)*A<)+6>-O' M'C$,Y/KAXA1:KDBPN7@JYM74(ORK2*.@E)$)=@$&A9GVU.17?^F*+64W,TG@ M27W"P`I'8CPJ_"-KTW,E+4IOF+O`]'T.WRL/:^]`R>;W( MUY.A6,E9EM)U:"_."CO*.OQB38UT9&IGM&GR_N/&==()"?G MOO[[Q*9,B*QK]7OF_:^^J!W[P' M9R;]T;#@>8">,)]B66LDZG9F<@+Y7R.ML,!F'KAKQ(AI-@P1L M>4FHKXMW<#SEK&%Y/N&X)4<,=A!.B]C%7D,)%VQ^8.YX$D&26)07I9@Y/MG# M+,%9D-J;36,(LYS8XVE%E+N,0VEYE:?@6:H3Y2VPJ9^:#VB(V/6B0$,C:>@O M0AOP.`:H9QZ22<[9!U>',9A#CSC40AV.J6BQX7@Q..=*_MAR(.D`>7A/GPP" M,?IQQ#/V!C&?XI.&6A12`GOT?9PV"9JYY#`L*IGD MLQJ(QCD4FU]G-;64=2VQ,K6I7_4BWQ_YBI@'B6\N>6>6X1+ZO4-``I8A3I]) M^LBB&H:9[,BEF"M$X^KXY0*'=1*`0Q%,\R-ARH=GSJ?!7(?2>D1.>#Y;K\N# M-+\SB&2.6Y;I*/^'`GIT83("VXX%H2+3954-\EN2QB_2AJAB-LT2'8/01%+Q M*"._^ED-'OF+F&WOT5K%<$H_I12P8+GP+".JU+X2:2KSLD7=`\JIS&C*1IYK^M(I^'B;V@2W`[_AX[9)J'A/68!B<>YY%%NC675&27^X!@>XVVGU>DI MU[>B%DRM"Y*3?S.WL3B%!"M]*`\($(1U>NV9:V!**%(5&R87R;#T.N3+Q.CY MA2PB@)7G_/WP=DCTN+(\@?IMBO5'@?0+A>=_O[^64,]$Z9'T2I1^4\12ZGRA M71.!)"7"GZX'Z]P\LV#@A(PVH(Q$Z25]I];')].Q* MV.VK[V$H\@J[*-I"IA2(ENV!)ARPF>9I7;-WUE::$6R,TQXI\^G?-[OBEN^% MZ=+KG9EGYJXI`QH`9%@T1:D377HV"B-J4_E[R(:Q^QL6"A8(I?[XAGJ9,/_B M>,XX'DO)?-?]=PIS@:_M&3CK.0-<;P_`[2`&O7580(S*&5!5[9OT;Q'=98A/ MB=$YO=Y/:[OOQH"Y;@BV"_`=LB?]/$%CBO^L?#$P^@\#W_6#O[_Y_P8#!N:I M^E=;@HHAB#>H?^FGR)^\,0@^D)'G/[W)Q8Z_4I1NJV,=K?-]1CNN>.XL!!<;7@M#M"E_LT9 M\S3)U5S>6=S[NME[\ZO9/FGC_Z5MAW,_I6[%;SZ(`!:,$9$T>>\C"&1L"^(\ M,_NS:"OR;5&C\A<64KD9B>VS=(_60W$OQ-FCG*H$^GL5516AP')I==2G8W_A MG#VB?X472+=#T1+I-J"0X%>J@+H=WO,.=0X&4UV7V1^GLG62>+"8O-^YM,@- M;YEGI^TS4QV:L!UJ!Z+27H5*?ASP#/Z_=M7HU&Y>3@Y+IY,+LUU!,BV/MN]+ M0N=2\.+\].*\6S$2FJ?R1'96X=<1=FI5\?MQ+V^FQ>?H1H`X1;DZ*K;7E:1% MOD^2KUXJCM].]]K<-2D<:E__\V?Z#P(I'Y)7E>1_'FZB3Q$?VFPA$8I!OB6. MW2\W+Q8IZ;;,[H'0+'1??/@PX0$W>O9NK]0;U/F1>_*S^P1ZX8Q_R@_$<^LP MG]DZZY4.N7.RQ+,4);< MX``SC&9NL%VE1$HY96;[&Q.#.C;9L>YYZ9"['43^`M36V[ARX[:%""DE:C+1 M=VO<3LNGU5+Q:,Z@MM;=2PDER2?6#R1JO[$'R[VT'YUP$^E?2O2^X!1EQ&U& MJZW#D:6TLQ8B=NNQZN-&['@EQVQ'ZS/C2:M=/O-1U=I;R)%NZV*M@Y9TZA*C M*JZ3"11*+?W\'[$#7*%;CZ43C95PP?K?S]ZZRS_\IK04?\$$@]GKZY/92%$N MQ%NA]((N\ARVIR^.[5:QG5E\SL^*XI.9/A)^2QIP7,?L4^"/OUA_`EA4KX)3 M:=8]0;E7?N=G,T-/5GUV^;''1FFWWOSO]YW+7W`K3KHS6U$<@W+B75R&F"=[ M0GVII/TM:3U=`=G3W4:G))B^-+5V=F"V4K$5(T?QRM54L+L/0VP@D=G M-^DT!R<)U\_R]NL[&XP\W_4?IK^!%>Z%F%$984^P$.>3+3LG4!H=:1VL^76E6;\U!90`H9TJ[3GK;0'GSC*7LN&$X^@EM,[X)\/HWY,FXD+VQ2N(7_=9<+:/H=2!+ MAVER$OWA'I;*IYRHONY<-#^QOJ@],YM#'[RKWDQ5X?+5L\V@98JQN))6RP_S M4Z=G=W#QS?8][!,+/]X%8KS+&G?"QEH*/N#-Z=>[15Z0.7D^JSG6@&#OX&_(3RN0QKRT"N.\D4R[Z&V) M\PI1(LRQ@I)N%;2]SDEWM?A*O[ES`/?#>-V+\XM.J=':3%]V>B=G&Z*56->7 M.%F$6MZ$-V*P(Z:U%PK,++8V.Q?7.7UC%WQKGW#-V)=J7X-=@77MX(!KSUY8 MK+#8ON1.Q7/H_.PY[M_?@+?%WGQ8]=UO3OC7IX"QE4421;=KL9-S0E4/[?;Y MRPD#_S+QP$!Z)#N<3?HBMYL%^/@+$2'P:/@?M"- M]6EW6SPN;0I$H,=U(V:EY\';7<.[ZUQD0E?S7]C@^^MXEVJ1]3,3P7BY]W!';R271=@JSOU`YQJSC<=I5F@7L`*U,J!2]%AKAC:0$.A)I+S'# MYH%>_SA-'[GC[1,=NG=220X%A&X'2['2ZO&XR*O8W8-!@XV_#UP6NRO[ZSW:B/R_QO. M-<".`LOF7;0MWE%;Z7_M#XVWI]A:VP^,$9B[\(>D)?:[WOM,6VQ]HRQX[JP'_^18VW`*()_@TVK(XQ$V^4:X>169B M>^\.P[4$;KB6RICSI/91DGM"(8<7P*#$A"LH63-$W:,>5HRUM3%;$;];P!07 MG9::5'(@!$I&LS4/TFGK3)-LJR,T6U1I'CLYUW8>EY&S=_8BY.3Z5I;\\2(0 M%LJD#ED!=FCS[P;3GAP!E!A)2]/6#8^[]&!N4;TB#;$Q$C!I?-*3%8JQ4CB9 MYPD@F3;)])OP?G;&NT[OI_=RC)/\RO^EB4QL9IJ/-$A6$6BGVE)NTMXMC6V4 MXL&1V/J,M=<363M%,$/:P8C9L8N.Z5W:M']=\NT7)V,>E1G@Q6?[?F"S0`77H)%LL$L6LOHLZ'`\ MD=4\E#K+1J'LC@^Z^^6#KXG2%6+)4"R,8V*(2@.ON9FO*?6T(12U(36U0:KZ M:/AYX:":XJ.1)(N(`2QGIX<9P+)GM:<(-PSJBE8]ADG31CN;\0=!OI!PYD\O MSPX%][A=Z=-\Q]>N<5=R/?;WMU5(FS M66[HCNDXGEZTND=G":QRS=>YEWC]JF9F0I(2OY7\68>$9>*9!:RP]BU@*5'* M[LVF.-5$\C6;S6WD7O497)_4\J*D3ZH^J5L$,A:@?+(,Y9J8+[/9"+''C&Y[ M![D(F]"T#&Q43$X"&H;MQY@^6A]!61RIFDA*LW%R9C8ZVUU^5)_1]8FM861L MNP0++2!XN*=UME4B1E6/5,:6^D!E$LK/6Y9MY)9J**4S6Q>PI)5G].S<"J(K M7M)J*;.B9\NJJUU5Q=`V_VS\&8>1,YS^8F3(U#W=B.US:BAR=Z:6=2\OK6W* M!6]1<&=D.0GPU#/M;SNF[H1"[M>/8`O@5>.V[\# M=(CKEN#3V1]"YGFW*$JK)>`J;BN;,-3G1I^;31'J-+KFV?$>G<.'L/:TF*"X M"!_MRX:P#,\:P[)#)_P1>SB:![[F,/L'4>['6?+@!VNE\:VC3;HK1-5\V3UW MA;AWGLOBR>X9TVTB3Y5F]4H#K\_I,9_3#3-]JLGJE09>GU.^YCC11S8KTN:T7Z^\\N?/UJ^4>;:]7BRR@34.Y=4QJ*98G-A?0 MT7EB>21V!@T[]4@4.SG;ARRNZI&J"QY:-&C1L#45.XUN;Q^!D*H>JKK@ MH86#%@Y;4[';.&WG7-+57S@4NIZ3\S%VF,:MCDK(#A3Y/0TD7#LA#>5]L0%F MLS/->V]^[5RTLP,P5T*OI,'G)M(G,13EW64SZ5>-^5E`_Y7(==_\VH53H`Q' M7AO>Q;NJ;($(>>N3.LKG8YZ8Z%WLM+&:WG3\5`J\HLP\3Z&F4HKETV]O-K_[CX5#O MG?7F-KT(#HOQO@6UY7B6B[\M&\+(YR=Y?+X4_+7VF$\LY4SS@HCG3EWM=#MF MI[?&9F>0V1,9E"%C!R*#V3.[G>[9-G3@DN(N\`>,V>$GL$?NP%IT!K?#(:/I MM7$0QB`]OOO?V(,#RXBZ,3`3<+TELL_L[I,>L^?A%"1`6YR'+7%*R?+1]^)0 M*HE/S(H`0&7X*R?CBY$@ER4N+DYP=M8:\*\R;6:&9266`Z(:6(,HMMS?G.$N MIAG^>F?^VVQ_,;O7RXV7@A`=`+&"O\N_?%[.P<+YQV'$QOAY>N*[[X M@F/(]INSIQ/A],7]KB[N3?-`-_<7>XMX\%\\,?Z=/MCP6UYIS]P*[XY;*AZ; MRS3U\3`O@GH44I#E6#(&JI0LL^?B0NE,']/>5QIXS;B"<>4LO16<6V$4Y93` M^F*8S#^L+XK'-=FQZL!O+5V[!Y*NG?I+USVC**1K?1%,\Z#KBZ,22JHQEA@E MV\+WW<'$U!;4BLL]/5%W M21.95F^K++O:\+@&5>NLO!SUUDEO%^EVL9=3YNNB8FL7%_G_(NG6+R< MN'S]2DNAHY1"V\VMJ<0^U@S4BLM!;3+KPZA!U:KJI4Y'98;_AP M>*!K,&3@5[R@[:S%D19'FN4TJ/ITZ-.A0=6G0YNRZT9^U\EF.S(KE^=Q;F7= M;D+=,K#3.CU@EN40EA*E`CU9"N!4$W'XKM/I-GI[&0E:^&P*^%0 M<4[87W^HXY%%[=;IP5KH5^!`U04/;35L?5)?ORK;6=W.C2K$X97QL39MRKV\ M;5U-O*PEQ=D-8]_=W4O?%W!/S39+@M..NE_6Q+SI-%SQT M=]P]>3]')!_,_;@_53U2=<%#Z_):GM7S_?>Q/K@#M(;_LWS$[%Q'ZZ)=\-+& M>;<3ADT?O8??F!6R\*L?.0-VQP+'SV_GF-/*^,X*(H>%U$Y7EE1?XL"T!8=`IA M\L4)L:/H9^^1P?M!^)L[2$#N_GNO$,^T*2P$[K^LT/HK\#W+^V2%$1Q:!E2_ M[*<@[Y?(.P3YUF,)U!=%H9;M8&<>^P;?$JVNO[+\UJT'8O0?'%;.6K#LJ$"# MY\[IB=+I=BEJ.Z;!ED=D$V3/SM3&SA5%]M+SX-4B;@H6WT#PU#X7BSA7")CMZ6@ML"V_O6:>"^":Z@2K4#CK M%$&!?GGS'-&,]L,[-:GWF`.(*EG%GR<.']=P;45LU3R./3OK2(9F^Z395:1F M'I1;8;&%(4<0=A%"L[<'"/?#$+`4P-MI=LW5('.^44;>R%E'G[W(5P9=\$D9 MR3B491KJ-!'G*X>OG)V<723J9&T@]@._.L]A%?S=\ZZY`_#O`C9D00!R!1]+ M%_J&>U6(<9+)*W#VPO!V2`N)"2D!<-1E]A,KI5_GS:\GY^W6:3<=!;,$Q$-B M\G%]3,QNIY5JSH*8W`]&S(Y==CO,OO#5C_[-HF03=S4DA$+*/QM_@LARAM-? MC$R$O7NZ48A]00!YKD7EPJ!^H2\8V<4*W!ZHLT;XZ[L+FY\7ND+)#8;G_:1' ML52AA7*E@=\T8[%&W?7Y+^8GL7"%:?A#(Y'!!@EA`Z2P,W3!=07=P*%[K*&@)BA,#P\ M8+FNH69B+]=\4Y;1?E$]9YEHW;?1<+FR`5YQ^&8%U4MF>%6&C]6 MG6L>KP\>%0)U(Y)WZH*(QD/K*ZVOUJ=@K],XZ5X:)E_>:R?I!(G0U-G+8F M_M8FCCE#^S5(KRF_`>4_L7X@2?\;>[#<2_O1"=>T,,\U^379QHAW:GE,]KA9AO95Z8FNLWI#W)&W@UC%WX4*2%_<%=JR-5M)_# M,&;8Z[%0Z[VM(I%(K+-F^Z+9V3[8FX!=(A*L#`DB`2Z:[?-FIU=+`JP,S&'? MT7:S;38[Y[4DP++XF,`=N+]32]R+A*E2&M1S_PN$BS@)\/^O/0D62T%!@7I* MP0*!$T&"3K.]O:]21A*L#%\@`4Q2!&8M"5`LBB"HT*FK2ECES`O\NZ`1C@O_ M;"=V$YO'I]VG:T:"I9ZM0+_7-.N)?@$'4Y#@`M3!;DD@^_IO[I5F9@$'(5\QZ[T'6M/CE6>9$]ZDK6G1%&_LBO]RMI3 MI*"7V95>YC$19(DL[4J?L_;T*.B!]J0'6GN"%/)'3Z0_6GMR%/=.3Z5W6GN: M%/%53Z6O>KS4R'JNI])S/0*"K/1C3Z0?6WMB%/1J3Z17NP>"<$>9WX+>#N7] M*;:N=Q[9G6MY8:%!6ZN&.TJ/?-F'YL'YZGN2*M=.P,`Z":B.YW:"*.!+NP#. MG`5N]6=WPDI\N?!?(!>83;?2$_@6L[_[^"OEQGJM2WI:^OMTPCB'I7`73O4\ M,SOJ9-U#X;<3FM+_X/*P+!_*67`:)&SJ5VO,B;9Z_\7,UVRIDKGH=_<%ZX_,NR'1__?[ MY1BT6R>GY<8`%1,L?CO\W<-)RC0D=5YWYJ+6.WE!U$XKQ$BGNV`D\R49J0`& M6S#2^4LR4K>P^?SRC#0#ZV:,=-HI-P9;,%+WO-RHR9_RM28]],[QC&CDQZ'E MV6'#8,\#-HF,"0N,$+6.88W]V(O"]_.[<8#&VB_.90MGBZ_DG]J)$SGQ^FCV M?ET)4PVLJ@[\UL>Q]'U/@0&_U"T]$K97`I#7_ M('G)`,]'%F"\VN.9C?Y0BTE]=NH'G][JEYSHMG2(W=EI+2:Z#?SQV/=X$#,T M_#2G^E#^1YEFA.PH)EY.E)9.PBF,TT4]YN!T.XV+TWW,P:DJC]<%C[*O M]&G=73SLK'%Z^7\VLEJ_2[9.&R]#'\K;Q)(ZH)&.W#F&9&**2 MH`IQLUQ(E036"I%5@ZJ9M>1D/?"8]9JH-X]%ANN'89I?M`?;I_03.XM9^.GT MUAJYX\61JHF%OS=_O*I<7A<\]&FMX6G=FS]>>B[?V!\_8FOFJ[!FCI%?]B05 M*\X1;S=C!2V$52*^ZS9..F6>-T"K:N:QL%59EKP`[@F9E]\ZS;E6V85%$#83KJC6Y\M*MRG2K,MVJ;`<2 MIAI851WXK8]C?;H^Z59E50%>,VW"M+I56;T[[_!?Z%9ER\[Q?F&MO%M>9?AV MN]6O7]5[LX]31-*:NCF9%HQ:,.JM+B`6=7,RW9RL9@V/=+NCG=&OVVF%KWYH^7GLMUG>\&SGHY6Y.]?E5EN5AQ MGM`%=+LHH`,Q;/9>Z%A5G`%U,:^615H6[5`6F9W&R4E7"Z.]"R/=G4R#JL/: M&M0Z@ZJ95<$#8\(X%]VB>?43;[-*SK[EE]AU7^@ZD M^H@T^?7UJ[_))60!X26O'^29I+=#6B2\3:M?:$%C`&C`*M_8\.]OKOB_?W2_ MW/SHMIO_C+TF%N:_,6+/X4_P1=X8-ALX8\L-__ZFV7WS:^?L]*33;K=3--:" M8;?`GZX+?*_=O2@+\%G*=U8"W^UP=#L+%_%I.&A:'L+<1A/+OS+[RQQ/FA92L M?QD$EO?`QJ#1/D[31^ZL*?[J\LD*[-L)/AC^BX7(_IY]\SQA`Q3S/OY*8?W+ MAX>`/5@1^^Q%@>,!)/^RW)CEXGX9_K@=JMC_H&]]GT[8Y;,3_KB/0'6(+W]A M>-:RY,D7PQ=E>:7+FA`>,+.AP:7]L)\`LV(@"W(TP9QULO0 MIAA8!T'D#PMW)"J`0^<%<3C=Y6:'C,]^S-;0GZ'UC.">@-L-(< MOY`M^./.M;ROUI@C^Q5@&D]('"C_BHYP&/[XA0/3*%^O9&<=C M09M?[\[^_;L=`I-OAT!FP6=J@H?N?V(FFGSULT.@\LD)L M9;;W2+*M37GNG'\.PYC9GY?1["H.(W_\HVLVK]D`R=8N*#+GHPIN9J:NXD/M!MEXS4EV,_ MB)S_POKTZ.U0"OB"!AH8GYV3+Q*CA:MM^\%4[*[]P6]L;#D8G<>X,?RGT'=G M[P3@HYWDHZM65#73-S9@SB/>Q(;?`\MF8.#39ET.!C0<)?T[>L-/%IC]G_S@ MVH_[T3!VY5-WONL,IL4@E1?GZETY7:+_;/P)U'2&TU^,S`5Z]W2C&_1%]^?\ M0AS__;/A1/#E@;+X;AN#9V_95PS?.@)Z2'8Q4JZB5,V$M:A'E&0N0SZN4&Y) M%]3-"9J7H?&FS%NVBQ20VS@P++D?@;(?`K M[[B@+[!5F`\K#TBFLD"L_!>#MT"A!+#*A"N9L&5,<]^"24SR86-/H/E8/V)%4:&'7-J`7(1D@[.@N7Z#V#0/#G1*$L+ MV'5)"8&1%8?`=9^'0`ADN.2ON-'`I%E*.JX+WP8KA]!$%F+`Q$C"="=\8)0' MPK-AA#'LLA4:-"P,/Q8R1-X"1+R_@G@2`90X-_V?%Y!"IY(X\:_H0E MO(`L'^*.I@!,_-#A9`X,'_6M@<AICOG@A0P!<8)1YPR@7,I=.G[#L\@'_AL\]P-487U_S%@?^(G'X_ M\F,7D^4`FN&0.'EH.:[RS(+5"3S:@:?`B5C3'W(^%[Q!;`NVII^@H$@,$ACX MR?3\)ZPY8`&=,DXJP9=`_X$;V_)`N\Q[`%;"DP4"4`"8&#B)# MSB`ST$I"M@`+E@QVHVO2+\W60IV7>NJ[-.=2$_7*"D>?X/'/'B`TYN%7>B3) MWM.FGS;]EM(#63!"IQ_M M&R[5N'A%!8270,+@05$\(6<3+)3OH\(+`6S4*IFT2=9*$GH4'B"Q>=JZZ)'T M/FUU3HW[)[")@`+_&_B>A7CY($,)MVO"+?E`A+%B,*C2>;$S\A:71!G;4)!R MI^LB8>-]L%T,G90M.5[G$J_N27&\0N=Y4ZS60D+:=&!*RYTI M6!Y>:)$]]0^PVGX#U^\C0^'TW7I>/X\YYWHK!6V-+^\2X*5IS3,`-WMG90!Y M:9[S;,"]6P:(E^8]SYXN@C5)S M(;R+/KQC6'-IFP_KZ5:PWF$0AMGA)[!E\#(0=K?`92^;1*1&OC_YW\7$[Z]@5-TS#[SU*V[Z..#UW+,!BK"O M?L3"3]P;]QX4]BB2>WB>/<_%D-L1.;)GHIU/BR4X*_3YSHI@:_8N7A#=]#[G MBQ7P6^TM,+YQ,;92)"VS>S:CK8MCS:V20I9E&#),3+'(BKKUOOI>@)\*1#E8 M^"^*XL(7OK/!R'/^$P/I2AY@V95OO5F1[#Y=Z\-=-;TPGFL$JA97/BM%UA1E M%@!2T31^K?W3VL`9`^;B6$4\?:B*Z&=1JXT_J_UR"O?\>0EN*=5XQI7@Y;`R M'\6^>H;[OMASUVM^$L&.>^=YGAQ5W;K"\X;7&;.5`\!.9]BOO?3:0]9F6'1. M>G'>WF7GAGT+ZUVO^87'#V\P?KCB."Q2`9J(:F#37(>*ASI/VXPCUPISXQ:# M>C+TAOIK1?%E@LP/3H`HFU,'>:N;)&X M5&"MZ#VV5,/OX=VYWE;[9(#%MG+9O;YF\V4V?9T^I_J,;[:WLA.)X3I#9KR; M,BL(5S;\TF>\=F>\W6J?&TE2HOF+T6VM;)=WX%.O=?L.]_N;$_[5'&*BBX/\ MR4)*1UXYEE*?_%J>_)^:AMGJG/VTQ^W7)W';NX--1HAH2VGWEM*CCUD+6"^A MI>7124O3;/]D-(W.:7<+85FH2>ZBEKF[N2).K\P_4Y6-^QNLPT1=[AT+*-!; M[(Z_\^/."B('%O?QF<`:1+'E*I6_HB].&`(H/-G0#\+?W('H!,/OP_E#^-6" M[>[D=?H2^'?254&E=SSF)#-@LK M\7EQJNVJX\GBCJ>=3-/8HR3EFAU1EM%R)]T_RD]+I0/%=H<9B-9M71P'T=;M M1=QMF=U#$^:S-PA0>X"HIO]^]J@,[E9697)%NTEN]W/H_.PY+E@Z0?-C+ M1^=RG=?ZZ%W`)I9CK]'?=4DR9'>N$>VJ#^X8N"5YWPCG&P'UCLIS\=JBD M_V'JX/9$F^FTNN1;NP.I"-MP`RLY2VG*(F_2]-W_&/A_L>`RI`Q*D>EZY8>; M'98L34S%Q-L$@KW#7YR`OX-=_N"$&&9#.3;V/=*Y$@C,'?T?W[6QB+F8)M]] M6G-^8Z^S\YXI]Z`X$DHIFC5.3+*;`"AXQ^PWEWV];) MG)VC+E[ZC4SF-;KPU@,<,_C#-V0S<#AQF`"S,1/^2A3'`S.N6=>54V72;EU< M*/G4A;^\0W@72[-<>,_,%X9WMJ7VHI:U*_`PVZ6B^PO@L:MI$)_\8,B<"(`+ M^4@(T:PV7*//9='N;5+N++$-]X[.S+2;U1[$)K-,3B]:W=,=.!"[0*I2U-W$ MI5UH\:1CO939)M+X^N[+:(.BG[/SO:I9P"("Z^+;^[K7L`S/&F,_#M@EV!9< MUADZS/Y!<>0?%VFAAB7_]7^:S9M/5'@V(CNGV

Y4&/1M<7%3TKBI-E. ML:_'<.>U<>B=E@")HO1N5PC6"H':_JE*R<05I7!E8*T0J)IQ]ZXV-JV-FE$O M^T[E,%NG>[K&7]1T[)J%@\"9%&@UMJ`*J!6_!R\W0>GSQ4A59/1 MNV;KK%=[)J^.T'K]:AO2=+K=VN]EA4`]"@DB5*79J2GGK5.P?$3&Y67\$(<1 M6I87QLUXXOI3QJ1EN6&HLSI2>AO"G7_H]-"TO*CI>=&FI38M1;>.WLJ^/)7G M\>.069V3=J/=KO]N5@C4HQ`A0E>:IS7E/!VZ7$#!?UI>C`-$L1V%#ERNT_3E M0^<<3XR6U34X!=JZ7,+HK2.P1XY#9FGCLFR@'H<$$:JRKB%S';C,]V7Q+IPZ MC]P\1\RCS@@Z;EDHSM_1EJ6V+.NO%[1E61>999Y6V;)\_4K;EA5E/*DLZYI: MHP.7"RBHYER:;>,;FP0.-I#0L.062=5-C"U M>5E1KKO0H-C&UB5E_[:!-S-H(K<:)3K\L M&ZCK"9'7KZK*>U)A'IV1>=QAS&LV4*[(M8VYSI'I?.AJ$U.;F$=@8I[652L< MF\SJM+6!63)0CT.$"%VI9U='&9_+EXTW^7"A[4UM;]9>6W1;M4VB.C:1=6J>-2Y.ZK^; M%0+U.$0(5Y5'UVK]N`.:VM;<72N0#V?:UM2V9OT5A;8U:R.R+AJFCFV6"=2C MD"!"4QZ=J:D#F^+B_,KWPMB-P*+4M^:KR=;[8&K+4EN61Z`76NVZ)NL?F\S2 M:9EE`_4H)(A4E3HMT\Y5CQ/+MAWOH?ZE[G9GIBG[CDN"\@F[ MG*QU$?(7'\SMTSDW(F`)CN(.\:CX\=K.I-V$;C715MW6Q58F4O6/3G;#^GY@ MLT#%PPA]U[%ANRS8KMK+T^V-YNIS1%WPT-)-6@=;V>)5980M8L`+4#ZIMZ'. M?_'$^'?ZOFOSSWSW(\M-\@^,VS@*(\M#RNR!K9;26&J9D@B8+1#1>)0*CXN: MX%&N_5AJ6@(>ANW'?9<=@6VY2+3V&N9YIV&VM[J'K3ZC:#RT`-J3X?$)\T(K6/$GL.?N!]9 M`0O?.&/+#?_^IME[\ZMIMO'_$A1W`=B.\/SH6X']A<+*X=:XMM_\VCW= M&:8J:(AM'#8?+&OR,WVW/[OH)7+(`QL#[WV43K"6^^R\6PF<(&!`'^ZN:9!0,G1&;Z@Y0,///(`NN!?6-CR_&`#9$F@36(8LO]SH*Q MF4NPTQF"_7K7.?GRMP_E@U[A(/S@@FV"SS@!0,("Q[<+(GSV[X0!BJZ<`O,U MQAV'XY_B"\#?>L0NUU:4?R1G@4C9%+B+J4QZ\N;7=JL+_R=A7/G!%+8KUPK# MVZ$01[?!-Z2T?/^>#>+`B1P67EFNR^R/4RFVQ(/AK9G9L)+^5^(07@ M%9_<%?`%3I[!)QI;@+=-_;(O)C=6(&'VRP98#5\V:TL3KHB']P!>*?K@7=Z M8/`6'X3\O>V\*/E6P[B:S&AN`>@UZT=?K`BE]Q2DI#=P)I8K[)U?`!OH>&#^1`Q*%-`2SO_H1"T$9?!_Y<0A.Q8V+$'+KY8QWI?!O05V,Y3?!K7[0IAUW_QZ?G+:.]L_:I_^?:/JKFU0^[X:,5#(YEFO M;9YT-T?K,P`.1DE4-G9$W+J+F'$&Z,TQZQ9A19&*I*#PU?'84G0_.9[EX:C? M[V`BA>"(@+`H@G&O%`CODD$[Y_M&Z27$B=GNG90"KSKQY@XWLBR\>7!]T#D_ M.>FLA5*NSZF$6`I'0P["H;]^9`^.AR$>P_>,:,2,T'ENC@&@D6'![V&Y$+M] M^D/ZHXTQ%/BW$X8Q+,F`=)'CTI^>.,(&P]`,A6KHZ=927WR.+H>CX[I<4EY* M7=JV@ZN`91+X`\;L\%/@CS^+#]\.P7!YA/7O7&O`RF:3G%RHX:AU,4EI`)R- MP7Z*F61BP9_\X#(&S(#.`PYWB%'$(4'\HI2`;:0`EDJ1#GCIK4X21]@,JY0J M7ZQG9QR/D_-_.<:827E)DC$+3M_\VFMG_*<-T%&#_UF0%3BEJWGSGY@DNWSD M!8FQ(`)Q878[[?1"8'V,5'HH*@S%RE4 M@ES@HZIY,&3P*_O&`]'+0.QY#]=`+M>?(#*?&"/Y\,D)PNB>1:LB%,M"H3G. M^\F,[[XA*'O&IDB@^06Q`:[WT0_8]>:8&Z"3!\N^\2FZ/;O'1XJ`R\DD\!^9 M37J#WU.!_O2*!/%6AD3G[L$6?4P5.S=@"$73/QR;B4A?)F[*9?J:H=`2+KA]_L5WK`(U)01=LRL@(5OA[\#`KC18(^%A5S\W@MM MR.+`=%YE`',CONF8YZ4%?F/& M.>N=EN$TK&"F>E1'XS175MEN2IB&*YS].L_!]G'YC$S_` M5*%[]D!^6381L5BN5%X&):6%_FS\"9]RAM-?C$Q:9?=TH[3L^0S0U9F<>X4# MOM?$S M,5,\7A.LJ@[\UF*JZWKP-W^8[F,%8=>,VV?,T[%B#(U@/3K%L1X#7K M:HE;0>`UVQZMQ-U#Z_].U3L[T9I?660$_#X@A"_;#!:C=-#?6_>MS=AC12/M M$O2"T(WM=6-[6M-L=,SS;81@)9B\;@>R)*`>Q0DYW2I<7VO!^M.1J,?7K^J] MCUI!+E&0W?K/"JG<@:P&J$=Q/D[V."NOXF)U+?6X\RG0G5*=A0H=VPJ!6DC" ME`36"I%5@ZJ9M3)DU:!J9JT,636HFEE+3E9]45;XHLSGI3RRM4K-+\S*#=TQ MQ1S.>GL,.E1B(\L%:VW(6I/ST=WCC6[%E5B=KZS*#=TQ'4"SU]4*JD2PUH:L M-3D?O:TF;]9/0;U^=?!KHW625TM]I[0)(N4Z\AD\-IXT73^4RABXJAFWU04/ M?6KTJ=%XZ%.C3XW&HZPL5D.4]*DIQ;WC`I273B0NF2^7#6!4;K9RL7.UQFSW MZL8R=E97L"T-:Q(K,QL79UN%RZI_IK1P*#%.^K1F3FM[JW*A+5B\XKIBNXM9 M+1KJQ`O:;M@!$3OG6]U!5_]$:=%08IST63VTU3!V;-ME-=,4F]^5?Z!&[DWJ]W<45U"FEAWL2QK>=4?LP[:X M+]E!J0L>^L#K`U_\P,]A?8"/'[+M?ID.YUXZ\&N[J91BU&S_5+_>NX=M&5TR MAJ@+'IJQR]!4NF1,41<\-'-KJ5U+/#1C:ZFMFYWHJ0!%19U.,CC2^MQ.H[W= MC60EF+QN![(DH![%"3G5%>S5:['R^I56D%I![B1A1T\%*!6LM2%K7]2RNMHNIS`$\O]CA,OA(;62Y8:T/6FIR/ M\WIG5;Q^5?Z+(UTV5DX\=-?94H>N:L9M=<%#GQI]:C0>^M3H4Z/Q*"N+U1`E M?6JJQO"U\#M"^!T^ M_Q&_\^OK5W^3JWV-QWT6X%KX"CXFWS$&0`MXY1L;_OW-%?_WC],O-S^Z[>8_ M8Z^)[:K?&+'G\"?NX@!8PF8#9VRYX=_??/[ZZ!&]O,_@0;>.6/)W%D18[OW0YOK,`#-,,[%MR/K(#Q=FL% M(#=_;/FEC]/\!2Z?G?`'O#GVO?L(:/V%(=H*G>CM4*54^\VO[91..Z%`_4CZ MAQ4$EA<5(&>S]^;7WDD;_T]3=26C>H\,)`6CM:"+O5_3NR2SSF._9 M/U\.!OB+\!L;,.<1K>'KF.$J65/^UF.Y-+P,?]P."QKB'<"C=7[RMP_K?CF% M]IL3_A5>>O;OW@"H:3D>XG[GN\Y@FC@5A=R%7_,\(G(7?S;^A$\[P^DOQ@Y< MQ3TYBOP7\T,ULJYCKO^6[PQ6'W5B#%@3QB!;?B>X<-3?A^)#L(&GAH.G8&#?QM8 M$R>R7"/RC6$,FT,/3EA`XHGO%_S)9H_,]2?TUTG@V_$@"AOT1[%V/X!U^=*# M4?((OHHERD]^X-I/6+,,A/F+1?S-/'!"RP6<'WTW'C-\N\]PL:%#<8"6\=TW MK,'(`6APW9#!(G^R`8I:`.<)EY_B*P'[3^R`FL05`LN!YS`I!3$"3!.,1X$? M/P"P<1_DD^$C9B#G(F8,'<_R<*A>B+_UX4N!0:;-`Z,X1,OXC(3S/#_"KUEA M&-/'1E;$\5<6>')$.^SP2#VL-MUZ,!7 M+=Q#ZP%^XP_E,4,F:QEW<*0&S@0XE2\+/Z$)(7X*F&MAX$X>L3@1JE-<29XS MD`:3"'@(F!I9.7M\C9$#_!/0"ZX?A@!$Z."S^#\3/"X->L7J.ZX#Z^)I8F-$ M%/%@D4.,`=VO,5Y$(L6?`U&&<)9`6""9N488"(,T\BPM7 M!,,26D0!FHMZ$,(@EY'2LTI';&"ZZL&%5/W%%>RE'W*5:"F<&@8? MI6<1""DHI)U`2KV1$6H30!>U.JVD(_N@47WL:.6"W.;"OPG8#'@7]'G$>(X8.Z%Z+ MV>\;R$M`","%%KY_8H#OR/C?`$0I\DN#'U:PB$,``,@,:W!]R'GY,PG&N*PX9%8NH+@U8RR2%9%OK;0&`(TP:-#-9U]^X%Y(-9= M_J`-T@&,#A3SCRQ9I&5]@0\LVR'^'4@B(U+%*J4AL!<3A<(1'<]DDB\=4C M>!KT%ZKLOY@Q8C:)%\#."]&P1QF)UB&8WH$0#H)32!B#5.!B3C@N@Y'OTIY7 MBXJQ.Z.8P'JBP\4("N3`!9I5*C'<;@;^\2-RFL>8'_-A#N#^:H#[ZP#\G05CLUA\]*[[ M[XLOYOFUDNZQ-XCVME'()9\"QCZC#\'""#?J"RB(<3S>,JGD!&/9[7:O-T.? M`T!^6&I9SSNDUMDAJ<4AW[L0^)>/U@'*V]UQ%YP_LW5^NB=J+87\T/3:"7]Q M>NV+NY9"GJ%7DA"7OSC=JM[R1?$C'*CT0]GDN,WOL79J3:U>#%[J!\:'(@NK M"9E*>B?%K<5'*9<3S:/V3VM;4\8`K*!P8F%(&^]-Z6=1,(H_*Y]<,GA])O4V M!Z\ULL%7OSV;Z9L,Z.SF9[/N?$#G7HW;3W[`72KG>>.\UF6;M4Y5\)H[N=NE M-ZW(KA<[?(%?CD+C!@"T"[@1E<01A#,SNNV&@1)Z+TQ_8`FUM-IE9I[PWN!8 MKXQ^0?G$^?ELB<#N66KOY0=[#69Z'MZ$V<*S-:8.]N:V6[ MB@.?;ZW`=[B]&`IK#@/&>.($"R,#;WWU&3^F,]YN]7H_&4T#_GNVLIQ4:_.J MGO5$FS\FD4E]SH_IG)OGIWC,S?.]GG)]_E:V@=B<^N4HX-_%?<6OKU^]?O6W M_]-L&I]\/_+\B!GWC+)4C&83KTF`SG_]/!1_^PU^,)[I5]%T`BA1^I'-[#?B MMX&/B(ZB:/+SAP]/3T^MYW[@MOS@X4.GW>Y^P#]_P`??X-(?YM:FW^(KSL_X MO_#C_P]02P,$%`````@`_4D.09`EI\O/!P``CW$``!8`'`!N96]N9"TR,#$R M,#8S,%]C86PN>&UL550)``.-3RI0C4\J4'5X"P`!!"4.```$.0$``.U=W5/; M.!!_OYG['YCT.82/^RA,N4[XZC`#30;H]=XZBKTFNCI2*LDAN;_^5K93DMB6 M;4AL.?`$)%II=W^KW=5J;3Y\G([\G0D(23D[:>WO[K5V@#GSAI/7E_K+] MOK7S\:]??_G@4_9]0"3L(`&3)ZVA4N/C3N?Q\7%W.A#^+A/.OK[3L').IIGA_A.X(?*N48.EWB'J0+F MZF6C3_7D:UDY-!CN+"WF:XBX6-94O%:(@T?D(`0CD.T'0L8=K<`.^$K./PE5 MVM[;CS%Y%W_\K2LE*'D6"(&,Z%;-Y1N30P%WT]2IH7;', M'Q'.?`[\-8'8LD7'(SHR&(W"V=H4X9O3>X*/C`J*U^5I?'+A@D"/@0XCD,@# M'^OYB=_:>03Z,%3X5:MJ!7<=AP=,R5MP@$[(P(?/H`J8A9',?D#,_,=`'=@$ M5%_`F%#W8CH&)J'+W)X:@BBZC0M1VP];(3%B]`YST>NL./K7Y?MSG7[UWOXE M0:E>N\WT,ZFF:54$Z`L^!J%F?9\PA5OJXD=`Q]IFT2,:/8J)S&)(S(P7=OVO MU7E<4S*@/C(!!39JVN"Z,IP^F>DX7SRW626HU::SU9Z5VJRR;Z/O05Y%`&XI MFS+0-`>A+`ELS#S/P0-DS[V%";"@P`;*(F@(/%GLO^65Q4-#L9A0?3!83_2R MP(:SC-?@5/(]_VLUW#O%G>]#[J.:I$X'U>R*.7Z@*[I]+D*8E1)T$"@=4>_Y M9\X M&].L,SX:<58(P^30+08P*:R-^5?7=6G$19]0]XJ=D3%5FJ7L%#F+8HNQS)2Y M<-I6[;DG&&D,(*I@HB&.!0R!23H!U`H?P367\I(+9)%%@=R9W0O"9`R<^V\@ M55RUZ'GW9&H^,:U_M6TVI4WH*S;#WVPRPUM0A#)P+XA@J!>Y(#@>@JA#33E- M$>(M-I(BXL>8__Z6>."TZ11^88CIIWI;K.. M!]`; M@T!AV$/<9&/:9BECJW<&$M!"AAC"SA%/GX=7^3$_1@]AI*O5@C,A2#H/HQ`V M>I0["-,`Y/B&B.^P(*4IWS(0-0,IDP0VUAP_`4/)?.2WZXXHHU)I.2>0CU4N M93,`RQ7#SMO@FF/&4W&L2-18'%VY@3\SSZW=<),J3ICN(M,VQH!UI!@-P"&% M];=,<\$,/B-#R]K,CRX&FJJM>%[)B!DXAX')DZ2.KM62<]6_:L^I(N3[EW8- MV0NA3.JM";+'+J9:PH#*863LFN]3\+B`KP(UU/,\_5ETD:^_NY(RT(_5Z4.B M*32L;XUFF<$:!;>SV;H>;[APKX@8G7&&B@U0MW$4X4Q&>HW&W9,IR!O*N`CK MK]'&Q&1U>9:H/'L#:LCQFPE$=Y*F<%LI%[7E'2],4^O:JC682&9.LZ@4&W/, M3207KQAW@VK>G/C2LU1XZLIQ+(N#JD]:7V>4J6OK)@TBF557J`L;/?5/P6*/ M<@H,S%693(I&0)W"]\O*`NNX"Y<]+ZO5K>SUN&FJ3=Z8F]:MOM]ZE85Y(^": M.U'6OE+E.7G)!DOBA+(P][G-L)M:L%;?LRV3_&]*=C6'I>:GI*KE?UP1B4Y@&1G%`4XG3V10(FB3\/ M]EWD8\E\>@L7(&XYG,2%M?/KL[7JL2CM9_WV9 MX1FR&BY;,;\40/1]]3*[H M!%L'<;J8,I MO,)$9N&%TSWO.C\"U''F*T5-%:@2D]BXE0QP)BI4)40MWD_ZMJD0A?A=#B_; M5*F3U%"V=0#<>1?$!.V#8CS-::LV4MFX;0R`I11VLV6SL=)[BWGQ++Z*+PZA MD:KA$!IE*][U4=,V_$J$(/IY4A`.-3^F8R9K.(IFX>Q\$+#V@*49P-"N?^CP M/B&^W@9]$%3WI"WGUJ8&EU+35-YE7,ME:FU-!L^`--%(7$)8&V-;+40\ M55@;[T+KR;RW$/%486V\'[WP/`R8/>]BZ@P)>X!;C*H]EJX9`^;EIFD\ZN7$ M+?PZS+2LZ><_)L0__@=02P,$%`````@`_4D.03`2J#6C)@``VGT"`!8`'`!N M96]N9"TR,#$R,#8S,%]D968N>&UL550)``.-3RI0C4\J4'5X"P`!!"4.```$ M.0$``.U=6W/;N))^WZK]#ZF(8B M-2#I6.?7+\"+1$JXDH`:RNAEQK$!L+_^<&TTNO_^WZ^+^,T+PEF4)K^^';W_ M\/8-2H(TC)+9KV^_/%V_^_GMF__^K__\C[_'4?+'LY^A-Z1"DOWZ=I[GRU]. M3KY]^_;^]1G'[U,\.SG]\.'LI"GXMBKYRVL6=4I_.VO*CD[^[^[V,9BCA?\N M2K+<3X)-+=H,J][HTZ=/)^5?2=$L^B4KZ]^F@9^7$*1RO>&6H/]ZUQ1[1W_U M;G3Z[FST_C4+UW*1,F&^_DR[@1].JC^^?4/UY>,`IS%Z0-,W]8]?'FYVZT5) M?A)&BY.ZS(D?Q^135(A?\M42_?HVBQ;+_FV,TY6)L!*"B_T"%_AMM[62` M-.1GE-"N\2Y$4[^()'4&KI@?)63;Q;H$6SPB;%++3[A`) MYT08'!3/Z-T:N$$Y6:T/D39)\['1(5,W6,K4""1K/$%I$I(F1J13X<:8HM&IK!C5]X6?SZSC]EMTD8811D.OK=[>)P?(5BX6/ M5^GT,9HEA*C`3_)Q$*0%Z7/)[)ZH*(A0=HER/U+6K5Z;>T7PA%[SPH]M`&F: M-M#/R8XLCYYC=(F>[,O88];*FAL_GBT64TW%)!R29H.G:04[9VD-=H:'!ND4SVO[-9JNI.<]S MZP^5[#/*;],LNT?X<4YV:+WH%K=12D@.HU%2[EQOB3@=04DQ1/;B82,J;7+` M%KZTJJ1!YQ,QM6.DF'EV*<\M4S][+@\O1?9NYOO+$ZJC$Q3G6?.;4FOO/HQJ MP\7?ZE][ZTTDP85NR(]9\Y78?T9Q^6V/7]C[\/;-"93(3_[SIH>(Q"T+>J-: MU`V78]P5FAP?F^;JDZ26:6:*TX6*PNI/IC)I4TRV';^^)36*C$B2+JG,M%>_ MJ8ZGOP1DK)/N=Q67]#]+'TY"5%4441^ MV&:&_,J[*GOR`YI%68[)?OBSOV!QPROJG5IAAVE8Z<>32/*:J1&#JGUH_8)( MCOV8'/[0ZS_02JCVK;+>V>'HG2%ZK?C3O2M^3*0.J>37L3_C*+Q3QOMX"(K> M$;E6\-G>%7Q18&IPN8ZRP(__B7Q\E827!`1'U[SBW@^'H':1]#4#'_?.0+-- M>2+-+N+]>`B:WI:XUNX/8-HEN\XH#<6=FUG6^^F0]+TC>JWX'\$4OQEL MU^0WK&VOH+3W\R$IGR%\K?Z?@-5?=0MU`EKEO4^'1\&6^#4)/T-M&ZM5YP$M M4TQM!A03EP=1%6_TX1"XD$*H^?@$Q,=U%"-\0;#,4BS>Q'=*>B,[)ULKVM^5 M?'UV@AH%Z6*1)J7)KS3_9),BIUXGU-E%/!8$%;W1`9UGI4`:BKCGVY.N?S=DVDY.,>OD5(/VZYCR;8F<`D2L+EF2,(D"P2? MU'WSTY;NLN-:QB!FM[`MJQO'W4U`!TO-;&;8*+XC2KS+QIO1+C5=GTEKW&S@ M<#G:^ZQ&CC\H&]_C^K:_E/>NLY=AS6O\6K!&5?:(X,QK8A#N#*-*T/->'#%K MP5I@]3GB@C!^R=.?I,J/9_Q,;Z&"7,!+MZ#[)EJ^W,YIO[8C*).P51[6?+NK M7Q$/#-'=F;"H[ZMHI2=_AK764U'E&W M%U2#-=YJ,B(#XM#41-:NI1^%5Z_4:PV-DW"2SQ'NX!4PIE`;V-2KR9PJ(.-N M!(86%]5%!=@$K#N>=D0W[F4P9`2E2X3SU7U,G?J3D'I]+^FNA8QYX=#A5P,V M!JNN]5((#LUS%2;I\/!&H.Y->KNL4EB'9J+6&P'2&W9?0BCL?%6;\$;.>T?U M@N0FF^HG%WXE;P1ZK-=B04HD"YM[V^][?T7WGNH;[VX%;P1Z^I>H6[SS9B!Q MBA]=N]D/>*:@%PT`?L:`/AZ;H[I5E^>Y?;.;=+NV=`K\#,\X.UR#,A.[.::+E MC"GC<;NH=PIL1=D3B4S<#BW1XS",JH_?^U%XDUSXRRCW8P&3G!K>*?#KM3T1 M*H+OT.)-SKG%HHAI:*CR'HD&A\!H3OVZ7A!13;I`-([`=8I1-$NJW7RP>L)^ MDL7EX_YQ^*\BRVN3^F3ZY+^*302FO^:=`CN`[*L_65*=0RO^`PU2D:#PRL<) M44[6@DR.^E$0B3:'\LK>*?#KPCWU%$5-&'^#"WV"L'YR\$Z!7TCNJ0,9U);Q MI\CVKOX&7/EYIZ[8Z`P8A_@(93.&[1=3JG$LCT^FCD^FCD^FCD^F#N!]SO') ME'.4')],'9],'9],'9],'<"3J:Z(59R#<9'/4QS]>[.QEMZ6;%<\G"=55NLJS0'F]5)?>#;JEA<,B, MS!)4'/]&L:;[T;DT@#AD_NU*>QO]65`;#Y&F^@.JDF6ID<:L?0"QO'31.&18 MW0FUI+0%$=0Z@.!?JBB,1X0T0E./O8="[0.(#Z:+QGA$28.C3+KIX-0`?C\V M:'2U$!B/,VF0&K7=ACA$W<$\'I/"D$6@W&.@O=V<8L>[HN-=T?=Q5T3C-Y#N M?8_3EXB,C_/5%R+,33)9(NQ3Y_%QD$,Y1O7NNPI?4!DG@BB,J#*QB_O*34W.&U\#O8* MQ60GL:4=AR:`R=CBB;/<26,2H9 M2<+Q@GK=_5M&LDIUV*N=_5*NJ@^'!O9O1(L950,Y1257KQ1Q$67SZO!"D]R> MHVF*T5<IT!?6V#>`H_WMM2\959I#MUE$61B1 M6?$25?]OJ:=^L**P'U%O!#AHX5Z[C)Y6'+H_VQ5\-UB@5F_8K0Y[DZ;'C"J[ M;)3N["X8J.D[HDW?EH4?4VL`^*[-#K=X^#/(L*(&YE8=*>CW`AP8,R>?'%N??10NW/B4M>"D7$-'&;3*.>:J!TZ MAG$DKU,\FIG4!8T!Q_$T,*G+P#FT"R>B!PB%V371PT5*^B;.(W*"H#9?\C'`OZX4PW9FG']"R7F(F4W4:!;6`@X4:I5$&TZ&IM]WCOOH8D]W! MU2O"090)5UA1->!`HM8&)!.G0]ME=>!&5D_@6*!&:=9$[=!R>C6=HB"?3*]> M@[F?S-`#V4M,$@J&AL`E_Z,;_1<_II.1@':=9L!CA*IOE[1A.63=8DMYCW"4 MAMNF.I''O$8SX(%#-3SH=6&Y]/B+*?N83$$8K\AL(XWWJE(?/&;H4"Y9>!QZ M&O98+)>54[L?-T\D;I)IBA=5Y$B%T-QJ+8`'Z]1X'Z"!R*%G8DWT/1IT5G@' MM"D&'1=30]&\RYXM,.X<+2O/HB?_%6521CHEH6--&B!E%X]#9\4&%(U=27[< M&!:3D+%3OHPR^KBGP$AA+AS:-'`TR>'4&U&`D<,H?0L8EEW@PX]G'\H.4/[* MN_8C7"[%DVE]%*[?ECZEYSC]@^93W?;<9!TY^C?FG8&:B(Q0U&5_H"Y,S-E< MNNDG*0CJYT$=/\FWPC$-&TK.4VN\9:QL@HWM9=^O(>\,U'YDC>9>>G!H^M_I M@V2Y*DI_[0(3R6M]33!%%/EQ_6]Q#S'6MG<&:HVRT&G,JL;NTE`9N6F,QLFT M=@2K?02I=[CT>D"_$>\,U`9E;8[0UH$14Z02K_235(9UY`(E(G=J>6>P@2?W MP1P;M!';(I>J!Q06Y7"GG\?1"]EXOJ"6-^:799ILRTC]0.K;C,W6@TNKL2]X M9[!Q+6UU`;,*DADLK8<`*18+'Z_2Z6,T2Z)I%%#'HF6X48(?+*(#%#@CGI/S'I!ESYI-%$%)N`B#.BIG2.75$#UX%').$" M/%\]D6]+XM@KU'8BHKT&G]Q[>16@[A@U^4#)EZ4QUQ5J@\?%5Z1$D\\NP+\4 MGZX$U;=/K(/Q]FG$BR)'>"VO-(X[IP9LD!C%<<6Q2?,1N3,0KPM,M$JWYW3[ M_DI_RJ1<\2O!QG<91)<8E!%#(O?T>45.4`L:#_1+AJ9%?!M-R>)>O?D5W/XH MUX4-P=)GZZH%S2$C+Q?K!D&?=6U3&R8"BA8=FBM9%YMD9G3JU/Y$VB^(;'M? M6Y.`Z`V7=Z,/4?:'RJ&=7PGBL+XCC>QHSJX`<1`7*Y*W$^!)[\1Q.T/!^UGZ M0O1`37D5B]7/V_Q5O_4JFQ^5XS>4SK"_G$?!`YI1];,/V$KU7#A:\YGJ,JL, MR/1.SR!7W&.68DVP([.R\C4YLW=0=HHUZ(.Q;?JL'8<;%LOM`%Y5--;_V.:Q M_K7WY9%!U>:/,,=;C9'0Y:`KN*U1HJ/?QRN!?A^O8,ZC@_5;">[0N>:!/O^0 M6,_792P=-ZTLY$SA75.\U"#3*F7K@*ALR.YH4J#LC;CN6,-Z:!MZ->VK=@>- MQG=$7M17F*)S- MCAB'.[.5:8Y<6;N-D65T4>>[M=:?G23\O1*G)'!(3W%'9UU!L1%8?3GRC_0Y ME>AU4P0X<*:^0K=$MWNOVLCT]$VFT9V2T.$J>_?4+@*[#Q?JZ[*)^+JLOB>3 MWF3W:@TXI*3.==!0E`[M84LG\,N;BYN$NG;3_":%,(PDLSQ0Q,BA-'#N^+@( MW=D_V?=.@(D':8=15;P.#<[BP@]^1\1]]8ST0LJS8!%/71 M#M5:H.TNJ9N/3::?45[+DUWY.$%A&=APL\YS5U*=1H`"0)HELB=LN\__+OU5 M-ID^H"5-_D70E-&5'O-H6<34B^J&OF82[XB46P`*_VB#1#W,LE>!MAW&MAZ5 M`KWG*A\Y)T2QA>HC+DX-"&>PKB@R3S!&:0@W,('^V$L,1VXG',!,<2>Q9>\6 M=L'EBT.,"HONO9/JRD>-"%(#*:\*^(LHMJY5>.F"^$[9<<5X;8:F_5BN'U$2 MD7W]9LU^1`$]K7].<[)!^98^S=,B\Y/PD>X<)1;#'FW!/F82C1&FH:H?0*NV M\4>TS,LOM;[_F2R^0EE9T8&DY!K]#NRS*'WBC8.W:^97[:E/Q@;UNB78IU6V MAG0'GN4K!$61R`;8W)S<;@PVI[0M!K<1[B/0T?H4K'KA(ZX&Z]FE?,!3A>*0 MF;B+[<[/"QSEJTL_5S]XMRO!^(.IZEUE)[J-QITC0PM?.<3KC*&BJS9V#:`D MR<-8$F%Q:#RUTYPTL09IU;;<] MUJL@8IMY@+M2J50&\FWJ1X\F+,L7)>2#UVD9*"-?K;,_T7M7TD]H=VG%`JQ" M^_)O3+2;`O*@&D);3Y!V(RBV+]^:.+V3I"7)%]+3,%]TI7(-(=@( M9",I6[ATDV-^2*_G=CH".0AMS>\G6U,K_@/E=8Z*UI2_$90(V,0Q+ONF8&;5;0K4 MOZOOQ-H+Y-HBX(!)H+7WKA(-U'Y,M)/6Z4G(=%/'T"9:RB(B>^E$+C`3]&\4 MU#^LK^E@(-RF.UBZ=*)0FG,SF7;(#F#IQ_?5NB$\GO(J`27^'7H0%<)I.+!D MTVE_?Y.239V"K3I`.7E-,S32[7[Y%@"E1N`RC-KLE; M"1FZAEL7TNUR)?]<4$5-IM7.>E-$W5%0I3&@U+N6V!;#;&AW(1?O;9K,GA!> M4"@;H]4Y\NER?1V]4G_M:E)Z$-\NZC4$E)UW&-T](#94NY"Q]R+VLVR=9&6" MRWUWTU-++X0R2\N%'\H0Z\+(;=V16RE3LU[R29X',T33&Z+!!U'Z1W=%Q.330.E/YV",_&8#?<6W(! MVO3'<9(07&U[5'735E\M3*:W:>EL6-WXC).PSK;=U%`8U4,_X9T=D-G'"OBF M-UBR_U3G[10_H`"1[4/66*>D]B!91>_LX.Q#2I`:/LS9B\P\2:B%;*PED@RX MW&K>V0'9C)0!-:0-LQC9N$3[DO@+&@/GWV037_L`*]^9,>IZ9P=D5M)#M7Z= MX!R'+=S-U'WUND1)IO[2CM^$]_$@+4\:X!IB+;GPU$?E9A*O7(J>TJUC4^U* MR%WNM%KQ/AZ0C:DOOH8V%XQ,+:<8>EJ^*#!&93A'ZC=6_4,P%!5J>Q\/T'2D MBJMATA7WH8T?3.OPM(X]4_K?R[R'5)KP/AZ0>:@7N(985WR'6B\E<#2+B"#T MM[J,,NIZ'P_(+*2'JN'0DB7H2X+1+,KH1!'N/"A\2E661O4FO(\'9]71!->P MY8(OCW2J:/M8#YI0.PUY'P_(9#,`8D.U+<>LO.$?E MVM['`S+CZ.)JZ.%:@:MW<1*<))8P=PZ+H0,YC/%9E8(QJ%84RWI MI(%I=PN#!PP6JIDSYI@HOB-*7(D2;(@;![/6/I*](\K&]Z1)A,E1L)17FE!5 M4`LV2C![1'#F-3$(=X91)>AY+XZ8M6`#^NISQ`5A.3!ODQFD^_G/:?Y/E*^/ MTNJ)X92:@0W)J[/SZXO.+FF-;\-&G-+`0>2Y>@WF-/MR^#7*Y_4!K/P;W^%+ MORV8>+Q]J6`1VA.TU<#I74";3OI`;1P"NY"@%DQ\7I-$2>$Y%&-T9UZI.LX: MJ\A**ZT+&<%W*)5:(&4A1L',0[4E;.]6HM9.0LE`Q"H/81MZ#.8H+&)4RW*^ M*B63&8@$M4"L1#QM>`HIK,1UH3-M&2 MXEY;`XM#H\7=V$R0-B(5$H7[B2&HW5GO.(81N7.?N"*HS6@`M5)0#HWK[AIP M&Q&H8>F45OT!L0.`:]0&S0HU@$55:$862QM<_I[2Y/;2Z9=?"309E#'F=A#9 M331DXQ8$,NM3#QY4(M;5>,[[IJ=]#*?D)W@*<&?*%DE- MLU3T9)Q6A3'Z`S/=`'=\<#]$V1_7&*VC+?48W*PF8"X#@"CG*<`A8[.HI_Z> MQGY>!H(>,+-W&P&Z1@`>\@P=R,S7MJVFE[59]P&]H*1`0*;1+2G&]'9T5FZU M5*R?"K4A#)Q\LBOMGC0QG5@9LQ^3@I2HE]4U[9!<.G M,I6Z/:$-TIT-L%A>J0>M2G5P(ZH:)WWX=-$#>B^,NF*HM4^M4=,N]TK^NJ#1 M?&ZC@`9]O4:HC,LT2=!%D>7I`F&N35&G.JQU5W4DL2[JU?%9?3[:0+A*9F1/ M4$;+NB1HXG1)831R75$_#@EAVBW!FHF'<-<+JMVWW6HB7:>%;-SI-@1K$+;/ M8A>I71_M+32J#MKB:K#FV5YG$%58#IGDMH2]D`:@9E>`=*N6ZUMIT]%"(EFY M]O(F^]S/RBBN-/9\Z4A:FTY.]VT[*=V1=Z3I',8V1>IT,>-O/@Y53"O#&P=^ MZRV3/^,!T'@9/NP;$!8<,[2RAZU1Q1RX$:@"([?W=,JY8-HQ2B*[G^Q@=LC%/AC4^:G6:7_S4GLZQ5,442=C:MZ[>EU&5=K;-6B+/4WZ;2=2 MS$#T.R7-./3>M)6'][(HO637E"- M!$ET8_IIK=Q?$?6$1^'X!6%_AAK$]S@21CG=DP2PD5(=V5Q)%22+&NE2S^0> M1YEKOZW>:4X*V(BP5GNH8275O?2'0^BE0S<*0+/J(+E@8^HZO>^3JJWNVS\> M0M^6#>L&'?@DK"6(-[)T10/?>\WKJ>ZN/^W3LV=+J+53RD6:E`HJ_/@VFNIZ M^2BVZHU`C/0#>HO</MPZ?Q&O M'R%^=ZYBF&*JILMDU0+WQQ$J7H,K%UUL++#EBL.+:=KV])H)+?-RAWGZX<-/ M-\D+RDA=F:^*:E4G,ISR!@5S3ZP$R:ICRKB8%5E.OO_I:K&,TQ5"BB_,9!6= M2&JJ0X8*(+O!=?[73PIRNB)_^:`W-&05G\RMZ1*2SL>*0 M$-1Q(G>I#@,2+';3K+7FQ=&'![3$44`OCW27"5Y=V/CBP]8)$28CEV=<4B9! MGG)$D`T,>578^-\]*% .2B2(41S<5;6A,X(/>.0)U3(;;VW+*Y2U(/Z,9J`"$J@-9' MP3US,4GXF0%5JWJC0SN<*V)J2+%T0+_SRS%ZD299$>?D\VK3EKB:-SJTT[D" MGH8(2Z?S]H%(%V0$^QFZ2!>+ M-"GOTM5?ONFVZ(U`C_A[>!#72R/&GYUD*'@_2U^(GNBL7-W+5#]OW\A4O_6J MZ9OB;:26^6"I5?1&+GCP]R*E2[,&7("81@I=N'R,<,E.#&:J:>_4!5]Z`VP; M58C=RXG>0E[]643YZB8A2BA*!X'UUFVCO])7M>S?U$F`^_`52!+OU`7'>/CN M-DA_+CTVZZV`M3\U9X(S_`7OU`4_=@,=SX9>H%,E"MU!ZZP&1Z?0HU/HT2GT MZ!1*==$$II'X@;:+_45O=1<_-WIIWQ3^S'P7[ M\<+\G":3Z30*$&Z%"*"B2&RGDGJP_I=J$>$5(%BUJS1GJ(#,C=$+4E`ZMP:L MAZ6:NH7"VS58$*8;4_AEA%%`:FKW=J4&8+TKE;N],A:[CI7<`4@M!]J#HU=K ML,Z8`^H:[+O_R?RJ\-!GZ*ZK4!?8AWJ?[*EJ MP^Z+MR?R]]Z$JE0&=L+>)Z/*ZG`HV.0#U8/DF+PN8\M]V[4SP0PXDI6#2 M?4JKE#4?;^7S:%>7`GWO.G$?J,)=.;/I:][!@]8=T=VB6$@IZ)0#=J3?[LYL MU>]*[$ZWO_-?U;3>+@?L^ZZH]1V)+7NO,IVU:B^MGJF6MVH#N:#OXK"><$I5!%B'>^?[ZZY7_4'/N.5_*,1U^I*1C3[( M^`RL?SU4/^,IPJ[%B=0B:3A9IKK6C12.0]BY':JX/N9/J(@@(3HE%VX<Q&`@("SY/K;C\FFY5%-]>4M4QVTH]ZIY!!:Z!F M,C6UR"(=VG[=3^,:1&4`GLQ/0IJ.*B*XDH",EOJ)_[[?]D^6B)[(D]DMHBHE MVD-Y=JOP;E]<$?9-/E,V]>?V_.H0+^GEBN8,)44\A_X`WL=TL7E*6\G=6O.% M[%V\O+9;S^7%7+)[@B)(=RZE)`)+/1>4ZL,_IU>CI1>G&XA_.59=\=#:![W[ M>=C_NY_Y?V#27'+M9SG9PZ,YE\EV4T:F]"0:>W<:!+`8WKP9P,(`AO`@QV7VO;L0;,ZE06K>AF$WS5)EO^4IK%P)ZDJRAOQUI+>^%-S;N\9:-6_5EA'H3P$^*=6VSO>#9I6N,$=E^ M5_(_+GWFI16G)-#KWUY*9`X,)B"KT\L-U9(?E]^LKZ_(&"YG.*[>!76`4BX9 M8T`&S2%'].Y0SQZ(J+6OXV?$FLF4Z@%E:3+`GSH\NV?VK>]_3O,H0!)O;D$= MH,>EQ@:4#)K=\WOYT:OZ5EQ"`J,LT!M38\KG07+(#[H6L9WV0/0LAE4<-"F2 MD3F+BTKF86P]^4-ULWZ33%.\:"=^V+=7R!71:[[Z&H7H`;V@I$!W_K]2?%%D M>;J@%EJY>XAB"[!^(CM"GJ\Z8F;GJP>T3#'M9#4W&FXDO5N'\#+1X(L]J`SA M/G!OE"Y0B?/);F&W?$T&$N^* M;-4\1)_CD^EV,OV2T#OPQYQL365Q^@1U8'TZ-%2LA,0A8U"SVOV&TAGVE_,H MH#>_Y%@A,&TKUX7UZ1B^$53!YQ"78L#C!1W]O0\Z5758;Q`E0MA;(.)*OR9Z`2GV@2L\XDU5KL`90/5MDGD,\IOTRPC0I7O?F`388Z)XL(H M+FA^E,T[MZO7("X(J&O"$7VU5.2EZ8:Q MF/@0A+G%),TR>XPI'1VX:6:@&LY7[`9D68CL?=4M8Y&I7L;NS9;5Z,[^A2VG M4I(:655P50NHN6M)?H.=]`U:&/51/6VF:$/AXLN^Y;6[8656]M<358*YF]<[8J M=HJBG>9G$TKI],-<,DNAV%L/:$"/?L9(O_X?U!+`P04 M````"`#]20Y!X;-OW;]I```I)08`%@`<`&YE;VYD+3(P,3(P-C,P7VQA8BYX M;6Q55`D``XU/*E"-3RI0=7@+``$$)0X```0Y`0``[;UKD^0VCBCZ_4:<_\#P MWMAI1V3;[G'<&7OV<:)>/5MGJSOK5)7'=\)Q8D*98E9IK91R)&5UY?SZRY>> M%"E*H@BF]W[8G78E`0(4``(D"/SK_WS;Q^@59WF4)O_VU8=OOOL*X62;AE'R M_&]?_?3T\?T/7Z'_^>__X__ZUSA*?MT$.48$(,G_[:N7HCC\Z=MOOWSY\LW; M)HN_2;/G;W__W7???UL._(J/_--;'K5&?_F^'/OAV__WT]WC]@7O@_=1DA=! MLJVA*)H^N`\__OCCM^Q7,C2/_I0S^+MT&Q2,A4&ZD'($_:_WY;#W]$_O/_S^ M_?-J:UI`6:2UD.D\EXB\X,Y^DQV^)13/.U;Y,3;$:10W98`DHW>)R\_^GQJW\OP5"0 MA(@#H@8D^J6$_3__R@FPQP]Q/39I)?&^L'61M24JR+8E<>2?`WR)$=]N4^+/ M'(KWK4^VR]+]>`$2M*2C%^5;8_UH>AN[(-\P?DJ?@ZK-MS@N*B^$*=+[[SZ4 MWHOX\]_()E1@2M53L*DM34-M5`,=J(B2QJ[<5`/0+VR(NW(8ZX]))_=(66_.EOW+8_X.>(FO2D^!SL^^RJ>J@#@=70V?WV8ANN MQR$ZT+6X6B?8A;`.24,IJLIQ+@3UBJA&%L2WQ)E_^T]\TDJJ--:IJ,J4*CZ] M&(C82$2&PDFK/9K="JQ"*F2)[0Y<5F0OB"$/J3'_&`?/"E'MC'$DHEW*NI^Y M^AW1`1`".8]"5^+7^X6;8M<>L*RX71VSC,X4Y=L@_BL.LILDO";NA$+RU,,= M":&&WN[7%D,1'XOH8!)QAX@.AY#.A4AW);9#DM*48.78986Y/'YX(F@5`MP> MXDAH.W0ISX3H[Q"2.8<^5^+7]VV;(M?ZW8V853Z6B3U+;`]V(;&V1/Y*_])TS:4<[%EN96J40-'=*-AA2=&W2[5I\ M%1+2)\#=H2Y%F"N/N1"WQH.(<9OB(8$01LT34;9'.XPX]TB+6J";@YT<3W%G M^0$?TJR(DF=ZG*N4:CV(V\,J%=VJ\Q\1U%0`B$,`'ETMQ('C@RRM_/2<9_6/ M=R'J'Z,89U?$W7E.,_TY;&>D4\'N4JF0!C8,E>/@I-@*N6Y%ME<.9$EM#W-B MB]/]/DT>BW3[Z^-+0#[;^EC0)%":>ZJWR%I`MW99SX/*MC$HQ,!6B`.B!B2@ ME7;"CV.;;2!G/99;!P66M;#>?8R2(-E&Q'5*\V@@1VT<.$1F@YX?=>+`>H;[>,6V_>(N,`4Q)CS5$PZB`"IY44J]!.!:U)L$7*?[($HT,MXWV*%P M]](Z)-5\()A\W^!, M9[%U4"YMMI9ZR25@HU$UNI09#@!GOZ//T""FO_1^\*Z*=43!2*6X!C(53&N]<1F6*^T5U5=W3^"*SPY27 M%`=L_)_@95@A'OVBW!WL/)`,\A==Z,A^=ADLDR* M_`%OO$(&HMB2P?6@B'UDUWCKE M1:-2AT.ZG6ZE!M(O[:@Z&-?J2Z*H0Q"%-V\'G.3X(@G7Q0O.6IN^1HN-H!TJ MLQDW79D24$B`L<(-#!!UW$THW9['%N9@.>,K97QM6\XHC.([9LJE51BA5%WC M8`(*&DZ:AI%PX>-PV.A%K-A#)BM0Y85RVJ`4+*0U"F4!=MJ4!"/%Z9XL)"N? M\_=C=*"WM&3WUVZQ.C"G>ZN6?ME0\^$KQ`!X-:02A+G,<+OI)$88![CF(%F` M`\.-<^*'.%0?8F$V1AP/6)B=`3@7961I+GW3?1.B7/9OXN"311'!4TL2/@5ZDL:ASC+J4H6)X-;(W,4 M#O5G!%]=>6F`5I:7;/OP5TQS>+J]N+R]NWVZO7E$%Y^OT>/3^NH__V-]=WWS M\/@[=/._?[I]^BND;HP5PZ[V&,,#ZI?Y/:P."$:'AN\U&X-]NI8=Q4-)=EP# M@5[0#@N/1@^@KVK+X^W[X$3/MLVO@KH``)=`$LW*ZPU:',5H^(AU5*0*'*$:1J;^A*.#EZJ-8!1&%>W2 M#!L_F\?-D'IGIG!0FJ97,0\T2RF>/JG2%"*!=,=`:0"*)W2/>&^3;7RD=Z+W MM-A5FEP4119MC@4-MI_2SX3K-"G("A!2GF\3X@WBW.0LUO9$3LLT6%XCN7!( M/8&X)EFA:@XD)D'-68A3AMKSH'(B#TZ+G:[8[UCZ17$"/6)>1H_D2A169P%( MCFX\,?U+$!]US<5Z1[M-?NZAMB>!MOD(>(780**^>7[$(6"&\RC:[45H>IL!D;E7]E@PZN4*QL,^91EI;1!/;GCTE#G#S7K`G9#]E(>ZO(! MITRG="OWZ5Y_C'-DI"Y(\YEW3P_\ZYH5X`['>/05O.ON[Q&QN MG)1R%O&0NS4/XA.A=W2JKU=(S(;*Z5!C/E1/R![@T-J?9%+`7"+' MZR?>5K?6[UU,%X[8$3H?J%$_>W%*F3CYM;'\9A;5H\UMN5VB)X'-^E2N-]4' M7`11@L.;(*,ZD3=XNL:[:!OI;NY,@!UN>4:\=+6C!$(E%'K75!@!^#74-C2) MIR8#(1\%$\IX2_V(G6])J?)J-UJ647]V"'.3US7X!I#GF:6Q>';&&69E+)Z- M<=XI&,KLJKPG`0.]"Y?:1XWV(0"6(;>LQ=@5UMM^;I_Q)N6JY0? M:C2)/:%.55:9/VHT)(%Z=5)"^[#S\!2HD;M."02\XU2TF^XV/B6J&[/0WF6B M95B8D+<^ZQMX\-)Z6!M,=DD!X8,JZ[O1&T,"*[6^?[M*J@![T=M@IJWCZ8+, M3'[?8>GK>'5!M!"'_MP,&9H)$T/7!(.U=G<1"=Q#EF_`?\#)UCP84$"#63T5 M-X.2UP!$-:1ODH'!7QN->(02@L%\PC+X,RF M_?K#F[.G24SX>.ID($N:%RS@YTT-6B8<-AE!PZC&B'.8MHIX><8TBS&?3I=& MR)M&;;PY5Y)4>?!020D!N8,HCS+Z=@^/GO.:4>_/,9*=A??@!&E`[@=W/*"S M(XD.LX,C/1BDXNI#]GXA\N#`:!H?7AX5V?XD7IT2V6?.GP,B$ULP:,<@CX;X MJQ3F!>W-.F4H(1R:,#7576D2;YFJH1Y4/%N$>)="/R`S77E7#7?_LHD5^=65 M^JR'.'VE5-$E/Z;@/\%4YM80=K&GC17@WD`I":-O$+/%5LWLB=,DXMP^>&EK M@ORL1?SNWK7.B_5.3*_UI5OCG#K/;0IE[R5G#]4?8$O/&Y&9[H!592Z5;CV] M'M&47;OF(-?:\^ M%+^L.P4)$+BP91P?Q$*&QRT-&1K\-#H?0<4WRW+A-A`RT`TY.M(!.7_OC]EK M3$+,IR#[%3=,CD:W=4`NW^7K:)?>VO/!3'RJX=`J/8Z#(!:/`_?E8*#7[Y:I M=OHD>E#>I6?.:@CG$1I.B%L0$U(NPGV41-0EH$68AS5V$-)E)#?(A12;<`@F M16T8:`6>QTO0@@&*"A?DP&G<:*8;4BPY``8>7XZ)*V'C2:,XTIO@L?=\/4W2 M$*,GO'U)TCA]IH_Q+R[1NUV:[7$6G^A_7)T.A,P<)U_S#!B42J$FC"*;<&A* M,6AL;!P3PREG78S11#V;HR$4M$6M6D5;=3O!]=20:%K/%EC?9E`*HF>R\"HU MK3'4M:Y])K:X3890>X,#5P-8AWIHPHFT%35@*L448%][*UAL.2N4 MX`+T3-98P+K:,0SH/@N+U](2=%SCC3X#JV>TT^RK/FKEY"718_*F%!@Z$"[I M:A3->*&HU&ACFK.^UALC_<@)3_`S?2CA9IG=)K,I54].9).'.C]!"J(DI_LY MSM?)S1LU8<@2DV`'_YQ%!5[O=O1O_.4D_8TFS-.,69JFH#MK MLC>'RU,IBRLCG9A0W-RQQOG7:)V@]@0TXX=K'Y\$L5G(7W?\%_$TEPY!Y52( MS@63V+?D4C$>KZ-\2Q,$\Q6MYL>9WT4)`:/NT`Z+`V7B3[#'9/R5) M/<_I?^UP4!PS,?!+D&4!00=V2KC@@A%OY/TVR%\0@=WG*,.\4':1DJ4C2QF6 M2RGNS;QG_$NN(0MJ[2A)!T)%2)$ZPTR;G- MX>.>@C>M?&NJ M`+OT%`)M^+(>LO0UXAY-6IG=@DX(=;QQ?BOC_GF=4Y/8_V3/#0DP.PZA66QY MESC!^A<32@CGEKR/:H75)4/+DT'T3HP&\Q'-J;_WTEC9I=R],5%*>[_BR\/= M5RRDCT,&[N>;@YS6'VS0UO?$L],_Y7.3BWKA&(@1QAD6> M)Y#FM@QC5[7D:HO5"-=Z7S;2*VMQ709YM*6)]E%\++0EL08A'5J(82ZZ@E$U M2ZR*Q*T0@^)O6#@I MS88*TU7Q(3#7>O\SCIY?R,07Y",&S_CS<;_!V7K':&N4QS$W!U,1.K02DWGN MRF>)"`E,B*.B5X^]!<07MRN&FFAM`60%_>=_^N'W'S[\"_I2+DT@ED;4_3KF MY&]1TK!0Q&4[$(^,!;>0"CU/$[IZ/A&;^Z:UHCC0>L>=9T)+3_-T@\S!T9B< MMJ$=RZ7<;[:L!$5T6X095.Q;6,H?X),,;3*LAZ&.:$9N37!TS6I;]])0%24[HH\U$DY#]5\R,[$7X7T=^!$CLJZ/]QDXR;G!/)5TOQ+9>9L`(7>NQR4M%1W.N)*IWFC\Y2V[W/*ZQR-];4^D]MR\I97J:RCJO.+V&8>@K56YT&\%3Q*LA? M/L;I%Y-JCWHPF//"/OJUAX,4`#$(#^+JR8RDAHP`G>\II4ISF"?#.'\K@0M* M!,M7"G%X>?HIQR3RK6H&7!!O[#4J(J/2J%.0N7Q=,877OOML)H8E&G1Y0N\H M)K(I?(WJ"A$U-@^4S@KKC.T=TSZJ"8W*,T$%#EL$8+(P2V\BQF-RK;F-LX6G M]`'3)8IBNB?7X=53:D^WEYG.H?8OM%Y2,XQZ&AIC5!,A*1F0_GQ^E@1@&8G[ MG57+F)3Y1.2O]-_LM6QY@^^=15I22;LV:Y&YG+OI(@$)L_M-$FVP\Q^=@ZX` M<.F:JVB6?=ET^^M[-A(UARY6]](HIV\D^1M&_K9)_E(%4DPC"F\9,"O`ZQ_Y MXY[P+\:`TTA.:WBD&*Y_M&MK>8T/9&>,V.3DWS$61^<7>WH2\X\AVVD&[M"2 M&O(CUWFHP6CE(P'(*PPW0*$,E`6V>'W>)7DQLE4N.'&I]6,4J&L#C&`!'C2V MDA8:WMU5<(C()S;KZFF,Q.VS1W/>>EY",B#TK@3_FH19C2A+H/`@Q)K%Y]4+ M^2_:E+P5#>4Y%@5PXBC81#%\9#1>4'N>)YIB@-?"BRTO0D3B,AR]TIN14?K7 M!PZJ>;W\&.I<"8MJ8']4S8BQBH-L`0[&%EE'U-@R!UG(^@E'GA'U8B0,H/QCA: MU,#KCRV9LQ05MX<&MX'@UD\%'BWWAKNW$4IXM2\KQW8:JALIMP0+JL(R)X:* M6I4%%Y#^J.(P2Q7M63_ML+JE$*YA#>H"^IN:9R4ES]-4/#LI>/[GW2GX'$QO M`2J2[)PO/_,(5=9D!`9/S`JOPFDIXU>+#-[,Z'D=:6XJ9'[EZ5EAO9OQ&U6\ M>I)?-UV8#356A\EY'H[%C MD+BLHSF&-^ET1@#3C%H!CDKX%6(85BP*K)"`U:JC0K8[*T MLALJQ40>3/3`E9N^(`LN5=E`%[JJK`.!W+=_YCV%;]YPMHUR[:&$'@QHY^ZA M7[]U"P!40?BPQXWA@FUR6(RDFN%#6V@3D=+M;A*,OU&HE>C3TZC33K3I?XBI M.P0ZE'QN3KWQI5='=POSYF?H/#]D=M]3;+?#VV*]NWG;LH>2#\1;6B>46MI2 M@?P/O;!X#>*!'M'CT+CL-C:./ZGU&`.GSG:)`%$,:)UPV\/:;=!_--"`]>ZR MPBK9MW'):D99W8H'M&G"5!7&RBS#FY(IITW*)FB@U+%L#`[GE:)[R>CO*:`Q M,>/0N*SQ/(Z_WJ/C/CNR0AP'ZDF1!JO)/(]7NM]')3<1I$&QP,B[L$I8'^+) M:?WC">HF%3<>@\,/>W)!7*PL.Q%OZB]!K'TS80@/;D%DCD:8C@L:''%HQ,#] MLABFO!4($_9HLA"3/9]LQ:S/$W0_SU+MK/FZ/19!5BS]I3;X.4IHX]0%OQ=' M>Y,,'N@N*G;PYEQA[!?8>4W+X^$0L[N]("XK?M\FNS3;\^8F!E7H33&X MK'IIS)54!K`!69=T1PU@#](D++$71ODV3O-CQJ]!R[0)XCA5J$#S)$;*IE0' MT1#<_1M3WF;B/HATC:';PYR^'&W1)S\2Y3\C^CO<4U`S&@\]-+I]\BE_:_EU M9V,,P(/G=(^?@C><#\IC9Z3;Q\P=*GN>+M/JY6P(L&0:DEHP4N$%M/?[][Q` M;@V#B#.I_:8->\@_ZY34).PYN;^N-C8#_V4^:L?1Z^`/+;`J&DWH"UEFX34W$PE.DY!I_W=_ M^/X[IOOL3W_[&$09"XW6.W'_G]_F^1&'3^EEEOZ*LXN>)8?L]"=UR6N2=&;4R'X9E@I)5*5*T8?.PZK1$[Q+,>X)_B8J7^AI\ MQ;I]9/1V/,A9BEF=2KI=9/7"='MD9JBO7OJRRZ=<(P7OWT#8P/E6HK1Z,S!9 ML',4*;6@M";2@Y"Q"^)L9<5Z5QG;1A-:I8T;C\B9?9O`HUS/AXA=B0.52*@I MHVBHO:O=E08F&*-FB]^PY+=I?`Z4WYZF:GG;1HW&XK[W1\="DOB1]M$.KX\9(4WXD^N,DAP%L?AOO76SB-MIUY#Y M*]$K]6VG#95H$<=;A7+K#`G4U9\`S>+BJ])V2(B]C.F+`^JY$$G]4)M&V+X> MEI1#;OHQ%[$%/X:_6\@)MO5.%'04-5QIA[?!-T%3D#CS7T;R)K?\+L'ISE36 M."TQL):+P*^(K+!YT2EG6GHH7`^;D1B0XP'^&=WY&U.TL>UKC,)@V7Y0G'02 M*C&L/YN1P>B!`K$0?=3K98EM84Q^F(X\+J(CHTW`2#Y(2,+"D&9EXZB\C_// M`"SSE6`T7*DO:I6602SH\`,.C\RAH/C9&_+H%3?*.O]T2),N$;0>DWC859^\ M*/7=X@S.;(/-59%?P0K<7$!+[,T"ZHCB1SVBS(K/E4\%&P?&,);'S2HQ(U6M M4J/O&#K25=I*Y@S(4IV[S+BS@]9M3MMFVD-OP;ZRC)%HSW/`'_"!]G1,GC5W MW69@SBSA(/V]^3S1OGR$48$`WCV[X\2=#IG)55LQ!F`6D_8G_%9.IZ!ZU;^1R38X?GH*"LQ`%Y_&JJ(B>;60*XO M#41#&$+#?1I'6[-:?CH@A\?\6MH538"H.I>C/4BB6I`%EZ?KPU+4/3;70#A_ MC1$])]$NVM+ZQ!)5NAUO+`*7;S%,>9)2\&I`U"MO@%OA?.:.^WV0G>A^,L`G MZ`N,4?(H/<`P@X:XG!Z5(:P"<'R-;)2W6F5$>).<:TQZ]];$DPU%+RY]=["S M$F&7D'&3G4,)`2;E6H^\*^8>[`7FU/MP/V@H*7KYAC/B]`EM<3(PWMV!+NL= M=6F42N&P`1[8Z/F4.JW2T_OMI3H\[5'.77EZF?:2QB'.!H`'N\C2?+A4%Q.9ZFJ(%L8'I3#98Z+G-V_-VZ??=.4P9CA2DO ME<7@M&H0TKFZ5#30'A][FDG/TA4>^%,E]F[GD;Y;WP0Y#LL>IB8;T4S$+M5L M[AIH$C18+YX:)1(X^3.Y%6)HWU]2O*AJS>S!+K?@BJ0F*[(Q71&GBF]%5R2C M,`^KMP;CLDFNT>8[%[./)D.Y"K9MA@\[N_5%88=\@M4FQK.P`GH%F&P&%&B= MET!+]_NHX+8H(>2Q;`J<;$?7.QN'QV5QLY$J%3PO]=S$X%=4ZP&K3@N4 M39%=J1K9*"1>JJ?)KCP6D6\*JD]\,!5;#W;79;GU7AT'-]"16)Q?P.-G2IO) M\ZAA$)?7ZVJZ)6^-#_7B/=3"Y#N]*A^0'.EF7#4>6N1'9IN80`,J@F'VA214 MGFTK\]AJ%+#W247&Y)$8@#K/)@PRVBR%=E5B(9])7J$2Q&6&H9IN*8-/#*6O M\/B)A@>;Q0CZ[](\IT_NJOHA=#QHU>4AH9$2$E7CH:7=9'/0P`#*N\YB]@F\ M!^9_#`NTLQV3^XH%G^1]T-*K`=QW.=KD^.]'LNWIZE!G/8Q4M(M/R@K MAR(^U@/SOA#Y;GL0Z25';CJD&`\M\D81@!H&4.CUSR@EL?'`QL_BP"=I'W;F ME0#.\UU)&!'$O)B!1L3;PUQFL[;IDS(^V<^B1,:*/_X]H5_$_WH@TV;T_Q4' M&6@R:H\42+FGS3'NKPF2G'S3D$7P_.N:70KHP)Q>`6CI[WGI6`_W4:Q'\G.? M1^\6A*\&=47[T/A]AT\W@P7N?&UAY=7-M_S3`.I/0 MG=^,9="L(_7TK4!7TWM+4&; M\@/>8F+)-L1#?\J"$!/[MBY><"8*4.7U[Q=QG'ZA='],L^OTN"EVQ[@'[FF=(5^A=@$;,MD4Y3%S7)4CUJA:AI$YD'E1-78TH.`\A86 M7J^>)6$+5J_*KF]5(%V.)32LZYE8G0.B]I9Y%-`[VG'-K>%]C8[RT9DWIWZ@ MRZWKDEN&+GK?4-?R?)^E!YP5I_N8%G),0AHK'*@O92[DYB@<2OX(ON1C0`Y* M5(("\W8();B/>F*!US:3D/HS5B"[2F4,[UK3;O>'(,HH)>OL.LH/:1[$Z]U= MFCS?1:^TQ2>M_6&N==/0.=3`B?Q*]>4K-+3=98F(AM$4U7N&2Q1.\5$W+:T" MXS5N\`JIHG,DN:NNDW`YOWY.,QP])U>TWV9""&ET7B86AOUGS$+F$?H[`Z?+ MB^T9G$NWR!P7*I$U>]7R-S1-?![J\O*+P<'KM>#8T9^#2*P031@$K@@U5Q>D M&_O)""T<7I=EMDZ$BK*)$W4:]ALG70OLP@[DT4`.@!?CN,O38YQR7'=A`_R7'RVBK>/R*>C`\A& MJ@_SZ?G]58;#J*#_TBJW'NJ,)= M'O,HP7G>?[OF.%5I2.1Z,I64(#:ZU=(E(?KY$YDE*X@?12MJFN[E9L#N>LR: M\2)=V[`;9BHH+4`?=&$)OJ":N4YCHEW**Z@[!!WXQZ&[:_$B;I<9L\?F!(#[ MZAC-ZK1;-8%T?[?,J@@^X&WZG$3C$G@-8)W>`@]S(E_M\NJ6#2`?]TQ+K,'> ML!K*F7QM.@3HO*=CR!K=$.?CF5V[F2O,(*3+[HZ#7$CW^C5$647./U69Q19H MCTCD4 M\UL:<$@`^J@WTSB]SU+:0AZI.(;=<8PE4=YSAD&=OWVMRC8V"SNN#_3_$SIO M63@9O6)Z`3R?+R`L;08BC*H MI54"?:,[7;BEU[L34%DX<*F;P=*D/;PI:&H6#G^.BI=K7`3;%YK8QS[!/9&2 M%T)?XQ3U$B=X%VVC(.9=%'-"ZT<<%+2#B.FAC3L"G!W\.%Q332]PEL);)ML1 MW:'3HWI^Q`A`)07M6Y":"%13@4HR?+`Q/JWTKK/27ZRM--#AF#_+&M)EC1K+ M&M;+FK-E/93+VKK4VM3+NJV7=2?(`#R&1F3D M*4%<9MVIZ98RZ]A01,;Z&(=-8@0V-69(9J3<-]5XZ)IQYC(_"`E8/VY8<.0J M`/&7XA@10)FKCJ]N!F^C0$"0OWR,TR^-ZL:FL;P)J+M"`"9\ M]!:6H%#-XLX^Z(9MGJ`>]4]F8$<9B&HPR*?[QAK2>:X_#`?6F7J]^Q@E04*C MN]LD+S+V+8?/XPWA(3I5#W"D:?.\WJ$*%#5@?=PK+;";*MCUHI&UB5PJ&UIK M@5VKVF?\I3Y^N<_2)*6I80V*S!W3\:@<*N`$/N6`Z`MJ'`2VD?BHA4OS#*F* M4^6VJY6C\7CSMG[6JWK/WM-/?DF/?GEBI^X>:)M]YKQ\03_][;S5>/!Q^X+# M8TPVT_M,M/!F-P2?T^*ON.!7`04.F70,AX@3L3F+&J=R*V4M"#S4F:PPB9M` M@@L19*C"YH%N+<0]\2T/%??\PBXAW)\(]]L2&U`H:HO7QI,`>F/9>!-`F,_' M+`1@2#M+R=M1[C148($O+UGP"0?T"X;KY'.:9'A[S#+R!2^#/,KI*"9)3WC[ MDD1_/V*C_@VV)H`(G>>NB3K87(EZ&/QUO'B;25\WE9.A=8*:TR$VWPI5,Z)Z M2@_,IINE>V5Q>I#GQ_VA+K^PQ\5+&J9Q^LS?'07URL;URGH1Q5M1,F68/P^[ M\X38RC[VI_PQ8\GS_O*+;1&]1L5IT+FRB=QENJR-M="Y7NI,6NZ*"=S$+`GL M'MF491;GN-\'V8GZ(_2=XC;=;Z*$+$Y0\G],0DQL21R70[BSDO+$XP/-/@7- MN+6F/5("[GS,/IB2^^!$?=^++T$6-DFN;.!%O8W,,BMS)@(V,;/6R-3Z)AWEFF^,II8J1FSV#@?HC-*UE(\SGC`<4"#O;1E/9.P3"LU/36R.8>[ MLR2K*]/[+@:IW\4@,0-Z2MO&AZE,E80.;W+<+=:&+=:VN5A8+%8F%HO8EK;1 MH8M5II9#G52=P=)`GEW9-T"=$RV+$]@PN'SG7.\NXEC,8APGCL;@SEB.X$KE M2Q`/C$"7MLVGF,X>C]1?(CP*O:OB-D#U&RN.'>4R!K=ZE[4^%GE!#%B4/%>: MFI:/7JY86WNFT*.OM:8B!KCAFKP&NA"H@;1V,H@+4CU_XXB%2^*-9BZP*+7" MIHTUJ9ZID>VT>KNVY6O"ME?PZS#[8C%V";RX")MG(51W8A.QPITLB3I&EZ=/ MP7^EV=61?*`]SO++TP,^I!F]YWS$SRR+9\)ITG3D("=(,]9"9S++DE>7)\00 MHPHS_5.%&Y7(/;":BZZ-0)6CS0D]X_0Y"PXOT9;$(<_`Q<#L:87Z6&_8R%%S2 MJVR_7D3.E'2UKH]#!Z?@ZD1#2J&11@^A`%'A0;[T67W#V;(>*.AT'M.)/,*H MIIF,JG5Q`-Z;9/3+TQ.9^^(MRC5Z9P3M0SIZBYN1G=TH)/J%POJ7B;X07U[D MI)FDN!Q:/]4:C'.O%`J60K- M7WO4H!!%-HBGFE6T?*+=9#*-(BDA')?0Z*>ZKYP$'=ET>OA@T.(8UHEW70M# M(S-]I2_ZACM_,'`DL1JM=494[V/TQJJ>#4J[#LAE8K^.=BGCO!S,C&@Y'%SN ME^3!:4[\H!Q)>>YJ"&^K(^SLZ.KNLM\T(? M>G!^`._>1^A/^WK=!-";K;*F<V83V8;-L<3,R*F]8">M:1"*&&7NEEJM: MB1:A?.X^KZ7]IU+M>]K:>K&5R]IAO)/O-<_KZ;900`U!P`>?_[HHV_^O?;MG_4/7ZHD"NCMRS(X7*M)_660*-D]-6(6C[,3U1/Q'5U'$G_]&5EG6A>:/ M#L2]18OD$B=1P4IS$9?>?C2OC4/T='WS^`W8J;N>LD?0DW19LDKI;_SB3L`? M;S0"3G]T*.",%BFAZPL.L?V"WX82I"')"RFJ/U]7BL@OSKO0DD4:RNUJC''9 M4;9!F92O3W\#SL2:2I_+N$_ZNE+_UFH`B.`-7F>W1KD6/N5EK_B\P'E+"^"E*HOUQ/RB*G7$.A;%+8?=3B]^]2#;H7S M#]X>Y_*#=RB4/CC_W8\/WK>:T@=O#7+_P9OOV@:Z20?4HSG$F5ZTZ.I^ M-_HCL"(`TF/HR).D](YUO!$TJE?:*#/)D(]"1 M^Y@F)W259H=49*MXLB68+K$'6X(DL_U;0CT,/$WLSN#9A`X(,EWL3O.>H"_O MZ@[^;<22/(`FD$ER-)A$=F?SX4-5P_$Q>DZB7;1E11RK7G^TKU_$6VX<@WCP M*<1$;.XKE8[D5E.UM(&IU012X$("&?@+"MNLI\.LOQ/80/JW6Q!O1;734:B< M[U.T4?7U[=5MPCKJ7.PI?;HMJG^\R]U)07%?*_$5^AA&6R2&(CX6;$LR))S7 MR0KQ(,8JC?53DZ$!\L*UP;T`W)IW@2'M2[V#7LGY#-*\X_1R% M6%3>:YVPW>.,[IMDJ37B;X["H4:,X$MZX,)`WU/8LC;EJG.$ND(U!IBW.V?, MGZ%IF,&AFGB7UF"L:G4-A#&\!1>VQK;>?<9%68*45NC#X4?"6B-Z5'JNXY`X M$S*_G$G$\JXFC/#$6Y MVT*]_W7#:\DE*D`/>*8H9]OO'H7!@CFY#DXYK>4K2O:2Z:,T?"RBPY%U"[E- M2$"NCX)'8'!F2,9P);5))K"\V'59SIJ#HQJ>N.2HQ`!C068S2)0IJQ@\<`;S MFL$H$5T7%V+2S'8XYA+0<(Q6P[;5,`>W43WD;8MS,AT+AP+"W!V+[90&0CG> M7940)<62Q\U&4O6OQB(^&*@2R%C*B<1'%>7Q,I0;%OZP0#IDC0^]E'?J>B@& M.Z_]EF8X>DZNCEF&D^WIB="2T\9+:?+G($IHH?)+O"-CGH(WS3'!*"PNJ\.- MXDXJM<:A40F.&O"((D#O*(JO5XAC000-6`VY69S2,42=,O0N)B-Q_C79!/-C MS#9!YBWOQ%)LRZ4HZ@E@^["/EU^I"-T(%,Z/\/8;'(8XO";[\RNQGJ^X:@V_ MWLD_$O]?=Y@W`9G+8[TIO$H[@QB'ZH$K1/&PML2\(T7?$((-[##,!M^,1=Y9 MF.R*N&21:!&A(J<&:X<#5E\1]-ALLCA+!VCC,5EP9$5PS6/KR]/G(\VUZ&2N M*KU:,V!G+JXA+XH.1N7YV.4)<4@YG1K&_YW)%C\B6I5,$5V"/@Z;R5!(_F]S M0DG%SZ?6(1^@OSQ&F=K.LQ&DC8Q!&@-'FR/]/K=)?;A63E@]U5#J_`@,[C(, M1W#5DSE4P=(SK<:1^:IA"*X6TQFSI,09'/8H/OKRDO(C'XJ3GP(USI6ALAAM M?<8V-[VF#S(#=FSVEH3`!=68AC/B0 MGGL((%1#H6OY^AG&(LSC**LY"A4:`F0$[/+EC6M@KDAM;3>`6TK-Z4U;^_WF M.NG+K!F/`E;M57P9JC^_0.\^RB4H/+(#IBRV;Y:#CA;%E:]=$/G!GERFV_FF M;4/1FRS@F[70ZJ.!U>B'=V<]YIH._^S&3*/AM<&88RV^I.=E*W[SAF*6E;!A M(LK@Y`EO7Y(T3I]/=Q&1I1R7E_+YSU'Q,FPJ1N-Q9C+&0<"#$H;C+4<&5AYI0.3QS&,HX M0VSOC2N&8`\K%^0(-./'5(&ZR3^#<*X3#2Y"(IE%1$D@U%&[HTDDZ!OL,%&@ MEU;)):T'(3$*ZH)_-+W;-)>3\%S>TZNEH7L/WS/2M>C^E)"H(WU.HG_@\"EX MN\0)WO5GEPY".!1B-=5R%?=Z)$TQ0^58*'F>2'I!2-\H2'@P!_3C)7MIUMKOMZM#Y@7.,@ODI#V#<[P M"]TP7C'-3U.Z:?8F<.;,65R3KC26J-\+W*A$CBAV1-"C&C^-+.L96'^WUAR( M3@+C'KI8HD`L$2Z7**-+M*,'.01;&DP^1U^M%PK6T7J]WM`Y^E+^@_\S2 M)$!%2FNK(=;XX3J-XR"3BAXX\D1A%T^Y7E2^MBWYHIFX@+ZM;=O4]H"M80?. MEV\2SA*'8T;K!XWS88P!+D]>P]5@CGS+IJY0`]R3U/@1S-U(^BL>?]4&`<2Y97@KG7R&F^*VR0O,F;^A_I3]HYVJ&O]U$IE MA+8O.#S&+&']+DV>WS_A;(\H+*J!<^ANE2-Y204OQ1A>7"J(1I*ZRM`W%%;P M!^K-]PT&$WM%\?:.3`#7F[=(,IP0Z^K-]XR$%6%:"'RPW+P:!$R<6W0/2,@* ML=+MT+7F%V,`3M1EZ=$+?&.\C4J1.(G2[(H]N"HBLAT\XBTM_O4Y+7#^]"5] M>DF/.0GS'ND)_T`!XDFXW%6)G,2IY!4P+*B!!@D\B"%BQ8U+5(CA`JYU[(;O M]XB0]4?H&LF.OC%E%?"08X;.=HI?3D!DQ>8<"H:L,<7G*,%:AK;*]0K*,BQG:!HM.@@;EOYJI55L`VLRY6S)"VH]C5JEPL4JF M%O(LE@G4NBYBG;J6U^XD#CW!)VM^X)/'7N"3-1_PZ6P\P#D\4__OPW?PULT5 MIV?@_DF*.LWY>[+K^IE->A-;C#?;R+PS-1U>YUD;CNQ,#,Y,SIDF?C@7FV.% MV3,P.WVJ.\WRM##!'O'>&?0%4D*`'?#>:;KI2#<`=_#M@):A'NYH5Y(:_40`_C/L`"Q7%-%^)E2QIZ$1"_01_ MK'R?).D-?0L"H.=AN9+,X;H/3@.Y1TH(M]T.%53KK">QH:]PUV+^7V6;C$.<_I.[3;/CS3?<;V[9Z4U\7T<;%FJKD;J M31$X5`)CGJ2J#@*0OQ7!J(<9K6 MM1>&T%8>CA=@;8^0VH&.SPCU@GP> M5WN=UW@@`A;E>9J=^AU(1\>%UGD,Z9>+*EC0A^7F"M9]6FX`::,+%,'X,[W:?)8I-M?J3'"H=(@3$'EKB_4%#[[PLCW M!,M[C@95>.BVDR"&B97-9;@00X8X-J!F4=:XWA&N,>WF5'3.K.5D?KNB+Q`I'#5:-Z)"AVI\ MK*7P(O&1D5VTSGWEU;3UG7`?5-PW^@W1YKN`T:$O[`-:LGGZWK9?$W%9L%J? M@K=H?]Q7*;L7>VH[IYFL2;BE=Q'7"N?;5/ MT&P#VJ49&MTV2E,0V>@"1VO7K'?_D<;$99L:=8Y#XJXKW#C>I*YC%)P:%([` MX[#1"J-$F5XXHQ['@@"<0G:5FZ"YR8S#8.=AZ?`DRS'RKGU]PPF?.A<6Z M"A*1";`^%GD1)-0/N^1EAW1G6M-QNCS.FL%YSP$%8NA$G$81"CN45SX.(DC+ MU'#40(L$7K`S+,L+D;.%X#'+%[H0+V(AROT?O00ARIAN%VEYO8?2QHIL%EH1 MXQ.L19;DOEZ2_^A;$EKARV198$^HYAH,Z7!J,D(K$1X])12]>QNA94T)H>#F M#6?;*,?,.FL"O/&H',9W$_B4/7YVI%IULVX=135,'C-T)3+$L$'%=_:XKAI< MM\[A&_8-;0G7N.0Z6X1KT_@.EFW0^&ZJ/G?#N]%X7.=&-NXXKX\9/2##692& MS)KF_._$HPAW(6[]*CO4;.`^+H$,>WXDY= MOBI_I>=8`BMJH85*2UQ@(7BN`'5!NGX;9'[B?&GOYBS.P&@IB:E,E"*^3[*- M#D%\SZ,[;;J2&LAI8I*&]MZ7+.7X%:H@D`"!RS,:R\2^8N)0,7%8B`GSG"*+ M7`!G"`TIA)P+I(2PK**W28')5RS&:*@$`Z*@,N5:_43E>'^TTY"#*J/!$,15JH-;++@#L<]'&LZ;Z=H:=/.BJYH_``?:85,_9X-O2!OBJ M>3W+,/CQUG0#GT\P#TT-9!!_;M3'0)OU*ML*XB#/U[N?@RP+ MDF*=L8/FTGJP>EM1$=%+LCC&X>5)C,O%0-U>.QNSRZH1LU=!\@XI1KK-BK%H MG?%KJN867&-&'#6Z/)4`>05A?U\V>FJ_P)JH-^;J=H?LWU\$)K`Z'-89KSYI M_ZM'IU4Z[.B[5,UC)EH[B491&E8TJ-.DY8$N4X*Z-/;D5M@4EUY1E?)6VJ.F^08YWG[SG+Y^&Y'@("^X9\#_W?4)^%__=LO^ MAZYZ.7-Y"\V.`'KTRA30@9X9\R#[H25$I7BK.L-DF5,J[3Y\5IP,F)3)O%S1 M:_#*.>`)?X)-*A(E!J!ZU M0A2>ED7I^1%*6V8QR?BA!TLE/Z&2'Y=Z-%XHN\HU`@.\QGT,HDQD./?0+8S# M:93^F:($U49COHUTDV*KGT3T#*GVMI,_NCIY"1BWU9N`'OVM]D2)6UA-'B?L MPWIMB,]>#P@<7FQ9Z9ZR&/,#C@/RUZ>T6V:5/EAHEV]61Y0V<+ON)C%S)13U MNHD4EVC+6N-(($9/J5RLES^`ZE0I!^U-L=BZ!.6ZE!?`F5B7(J6G/FQ=#M6Z MF-3Y=Q7N`BY,8+@TD,&R/;P-BG2QF/2=;+.+O$NS?#U$=-JV?1UJ=((V4'NS#!96@LIDY15 M2V!X40LQJK=EBKK].'V=T!L&CA^1"7C%?#H%C!E;='&^L,4)6HNSK18G2EAQ MB4:R#ZW,E:$-7YR0+`XK2O]EB<4Q,WH+K<[32]F0IV^%-KB[2.P:DUUZT,(< M9,)#D)S^^9]^^/V'/_Y+WDED3M@8VNFR(/\*BO:B%F+F>G5Q1/Z6`1I9FZ:J M;7BM8+;J_5TDR3&(FYF<_&&O>)2TWMVEK'XX?T%XD5"W-3O6N9\&?N'\*0`\ M1@OKHG$V./;Z/2'%7SZ@+Q\74L^23M)X%$S['XMY*EAH7W/9A0KX0D6M7&M: M1#&AKY?$0A$K%-.%.K06*A`+%2VU4&.]U+-9*2_\6UN&2>7YSL9OP0SSM)HT M>\!;')%_EGFG@YF@PX#.3*8!#_UY7C1+0L`T,LMA#[SP;8%6G M$S^>=(Y@*%00#O<^4R-7^N>8?8#>O)XN]]^;MP-.Q>M8+"Z9@_9P,:E8))@KZ^*129AQU=&F%TI*CD''DFRII)$ZO M0WV`%J+(GY(,/TQ^TIQ]\ET?`:'"\0K9#P1'PWKFZS8KS MLQS>#B*?W-XNCQ.=7Z&__96:O/&!AYCM\81YKID_&[:IF([V@-M8;%26:F3W MWA\W<;1=[W:8]7,X9C39MWA*'YAMX,T;'HG%U6?[S\#HKE;5#*ZEBA6MI'^. M#97H4(F/[OY-C*A""50":XD58'GQ![X":;D"AW(%B)YFS17(2Y3T['F79GOT M^/Y[]"ZB%?.V.,^_AJJXM=C2W&N6IE\XZ-)\%$L#6=1KKI7H5/^:C,Z"Q;M, MDV->'NI]Q+32/I9\'J5U,X1V9LE,N>D*)H.K;X0%9%_<`F.?YO%5I3CN!%\] M[CN0=5F>,4`[,4JWVC;!#-1Y">%&%W)&QQ.]`]!$&2H`EP5_531KNCS0@KU, MA'YA@_\/6'W:";2G`[0[+4&KE1>ILFS_:'`AOXL2?$MV7&T);`T0I+`W:3<2 M>`J`&(0_4F_(1&K"!*CX2Y(TJ`(UA`5?[_&XWP?9B3Y7Q<3!S'#(YOB<%G_% M115>7VRHH[E5A[1CT3CS_D;S)YWH<@3\B;I`(62*($$$2^,HZ9<2D7-%L[%=R+<5L=*0.ZA4QX!/<5IFMEV&4?BL/%"73P+J"=DYW%DQINW M[0OY##C\.2I>A-_*?E,:E4FXW+T_G\2IHG%1V[KP0VAJ7BI4B.*J@L_>PUPW M)L8.VX_5T^<^HUIS';`QGXCBO*#O/ZP0D;@/4(_&;7[OMNWABT&-#ZXX_T*_ M=QF[L@&0C[FG:W7G[?8$1%;.\)OFK_:H'N@GUYS3:Z$/5-LJU?"' M&8C;2O9GPH/AGV=37[;NLZL)-]NPR"GL@;Z'SWU%T'`G[H MP.UAY;;IKO(-8"&/('HX,3B)J*[GKQ8+0:8>1Q@P5+L\K2N$8$>L9].\D0%! M'*/UL6Z(!2\-C*M#_.B88??\=\Y9^[]5AATJ"!\\\)$#7ROBX M?<'A,<:"GLL3*^8_=-:MA7*H@'KJ)4D5H^LCP,L3X@T:@`^_)_)1G0)N!OAP MJ1P&$M55"QV(^]VINGGZ1,LT9]K=2!KK=/>1*54T)Q1GQ7P8X&'W,,'W:4&< MN2B(D1'I;JV^0C)D*]\="-3_U/Q*IW^\^UZEPW<@90,DC^YP1I'NW\V-3E84 M'3$7N*^A&$4Z-6_O_83?BF,0#U_1#$.ZNY4QX$+:S1LP9?OZ=P+L:_B;%]L< M0=VN3.#CMD!1LHV/(3W$I&^EV1/Y`ZU^PN.9O('T=PAS3NG#`,CK%5-%ZMRH M#()Y=#BR4E&?6-GL&(ZDC1N:=<9BRTMN6P8/#AX'W M!0-0KI6[?2+YE[2(DN=V+^X>Q=8!.51J+>T#Y_TKQ,?S'I!@+?LFLB#>F[]R M%K)>%ERJPK`4==5``^'\Y$W:<1\P55',U?,01[HR)T;0+D_BC+C1>8J_$Z[B M"@E($2Y:2F!Z?LW`T6=<-)NA"PQ`(>-\ M!K.2PR:OA23A@&E6RXA(\JQ:MB)+(W!K?3\JXY>^;SE+&3B M"^*ZO^!,5#WCK]J5EF,\(H?=_$;SJ+T6$-)88:%61>"INI9S3%!=^FSQ*W9> MSB^N^"7J%PA^11E`4=@!K/L>%,.@/?6F:6ZW@=Y(+!9LCD!8V[-HBXE]4YH6 MY7AG%D1-<5>.2OUO^!9D+'4W8&R!.>5/:1'$S8V4C`32YQG+?2B7&U`S!^2[ MK8"JP=;Z^?(C+#%-IR52)YM&L[F/QN2X5^\X+O6GR*50R=W=H-/.%N&X+N8K MMVQ;E7LA]&,?ASQ++(,WSIV@PGUM@<7VX5W4YOSQ=!C%MG/GX@G'QYRP] M'DCX,Y1?9P;N\'C/D)_>KO<,;D6C"@&*&"PJ@:&3[RSPMAG+F\N#OC&RV#WI M,X*%4ZX>DCY&"?E;%,15Z9BK@-6KS^\,$J'FHP91RLGKH%787HE>H0ISHUA1 MB=N+A*QS6Q<88S!/=]2&8B)>,"-RD>?'/:?F(@D_X>(E#=,X?3Y]3#/R&R[H MG^^B8!/%41'A7).09A$WA!F9L1)J?4$-K*RA9`,OZVK*,;.?&K@!$]\67Q?> M7R7HK,N^L2ZT-6=0KTM2@XHO!UV5/?]B!##NFP]SO*2:N7 MNV\*I9-#$\7JA?=!P4J-_TM*&R;&-/-MNI?71>+)SB3Q-GJ/JC%XIV?&3%;, MO%8C?=,RO3".V<`Z&"Q7M'*XU6M;` M1B]T%29O:M79__YP-W9M@-\F MSC8*[6O@Z>CGLCD0_?!AO!.&Q>9<23W*Q)O MB00@:D"R.V(*#'TCO`QS&SUS;GL6C9!'N561";`_*D9INGB+=->^)L!>*%># MES'")P2/0GJH5`LPY8Z2-:NZB+4YR_!%CUM-JG>"K8UZD>YPIJX>-`W<7 MNYKR(T5H#!`)2$1!>4<\`HQ*:+#B8^?-G&'(.9.[6'"WH]RQ?G4IX6XKH"$# MQE$ZUHD.S6`M6(+2XMPDSU&"63>[:V)\XO1`/UTY]4?R\0=LPGA$SJS#!!Z5 M6T\#!VH@:2@7Q0.M5#8YQ@V.PP;'M<+M"!Y`19LJPFV5&XW%'^_VSB`YV`C: M"]_V3I/*JO4`?4C?=&P)SO4TKZ!^7&GVL4 MB[P`[Z'&'`Q<>(0E@YE@$/A"PTQ;^C=)!8PS?_01$Q;#1URL=Z5+K&Y9-0>E M9SZJ@N\9WBK'2/Z'W=#;[%%^E^PV9/KS8$JK=DV^G>W@X`Y?[ MCL6C.-6T+2[QH!)1W1:"XT(,&7@89Y=QHH.T2N"V9#XHF3\F(-)G&\LZKF5':!N5S635Y@I7K+C;YG&%!SEM81Z>4)-<>) MJ1";:R4,:KYJMN];(3XC6&UF!TM7MS5.Q5/MM-&_$//_V?"2!];7X4!\D31\ M+(*L\'XM6I+!FC4&R9&:ZP_][1HM+B>V?LS37W30N,ML9[6K]J[7DOL9G1+V<[ M(X/A.UI3%&'),E2S.$*<+SME<:!;1MK_JF`FGW MQ-NM71_I&3.G@Q>J;1S9H`C+7S:#&\KJL,>'S+&E*S#P[&RM3.VY5 M2P?0_EAS^1DX9%'QZ+Q9UB3M[>V=-0[3N;E6C6C]9TR;Z^'P@LA3\(Q;;0'< MG.GJ*3@C%\Q\59V=_Y9T($%(ITW(;^1`=,IJHPU;Q6USM;^4JQ6(U6HW)_EO M<8(*MI:Z(]=SB2+F6H"-W@)L2@NP6Q:`[O_69SFVS>3 MHW<@BR1XMPL-L/8QS78XH@_$::6PGO-!H,!U)ET^[50+?X$E@]P&;:R$7N]= MQ+GN9XZ_R^`.)ZXROMWQB3W>["`D>E+P.[BD7NV$+DRU[>AL'E'>[99#GD!U M?P(=MHTDQ*?]T/8:+QJ\]5R8G>M^M_2Z&VQPT)=TT$LT=2?SY.X/Q'I:C^;& M4>'=%J7B;KAWF$'#/B>S^[0965G-!4(PP[Z!\,T!@5:X?@/7;!]XI"M9I*(4 M?//96UZ>A=&?\?X0IRU.73S?_;LYK!&[C5+$GX35G- M:EV]L)JSO(>S8VQP@XEPMY]#: M0L37G>;>ORV7<^R"]W0)_^TYG$8:[N24L9^"WZ+Y=.MV#A#Q&S.?$*ZGQGS^ MAGS/L0O>;SY_8YZGD89#F$\H[W/[@L-CC->[Z3E-0PW3+<[ATOA97!G)M@G< MK$CV[%11Z`[M3E8JW;4>1*M72O=RVH=V[]8U3K)6UB9P;8SXU*?!#O&=<0Z- M0I="*;&!29FF%[HKG9Q-J$N5Z/WN7;%N#_(NS%"J4DUW$M)"\)^#_7#K]F6F M\RETF+9>.C$&[@'O#\=>.>UKUF+AMM8QJ%PL@$946X@?[2`U#N6L$, M4"]Y9(VF+CQYN02!;A)MCQ/(UB0FPM1I0J(%\6ZG5"GIG4'79QO(?=H%3=;" M^L&8%XVE%UP:?80X$"!JEL:K?=58BZP=9M68;>V9$A7T;"S)\0..`YK[ERHL MVW#S-3O8W>[!%E:C?X?K,14"-1*XT5.*=/LZ=-.V19>'FX'64U@LEB<3RU.D MG8=<='F^B`D@O1UO%P7:@[)E6GH\K=FH;9C/7B/^@&E($R7//R7!GC9J_P<. M!7%J4SD>DSNS.('+_N?N/2:P0H,:>$K#"&3GK/';H[Y9Q>^QP2]>B%]#&P;& M,*1]FJJ['5LT&HWK2%`8/N4YB&*=F*U;Q5LP[6?6MF+2>:5LP$KG3=ZV[,X"[\+*YHB07"E7`N MJR[#'C00'A8W1<-@#>#9G-B9UE];XD#/?.YS..\;L9+@M38]+2VVU-).J7EL MTA[,^X/6&0M7AKS_W:I?6C]S-9YXL3.%3F&R*KZX2A.V6QV#^"[:C3U?,,8* M?-9@SKWQN8-4HK`^B&A@110M1,^>_W:KH>FYL\Q:_-S9/.ISBFV#8UI'HM,Y M)PG+?89FY]'<[&S[@KY?JB71G".%E(VEQP[ED<,Z0VP\ M<`+L>![2FH=4SX-+GW50BKJ^IAK`"P483'W50D$K@3(M4Z,&P'FI4_CH504/ MLDT-),I('2SF?A*JV2$V8>>/M\DKS@GLT,6'.:B[\,>$#\E!*8$0A4(E6"4[ MT/F@%GB*2I[$V3/DO:&QJ'6\IF$X"XIP<7P^Y@69XL<;4=G8,`]Z&-"9$ACP M(*7C,Q`J*S^B$LB;A.B9_)0EJGU(ZC$5K[;H#T)9$'S1&9C\\MTX^S\,Z$SP M#7CH"DK9$)G">&?YY_+CD=4W%:^VX`]"61#\:[PI;MX*$H;3(-S,V&MAG(F[ MGO*N9-#1J!KNP+@;'3:-XX'Y,LX9,5/6"9R$E!-<<>+!_F2@#&T-U0'8C4L^ M?/>`Z;4D;5X]-C!1PT)$)AI.=&X\,>@5G"\[E!6NLHHK^'UJA,`IPQ,EH`6% M6&^+5#')T*9E`NI,'8SXZ,J-`%+H`O@.,)\G21,@]P)S46MK@@&<7448&:D; M0$*H@7%LVY(8[X+UV1SY%*X;"YE2`Y8+V*_QMMIO1FJ`":C#*,:`#SF8V38< M".^4P`)//JF!N:AU@X-!.*LG5Q\ZDQB?7*D``4ZNE#QH3GH^2!H`K0!S^>E* MOQ[PG*30G'!8=! M(@'JBS;882UFK`6"-7C%&"5^;>TP`[6@(BRWD,[2.3X>\I`&X9RIQ3`'7:GA M^91,9+H7&N".T2QNNM<9D"Z1H6"UQ7X(:$F!7R=XJLPW0.'%OLG'*,DG@,!W M';9Y\E:9#?F1]!FE">2+=G/=,53K&LZ*9K/M\BI-\F-<$/1F;MX0F$.-'J!? MEA3A^-0@_DC^5%ZV-2_P'IR92'6%70MC^NQOR+ZVWP MY%%L;RYJZLN^Y>+[ZI%]X_E4N;4\I??D"[\$.;Y*]_LT8<6:S$M$C,?HOG#$ M!*XUY22:3]`JG_`I125"Q#&*^G'>U)FPN`CI#J6-1:B'_%U4(Q]CST.-?"C[)'K M8/RLLH&W*IB!^NKG,NR(HO?IH>G,95F0J3DOB:UP%9(?J2W+58^+@\:GWYQ: MXP[BTP?LT^.W;7QDME!4O?2ND-P4*V'RS'847D@;>//W8U2<;A-BCIG4Y=6I M0FW)616-ZBG]YZ,^.')/B?\6=L8JVS?(G!C4H*9Q?-DIH="@"'&2SLR(VUYY ML`+&'BS`TPM&"?N1;@])FKRG!Y&T3"B;XWU["XCJ*5>-G8!707Z79NB81,77 MYE@KUM9![]IJE(VM!DK,M(."S9;/;A00<"!1@ECM6^=G!G#&W'3JQWNX@$WITI:!`H8L4M^:+1*S8S M&E.PN;0@D[CM,2=((.I1+W;"5I[&"72>F!N->HFEXP5YI(6]S#Q;'3(YW23/V:.\`1IQ(KV3H[LQ!1-N3)73Y\NSIQELG2A; MW#.I4M4\>/\T0N0Z3_\,`"VHQ!/Y?;).F`$[4PI#7N1+80+FM5K,8LQ3Q1@C M>&W-,();?\2Q,=%TCOFTW0."2$65G[)+HR7?[+`)RF/A]+FBKW6:XO+M2U2]N<5"JKEC*KE?.U;SK/(=K%E7VPW,YQ. MT&_/M"LSS]V3\)LRW/J,9^=V&B;/W(/E'F^#6R.3WG7[;5G?_E1GY_.?C6UE M_X_R0&CGS6\_+&$_>Z9O6LEAZN]8_AVNG[2)FR''8SP?U,9-<=S!IBL"AHV7,D]0JKP1$2F=*`$-Y M19-9XPSUU$G`_0RY='K&R6#7G3&$/IMHB+_@9H47PENU4[/0/.<0#RE6:(&` MB,_$J\.$Z!;*KW&U8F6J6\3YC50NS5E$1#H]LA82]4[B5:F4=?&"LZ>7(!'' M1W]F*10EK>R_Z-O6CT&4J>X@X4GR/]:RL>Y.JJ@PNA`EK,JVYJ35YHW_@3T* M1Y0^F`M(#S\(6PQV?4C#GS+#ZMP"OH57)BC0,Y,?5J)KEV;T84E?#196?BLO M-YOPF-$C./K$I(PP203)A+6@PMI?DH4]/,G1.SH-?@M(0(I7Z$#&%^F^?,3" M(=C(5>=OP>&0X6W$M8K%L+D81V@@./>L5$L19,^8(_CZ'*-9:WO"4E5;1M-S M-LY\1?(%D?(]YTY4H\'W6;1=).7'8-)S\5!CXE5990PC-O?9 MA0!35O-&E+`B)IF.:&YZU$#RHHIG&1P8ZZ6U2&%X1AOOG]G-[WIW0?:U]!6' MG2>,?45D3`'=O6H>YD%ZP,SKO:UWJ`22'_':=]/,7BE/YH8H6U!R(SW'A7(Z MEV('\NVPH=/;#RCF."WHSUO8^' MUEE+7'B@JCJ%Z%?37@B+*CIV`9S3>RW%`;PBST\;!Y_T+S.\N'C>M?H2O&4EO2IC^KM8`=^ MN#A^-8Q?_[5.OGF.=_4BF)BM5O\;\ELYA4]O'^>O3KD(SV(1FAU@B,HWF\"P MS)ZE%F'.@TE;,M*3&)%.6Q[O'F).-"HF#S7'HH8VG)=ID(7\];@Z@+(XPWD8 MT,ZJ+&5$V31(S'.&EG1@F49:TSU'1']BB,_1JAH)SGS+NF&"(Q;L7,UKG^FQ M:&);Z!?+/^'$L)Q5'$Y*M^_%`)S=T<^5:3)&^7H0"00>IKZ;,5@:L#C:^=4O M;,SWD:W-JI6H3UN_,`S>W>-K=,ODVKT/W.+Y5N/M890\KY/J3G[P6$L#Z?PT M2\>%^A"K5(SR7=PZ:21(P1Y=36"(]O\4#)7/WHARU!D[P.=4"W#DP:'4H/KT MGT6IP4`28#;#U]Z;[K6W_M%RHS'3SYBF7Y$Q1`&"9_R`:>\`PO55FK`J0,<@ M?L+9?O!EL"=$NDZP\81MN.H,#7)7J"08"8I113)JT(PHT:")/+Y^M7*KJ]_Z ME19VE\9Q^H7^IMXRG&<`^;*,ZHPA/RBTX!!>[-.LB/Y1^ICK75F44>D(:B"< M.8`ZJJ5'@.78,AN>N(`_+Y7J;>3M3:.^UEW@1'5;Y`/Z<8-2W_;?U,,M:&"E MWJU*#`:*.`SH3!\->.A*1KV#M^N3P*OG+&9>I9T66%L7X@90>4T5IJW#@U`6 M5/DJ#O*\0KG.'N@^7@9_CWA[S*(BPOE5$,%0?[=2X$4=.0Y&ZBX(`8/T48&S+(BM3+DA9JZ-]`].Z M?DD78-S,#BW".6T.GA,O.MI%A.NZ37A>RP'K\(V#[0O:,@%JOGE(L_*16+/9 M]S--C:3OUE[2.&3/U;"HA[(Y%BA)"_:7=!-'SSST;:XV-5;L=_8,+J.OYX*2 MQ"U_=K%B+^$RM,&[-,/DYRW."F*;H`^W[%FOMN6U@!?<-C]]21E]-1#FA>DTHHNT"&)BLEH/16%;I!G37AM:1C5\Q[1^P>[M MFM89ZOP^_)JE29!\#/*"!&^XP-G%9J!-Z`"4LYAKB'HIT:4:CQH`Z&(#W*?:%A^7 M*W07)0EMO41^^N%'Z#:GUO@"#-:,-*0=M.E!EM/:X=[QPX#0NJMK>*Y67_A6 M\Q;9Z6KQM:=J/(DW>L?HGS8/]*X?A+)Q`Q4\!N1#7,5!%JQWNVB+K\B'P=E= MM(\*FBJ8%0G.\I?H,*#CXQ&YNU\:SZ-TG10@A@,Q)(AC01P-$GA0`Q&P6;#! M\<5[3S@VO#-RSS+D!WHAXF[*V@=M\,%H-H."G];/]7#+2CB M?;1-HB'=:P]RIFX=VJ2S&/8SL$H!TVBF,49$`BI$GQ"V=:`UPH;8LQ1;Q16' M/,2=R#?IDKX33W5>Z$+"4)2&"90$R9$F3EXZAX(NB5U'S.O?K0DY/XX>$/-R MD&-!KVA3?:^EK@G&"/L`D:#B/G4!78M\6PC[A%Z,L!%;I$GQ,A1--,>XBQ]: ME$D1`_T5.D*`I-#0_1\F,3Y!>O>R^'7\^<8`&\]DD^08Q`/RWA[D[C%LFS;I M"2;[&5CD@6DT?-AJ1"1XO:$^6>R\5VV.<)VBT9M\=1UVRTQ"@PZ2, M01[D8EN*E#H*A!@46!J&$V9<)EZ825@WXV(`RL8%3[K?1P7K@'61A#2Q@\R& MDRW-\\!O+,-CD[-D#_75S@@4[BYUQO`EG?37P*S22PL<"7@2,PH,4+I(Y M&(@W\A6B($C`K!"!\B-V&F;EKJ4+4;*-C^SU\B%+":;BA(K@#;W#;^7?_W+Q M!.(7CA(V?235!;*P?74F^)P6T18/U"?7PCC;OO24#PD^XN-!2XY/Y4#L`LM0 M;K9]S5S\A"\^^/F>@?2W=R\=@`5M9%AOW@JX&P?)4&!H;1N#`];\=@)?8GB&&T:3!%N(K)AYAV>4+#= MIAG;*HN45?"@O^5D9V7_4>(#U%:-=K2UM&^@:]]2T'"(,O9-:>EQ70'N_N$. M/4D%O2J-+L>!5/*?1#.N:8:NO*R3C:X'V#L6KF;%35)$Q>GG*,0/^!4G1WQY M^A3\5YI='?,BW>,LOSP]X`.MX9H\/^)G=I!I7M)B!G:0BA=S5D-7$$-@HY6[ M&#Y4(5S1OU4X48G4GU(9BRQ)6B_)IF=)-F.6!*;&QFR]49?@F([:1OQX+'(R M\WKW4T(?5SP2#P;G`\D;6AAW\:.69I*FN17#@+ZM2-=[--CHM,;,W!O]J**GZZH<;#W%`XIS/<*<6@_]R,E9Y]Q M032&*Y*_FTY;T,;M.`+61G=AKIZWR2[-]LR]-LUW-(!TUTW8@`O%[H$:0'7" M'WA6HW6.`)OLFHI8I[GN()CKC:.LL#V@RF<$""^*SF(%=PX')/&):A[DZ@@7#N.049;<.4W^.L;'T=;2^2\#J* MC[3IX7#088S!I?]DS)7D0@E(EK;(8%>(0;-<<@'O020RGI/C1,_R:4R!'>M59V>H54G!TICOJ[[:#!Z-;HU$H]##1O+H=0E MH-M#N-&=AN%`#21"!:%TS1JO@>"U;L)2]IWA+#**BP M&Q*1XU54C0E>2356Y5LIUK9 M7J$G2IZ']GG(>!E::"4:N(RBBZ2(0DI6](KK;E@W+&\?AQ_)`EW50KK>=;U" M\^0B.Q.!Y!E96B-=RE%SBF8/P7(21&=!C6DHD!Q0^9.(M/2:I09KMNNN63IF MS6`RE6SJHSIIRX)VAQEM%D2Q+B#S8S&X1TJ#3#7,A5%*3E./FC+*.XRWA3@CMVD=3$-:D8?5-W!)_!#+I/IV91F MF>"=T.F:9CD\O+-9W?(S+N[2O#[L,LSP'`)SEMXY2']?!C"%:,B=+^4J;?"B M3.JGEPRROH9`7@X^5%<6#=:&Z1HHIR&ZCOI1%:#A MXO(Y+&S;1:P_DR`=_0!:J]!`H.3(7`UBP26^%B=B-\DS\;1Q1I!?XU<,6[EB6@#"6I@010-WP89(N`*%K\MELW\ M<:L\XP;/88/G'>69;>9I#^&,G<6O#_3#WI,O M,6!E!N'.#'$C1'_.*&8BX5N%`B$(!FXOQW'SX\<$ M\)0*GGBB[@_7D)&\(*Y2)* M,V)$@R7(>_S5I+>4SVSE:+E>M*,K]]JW&UL550)``.-3RI0C4\J4'5X"P`!!"4.```$.0$` M`.U]6W/;2)+N^XG8_]#A?7;+HKP]XXGMW:!N?716$A42W=YY0D!`D:QI$&#C M(HO]ZT\5+B0`UA4H,`&8+S-N&UG,+S/KEI67__SO][7WTQL*(QSXOWXX__G3 MAY^0[P0N]I>_?O@ZO_WX]P\__?=__=O_^4\/^W^\VA'ZB1#XT:\?5G&\^3;Y].GBK/CP0_;E/]XC7/GZ^T7Q[?G9_S[+M!OWZ(\'KC4;;3OUN%:/'K!Q\% MODL&.)]\^N7B$R7_]^O`2=;()QA=\K\XWF)_$83KE.D//]&!OS[?5;BG@P0N M^MD)UF?TW\^$0YRUY.\EMF-$1Y\M;K%/-(%M[RF(,!W\RK.C""\PVR_8H\LL,JZU!BP+>]$!B@, M$;'J-^0GJDM*GXO:6OUSA.UTTBZ M&D4CM)886M*![[1/*@S"MKP\HO@^B"*R/+ZLR'ZLR$B=JOUJ^AJA/Q."[>:- MBEQYW:R1&5K5`_%"W&QU5QWT.!CF-EG/S2+(AS2Y/]S\F9#SN!ZO//(N=HH@ M7]CMRL*NQ:_VL-VLU_HRY@UA?G74XXU';GBEU&**37NZ#G$YM=338O@TG?&F::F9<,<;^77DZS^N(9O#'KL M=,OC9Q,\?NZ6QP9KIVPH M@[=QNW:7UMTAI0.9/WUJKD1<^LXXT]2X;!C#YV0]\7&(N^%)3W#B,;0X9+V4 M>6&8_8Z/EO2IA+Z3?:'O9.>_I!#RO[ZW7Q&'X_*CVY?*6!G1V7_]=`P.,T_[ MC=^,U1KU47E^B>TP;L%UB?Y(?,^#V/8:<5RB/!*O=/XTX71'=RR9DFL$:B;3 M/:5!7N-#/K4%N9<@6:4V(8KH^2&=_2P=H\7R>1C@$ M3N4G/!I3$(3213O]*ZL8?NJ358$.7]JYIJ]1'-KTD3(;RJ,HTQ^PU(FM3Q]^ M.E/F,Y=$*N6%';VFHDZBCTO;WIQ1]L^0%T?%WZ2`/GXZSX,=_CW_:VOW7)IZ M@ACLLS^TSG-6RRJ7EFF#@")OWN?7+,.0NXC]7P<6Q55"<3.9D6([8RY]8?QN&J.L\ MY^+]#"7>W=U<8-[,;ZV_#TO@!\SGDO\/*,GO9]LM^1O6$5/PM?5E6-)GL)_+ M_Q=8^6=FH:Z!TO?6^:T?D6A:);RJ:!=O&Q=<>:J&,:( M%'S92,%,*FC/LKZ"N3#XWGP]#7O#?+3LBZM:_]'R%W.Z@YV=>4*I_+Q>_;"' MKN]?>.H[Y'P4ZVH&*_?I*"NP]CVT1_U0-R(=,I@?A2IIJ0/1$9;\,[3SG:L` MSH$U9WD4ZLG3O:)GY"#\1O>*1Q3GHA!-.`$9N!]?4Y]2+./8#^FM5(JLA(H7($:_,5`4^^JD/A!$T-2OZJB:_B!'4.Z4_F`>7ZXA9[R MXE(4^?%G;K!!8;Q]\NPLLO3/!&_H`9&L4\(IRR<#?\I0/1Q)08QC<<[$(9V6 MUCFP`TCO3)NR:VKYA)R!I31C8H.'R=0*5Q35(:SS_@47OBC.\G&[MW_I6]P3$%P;_RLRFL"7BLUY&L M022`<1Q8IHZ3K!./5BKBM1*A!+\@6JV MF-OO8A^2Z5^S)N#1:\+KZD2[%[`]Y"/T=1*=6`'QT@75FV4=\H7/N4+G_*%3_G"IWSABC?GE"_<:V6>\H5/ M^<*G?.%A:_B4-CQT%58--"N=-$WB51#BO_9W%>E;89UP2&G%Q517J/_TRHKY``R?X!^8[Z?FGP@>I>\9S& MH0#/HFXUKTL8^*7&!ZU7M0.:N+PQ>(!F"PW7@?`+F+=6\Y%+/&=A6<=^G&PH,LAP+B#3;/UQ.Y$8M/H-]=!5)C6WZ9\5$XE*Z"B%AY#DNX=I6^@WY, MU5;;`??C<`7]%M+6Q6&P$,9&EKZ"?CS55ER-]S%49IEM4&C3W+F\C)=*N4\N M#?1SJ;9"A4C&X=%Y)IH@4EQ-??>:K#A>D%9_RO$*-T4!'?2SJ5!OO+U2@F<4 M&^@+2@-7"<@'._P#E40D?!_G$4$_IS;0LQC,2'9:Y!.Y>`3CU%UC/^V_&N,W M)%>UA!+ZC;6!OA40C>,IYD`V.CLT]!-J`\4R,8RA,,<.V#[)2D65^Z^A'TG; M*+.*HK-8^B.J\S'P@RJZHB*N_"0MI05_)FV@:S50XWA/*3*$T7',U&^`/[6V,2.S4AC'$9\KSR:[ M"?BC;!OK$*,:@P^NE&Q/))?5LDH(VGSO#?PHFP#9=W/['44/V`_"-)LU3X7U MW>HH6<+B`XI7`?F7-Y0EZHL.FD?D`OP!6=M1>&SAC.%@O)-%/E\OR4U=_#;` MH0!_C6YH+FP@XSCX9J\@DKOK_B/P,MW:*JSQ;BH$"')"%B4XBM@FA0LJCP2\ M#K>V/H5(QA$(5(=X:4?8H>\=V$MB8:"7A!*\)'=K;;,`=1@6=$2E?T-XN2*0 MIH0->XD>$YH/.%NDJ$N!4.JVT&Q`\*+>VB;2`F=N.5^&'E`6S1:\TE^`%4`R M!M*JO@=LZ14#41D)(B9-^_#4DV!,=8G*SU0C>7#GS1]6V3PB&ZHXWQ46T2-; M%J870B=$-O6I9O^O$I9S9%:@X^Z,F26$X,;AI=0M'*DFO08VWNX'H0,1(0Q0 M;RJTE^\H5GN&9`J,A@L]&OXEZ,A,8VMU!W+I,#SHR.DAM+/VK1=\C^[(U25$ MY+0`=XK?\:)W9#\@.]7M:S+)F&)DSZBQU^N[;U9(J"^'6_U"0F,IS4>[R!,S M)I?&-TQ6Q,OMUPB1(\TN(FE*SAYO6;%6A4@K[<&@#X5LS7+>R!NA&X65Z/I2 M@`]"S30E=:>,I<#?_NX0S8-G1$YL#O;H"6]_#9D'YE:%+GX..C?&I(5U)9]Q M>#^*ER647F7(E215M>B8P22`3K+I2LF<`PM7!J-8P*X1X=;!*2CR9P_E_I'I MFEY*_Y)9B`HY=)+.<>U%52+C6%*&%70,'!5P7$,T*K;6/J=>A,C7_:M MS=1JA2@.`IWW=%Q[TY/+.)+5#S%/'2=(B,")N!%^D[CC5,C!,ZKT]*IJ&QR@ MH\C$84B,/E/M9Q59DV6A[0H#@*=B=6,97*CC.#$=`GX*T<;&KCQ?1D8*GE35 MC4$P0([V.$)MOU@:G^PM71?IW<%QPH2PN6_WI;]XJ(P*GG?5X8JBC'^L)Y/B M>"^O5B:E[4,^5`=VPD(YCE+)ZCY6(T]2X`E0)GW*FK#'D.#)@9PE_1EZR10, M!IY\9>`I4P9O'(=9LIGF[H6I\V>"0T3$0.9%O'WR;)]FD-*BQ4WD0 M\"RNALKF/(?JX1[%U5A=@$96%/!$,*,&HXG;U!+3PYTH;_-J9B<2#`:>)69@ M)Y+!&T>U.8+:0<@MRAT09F),KGF2`D<"*FL"['=MJ$YNZ(T0Z"C>LI_1)M]2 M9PMU&Q!061/H8E&H"XS(R<&:P)=LLJDC6CB'D.5TYO%`CGQ;''S[JQL?XF>R1HV\ZD4 M:.H/^3]Z&WNS/4E5*IUAK$E?LIP43I?:P,;A1V<#9* MX08T>HAH'$^5A3QH707RQ_VCB>\RKK77.'*\($J4BDZV'=JZ@$[$;VTW1D0` M[7BBI2K]*^L6QN'Z=EEML@]9GE7WGEP&09_H'`:U9,F6#Z" MYH-9%\`>2"/ZK9I.2VD`;S5<6Z'<4OPTV)#F7!`VW2E93,-XMMB)JE2+B&LG MN@-9%\`>R,YLI)$DQK%K'=@^V:"3-$DK"0GH7-2SD`H#VU[^WV+S,C:V=0'L MO^S`XLP*I[<[6O;^%Q%F9HL\#KIHF#0/Y&^G^H-8%\!.S12ULV%#AXYS]?R,W"1=HRCG(7Y+^T^6TB"^;@*_ M#H^&(^:OQ/N3&MH"9@ZDO`Z>S9Z1AM:*L%? MJE<#Y)HZ>V#!G5Z%3*_$GR9O*BC%`>`WJ.'(J; MLVWH`!KV;-D]/CP@FT++:F-E)4?(7:M<;^'(EKGC;"]WE;.9B`QB@K'X49E4 M0CKHB203,GM:22$->RK5JTL<_213^7G-\YB$%N9HQF%*[90F(X:>0THRYYW= M5,`->S:E>_!AI=YCV^!.M#1A;,_',_)H@E?Z+):6QWVEG!;I["HSKM7`(--1 ME>/+,L=*<[7=R.`3N;4J.;.\O5B&O030UR2<%>],>P^EWAOD0[@)!:SHQ@-!SV%MO;"GK#[H8<_0%[2D8$N!DD=O7Y5QH/*N)2,!<;_4 M>-%TO,BIH2>62-@4-H$I>IT?W4%9Z[6NXJKDD$#,FCHO*G.% M2P,]0T2"9<\0(91ASXN7Y#5"?R9DQ)NW-,W\Z,ELU=]7REYCDX!L)S5>E#81 M'@WTQ!`)EK-UB*`,?6*DT1.!.'KB%$71W$]/CAFVEX7?B-SRI<^@)TB3B(@Z M_Z-(5R07K8A(P$T5D,IBJW9%Y9-!-Q-MHEL9GG'D@WRED9\W48S)A5-8N:CZ M(71OT"8*/40`G4W1:449]8FK0@_=-K31#%8%UN<$"H?P'-I97#=%VB[M05%I3;'_]ZGG!=^I0&Z# M\#I(7N-%XNT:6*3B$2P0)G\&O-=G@W7$-/X.:OP_;:,C6A_#2OZ+)[3Y!N,]@IZ^X MZ7]ZJ18U+*?QF.#-+AMYE5JAS:WH2^\N,T7T\Y;@*W)-Z3*Z?D6N2[L$%TFK MRO>:QB."=[K4O^.TP[IS5@U[;:E<].C=[HKPC6/Z)[%GDD<%WN&RH6=2B*=0 M-IAKDE\H@%['B=5^)0#"V,9^C-5GNPHQ>,-)_8FM#*M0Z\#=E7F8-:V[M/2Q MWAN#E!:\D60S_X(*JD+]`Z]_/G73W-J(=M:D,;?JRI=0@O>(;*)Z%4R%X@?O MK(P0$2CUR%\3@_>"].Z<5S92\$%*J<&[/#:;^VJX"B,8N--P'V%?CL&?I5B( M".[2@PTYQ%(?B]PQW6`T\(Z/C0HO-,19&`V87Y)[$-Q+@7K*\])XR/V&X]4U MBFUG1;WI:=+24T)F!X%>NO-<(C_-1+>]?3VC6V3'-`-2]3!Y+`;`&T;J'TB/ M*IK"1(?N*2W*7&MX0SDDX"TB&[D\16`*'0_ZK/MG^HW.TL[,>W5&W9"UR4M^O82O=C^L16-;*:>E[.OO)]JC@"=P]Z1H>C`[VVF M^WYYG25Q%)-;+#G^[\PY*")-2BWQM+T?S0:&SH;OR&@,2*7#''J8:ILPEZZA MU]S<65(>QGZY?;#_%817210':Q1&E]L=GSG?38ZF30>'OB@UJ-AI!/.PG2*U M@IY`;P##+NNYMZ,Z5]2KYM"`<^PE*L\(+4>$GH+Z)4%;`!WVO%-[U*91P-@[ MO6JWF9/\QUQJ4DJ34#P$]*QKE.>@@6T4/CXNS,OMG/SV]!V+2O(I4$-[XW0T MJAGU4`4Y;G.@2*^#M8W]1E$O.VIH5YFB,G7C7RKX1F$)]*9/#ACA#N,#6K^B M4*!]#@6TSTM1:6R-"S"-0LNW"3E=TM0H(IA;_)XF24D5S2>"=E6UTK48%O1; M2H%WW5_Y5 M19D6NF"BFG98[F9%<*-8U+E2VF-O,LOWU%"U$[54J3F_J^A^("<*=1XE!-K) MEZ)_1*Y5P9)Y3M@$0_23\)'T:`6-D//S,G@[P_X;BN),K]F?ZQK-_M:Z2_^/ MK@:_H6`9VIL5=I[1DJJ#[0=1HH/V@/!U5=6M,IAQJICKW5"DA/)L**M-4]N] M]&<4^DY7K'";*3S_C[K&\[^VOKXPE+K_1RC_A(8"JIJKLCYPY;S<")3S<@/E M4&BMG(QUZ'NBH;IIMK^4O03LOH%V`:CN=DS&1Z0OJ1>O]!7TM;ZB`X&:]MSV M:-5KKJ<'[.-ULI9JJO(==-^"FB+8VCK@V)"^/"!%V>]JBBI_!]TW0$U1=8Y- MK8!@FBK'J4GVK,./P8OUZ^Y>'`C0L?:&JJ#8:S1;5"!*GZ"Y-.`%]SFJ8NM5 M#`-X]^/7K\I9G?G\XP?G2_`R^&*)LYX4V!CZJIO_"5X#B5+VGX`7L=?71HUY MZ).\=([,O\O4&GYYG.DBF$HCO65&X.=!27];06Y?7=U9V?5@F9KBEPT41G?0]6 M^[VM"CDK`!?C*%3>?1P%5&GV;LQ!%3'TV'B:O[6U$\V3S=%@"#`?N2XPW29H3DY;X`*D\`EAE M]BXL0`]UAXG^+>-MWQT4$2#I"8BV7;_':QRS+H#"[P=8FUV$9!P;/+\)[F\V M]FEV^"5:!#0W_%VPQVN,,LS:[)KXQN'[F<4K%#*Z3E"\?(E4>R=/W7\E67`) MV0)G"[$9=?.#@RSVWJ$HH(\9AFXF!QV92PT4#O^12$!T1]$>S)H,L`UF0YB] M/9CD1^KL1'VY?4RH\[WFN^>>4E2(KEUJPLJU"M;IDO]X1`_%^#6A[-SY M^YM3`67WO,Q_5%(=P9H,J$UE$VRYDGO;F3)Z1@XBR\VKAZYK+A*N=N6DUF2H MW2!EH')]@K5QU-,G=7)4(T)F/LM5J#N$-1E0[\9&X'(]@[5R;*OGMDJV+@;4 MJU$?6:Y>L(:-7/46NTC:`R#P@N7V'CNT%&[AJ8IH?UJYFC7'L2X&E![8'.'. M9=0[O=^\;RAL"# M*;J\\K7@KGSXL74Q0)<>!T:AT8&[[K[2YB[!TL=_T>J)[UF[<*;+7D)A70S0 M>2;"4BBX?Z]LWQ!>KF+D3LG(]A+=O#LKFMWP;,?H-@A?B.2S9H^SQ6R#LJ`F M6HR^XB2D[D'N2FWJ!ZR+`?F^.H!>F!"80ZR3IY^R3$I.Y'/!FJ$X@G4Q("]: M$VR%073A2SM&*96\@Q^F=Q;T&@,5GDU_>E>&7Z7=%9,`HD@*Y63?JUE6(87Q M-71Y%+XHV;.#`V$4$9%5;)+TNL./H2NA<%2CHL<>UCXQI4::U2'-J^.10-=S M96M)1:-5#'U-VWI!/@["TB[T0CM3(O@'J648_1WH,K#Z5F,< M/G0(7.L%96YL.=F-!%T:IJO%I`(0.KZMM>)O/(-;27DPZ"HS7:F_CG$<0615 M:=TKI+9R**`+UK0X]%7V:+:IKER!R1$X,5J2GF68U@4&?HOD9GX37VR#M"!33/JA9OV.:\TZLT\EZ M)!;G7G.LXJYC0SA09C`9YH44G;O3E>S;"OD9IB@WUBO;SR4T2^(HMGVZZEW: M'KWQB$X*3<<$+B;4^)#0"F]OLTH>[/`/%.=YQJ5-;H^18+MY)VV")T3A6N%K)7DP+2QO:=LIQ2Z(7A$8)6)VCH< MA(#`4UF4%'CGQX@(/=;17XT&K*20*?6Q\(#GJ73QF%<2U?X^DQYW1&D&RF.` M5?HQ^=0GPS>2[!,NZ"*Q-KL"[3]1C\I0&0RL?D]'IB(&VF6"RA%MYC[PEW,4 MKJD4]A[52V33T\TM?J3:LV M?K/#T/;C69A>D(H9D@:XX1C3"[7GT1I)^7=1_J&PLT&[D<'J#;6,4S"`NC"M M_KDJLVO1#A[?&5W_$*S,4$LGTR&(0CE@?L7RO&_1[K@`57A&TF,30Y]JA&!E MAIKI5P-4H>_6KD+#X23,A29GGT9&9<;+C_94(@>K+=1FVFI`VX4*]6$RM[D@ M%'4H[[']BKUTBQ'>`1C?@Q46:GO,YV$IE#OPN,##8J.TNL+,/_Q[@<;5!P&K M0-3.##0!%K8Q\-HUFE5JBQFRU;(4M2'!*AN9MAL-N(45]2\H,1<'WF\ M]#-*VRG,@WKD+'TZJT98RQ)%VHP-5BJIU;G"$.[":OH7R#AU79RQTC@8O=E` M8&62VMA#(Y"%\OL7F9@:Z+<@\=Q=()7M>=N=U=_Y<5!Z7I_YLS#KY'"=(!JU M3=_;N09A8G"PVDAMC,08\,)P^A?$N)\'4]\G(BF[2K-7\_RQ;K:X#](8[^P! M=NK3E31,]LY5A?6D[4]8%X-R*W8"OS"E_OD7,X=,$&:%@5%4.$ZE_D89H74Q M0/^C$JA"F;WP1YK)?LOQ%;XXD2=#1&9=#,HGJ0RIT#A8\&(7K]I??7M-6[_] M16Y;>=*'\B,V@];Z/"C'I1ZN72KURW$>PD*K+"#$80`+F/XRM=D7?E'--4+UG\H\H0UN=!.2`; MP2NL8@31CZ6,OA`O,<%`_U;7'!BTUN=!.1[U:!R'%`?POH\0+^A)KQ"U0./1I2N;^6,G%;[0&4@Z_.@G((M0!9VTC_77]GM M\92\>MB9+0@_-!F32CP/GM,ID25>[1I1\&,0FXYH?1Z@L[`=VL(N^ILO`I(TW#C^&;KDA5!!GOC)!C$*9+^3,A:+I4\%RBI%; M/5V!"KKE!EM7G+DJAC$B!5\V4C"3"KH[AKZ"N3!,5>+U@!;B^M9TKU#FGD\$ MW=]"=Z<5(X&NLLR](;XDZ[4=;FG`9=DJ'X/XGRC>>46D]>_UAH%N7B'6%>O" MJ(^OKUV0BCBH/9#4ST60%*TGW;2A>'8;3O^-'YBJ/Q94`XNF:F090T/8?;6( MJBSV<^.9ZD;@(!10036\,*EE*4!3:WJSW-:.-NW,7'="$CT32&F!.V*T-0,] MG!VVJ@+U$^8>U9.[D'^G<5;(33R46\?E-KT3R'R&`JJA.`XE$,9Q81V3]U"B ML),+\>1"'+XR]\]X4K_2P;=#D0B`7DGGW[^"\@UP8T!ZDOOI_H=V$ MAOR_!IO=0OE_2Y)0LJ5#$`X:QO@]N09?70@2@/,A830KL.6YB%'-<8',?50\P] M)D)R4QUE_X#8_78TJ(%;[;:P`%5P'7J,P0SA]R#&_E*Z9_")@#OL&E/[`:;> MMF#MXOD/MIEN`R6J@H)NHVK<1Y;M3M,D7@4AK96@YBVK4X%UTM6/=19C@+ZQ M=;$F:ZA83`C6$5=7RPHPQK'Y'JYTSXBN62@#OO&PZ.E4@1JLV:WV6Z0BEMYN MPYF5YM6JR'WQ:T3.#X\HWA=5#]XPW8SXKAG5$<`ZUZHJM0D>Z)U94$VVMN44 M_!-(4S^(5RC,?0-93C)7O[H#@76JU5-S(UC0+-D%EP.H58JM1?`)EES-D+!\9GF M04@")7??0`=&JFJ&K=<*C/$H3QJ64_H*.@:RH@*!EO;,%R>QN$ MV;UD6KF7Z%P&FHX-'8%IPDPD!MA&-*,X-K`D0:NA.S$MEO^&77*SEG0V5QT" M.AS4B-+5[8DG@M&;#6T`W]!<*"E4%"BPF130Q[NO/>/HC]L0H7+7)4T[80T! M%A\*9#!<&8PCCD$T1WX//*)&I-F?F/V,VWPPX##8=A;`7ET:"J&[X^\Q'@ZOF&YL9)M*T]$O23:1O%-P(+?5%K:02W02*;\;H# M0;^2=F\"5:P#+QO#%Y?*D[H"-?2#9F_((=\_(+BV:(XB_)+PSO8.'B0QU!=_-*.TG:\&W*Q30>&#E#5T(!Z_$TMRI$^,W M'&_S/-L706H\%KB_O;4.6).WH2!&<9)+I74P=RO7F/TGN4"GW^W0 MS802S9(XBFW?I&BI'.N.(R2QU0K].Z'4E`Y@5!BC)>E^O162'VH-!O>1T86:-P$-'9O9C MN8,]/0(])?5PJ6/*QE3-K>SX>..[PS?2;XB^SQ)=D6EG+Y&LL-.1.8!Z"^NW M0=21%BP>).BQV]Z/0^9/P5M^9 M6'_P(`?5VD=Y>=AC+?T"%J!33>'GPI&$/)*HBLXEEM7C!9T9&0O0N;@CGQE[ M(?_@D2+J%<^.O&L(F8!.4Q[/[)"*&;HUW'#FQW'W#B$3T&G;HY\?>S%WV$P/ MW+T].;FWX=S;S@JYB4?X;?XX*2L"9^PW1NNJ-BF@43CC,DCRHG*5[\`=O2;5 MR+:4`[RCT'9S<>WEX;OT6?K17LO+SW7Q<]#NU@/#,!V!(H;>US)GY#^N8N3 M?^[DGSOYYT[^N9-_[N2?._GG3OXY(#/,#W#2!NV5[WX,=QT7^LE!=W+0G1QT M\DJL4\_+YTZ1\JA>>95/.V+GFAKX4>P[!A-9`>IC]:.ZJ<,IG=2//A+`)BP5T:E2ZG`K MI9[WHP%%)R9N6$RF:J,.^4@QSLJHY_UH;M'+2YA4<*9JH?9Z6HRU$FH_VFV` MK/[ZDC)5^;37ECZ>PWL_VGCT^O#^2\=U3KL(1JXAVD717@5^*M;$]N[Q0C

$B#O><,REN&]1YF"71A+ZY>G?M9/_GP*8#\%L)\"V$\! M['NSO/+L*)HM\I5V%C[3Q5(2S,ZE^0$"VX78QVL1TEAU`15TR+E091I:[DT4 M.?\TB39Q&O%,?N-O=_X;B@BM+%I.T&ZA0!9*I<#%S&OQ_MI^02PSYET]ZTU!&"!U(W4"# M*I!,Q4N9T^`U>HUOZ.TKHE=(M>DGH(&N$-E`;Q(TT(5\53;!\T_/:!-BAWH4 M=7=!'BU4M*Z9;5"$RE2DC[E).'/B@,.V;"[*2:%B6%LH4@V4J<"63O2H>:*1 M4H(%B9I1HP"4J<`-DWNBLUM&-/4H)P6+O&RU12JA,A5KT,7Y]+S&M_+YE$T( M%GQHY(`JP&3J%=V<#F_1:UCP?8^6MC=UWW"D>M%0H@:+LVNA375@IMZ0S:GT M@4AG11FO791DJZN$#BQ2K(4:52`9>]H]@@9G/FJJQ!TI6.!3%WJLHC+V\&K\ M.OE@ITO)5>!'B1<3SM765S$96)A/*TU*$15:[)$?IWSWU3SKR$G!XFH,.0,$ MJ`I5MO;OG"JF,,M)0`79#*MDRGFW%25;+BU%I%(Y<#'?W>;!4T(V/H*,8%\' M?AJ6HUY)17=$ZQS8F65(U\P%JY50>O0D'R'GYV7P=H;3DU"VE&5_KB]BV=]: MV9&)BJK`*XM65B.T)OU(K&ZDT*J):``>4NEBA8F3)I=?LUN*FQK:FO0C&]J` MH1@527^WI*;X;OY,<+R]\XG\DG3/WUW3]J)/,ZW2647W?6YN/A`GUJ0?:<_P MMMI*@B.I7-)8=KM40L[2:O@7K$D_,ID-6&T7DNDPR``\&'].QDL(E%-(_BDD M_Q22?PK)WYEE4>-8$H5?_NP'"+ROPQV5JJ7A]?TJXE[7A5AC_8^;?PS\V6*! M'1262K-1]B4O!!(ZZ(AYM=Z&"B#ZJK?BIN,08>`WI*`Q+@5T:+R:KH3L]]8K M02RL>&BZQB%R"*7V/%,:`#HZ7GG"*:.!OH[K+YG4LZ`]+1N-!AU3WW)YE4&# M#K"';)`T_L?1`[S0JS=T2:K^=$@"?DH]L(R&;K:&T$=QKRI76):V23K\&#RI MH"OEA[>W^X M)>?=?R([.Q07#TV*X>X*M."9"\=4O:H\3-THS$WN.?GWQF:@0@R>^G!,.U`6 M"%BFKYFM_9G*3G*?W'T#GC1QA,MD%2STFF]0R=+36^DK\)R*JA8$FCK,F!BV MJAZPC]?)6JJLRG?@N1-U5;`5=LCSL*]%#_:[FJ[*WX%G*RCJZH!GL.O,#Y+$ M`IUU,(PDEB_PSGQ^Q#`S1"V/39,GK*A0@Z4;&-8AZ\BM+H!1[/1M2[S_CB): MB3EMV8$<\L=Y0/^J')B\7(9H:C\ MJ3:`-8%M6M9R:=(`:>IQ8:"[7_JW4=;Z^XZ_0'7R.]8$MGL8U/['E86I4JC] MV0`/DGMG\0J%\Y7M,]O#IO]%TREO;1SR;M+0+%D3V/9D,!NK&;&9JA([T-56 M4XBU7F!*LZ-W/%H3V`9M4*M\)W(T59NWASU[,H_$;/&"G"3$,4;1E>UYR+W< M[F+%L@^U>SVICVQ-@)Z(S-BJ"?0_=/_=W62;DL/9NMK"N+.6N](?M2Y@"V!! MK:!J@C%5%]E\SED^\::;31B\D;MH-:&*M8RI$5H7(RNNH`$;VEDMU38C24ZN M:1:1=0$<#MZMEKF0>^L%+CB7)\1*]2T?PKH`C@CO5ON*`H#VV6K&H90/]O3- MK8AI3B58U*2:!P5RS3@5S=&M"^!8\FXLR)QLH#V_W1C794!.3EE,(7_?,?8+ MU@5PN'H/C>Q`/@-SZV8PTSY`1XQZ'NVXO'?$%_K5^@1='(Y4JNM:5X%?JJ%Q/;F*%Q+`W-ZP:1U`9Q^T%GMPWZ)V)2GTOAJ.ET'88S_*I;^G4.6 M?Q[C4E@7P#D+W:R>8KR]]>CM[+$2O*:@7QFA]1DXYZ`;-2O!-M86S;BZ6SZG MS'S^L:G]T-;G43J!#0FFOPW:V@&I9>ZF1R,]:`S;B$YAN+MU.4]90N^ MMCZ/TIO,QUIHLPOW\#&:.5!CQ6F/J-L%-84VLH8] MPKX6^__=CNP_0L**?VM',;E)H!B%TU=)D3@A%7B#!E6=L$Y:4F0#4Z2\P*>, M$+R'0P?JK(#K;:S>E?U"#OWVE6>'=E;M_HH`1N$])H<:>GD(8Y_<_U9X(U&Q M[D#@'1_:J+P)V-X&\SW@B-[OLTZ\01C=>XY$UUP*\,8.;90J1-7;\+LG[/A8 MIK#R1]`M&EKIJ`ZDMX%KV?L.YR)3_P2Z<4&SVPH+16_WN8Q-;EN*PX_`.@FP MQ,H7?(G9OIX:'\@\7\EVE/TW8)7\.6)E;A4U=OLJ^JGOD]55(OOR1V"%]S6$ M?\`O]*)CQA'"7'KO%+C.+;XZN MJ$5)LX)$&2RLS\&*T1M<:KFX.LR+/$:$U0M:4LG<^8L@7&?08`*KT89F M5?A+A1@J'@ELN-0-L:]X^PV[Z!F](3]!E]L'^U]!>)5$<;!&872YW7&<(]"( MIFH\.G2PE4A9["EG"/0H8FVJ<"515HHJI4JV7;"ACL*M=/^@[-%!:"T M/S>7!CJ4BJTGMDZ%('JDV@@Y/R^#MS,G2/PXW&::S?^CKM3\KZVO+PSM[?\1 M.D!**/JJMJI,&U)+LYI[_(MF$D=DM9DMOOHTP..%R!/)NIP*:*#CG32THX1E M'!ZB@UVE(B"5IQC%$:!CGSK=2#5D,`ZS*>3R&PJ6H;U988<&M)";GOKE@T\+ M'5&EH4W.^5L%88_VXJZ6C^F:;G.-UXZ,'#IV2TF939:%/;P?P!2>4$A+/=I+ MT65==0CPV+&N3*(*L<.M`M1!EOL.?Q@_&;\`VX&$E%N9RBB'X[32`#2*=;(H M/9")AIXKB^5$Y)K@$D$YJ#34QG%4""%UI^IC+'V/*+X/HH@LYVE..M##P(T= MTNH[.S84%CP>"<3#0)V72SO"SM1WK[&7T")A^F@X(T"OE2*AD93A*;4U3.0@,0FL<:->_AI+95J*-=LRVDDOM`+R^M?!&@GXEZ,I> M1'C'X_R@.;RV%<;EE#R`)^^GP5Z$O$>;MC&W/'8MPQ,9-XQ*DH4DR M4NB[1\?JU[&YJE!&83BERJ/2VF`'WT+?5E2TQ-8O$\HH%)K7'94JL_(=]$6D MN2(/8(S#;9#7_\5D8WPJV%:=I$)*Z%BI-E-6"FP<[H82T&OT&N^EI*-[%B5T M\),1W?.`0:?B]>*2.Z']@^#*S!Y%J'W2*5B@G_:&[X[V/,H]T7`^.S3WOWD?/^O>][?/O_\ MTV_*G],%\2(B9S2Z)@NJEL2GG_;F4;3\.!A\^_;M':>"BX"^\\5B<'@P/#SX M]0C)A71!>70NY.*43DD<1I_V_HA)R*:,!GO>SS\!!UQ]1.2@`[F??_(T0@'T MV]$[(6<`=3`<_./J\D[SNN=EP!]#QK\6,)X>9&APC@;X^($HFD=!B"#*D/(( MOPR2AP7PL('^/R[A!67BK`&!<141[A<9J@B1BCW\\.'#0#]=J0?T.2,1#6K? M\6$@14@'*5C^/;':GQ&RS#"G1#UHK/2!-L;^P7#_:)A'\T7,(_E<5)BB_KN9 M>!RD#^M08REAU-7AID]KD`/*['CPH`:%/OES.PX^J4%B_)&JR(Z6/*M!Y(3Y MRHZG'R':L(JFF&]'@@`Y.&'^]N+6I^DY3H5?HSNC?``_K+H M&6G)A::]YS%032-$]M:`3AEGFB-P8MZ^9]#R'T<\\,XT#>]B1>2W09F"(1HK M&HSY9_T9;*60"P1`;Y1BI2`VC!7!;O`^"?TXK'_!H*#>-?5]!Q+H]60\/6<< M7"0CX8U0FLV3D"B5+BNH^8ZP=AL<@N(S`O#Y1*#]0!C\I$3(`ASYWC$)T4][ M=W-*([53ILCK(55#HH4;`OXZFM.(`1\JL4578+LQCM8QAO?G`NW_VBGCY,;^ M!<1S"UJ9$NG7=H6_[Z;P#$1Y8NJ-EU1JL4#U]YS$`0.8'56[&D_',/+DB5B` M:'/0'7ND5DLT0=J-\\LZQBF0]RZ%>C,23((3HN;GH?BF+GC`()J)*M.D"F$W MRJ]K&06(>YKZSAKC@D<0FBUNX(\(;NE2R`ARS\0,-<_L!O@+1DI,^:%0L:3P M3XKM)>A>AK]3ZKV+%PLBG\?3.S;C$._XA$%+NXH_E%6<0_,0;Z<4 M>1<)_^M2G>3BE23_1C`D0Q+H8X+;=A4_/, MKM8CJPO9U^A>'G^GU`N"+UBDPUSP`K!,X7I/^2K4:`*P*_I]=?'+2&B?4""R M4]J^HS-4PT5YY]'RO5VWOU0&<8*YL[N,US3"#!DRA[LYD:F?+7]IU^6O95T" M6I)N`Z*G,7=*E7?Q@Z)_Q"#)V2/.59-JE+ZU*[.2TZWPO`1QQW2I4RK1G*!9 MD[JN.'8[;)#<>7\VGW9K7Z.;WB<$EDHQ[':J9(A][)10WC$KY1*^)-TK M6*3NJ57[AYW2R=W4LRU/%&F>2`IY8E[_O;'L=MDXQ]Q-F]GSH,K\J(.PVZ*2 MAM;E2SNJ\TK(7M!WW5.[KJNY:36LWTTUET+YO([MC^P*KN2DU5A_-_7;+90Y MI1%A8:_HQZ#8[5'-8WN$/RGI-T/5:GU"GZ*8A&O8RV#:S59)F=^8K?, M5SHW*DRHFF=V$U02[?+1TJ[.CTH&4'1:M8_M:J[FT=8,X4W5>5T6W4X;E%WQ MU<2X2?&[Z4RZ9UN%.=`?S6JBHTKVW#]+V\EY4SK^*]BFYIG=`)4TN7Q"N*,* MMF>YU76@%L2N[AZ9\)O:RSH==M#[L$;QG8]L5^O!\$WUF5H/.ZC^L$;UE82Y M7?6';ZK/U'K40?5'-:JOYL:MJC]Z4WVFUO<=5/^^1O75_+95]>_?5)^IM1K_ MMT':S5`]3&XUPT[F`;G"&E*JS2EM,+3"V0U1R8(;2WEV-?RI[/47(\[:QW:= M5Q-@VUG`FZ;K'4\;E%7O[ZMGP@UZWTU_4SIQ*0SSFF=V75<26-MQS$X.<;L: M"^.[&<2N\$H*VZ#P_Y2QC7^P5<0MG7JZY\)'O&'^:4^QQ3*D>^EWWZYJ800$0L<2^?JH'A?F^P M#8%`Y7T%*EK)+7%"\M!7'$"AH7N2P-CN*TEI.FQ7GH%IL@"?5JT7X`&((F3D M<6L_F;J6*$DKFDOA:S(-*/C?OL';QZ_VAX?[1\-W3RI(&.OQ_DRBGN\W>/W> M;V\WT_'-!@%?^4N'ES5V>*EYIWZ?%7%`PTB9;_97I+I*W=!4I8D7"UKZ>0,> M;'UKNC"1QS/_;,*&K05.)S[RB-E_&W!2:9#3A8L,27_:X.W5?CE=7K_"2C[N MKPCT9:#<>Z?+ZPT.?MCDU>5./)W>;9#TIWYO;^L8U<49A5(6L-`C?4`G./QU M$PXZNL+&ZL>$X-?K\-'<66O]-5/3LMHD[:.G>5EUE1KQ(.D(E=M/&#VH2!+3RT*' MAO_J!I\$F+HYW4?XCO'91407F/_L>22%^K072;QZFD`M=7.%B<8+8IG>/N,L M#+'LT<"J&)!9%./3OTL1+\U+&)#?\P:?O8J`65G!>/J%2$EXI"Z4BFDP$<=2 M?*5RI+`N";_#Z.Y$*'.W*!%X/?R\`A8"W`:1SS853$FH6G20/'M(6A)]VO,E M#?"&^A94H\NY(.W&L.*6^D(&-!AA(Z55HRL^FX#("GAEYC9@.@YZXWX_E03T M84L:2:K5L(?E>#KR?2`3@'?%]BMJ(JP=%Q)M],-[%8,C+Q*RC7(L@%M]V%$G MNP7P50A[2X-8#U,40;)'>.$CS94$W2\%+\N)'O")2I^IG&O(*V:+1%_#W+$W MV;&M(6V0#JT>=E9Q"_(X+,V#5M!$K*1!YLFEO"?HCFS'E.N6P"1 M<.6RSRF)8MFHJ1_W3M>T;?K=Y?*#)H_2`=HU";$[>!"'L%#?R+3"55OR6D3_ MI%$:]4&>@*^Q"KTF`>?T8"VE2>/?6QKB?LU$:*CQ$A_AV#;#O$$[VR3KG,Y, MB[Q1&*8\CR!6?#17P^T:Z8[DG+S94!_'$9ZCX`\#9,82QOGE,H[Q6=QN$EF]*L^9DE?NX$[E`0?1*K2"RH''-Z12$\D@7/7WU8,$\@ M%A!@O!CO_RL>1)7I_+NW4-3:L_;--B30(.313('3&O M(C.8S]:G2P^#+!>SG'=TJ>U7B:)=\FP.WZ^CM')C*=7Y/^$-".PN$'6!3XO.62:=$;EB^Z9@(MXT"@7 M?#77#.^&;57:+NF*Y)2PJ?-4M]2G[!&)G<:TUII=H#<5+QO$WTLZ=)8%GA7$ M):U2UF!MYFA?0-8U!'5)2C.?)M2?L,>W0K^+4Y@MELSFL^*-'*B'V@;5S3OB,WD(4 M<"YDX8>5LCV9>A&@FL1 M03S\34SF(L:K-W=H_6K>L!:Z4YD%74::K1RSUXS31L%LA]@VW6R9M%MZZV;X MR2:C9N+JF.G&_EFXV:0IXKND@5+90D/BW0;I4(9]]A11'M#@"D]1L.D+^//D MY!TR+J"*H,6UL@M\(2/C20(I-G?'@#:^^-A$4>K3<"8QAG<$]\JH1@?51 M#"$MF,#/EZ)H+Y77QKH4"CK0%[E>;G1VB!?9ZCM:H$T[JV`M]%<11]]B MR#N>_K?N8M5CBO3#<\Q1Z,&HQ_,7"-L3&51JMQ.2%F9%N1.FM,*EY"/6)[/A MU-BF?[@B\BN-TBK7W.1>B02BF+HT;?7BQ.B/[9#P.&;-\@Z&A+F]).%-,G++ MBV,]W*N8Z'D1=+D:55&+I!6P5R%H2ODOM_0WEZ5 M[2@(]*UG<#U2^)0&"C?PS.T#K"0JREG8TNV-^RHFN[;>%Q&'01:)D3!\SH8$ MN+!\2?J8C^4QG0J)&]J8S^$Z5=@+W@J]#2?;5G?_,[N/.(?,W/CT=%/S6O#4 MNX^GET+G>LGB-N)!>IG!8-A'T^94W4F5+O1-7R&38P^JS,&`;25IAW5H$-3< M82IYP32`S4O9$_$U'%3?5]_$S^$ MS!]/IQ3'XDTLT?5'$W&K!4M<=7;&40B:UB?R&@;$L>"Q,NXH+;%NW"GKB.#0 M,,BJHQIKC1OKJCIB.K3=:SSRBG-M!&#='.SI4OS4",SQBG.AX^I8\T%$L$,D*\%H+W:&)5',KTU(FU0SHDL?;Z#YJ;7:R.4&7S([A M5T6B6XIV`[[N`0KO[/Q_UAVGDLGT0_YNGF![YS4-=W8;)WX3N/,6+Q519S8T MQ?2P_N.EU7;K=R:T\1'N5K?:3%'PX<'!7\PA06K-AA+B!FB7_.`HGL%:C$WN MSA;+4#Q36N_>VV%=DNQ_"(]A\AT>#`]:K=8.ZY)D6-&A2UDQLZXW5R.82_+D MYLSPX)8N)?-7/0`:IU@]N$ORC?U(U+!K,5L7:$>E:WN M"[1+TJV\WK#$;I.'K(-U2;)S^B`-NY=T1L)1\,A4PP+0$<$E&:^(].?(;VG% ML@S,5M!7(9>UX4@7:+>DTV,,0EX5AQBCU@[)-DB7I,HOR>V^I`NT4]*9-*YK MAZ+&7+`_$>MALJJE2QRF90R;$65Z[_I4^;3,K-HH]246'+)'FFMV.L0<$D'C0&!X^O_.>CUGY1(:Y=02US: M!=PE^29S2?L(V`W>)0GM&_UM=4OM"/\)JWRRHCPM6<),]7++MBEOO%/LAMXJ MB_`8ZYXF<\+3LZ*_)]7:J=SZ/PQ_LNJ2[Q,*].?B-9SFFCK0T7(IQ6-:))D[ M@[75C-;#YB5^\=9!AEW+0FX5RP[GI$CMX9I-P"Y83HEK7RSR\T_??TO7R<(- MW8DPHK:O/KT);ACLNZ.C8P&>+HDKU-;T5"3JE*ZLBT$BEEY.80GHN$I;D=Q: M@,VT3\WV.U784W3,LZ7*YB,:@`O249\M2/ARPHU,Q433?>@&(+=,E9W^IWIO M$JH=UBW9K%>XS7#3K:-TQ>\)"4,L<\]2U@2PW*1R&]0B"79+EA/F<6]HO?.\6Q)CQZ8I8N+\FW/WB?+(@^!FR1 M%%%=M+!]JG579=Q\WU'1/ZB!FN#1W#*R\U^[-#*2OA26JL3"]RYQC"DBB_1. MFFXJK'^Y@O*6'[[H@^70GO%(4G#VEQ2SQCO\4>2"C:H/-]UUV6Z;$(@22:CY M2S=$8>+JF5#L$-(`]OUBL.V5KZ=-KOE,BX`WWV%MKJ;_C6!N95J:0]/6M2J) M];%;$N`Q.POH>'K/,3C2K39LA9--8"XYO3LZP_]R/_W7=#36#NR0B[NF$3:# M-WTB&^1J@W1(J&Y7]\XP75[WUFL!V:6Q6EL+T:-LPD6Y.A6".%OL,5#^G"[( MYY]_^C=02P$"'@,4````"`#]20Y!7IB]!H[M``!(!`T`$@`8```````!```` MI($`````;F5O;F0M,C`Q,C`V,S`N>&UL550%``.-3RI0=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`_4D.09`EI\O/!P``CW$``!8`&````````0```*2! MVNT``&YE;VYD+3(P,3(P-C,P7V-A;"YX;6Q55`4``XU/*E!U>`L``00E#@`` M!#D!``!02P$"'@,4````"`#]20Y!,!*H-:,F``#:?0(`%@`8```````!```` MI('Y]0``;F5O;F0M,C`Q,C`V,S!?9&5F+GAM;%54!0`#C4\J4'5X"P`!!"4. M```$.0$``%!+`0(>`Q0````(`/U)#D'ALV_=OVD``"DE!@`6`!@```````$` M``"D@>P<`0!N96]N9"TR,#$R,#8S,%]L86(N>&UL550%``.-3RI0=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`_4D.009LR.1).0``!!P$`!8`&``````` M`0```*2!^X8!`&YE;VYD+3(P,3(P-C,P7W!R92YX;6Q55`4``XU/*E!U>`L` M`00E#@``!#D!``!02P$"'@,4````"`#]20Y!($1H[6T3``"(T```$@`8```` M```!````I(&4P`$`;F5O;F0M,C`Q,C`V,S`N>'-D550%``.-3RI0=7@+``$$ ?)0X```0Y`0``4$L%!@`````&``8`(`(``$W4`0`````` ` end XML 39 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Income Statement [Abstract]        
Net revenues $ 1,974 $ 283 $ 3,138 $ 822
Cost of revenues 494 238 743 393
Gross margin 1,480 45 2,395 429
Operating expenses:        
Product research and development 1,478 382 2,165 658
Sales and marketing 1,718 363 2,517 715
General and administrative 1,691 921 2,686 1,785
Total operating expenses 4,887 1,666 7,368 3,158
Operating loss (3,407) (1,621) (4,973) (2,729)
Other expense, net:        
Interest expense    (81)    (135)
Non-cash items related to debt discounts and deferred financing fees and the valuation of conversion features and warrants    (1,014)    (9,568)
Total other expense, net    (1,095)    (9,703)
Loss before provision for income taxes (3,407) (2,716) (4,973) (12,432)
Provision for income taxes 20 6 42 11
Net loss $ (3,427) $ (2,722) $ (5,015) $ (12,443)
Basic and diluted loss per share $ (0.10) $ (0.10) $ (0.15) $ (0.50)
Basic and diluted – weighted average shares used in per share computations 32,969 27,642 32,889 25,039

XML 40 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Deferred Revenue
6 Months Ended
Jun. 30, 2012
Deferred Revenue Disclosure [Abstract]  
Deferred Revenue
 
6. Deferred Revenue
 
Engineering development fees are recorded as deferred revenue until such time as the engineering services have been provided.
 
As of June 30, 2012 and December 31, 2011, we have $1.4 million and $1.5 million, respectively, of deferred license fee revenue related to a prepayment for future license fees from one customer and a total of $0.1 million and $0.4 million, respectively, of deferred engineering development fees from four and four customers, respectively. We are deferring the engineering development fee revenue until such time as the engineering work has been completed.
 
XML 41 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurement of Assets and Liabilities
6 Months Ended
Jun. 30, 2012
Fair Value Disclosures [Abstract]  
Fair Value Measurement of Assets and Liabilities
 
5. Fair Value Measurement of Assets and Liabilities
 
Accounting guidance defines fair value, establishes a framework for measuring fair value, and expands disclosure requirements about fair value measurements. The accounting guidance does not mandate any new fair-value measurements and is applicable to assets and liabilities that are required to be recorded at fair value under other accounting pronouncements.
 
The three levels of the fair-value hierarchy are described as follows:
 
Level 1: Quoted prices (unadjusted) in active markets for identical assets and liabilities. As of June 30, 2012 and December 31, 2011, we had no level 1 assets or liabilities.
 
Level 2: Inputs other than Level 1 that are observable, either directly or indirectly. As of June 30, 2012 and December 31, 2011, we had no level 2 assets or liabilities.
 
Level 3: Inputs other than Level 1 that are observable, either directly or indirectly. As of June 30, 2012 and December 31, 2011, we had no level 3 assets or liabilities.
 
    For the Six  
   
Months Ended
June 30, 2011
 
       
Annual dividend yield
   
--
 
Expected life (years)
   
0.08 – 3.0
 
Risk-free interest rate
   
0.08%- 1.27%
 
Expected volatility
   
110% - 263%
 
 
The assumptions above were used to value warrants granted to employees and consultants as well as the embedded conversion features associated with convertible debt for the six months ended June 30, 2011.
 
On December 14, 2011, all of the outstanding convertible debt and accrued interest was paid or converted into shares of the Company’s common stock. As of December 31, 2011, the fair value of the embedded conversion features was $0.
XML 42 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
6 Months Ended
Jun. 30, 2012
Segment Reporting [Abstract]  
Revenues by geographic region
 

 
   
Three months ended
June 30, 2012
   
Three months ended
June 30, 2011
 
   
Amount
   
Percentage
   
Amount
   
Percentage
 
Net revenues made in the U.S.
 
$
1,218
     
62
%
 
$
130
     
46
%
                                 
Net revenues made outside of the U.S.
   
756
     
38
%
   
153
     
54
%
                                 
   
$
1,974
     
100
%
 
$
283
     
100
%
 
   
Six months ended
June 30, 2012
   
Six months ended
June 30, 2011
 
   
Amount
   
Percentage
   
Amount
   
Percentage
 
Net revenues made in the U.S.
 
$
2,000
     
64
%
 
$
130
     
16
%
                                 
Net revenues made outside of the U.S.
   
1,138
     
36
%
   
692
     
84
%
                                 
   
$
3,138
     
100
%
 
$
822
     
100
%
 
XML 43 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2012
Accounting Policies [Abstract]  
Property, Plant and Equipment
 
Computer equipment
3 years
Furniture and fixtures
5 years
 
XML 44 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
6 Months Ended
Jun. 30, 2012
Segment Reporting [Abstract]  
Segment Information
 
9.  Segment Information
 
The Company has one reportable segment, which is comprised of the touchscreen technology licensing business. All of our sales for the three and six months ended June 30, 2012 and 2011 were to customers located in the U.S., Europe and Asia.
 
The following table presents net revenues by geographic region for the three and six months ended June 30, 2012 and 2011 (dollars in thousands):
   
Three months ended
June 30, 2012
   
Three months ended
June 30, 2011
 
   
Amount
   
Percentage
   
Amount
   
Percentage
 
Net revenues made in the U.S.
 
$
1,218
     
62
%
 
$
130
     
46
%
                                 
Net revenues made outside of the U.S.
   
756
     
38
%
   
153
     
54
%
                                 
   
$
1,974
     
100
%
 
$
283
     
100
%
 
   
Six months ended
June 30, 2012
   
Six months ended
June 30, 2011
 
   
Amount
   
Percentage
   
Amount
   
Percentage
 
Net revenues made in the U.S.
 
$
2,000
     
64
%
 
$
130
     
16
%
                                 
Net revenues made outside of the U.S.
   
1,138
     
36
%
   
692
     
84
%
                                 
   
$
3,138
     
100
%
 
$
822
     
100
%
XML 45 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
6 Months Ended
Jun. 30, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]  
Stock-Based Compensation
 
7. Stock-Based Compensation
 
We have three approved stock option plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. All employee and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants was based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments.
  
Stock Options
 
As of June 30, 2012, we had two equity incentive plans:
 
The 1998 Non-Officer Stock Option Plan (the 1998 Plan), which expired in June 2008 ;
The 2006 Equity Incentive Plan (the 2006 Plan).
 
We also had one non-employee director stock option plan as of June 30, 2012:
 
The 2001 Non-Employee Director Stock Option Plan (the Director Plan), which expired in March 2011.
 
A summary of the combined activity under all of the stock option plans is set forth below:
 
  
 
Number of Options Outstanding
   
Weighted Average Exercise Price
 
Outstanding at January 1, 2012
   
19,324
   
$
92.19
 
Granted
   
1,460,000
     
4.26
 
Cancelled or expired
   
(8,124
   
69.36
 
Exercised
   
---
     
---
 
Outstanding at June 30, 2012
   
1,471,200
   
$
6.79
 
 
   
For the Six
   
Months Ended
June 30, 2012
       
Annual dividend yield
   
--
 
Expected life (years)
   
3.8
 
Risk-free interest rate
   
0.55% - 0.57%
 
Expected volatility
   
186% - 187%
 
 
The assumptions above were used to value stock options granted to employees and directors during the six months ended June 30, 2012.
 
The aggregate intrinsic value of the 1,471,200 stock options that are outstanding, vested and expected to vest at June 30, 2012 is $2.8 million.
 
The 1998 Plan terminated effective June 15, 2008 and the Director Plan terminated effective March 2011. Although we can no longer issue stock options out of the plans, the outstanding options at the date of termination will remain outstanding and vest in accordance with their terms. Options granted under the Director Plan vested over a one to four-year period, expire five to seven years after the date of grant and have exercise prices reflecting market value of the shares of our common stock on the date of grant. Stock options granted under the 1998 and 2006 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant.
 
During the three and six months ended June 30, 2011, the Company recorded $35,000 and $70,000, respectively, of stock option expense related to the vesting of stock options.
 
We did not grant any options to purchase shares of our common stock to employees or members of our Board of Directors (Board) during the six months ended June 30, 2011.
  
During the three months ended June 30, 2012, we granted 1.1 million options to purchase shares of our common stock to employees and 360,000 options to purchase shares of our common stock to members of our Board. The options have a 7-year life and 1/3 of the options vested on the date of grant with the remaining vesting monthly over the following 24-months. During the three and six months ended June 30, 2012, we recorded $2.3 million of stock based compensation expense related to vesting of such options.
 
Warrants
 
On December 3, 2010, we issued 120,000 warrants at an exercise price of $1.625 per share to an employee. The fair value of the warrants was $198,000 on the date of grant, using the Black-Scholes option pricing model, which is to be amortized over 24 months. During the three and six months ended June 30, 2012 and 2011, we recorded $25,000 and $50,000, respectively, of stock based compensation expense related to vesting of such warrants.
 
We issued 80,000 five-year stock purchase warrants at an exercise price of $2.50 per share to our legal advisor during the six months ended June 30, 2011. We also issued 20,000 three-year stock purchase warrants at an exercise price or $2.00 per share to our US based employee during the six months ended June 30, 2011. The warrants to purchase an aggregate of 100,000 shares of our common stock vested on the date of grant. The vested warrants granted to the employee and legal advisor had an aggregate fair value on the date of grant of $230,000 and is included in general and administrative expense for the three and six months ended June 30, 2011. The fair value of stock-based compensation related to the employee warrants is calculated using the Black-Scholes option pricing model as of the grant date of the underlying warrant.
 
On September 12, 2011, we issued 20,000 warrants at an exercise price of $3.90 per share to an employee. The fair value of the warrants was $75,000 on the date of grant, using the Black-Scholes option pricing model, which is to be amortized over 24 months. During the three and six months ended June 30, 2012, we recorded $9,000 and $18,000, respectively, of stock based compensation expense related to vesting of such warrants.
 
The stock-based compensation expense reflects the fair value of the vested portion of options and warrants for the recipients at the date of issuance plus the amortization of the unvested portion of the stock options and warrants. Stock-based compensation expense related to stock options and warrants in the accompanying consolidated statements of operations is as follows (in thousands):
 
   
Three months
 ended
June 30,
2011
   
Three months
 ended
June 30,
2012
 
Stock-based compensation
  $ 183     $ 2,317  
   
Six months
ended
June 30,
2011
   
Six months
ended
June 30,
2012
   
Remaining unamortized
 expense at
June 30,
2012
 
Stock-based compensation
 
$
472
   
$
2,351
   
$
3,607
 
 
The remaining unamortized expense related to stock options and warrants will be recognized on a straight line basis monthly as compensation expense over the remaining vesting period which approximates 22 months.
 
See Note 5 for assumptions used to value warrants during the three and six months ended June 30, 2011.
 
A summary of all warrant activity is set forth below:
 
 
 
   
June 30, 2012
Outstanding and exercisable
 
Warrants
   
Weighted
Average
Exercise
Price
   
Weighted
Average
Remaining
Contractual
Life
January 1, 2012
   
5,405,606
   
$
1.57
     
2.45
 
   Issued
   
--
   
$
--
     
--
 
   Expired/forfeited
   
--
     
--
     
--
 
   Exercised
   
(223,500
)
 
$
0.61
     
--
 
Outstanding and exercisable, June 30, 2012
   
5,182,106
   
$
1.61
     
1.87
 
 
On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.
 
During the three months ended June 30, 2012, a warrant holder exercised a warrant to purchase 21,000 shares of common stock using the net exercise provision allowed in the warrant and received 13,831 shares of our common stock. Another warrant holder exercised a warrant to purchase 2,500 shares of common stock and paid a cash exercise price of $3.13 per share for a total exercise price of $7,813.
 
The fair value of stock-based awards to employees and directors is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term and forfeiture rate of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior, as well as expected behavior on outstanding options. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of our stock price. These factors could change in the future, which would affect fair values of stock options granted in such future periods, and could cause volatility in the total amount of the stock-based compensation expense reported in future periods.
Below is a summary of Outstanding Warrants to Purchase
Common Stock as of June 30, 2012:
 
                 
Description
Issue  Date
 
Exercise Price
 
Shares
 
Expiration Date
 
                 
September 2007 Investor Warrant
9/26/2007
 
$
31.75
 
233
   
9/26/2012
 
August 2009 Employee Warrants
8/25/2009
 
$
0.50
 
240,000
   
8/25/2016
 
January 2010 Investor Warrant
1/28/2010
 
$
1.00
 
40,000
   
1/28/2013
 
2007 Debt Extension Warrants
9/22/2010
 
$
1.00
 
16,000
   
9/22/2015
 
September 2010 Repricing Warrant
9/28/2010
 
$
1.38
 
4,000
   
9/28/2013
 
October 2010 Repricing Warrants
10/18/2010
 
$
1.38
 
2,434,830
   
10/18/2013
 
October 2010 Employee Warrants
10/15/2010
 
$
1.38
 
1,440,000
   
10/15/2013
 
December 2010 Employee Warrants
12/3/2010
 
$
1.63
 
200,000
   
12/3/2015
 
January 2011 Employee Warrant
1/21/2011
 
$
2.00
 
20,000
   
1/21/2014
 
February 2011 Legal Advisor Warrant
2/22/2011
 
$
2.00
 
80,000
   
2/22/2016
 
March  2011 Investor Warrants
3/9/2011
 
$
3.13
 
617,943
   
3/9/2016
 
March  2011 Investor Warrants
4/7/2011
 
$
3.13
 
49,100
   
4/7/2016
 
May 2011 Consultant Warrant
5/17/2011
 
$
4.05
 
20,000
   
5/17/2014
 
September 2011 Employee Warrant
9/12/2011
 
$
3.90
 
20,000
   
9/12/2014
 
Total Warrants Outstanding
         
5,182,106
       
XML 46 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies
6 Months Ended
Jun. 30, 2012
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
 
8. Commitments and Contingencies
 
Indemnities and Guarantees
 
We have agreed to indemnify each of our executive officers and directors for certain events or occurrences arising as a result of the officer or director serving in such capacity. The term of the indemnification period is for the officer's or director's lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited.  However, we have directors’ and officers’ liability insurance policy that should enable us to recover a portion of future amounts paid. As a result of our insurance policy coverage, we believe the estimated fair value of these indemnification agreements is minimal and have no liabilities recorded for these agreements as of June 30, 2012 and December 31, 2011, respectively.
 
We enter into indemnification provisions under our agreements with other companies in the ordinary course of business, typically with business partners, contractors, customers and landlords. Under these provisions we generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of our activities or, in some cases, as a result of the indemnified party's activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by us with regard to intellectual property rights. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is unlimited. We have not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, we believe the estimated fair value of these agreements is minimal. Accordingly, we have no liabilities recorded for these agreements as of June 30, 2012 and December 31, 2011, respectively.
 
Operating Leases
 
Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,207 square feet of office space located at Linnegatan 89, Stockholm, Sweden for approximately $6,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $72,000 per year including property tax (excluding VAT). This lease has a notice period of 3 months.
 
Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,723 square feet of office space located at Linnegatan 89D, Stockholm, Sweden for approximately $8,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $93,000 per year including property tax (excluding VAT). This lease is valid through December 31, 2014, with a 9-month notice period. The contract will be extended for an additional 3 years if it is not terminated according to the terms in the contract.
 
On March 18, 2011, we entered into a twelve month lease with CA-Santa Clara Office Center Limited Partnership for 1,718 square feet of office space located at 2700 Augustine Drive, Suite 100, Santa Clara, California, USA for $2,647 per month. The lease expired on April 30, 2012.
 
On March 22, 2012, we entered into a three year lease with 2350 Mission Investors LLC for 3,185 square feet of office space located at 2350 Mission College Blvd, Suite 190, Santa Clara, CA 95054 USA commencing May 1, 2012. The initial lease payment is approximately $7,000 per month, increasing to approximately $7,700 per month over the term of the lease. The annual payment for this space equates to approximately $84,000 per year including property taxes.
 
On April 15, 2012, Neonode Technologies AB entered into a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $13,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $161,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2013.
XML 47 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share
6 Months Ended
Jun. 30, 2012
Earnings Per Share [Abstract]  
Net Loss Per Share
 
10. Net Loss Per Share
 
Basic net loss per common share for the three and six months ended June 30, 2012 and 2011 was computed by dividing the net loss for the relevant period by the weighted average number of shares of common stock outstanding. Diluted earnings per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock and common stock equivalents outstanding.
 
Potential common stock equivalents of 103,000 and zero stock options outstanding under the treasury stock method, 3.4 million and 5.4 million outstanding stock warrants under the treasury stock method, 52,000 and 55,000 shares issuable upon conversion of preferred stock and zero and 1.7 million shares issuable upon conversion of notes are excluded from the diluted earnings per share calculation for the six months ended June 30, 2012 and 2011, respectively, due to their anti-dilutive effect. 
 
   
Three Months ended
 
(in thousands, except per share amounts)
 
June 30,
 
   
2012
   
2011
 
BASIC AND DILUTED
           
Weighted average number of
           
common shares outstanding
   
32,969
     
27,642
 
Number of shares for computation of
               
net loss per share
   
32,969
     
27,642
 
Net loss
 
$
(3,427
)
 
$
(2,722
)
                 
Net loss per share - basic and diluted
 
$
(0.10
)
 
$
(0.10
)
  
   
Six Months ended
 
(in thousands, except per share amounts)
 
June 30,
 
   
2012
   
2011
 
BASIC AND DILUTED
           
Weighted average number of
           
common shares outstanding
   
32,889
     
25,039
 
Number of shares for computation of
               
net loss per share
   
32,889
     
25,039
 
Net loss
 
$
(5,015
)
 
$
(12,443
)
                 
Net loss per share - basic and diluted
 
$
(0.15
)
 
$
(0.50
)
XML 48 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 2) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Stock based compensation expense related to stock options and warrants        
Stock-based compensation expense     $ 2,351 $ 472
Stock Options and Warrants [Member]
       
Stock based compensation expense related to stock options and warrants        
Stock-based compensation expense 2,317 183 2,351 472
Share based compensation remaining unamortized expense $ 3,607   $ 3,607  
XML 49 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurement of Assets and Liabilities (Tables)
6 Months Ended
Jun. 30, 2012
Fair Value Disclosures [Abstract]  
Fair value assumptions and methodology for assets and liabilities
 
 
 
    For the Six  
   
Months Ended
June 30, 2011
 
       
Annual dividend yield
   
--
 
Expected life (years)
   
0.08 – 3.0
 
Risk-free interest rate
   
0.08%- 1.27%
 
Expected volatility
   
110% - 263%
XML 50 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Details Textual)
3 Months Ended 6 Months Ended 16 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2012
USD ($)
Jun. 30, 2011
USD ($)
Jun. 30, 2012
USD ($)
Jun. 30, 2011
USD ($)
Sep. 30, 2011
Dec. 31, 2011
USD ($)
Jun. 30, 2012
Amazon [Member]
Jun. 30, 2012
Amazon [Member]
Jun. 30, 2012
Kobo [Member]
Jun. 30, 2012
Sony Corporation [Member]
Jun. 30, 2012
Sony Corporation [Member]
Jun. 30, 2012
Minimum [Member]
Jun. 30, 2012
Minimum [Member]
Jun. 30, 2012
Maximum [Member]
Jun. 30, 2012
US [Member]
USD ($)
Jun. 30, 2012
Sweden [Member]
EUR (€)
Summary of Significant Accounting Policies (Textual)                                
Basic deposit coverage limits per customer                             $ 250,000 € 100,000
Useful lives                         3 years 5 years    
Entity-Wide Revenue, Major Customer, Percentage 100.00% 100.00% 100.00% 100.00%     53.00% 53.00% 11.00% 11.00% 13.00%          
Percentage of net revenues earned from major customers   99.00%   71.00%               10.00% 10.00%      
Days of reporting period stipulated in the contract                         30 days 45 days    
Excess of insurance limits 10,400,000   10,400,000                          
Gains or (losses) resulting from foreign currency transactions 73,000 8,000 11,000 (57,000)                        
Foreign currency translation adjustments (72,000) (21,000) (28,000) 18,000                        
Fair value of embedded conversion features           0                    
Revenue earned, Number of customers 12 5 16 6                        
Number of customers who contributed in net revenue   4   1                        
Accounts receivable due, Number of customers 11   11     5                    
Percentage of accounts receivale due by three major customers 84.00%   84.00%                          
Percentage of accounts receivale due by two major customers           87.00%                    
Number of technology license contracts with customers         12                      
Explicit return from licensing revenue       0                        
Advertising costs 85,000 29,000 282,000 74,000                        
Unrecognized tax benefits $ 0   $ 0     $ 0                    
Weighted-average exchange rate for consolidated statements of operations (Swedish Krona to one U.S. Dollar) 6.95 6.26 6.85 6.34                        
Exchange rate for the consolidated balance sheets (Swedish Krona to one U.S. Dollar) 6.96   6.96     6.92                    
XML 51 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
BASIC AND DILUTED        
Weighted average number of common shares outstanding 32,969 27,642 32,889 25,039
Number of shares for computation of net loss per share 32,969 27,642 32,889 25,039
Net loss $ (3,427) $ (2,722) $ (5,015) $ (12,443)
Net loss per share - basic and diluted $ (0.10) $ (0.10) $ (0.15) $ (0.50)
XML 52 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Statement Of Income and Comprehensive Income [Abstract]        
Net loss $ (3,427) $ (2,722) $ (5,015) $ (12,443)
Other comprehensive income (loss):        
Foreign currency translation adjustments (72) (21) (28) 18
Total comprehensive loss $ (3,499) $ (2,743) $ (5,043) $ (12,425)
XML 53 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity
6 Months Ended
Jun. 30, 2012
Equity [Abstract]  
Stockholders’ Equity
 
4. Stockholders’ Equity
 
On February 29, 2012, the Company filed a Certificate of Correction with the Secretary of State of Delaware effectively reducing the amount of its authorized shares from 848,000,000 shares of Common Stock and 2,000,000 shares of Preferred Stock to 70,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. This reflects the new capital structure of the Company following its 1-for-25 reverse split that became effective at the close of business on March 25, 2011.
 
On May 1, 2012, the Company began trading its common stock on the NASDAQ Stock Market Capital Markets under trading symbol NEON.
 
Common Stock
 
On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.
 
During the six months ended June 30, 2012, Series B Preferred stockholders exchanged 19 shares of Series B Preferred stock for 2,509 shares of our common stock.
 
During the six months ended June 30, 2012, a warrant holder exercised a warrant to purchase 21,000 shares of common stock using the net exercise provision allowed in the warrant and received 13,831 shares of our common stock. Another warrant holder exercised a warrant to purchase 2,500 shares of common stock and paid a cash exercise price of $3.13 per share for a total exercise price of $7,813.
 
Preferred Stock
 
The terms of the Series A and Series B Preferred stock are as follows:
 
Dividends and Distributions.
 
 
Series A Preferred:
The holders of shares of Series A Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series A Preferred stock held by them.
 
 
Series B Preferred:
The holders of shares of Series B Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series B Preferred stock held by them.
 
Liquidation Preference.
 
 
Series A Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of any other series of Preferred stock to be established by the Board of Directors (the “Senior Preferred Stock”), the holders of Series A Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series A Preferred stock then outstanding.
 
 
 
 
Series B Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of the Series A Preferred stock and Senior Preferred Stock, the holders of Series B Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series B Preferred stock then outstanding.
 
Voting.
 
The holders of shares of Series A Preferred stock and Series B Preferred stock shall have one vote for each share of Series A Preferred stock and Series B Preferred stock held by them.
 
Conversion.
 
Initially, each share of Series A Preferred stock and each share of Series B Preferred stock was convertible into one share of our common stock.  Any modification to the conversion rate requires shareholder approval (see below). On March 31, 2009, our shareholders approved a resolution to increase the authorized share capital, and to increase the conversion ratio to 480.63 shares of common stock for each share of Series A Preferred stock and to 132.07 shares of our common stock for each shares of Series B Preferred stock, thus completing the restructuring begun in December 2008.  
 
Conversion of Preferred Stock Issued to Common Stock
 
On April 24, 2009, we initiated the process of allowing the shareholders of our preferred stock to convert the Series A and B Preferred stock to shares of our common stock. In order to convert the preferred stock to common stock each preferred stock shareholder is required to submit the preferred stock certificate to our transfer agent and request conversion to common stock. The conversion to common stock is not mandatory and shareholders who own preferred stock may choose not to convert their preferred stock to shares of our common stock.  The following table summarizes the Preferred stock not yet converted as of June 30, 2012.
   
Shares of Preferred Stock Not Exchanged as of June 30, 2012
   
Conversion Ratio
   
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at June 30, 2012
 
                   
Series A Preferred stock
   
83
     
480.63
     
39,892
 
Series B Preferred stock
   
95
     
132.07
     
12,547
 
Total  Remaining Not Exchanged
   
178
             
52,439
 
XML 54 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Convertible Debt (Details) (USD $)
6 Months Ended 1 Months Ended 6 Months Ended 3 Months Ended 4 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Mar. 16, 2012
Dec. 31, 2011
Senior Convertible Secured Notes- 2007 [Member]
Jun. 30, 2011
Senior Convertible Secured Notes- 2007 [Member]
Sep. 22, 2010
Senior Convertible Secured Notes- 2007 [Member]
Jun. 30, 2011
September 2009 Senior Convertible Secured Notes Financing transaction [Member]
Dec. 15, 2009
September 2009 Senior Convertible Secured Notes Financing transaction [Member]
Jun. 30, 2011
September 2009 Senior Convertible Secured Notes Financing transaction [Member]
Dec. 31, 2011
September 2009 Senior Convertible Secured Notes Financing transaction [Member]
Jun. 30, 2011
Senior Convertible Secured Notes- 2010 [Member]
Jun. 30, 2011
Senior Convertible Secured Notes- 2010 [Member]
Jun. 30, 2010
Senior Convertible Secured Notes- 2010 [Member]
Dec. 31, 2011
Senior Convertible Secured Notes- 2010 [Member]
Dec. 31, 2011
Senior Convertible Secured Notes- 2011 [Member]
Apr. 30, 2011
Senior Convertible Secured Notes- 2011 [Member]
Mar. 31, 2011
Senior Convertible Secured Notes- 2011 [Member]
Nov. 30, 2011
Senior Convertible Secured Notes- 2011 [Member]
Mar. 31, 2011
Senior Convertible Secured Notes- 2011 [Member]
Jun. 30, 2011
Senior Convertible Secured Notes- 2011 [Member]
Dec. 13, 2011
Senior Convertible Secured Notes- 2011 [Member]
Convertible Debt (Textual)                                          
Maturity date of convertible notes       Aug. 26, 2010       Dec. 31, 2010         Dec. 31, 2010       Mar. 01, 2014        
Convertible notes payable           $ 126,362                              
Proceeds from Issuance of Private Placement               987,000         1,597,000       3,700,000        
Extended maturity date of convertible promissory notes       Apr. 26, 2011       Jun. 30, 2011         Jun. 30, 2011                
Debt-for-equity repayment plan       15% discount from the average market closing price for the five days ending on the 25th of each month over the eight month period beginning September 26, 2010 ending on April 26, 2011.                                  
Percentage of discount on common stock under debt-for-equity repayment plan       15.00%                                  
Trading price of Common stock for automatic conversion of notes                                 $ 6.25        
Maximum financing amount for automatic conversion of notes                                 5,000,000        
Right of holder under debt-for-equity repayment plan       Convert the outstanding balance priced at $2.25 per share if the market value of our common stock is greater than $2.50 per share for five consecutive days                                  
Per share price when holders of notes had right to convert outstanding balance       $ 2.25                                  
Market value of common stock when holder can exercise right       $ 2.50                                  
Stock issued to holders of notes         31,570                 3,557,171              
Debt maturity, principal payment         84,657,000                 1,750,143     3,700,000        
Debt maturity interest payment         1,054,000   15,000   15,000   28,000 28,000   28,442     130,000        
Conversion price               $ 0.50         $ 0.50       $ 2.50   $ 2.50   $ 2.50
Number of common stock issuable upon conversion                                 1,691,320        
Interest rate payable on notes               7.00%   7.00%     7.00% 7.00%     7.00%   7.00%    
Warrants Issued 100,000   200,000       986,983   986,983       1,760,712     49,100 373,730   373,730    
Period of warrants                 3 years               5 years   2 years 6 months    
Investment Warrants, Exercise Price $ 3.13               $ 1.00       $ 1.00           $ 3.13    
Period from which Warrants Exercisable                 Beginning on the six-month anniversary of the date of issuance until the warrant expiration date.     Beginning on the six-month anniversary of the date of issuance until the warrant expiration date.                  
Derivative liabilities             4,600,000   4,600,000   8,700,000 8,700,000         4,100,000   4,100,000    
Loss on embedded derivative                       4,300,000               1,400,000  
Fair value of embedded derivative liability             0   0   0 0     0         6,200,000 0
Converted accounts payable related to private placement of convertible notes                         163,000                
Additional proceeds from issuance of private placement                                 491,000        
Notes would automatically converted into common stock on or before due date when                                 (a) the Company's common stock is traded at a price per share of $6.25 or higher for five (5) consecutive trading days, or (b) the Company consummates a financing in the amount of at least $5 million   (a) the Company's common stock is traded at a price per share of $6.25 or higher for five (5) consecutive trading days, or (b) the Company consummates a financing in the amount of at least $5 million    
Additional annual interest rate for non payment of loan principal and accrued interest                                 10.00%   10.00%    
Investor receives number of warrants                                 Each investor receiving a number of March 2011 Warrants that was equal to twenty-five percent (25%) of the investor's note to the Company   Each investor receiving a number of March 2011 Warrants that was equal to twenty-five percent (25%) of the investor's note to the Company    
Proceeds from exercise of warrants 8,000 515,000                           491,000          
Debt discount                                 2,900,000   2,900,000    
Interest expense on debt                                 1,200,000        
Value of warrants on relative fair value basis using Black-Scholes option pricing model                                 813,000   813,000    
Accrued Interest   69,628                                      
Notes converted to common stock, amount                                   575,000      
Notes converted, original debt, amount                                   4,200,000      
Shares issued of unregistered common stock to note holders                                       27,851  
Notes converted to shares                             1,513,237     232,125      
Proceeds from public offering pursuant to registration statement on form S-3 (in excess)                                         $ 5,000,000
Bonus interest feature common stock issued                                         99,461
XML 55 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 163 252 1 false 52 0 false 5 false false R1.htm 001 - Document - Document And Entity Information Sheet http://www.neonode.com/role/Documentandentityinformation Document And Entity Information true false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.neonode.com/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.neonode.com/role/ConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.neonode.com/role/StatementOfIncome Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://www.neonode.com/role/StatementsOfOtherComprehensiveIncome Condensed Consolidated Statements of Comprehensive Loss (Unaudited) false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.neonode.com/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 007 - Disclosure - Interim Period Reporting Sheet http://www.neonode.com/role/InterimPeriodReporting Interim Period Reporting false false R8.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.neonode.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 009 - Disclosure - Convertible Debt Sheet http://www.neonode.com/role/ConvertibleDebt Convertible Debt false false R10.htm 010 - Disclosure - Stockholders' Equity Sheet http://www.neonode.com/role/StockholdersDeficit Stockholders' Equity false false R11.htm 011 - Disclosure - Fair Value Measurement of Assets and Liabilities Sheet http://www.neonode.com/role/FairValueMeasurementOfAssetsAndLiabilities Fair Value Measurement of Assets and Liabilities false false R12.htm 012 - Disclosure - Deferred Revenue Sheet http://www.neonode.com/role/DeferredRevenue Deferred Revenue false false R13.htm 013 - Disclosure - Stock-Based Compensation Sheet http://www.neonode.com/role/StockBasedCompensation Stock-Based Compensation false false R14.htm 014 - Disclosure - Commitments and Contingencies Sheet http://www.neonode.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R15.htm 015 - Disclosure - Segment Information Sheet http://www.neonode.com/role/SegmentInformation Segment Information false false R16.htm 016 - Disclosure - Net Loss Per Share Sheet http://www.neonode.com/role/NetLossPerShare Net Loss Per Share false false R17.htm 017 - Disclosure - Subsequent Events Sheet http://www.neonode.com/role/SubsequentEvents Subsequent Events false false R18.htm 018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R19.htm 019 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R20.htm 020 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.neonode.com/role/StockholdersEquityTables Stockholders' Equity (Tables) false false R21.htm 021 - Disclosure - Fair Value Measurement of Assets and Liabilities (Tables) Sheet http://www.neonode.com/role/FairValueMeasurementofAssetsandLiabilitiesTables Fair Value Measurement of Assets and Liabilities (Tables) false false R22.htm 022 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.neonode.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) false false R23.htm 023 - Disclosure - Segment Information (Tables) Sheet http://www.neonode.com/role/SegmentInformationTables Segment Information (Tables) false false R24.htm 024 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.neonode.com/role/NetLossPerShareTables Net Loss Per Share (Tables) false false R25.htm 025 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R26.htm 026 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) false false R27.htm 027 - Disclosure - Convertible Debt (Details) Sheet http://www.neonode.com/role/ConvertibleDebtDetails Convertible Debt (Details) false false R28.htm 028 - Disclosure - Stockholders' Equity (Details) Sheet http://www.neonode.com/role/StockholdersEquityDetails Stockholders' Equity (Details) false false R29.htm 029 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.neonode.com/role/StockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) false false R30.htm 030 - Disclosure - Fair Value Measurement of Assets and Liabilities (Details) Sheet http://www.neonode.com/role/FairValueMeasurementofAssetsandLiabilitiesDetails Fair Value Measurement of Assets and Liabilities (Details) false false R31.htm 031 - Disclosure - Deferred Revenue (Details) Sheet http://www.neonode.com/role/DeferredRevenueDetails Deferred Revenue (Details) false false R32.htm 032 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.neonode.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) false false R33.htm 033 - Disclosure - Stock-Based Compensation (Details 1) Sheet http://www.neonode.com/role/StockBasedCompensationDetails1 Stock-Based Compensation (Details 1) false false R34.htm 034 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.neonode.com/role/StockBasedCompensationDetails2 Stock-Based Compensation (Details 2) false false R35.htm 035 - Disclosure - Stock-Based Compensation (Details 3) Sheet http://www.neonode.com/role/StockBasedCompensationDetails3 Stock-Based Compensation (Details 3) false false R36.htm 036 - Disclosure - Stock-Based Compensation (Details 4) Sheet http://www.neonode.com/role/StockBasedCompensationDetails4 Stock-Based Compensation (Details 4) false false R37.htm 037 - Disclosure - Stock-Based Compensation (Details Textual) Sheet http://www.neonode.com/role/StockBasedCompensationDetailsTextual Stock-Based Compensation (Details Textual) false false R38.htm 038 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.neonode.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) false false R39.htm 039 - Disclosure - Segment Information (Details) Sheet http://www.neonode.com/role/SegmentInformationDetails Segment Information (Details) false false R40.htm 040 - Disclosure - Segment Information (Details Textual) Sheet http://www.neonode.com/role/SegmentInformationDetailsTextual Segment Information (Details Textual) false false R41.htm 041 - Disclosure - Net Loss Per Share (Details) Sheet http://www.neonode.com/role/NetLossPerShareDetails Net Loss Per Share (Details) false false R42.htm 042 - Disclosure - Net Loss Per Share (Details Textual) Sheet http://www.neonode.com/role/NetLossPerShareDetailsTextual Net Loss Per Share (Details Textual) false false All Reports Book All Reports Element neond_DebtMaturityInterestPayment had a mix of decimals attribute values: -3 0. Element neond_DebtMaturityPrincipalPayment had a mix of decimals attribute values: -3 0. Element us-gaap_DeferredRevenueCurrent had a mix of decimals attribute values: -5 -3. Element us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability had a mix of decimals attribute values: -5 0. Element us-gaap_ProceedsFromWarrantExercises had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice had a mix of decimals attribute values: 2 3. 'Monetary' elements on report '031 - Disclosure - Deferred Revenue (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '037 - Disclosure - Stock-Based Compensation (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Feb. 29, 2012' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Process Flow-Through: 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) neond-20120630.xml neond-20120630.xsd neond-20120630_cal.xml neond-20120630_def.xml neond-20120630_lab.xml neond-20120630_pre.xml true true XML 56 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Details) (USD $)
6 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended
Jun. 30, 2012
Vasakronan Fastigheter AB, Linnegatan 89 [Member]
Jun. 30, 2012
Vasakronan Fastigheter AB, Linnegatan 89 [Member]
Month [Member]
Jun. 30, 2012
Vasakronan Fastigheter AB, Linnegatan 89 [Member]
Annual [Member]
Jun. 30, 2012
Vasakronan Fastigheter AB, Linnegatan 89D [Member]
Jun. 30, 2012
Vasakronan Fastigheter AB, Linnegatan 89D [Member]
Month [Member]
Jun. 30, 2012
Vasakronan Fastigheter AB, Linnegatan 89D [Member]
Annual [Member]
Mar. 31, 2011
CA-Santa Clara Office Center Limited Partnership [Member]
Mar. 18, 2011
CA-Santa Clara Office Center Limited Partnership [Member]
Mar. 31, 2011
CA-Santa Clara Office Center Limited Partnership [Member]
Month [Member]
Mar. 31, 2012
2350 Mission Investors LLC [Member]
Mar. 22, 2012
2350 Mission Investors LLC [Member]
Mar. 31, 2012
2350 Mission Investors LLC [Member]
Month [Member]
Mar. 31, 2012
2350 Mission Investors LLC [Member]
Annual [Member]
Apr. 30, 2012
Picnic [Member]
Jun. 30, 2012
Picnic [Member]
Apr. 30, 2012
Picnic [Member]
Month [Member]
Apr. 30, 2012
Picnic [Member]
Annual [Member]
Commitments and Contingencies (Textual)                                  
Area of leased space (in square feet) 2,207     2,723       1,718     3,185       2,853    
Initial lease payment                       $ 7,000          
Lease payment including property tax (excluding VAT)   $ 6,000 $ 72,000   $ 8,000 $ 93,000     $ 2,647     $ 7,700 $ 84,000     $ 13,000 $ 161,000
Operating lease period 3 months     9 months     12 months     3 years              
Lease extended period if not terminated       3 years                          
Lease expiration date       Dec. 31, 2014     Apr. 30, 2012             Apr. 15, 2013      
XML 57 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2012
Equity [Abstract]  
Schedule of preferred stock not yet converted
 
 
 
   
Shares of Preferred Stock Not Exchanged as of
June 30, 2012
   
Conversion Ratio
   
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at
June 30, 2012
 
                   
Series A Preferred stock
   
83
     
480.63
     
39,892
 
Series B Preferred stock
   
95
     
132.07
     
12,547
 
Total  Remaining Not Exchanged
   
178
             
52,439